Tun yaushe waɗannan alamun suka ci gaba?
Ya kamata a bi da duk ciwon kirji ta wannan hanyar musamman a shekarunka.
Da zazzabi.
Hakanan ana buƙatar bincika hawan cholesterol ɗinku.
Kuma kana da zazzabi yanzu?
Kuma kana jin irin wannan ciwon a kirji yanzu?
Bugu da ƙari, kuna da wahalar numfashi?
Za ka iya gaya mini wasu alamun da kake da su?
Kuma yaya zafin jiki ya sa ka?
Ina kuma fama da tari.
Ina da ɗan sanyi da tari.
Ina fama da ciwon kirji mai tsanani a yau.
Wannan lokaci ne da ya dace da zafin ciwon daji da kake fama da shi?
Kuma ciwon kirji ya faru.
Ina ganin ina da zazzabi kadan.
Kuma ina so ka bayyana inda za a ji ciwon kirji.
Suna da zazzabi kuma.
Kuma da tarihin da kake da ciwon sukari
Kuma kamar yadda ka sani, ina jin kamar na yi rauni a kirji.
Kuma kamar yadda ka sani, mutane suna ta yi mini magana a kai a kai.
Kuma kuna jin zafi a kirji.
Kuma na ce wannan yana matsa maka a kirji.
Kowane mutum a cikin iyalin yana da wata matsala ta zuciya, ko cututtukan zuciya, ko bugun zuciya, ko kuma yawan cholesterol, ko kuma hawan jini.
Shin akwai wasu alamun da ka lura da su, ban da ciwon tsoka?
Shin akwai wasu mutane a cikin gidan da suke da irin wannan alamun?
Shin kana da wasu alamun?
Kana jin kunyar numfashi?
Har yanzu kana jin ciwon kirji?
Domin wannan shine lokacin kamuwa da mura.
Amma ba ma bukatar mu manta da ciwon kirji da cututtukan zuciya ke haifarwa.
Amma matsalar da ta fi muhimmanci yanzu ita ce ciwon kirji.
Amma ina da wahalar numfashi.
Amma na san mutane da yawa suna ta zuwa wurina.
Amma muna bukatar mu ɗauki dukan ciwon kirji da muhimmanci.
Amma yanzu tana numfashi sosai, ko ba haka ba?
Na manta da shi sosai saboda ciwon kirji.
Kana jin kamar wani yana matsa maka a kirji?
Har yanzu kana jin kamar kana shan numfashi?
Shin suna da irin wannan rashin lafiya?
Kana da wata cuta mai tsanani kamar hauhawar jini ko wani abu makamancin haka?
Kana da wasu cututtuka, ko kuma cututtuka na kullum, kamar ciwon sukari?
Kana jin zafi a cikin numfashi?
Kana da hauhawar jini?
Shin kana jin kunyar numfashi?
Ka san alamun da take ji?
Ka ga hoton?
Ya sha ruwa mai yawa a yau.
Duk da haka, na yi gwajin ciwon sukari.
Duk da haka, ta na da irin wannan bayyanar cututtuka.
Yaya zafin jikinka yake?
Yaya za ka damu?
Idan zazzabinka ya ci gaba da tashi
Idan zazzabi ya kai ka ɗari biyu ko sama.
Idan kana ganin alamun ka ko kuma matsalarka suna bukatar a duba ka sosai
Na yi zazzabi a jiya.
Na kuma yi zazzabi mai tsanani.
Na yi zazzabi a jiya.
Ina fama da ciwo mai tsanani a cikin kirji.
Ina da wahalar numfashi.
Zan aika maka da hoto.
Ina fama da ciwon kirji a yau.
Ina fama da ciwon kai da zazzabi a yau.
A ganina, shi ne mura.
A ganina, wannan shi ne wani abu mai tsanani.
Kana ganin kamar wani mai nauyi ne yake zaune a kirjinka?
Ya fara ne da ciwon kai da zazzabi a lokaci guda.
Ina ciwo a tsakiyar kirji.
Wannan matsa lamba ce kamar ciwon kirji.
Yana cikin kirji na.
Yana cikin ƙirjina.
Yana cikin tsakiyar ƙirjin.
Na ji zafi a kirji.
Na damu da ciwon kirji.
Ina so ka bayyana mini irin wannan ciwon kirji.
Kamar hawan jini ko ciwon sukari.
Kamar dai a tsakiyar ƙirjinsa.
Yanzu za ka iya cin tachipirina candy domin zazzabi
Yanzu Mary, kwana nawa ka sha irin wannan bayyanar?
Yanzu na ce kana da ciwon kirji.
Ina fama da ciwon kirji a wasu lokatai.
To, shin kana da wasu alamun bayyanar cututtuka banda wannan bacin rai?
Ko kuwa kana jin wani yana zaune a kirjinka?
Yana kama da zazzabi da ciwon kai da ake samu daga tari da ciwon tsoka.
A tsakiyar ƙirjina.
Ka nuna mini inda za ka ji zafi a wannan hoton.
Tun lokacin da kuka kamu da zazzabi.
Saboda haka, kana ganin wasu daga cikin waɗannan alamun suna da alaƙa da ciki?
Shin yaranku suna da irin wannan yanayin?
Ka gaya mini game da ciwon kirjinka.
Zafin yana daɗa ƙaruwa a dare.
Zazzabin da ya same ni a cikin kwanaki biyu da suka gabata.
Na fara samun zazzabi a daren jiya.
Wannan shi ne Dr. Porter a cikin dakin gaggawa na cibiyar tantancewa.
Za ka iya gaya mini game da ciwon kirjinka?
Na ji zafi a gaba na jiki a nan a kirji.
Na ji zafi sosai a kirji.
Da zarar na ji wannan ciwon a kirji,
Wane irin ciwon kirji kake da shi?
Yaushe ne wannan ciwon kirji ya fara?
Menene ciwon a kirjinka?
A ina kake jin zafi a kirji?
Kana da wani m ji a kirji.
Ka san ina da ciwon sukari da sauran abubuwa.
Ka ce kana da wannan ciwon kirji.
Yawan adadin cutar korona (COVID-19) da ke ƙaruwa cikin sauri a cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai da Birtaniya, daga 1 ga Janairu zuwa 15 ga Maris, 2020
Yawan kamuwa da cutar korona (COVID-19) yana nuna irin wannan yanayin a cikin EU/Yankin Tattalin Arzikin Turai da Birtaniya, wanda ya tabbatar da cewa ko da yake matakin ya bambanta daga ƙasa zuwa ƙasa, cutar COVID-19 tana daɗa muni a cikin dukkan ƙasashe.
Bisa ga abin da Italiya ta samu, ya kamata ƙasashe da asibitoci da cibiyoyin kula da marasa lafiya su kara kasancewa a shirye don ƙara yawan marasa lafiya da ke fama da cutar COVID-19 da za su bukaci kula da lafiya, musamman kula da marasa lafiya.
A ranar 31 ga Disamba, 2019, an bayar da rahoton wasu cututtukan cututtukan huhu na rashin sananne a birnin Wuhan, lardin Hubei, a kasar Sin.
A ranar 9 ga Janairu, 2020, Cibiyar Sukan Ciwo da Rigakafin Cutar Sin ta ruwaito cewa abin da ke haddasa shi ne sabon kwayar cutar Corona, wanda yanzu ake kira kwayar cutar Corona 2 da ke da alaƙa da cututtukan numfashi mai tsanani (SARS-CoV-2).
Tun daga lokacin, an kira cutar da ta haifar da SARS-CoV-2 cutar coronavirus (COVID-19).
Dalilin ya zuwa yanzu shi ne cewa kusan kashi 80 cikin dari na mutanen da ke da cutar COVID-19 suna da wata cuta mai sauƙi; wato, suna da kamuwa da cutar ta hanyar numfashi tare da alamun bayyanar cututtuka ko a'a, kuma yawancin suna warkewa.
A kusan kashi 14 cikin ɗari, kamuwa da COVID-19 ya zama mafi tsanani da ke bukatar yin asibiti, yayin da kashi 6 cikin ɗari na sauran marasa lafiya suna fama da mummunan cuta da ke bukatar kulawa mai tsanani.
Yawan mutuwar marasa lafiya da aka yi asibiti saboda COVID-19 ya kai kusan kashi 4 cikin 100.
A cikin wannan binciken, mun kimanta yanayin yawan adadin COVID-19 a kowace ƙasa a cikin Tarayyar Turai / Yankin Tattalin Arzikin Turai (EU/EEA) da Burtaniya (UK) kuma mun kwatanta su da na lardin Hubei, China.
Mun kuma kwatanta adadin COVID-19 na yanzu a cikin ƙasashen EU/Yankin Tattalin Arzikin Turai da Birtaniya da na Italiya tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
An samu kamuwa da cutar COVID-19 a kasashen EU/Yankin Tattalin Arzikin Turai da Birtaniya
Bayan abin da ya faru a China, COVID-19 ya bazu a wurare dabam-dabam kuma halin da ake ciki na COVID-19 a sauran ƙasashen duniya yana bin halin da ake ciki na wannan ƙasar.
A ranar 11 ga Maris, 2020, Darakta Janar na WHO ya ayyana COVID-19 a matsayin annoba.
A cikin Eurosurveillance na 5 ga Maris, 2020, Spiteri da sauransu sun ba da rahoton farkon tabbacin COVID-19 na Turai bisa ga bayanin WHO na halin da ake ciki.
A cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai, Faransa ta ba da rahoton farkon shari'o'i uku na tabbatarwa a ranar 24 ga Janairu, 2020 ga mutanen da ke dawowa daga Wuhan, lardin Hubei, China.
A ranar 15 ga Maris, 2020, an gano shari'o'in COVID-19 a duk ƙasashen EU/Yankin Tattalin Arzikin Turai 30 da Burtaniya (UK), inda tsakanin 31 ga Disamba, 2019 zuwa wannan kwanan wata, an ruwaito shari'o'i 39,768 da mutuwar 1,727 tare da shari'o'i 17,750 da mutuwar 1,441 a Italiya kadai.
Samun adadin da kuma adadin adadin COVID-19
A Cibiyar Tarayyar Turai don Yin Rigakafi da Rigakafin Cututtuka (ECDC), ana sabunta adadin shari'o'in COVID-19 da aka ruwaito a kowace ƙasa a duniya, ana samun su ne kawai daga tushen hukuma kamar Ma'aikatar Lafiya a ƙasashe, hukumomin kiwon lafiya na ƙasa da na yanki da Hukumar Lafiya ta Duniya, a kowace rana da karfe 8:00 na safe.
An yi amfani da wannan bayanan don kimantawa da kwatanta yanayin COVID-19 a cikin Tarayyar Turai / Yankin Tattalin Arzikin Turai da Burtaniya da na Italiya.
A matsayin ma'auni na yaduwar COVID-19, mun lissafa jimlar adadin COVID-19 na yau da kullum a cikin kwanaki 14, sannan mu yi la'akari da yanayin COVID-19, a duk ƙasashen EU/Yankin Tattalin Arzikin Turai da Birtaniya, a tsakanin 1 ga Janairu zuwa 15 ga Maris, 2020.
Mun kuma ba da jimlar adadin shari'o'in da aka ruwaito daga kowace ƙasa daga 15 ga Maris, 2020 da ƙarfe 8:00 na safe, tare da kwatanta shi da adadin da aka samu a Italiya tsakanin 31 ga Janairu da 15 ga Maris, 2020.
Hanyoyin COVID-19 a cikin EU / Yankin Tattalin Arzikin Turai da Burtaniya
An bi kwatancen adadin adadin COVID-19 da aka samu a cikin kwanaki 14 a cikin ƙasashen EU/Yankin Tattalin Arzikin Turai da kuma Burtaniya na lardin Hubei (China) (Figure 1).
Ga EU/Yankin Tattalin Arzikin Turai da Birtaniya gabaɗaya, jimlar COVID-19 ta fara ƙaruwa a kusan 21 ga Fabrairu, sannan ta ƙaru sosai a kusan 28 ga Fabrairu, 2020 (ƙarin bayani).
Wannan ya kasance ne saboda yawan adadin da aka samu daga Italiya, amma duk ƙasashen EU/Yankin Tattalin Arzikin Turai da Birtaniya sun nuna irin wannan karuwar adadin COVID-19 (abin da ya dace).
Hoton 2 ya nuna jimlar adadin COVID-19 a cikin ƙasashen EU/Yankin Tattalin Arzikin Turai da Birtaniya idan aka kwatanta da na Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Ya nuna cewa, a ranar 15 ga Maris da ƙarfe 8:00 na safe, wasu ƙasashe 15 na EU/Yankin Tattalin Arzikin Turai da kuma Birtaniya sun ba da rahoton jimlar adadin shari'o'in da suka yi kama da na Italiya makonni 3 ko ƙasa da haka.
Sakamakonmu ya nuna cewa adadin mutanen da aka samu na COVID-19 suna ƙaruwa sosai a cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai da kuma Birtaniya.
Hanyoyin da aka lura a cikin adadi na COVID-19 sun nuna cewa annobar tana ci gaba da ƙaruwa cikin sauri a duk ƙasashe.
Wannan duk da cewa ƙasashe suna cikin matakai daban-daban, duk da bambancin amsoshin lafiyar jama'a na ƙasa, kuma akwai yiwuwar bambancin yanayin a cikin ƙasashe daban-daban da ladabi don zaɓar marasa lafiya da za a gwada su don tabbatar da COVID-19, gami da gwajin bi.
A farkon watan Maris na shekarar 2020, likitoci a yankunan da cutar ta shafa a Italiya sun bayyana halin da ake ciki inda kusan kashi 10 cikin dari na marasa lafiya da ke fama da COVID-19 ke bukatar kulawa ta musamman. Majiyoyin watsa labarai sun ruwaito cewa asibitoci da cibiyoyin kula da marasa lafiya a waɗannan yankuna sun riga sun kai ga iyakar ƙarfin su.
A halin yanzu akwai bayanai game da shigar asibitoci da/ko cibiyoyin kula da mutane da ke fama da cutar COVID-19 a EU/Yankin Tattalin Arzikin Turai na kashi 6% da 1% na shari'o'in a jere (ba a nuna bayanai ba).
Duk da haka, dole ne a tattara su a hanyar da za ta iya kammala bayanan kulawar da ake yi a yanzu, wanda ya dogara da yawan adadin da aka samu da kuma yawan mutuwar.
Wani bincike da aka yi a shekara ta 2010-11 ya nuna bambancin da ke tsakanin yawan iyalan da ke kula da marasa lafiya a Turai, wato, iyalan da ke kula da marasa lafiya a Jamus sun kai 29.2 a ƙasar Jamus, kuma iyalan da ke kula da marasa lafiya a ƙasar Portugal sun kai 4.2 a kowace mutum 100,000.
Wannan yana nufin cewa ƙasashe na iya samun albarkatu fiye da Italiya (12.5 gadaje na kulawa mai tsanani da matsakaici ga kowane mutum 100,000 a 201011).
Ana samun samfurin yanayin da ke da alaƙa da gamsar da iyawar kula da lafiya, tare da kimantawa ga kowace ƙasa daga cikin ƙasashen EU / Yankin Tattalin Arzikin Turai da Burtaniya don yaduwar COVID-19 da aka shigar da asibiti da ke da haɗari &gt; 90% don wuce ƙarfin gidajen kulawa na musamman, a cikin sabuntawa ta shida don kimanta haɗarin COVID-19 na gaggawa na Cibiyar Turai don Yaki da Cututtuka da Rigakafi.
Tun da yake asibitoci da cibiyoyin kula da marasa lafiya da ke cikin EU/Yankin Tattalin Arzikin Turai da Birtaniya sun kasance a wasu yankuna, yawanci asibitoci da cibiyoyin kula da marasa lafiya suna aiki a wasu yankuna, ana so a ba da bayani game da asibitoci da kuma iyali na cibiyoyin kula da marasa lafiya a matsayin Sunan Cibiyoyin Kula da Yanki na 2 (NUTS-2).
Kwarewar Italiya da kuma abubuwan da ke faruwa a yanzu a wasu ƙasashe sun nuna cewa annobar COVID-19 tana daɗa muni a cikin Tarayyar Turai/Yankin Tattalin Arzikin Turai da kuma Burtaniya.
Saboda haka, ya kamata kasashe da asibitoci da cibiyoyin kula da marasa lafiya su shirya kansu don yanayin canjin zamantakewar al'umma na SARS-CoV-2 da kuma karuwar yawan marasa lafiya na COVID-19 da ke bukatar kula da lafiya, musamman ma cibiyar kula da marasa lafiya, kamar yadda yake faruwa a yankunan da aka shafa a Italiya.
A cewar cibiyar Turai ta yaki da cututtuka da kuma hana su, an nuna cewa tsarin gaggawa na gaba ɗaya na gaggawa yana da mahimmanci don jinkirta yaduwar SARS-CoV-2 yayin da aka sauya tsarin hanawa zuwa ragewa, saboda ƙaruwa mai sauri a cikin adadin lokuta na iya ba masu yanke shawara da asibitoci lokaci mai yawa don fahimta, karɓa da daidaita amsar su idan ba a aiwatar da su ba.
Ana kuma lissafa matakan kiwon lafiya na jama'a don rage tasirin cutar.
Akwai iyakacin damar da kasashe za su iya ƙara yin tsaro don rage yaduwar SARS-CoV-2 da kuma rage matsa lamba a kan kiwon lafiya.
Idan hakan bai yi nasara ba, tsarin kiwon lafiya a cikin ƙasashen EU/kasashen tattalin arzikin Turai na iya fuskantar karuwar yawan marasa lafiya da ke bukatar kulawa ta musamman a cikin kwanaki ko makonni masu zuwa.
Cutar cutar korona ta 2019 (COVID-19), wadda cutar korona ta 2 (SARS-CoV-2) ke haifarwa, ta kashe mutane fiye da 3,000 kuma ta jikkata mutane fiye da 80,000 a China da sauran wurare a duniya, wanda ya haifar da bala'in bil'adama.
SARS-CoV-2 kamar SARS-CoV, wanda ya sa dubban mutane suka kamu da cutar SARS a shekara ta 2003, zai iya zama sanadiyyar cutar daga bats kuma ya haifar da irin wannan bayyanar ta hanyar irin wannan tsari.
Koyaya, COVID-19 yana da ƙananan haɗari da mutuwar fiye da SARS amma yana da tasiri da tasiri tsakanin tsofaffi fiye da matasa da tsakanin maza fiye da mata.
A sakamakon yawan wallafe-wallafen da ake yi game da cututtukan da ke tasowa, wannan talifin yana neman ya ba da cikakken bayani game da batun bincike da ke ci gaba da sauri.
Za mu tattauna abubuwan da suka shafi annobar cutar, abubuwan da ke haddasa ta, ilimin ƙwayoyin cuta, ganewar asali, magani, tsinkaya da kuma rigakafinta.
Ko da yake akwai tambayoyi da yawa da za a amsa, muna fata wannan bita zai taimaka mana mu fahimci cutar da ke barazana kuma mu kawar da ita.
Bikin bazara na 25 ga Janairu 2020 ya zama abin tunawa da ba a taɓa mantawa da shi ba ga dukan 'yan kasar Sin da aka bukaci su zauna a gidajensu a lokacin hutu da kuma makonni da yawa bayan haka saboda sabon annobar cutar.
Wannan kwayar cutar tana kama da cutar Corona (Cov) wadda ta haifar da barkewar cutar ta SARS a shekara ta 2003. Saboda haka, Hukumar Lafiya ta Duniya (WHO) ta kira ta SARS-CoV-2 a ranar 11 ga Fabrairu, 2020, kuma an kira cutar da ke da alaƙa da cutar Cov-19 (Covid-19).
Cutar ta fara ne a birnin Wuhan na kasar Sin, kuma nan da nan ta bazu ko'ina cikin kasar, da kuma kusan wasu kasashe 50 a duniya.
Ya zuwa 2 ga Maris, 2020, cutar ta haifar da kamuwa da COVID-19 guda 80,000, tare da fitar da marasa lafiya sama da 40,000 daga asibitoci da mutuwar marasa lafiya sama da 3,000.
Hukumar lafiya ta duniya ta yi gargadin cewa COVID-19 ita ce magabcin jama'a na 1 kuma yana iya zama mafi ƙarfi fiye da ta'addanci.
A cikin ƙasa da watanni biyu, an buga bincike sama da 200 game da COVID-19 wanda ya haɗa da ilimin ƙwayoyin cuta, annoba, abubuwan da ke haifar da shi, ganewar asali, da magani, tun lokacin da aka fitar da rahoto na farko a ranar 7 ga Janairu 2020 wanda ya gano jerin ƙwayoyin cuta na marasa lafiya da yawa.
Wannan bita na nufin taƙaita ci gaban bincike a sabon batun da ke ci gaba da sauri.
A duk inda za mu iya, za mu gwada COVID-19 da SARS da kuma wani cuta da Coff ya yi, wato cutar ta numfashi ta Gabas ta Tsakiya (MERS), wanda ya barke a shekara ta 2012.
Za mu kuma tattauna abin da muka koya game da rigakafin cututtuka da kuma yin hasashen cutar da kuma wasu tambayoyi masu muhimmanci da za a yi.
Ana ganin cewa kwayar cutar korona ce ke haddasa cututtuka marasa mutuwa a cikin mutane, kuma a zahiri tana haddasa kusan kashi 15 cikin 100 na cututtukan sanyi na kowa.
Duk da haka, a wannan karni, mun fuskanci cututtukan coronavirus sau biyu masu haddasa cututtukan mutum, SARS-CoV da MS-CoV, waɗanda suka haifar da barkewar cutar a China a 2003 da Saudi Arabia a 2012, bi da bi, kuma cutar ta bazu cikin wasu ƙasashe da sauri tare da yawan yaduwar cutar da mutuwar.
Saboda haka, COVID-19 na yanzu shine annoba ta uku ta coronavirus a tarihin ɗan adam.
Kamar yadda aka nuna a hoton 1.1, an fara bayar da rahoton rukunin mutanen da suka kamu da cutar ta huhu da ba a san su ba ta Wuhan a ranar 31 ga Disamba, 2019 ga Hukumar Lafiya ta kasar Sin.
Bayan kwana bakwai, an saki wani kwayar cutar korona.
A ranar 15 ga Janairu, 2020, Wuhan ta ba da rahoton mutuwar farko.
A lokacin, annobar ta bazu cikin sauri zuwa garuruwa, larduna da ƙasashe masu makwabtaka.
A ranar 20 ga Janairu, an samu rahoton kamuwa da cuta tsakanin masu ba da kiwon lafiya, wanda ke nuna cewa cutar tana iya yaduwa daga mutum zuwa mutum.
A ranar 23 ga Janairu, an rufe birnin Wuhan tare da dakatar da duk hanyoyin sufuri na jama'a.
A ranar 24 ga Janairu, binciken farko na asibiti game da cutar ya ba da rahoton cewa daga cikin marasa lafiya 41 da aka tabbatar da kamuwa da cutar, marasa lafiya 21 ne kawai ke da alaƙa kai tsaye da kasuwar abincin teku ta Wuhan, wanda aka ɗauka cewa wurin da cutar ta fara ne daga asalin dabba da ba a san shi ba.
A ranar 30 ga Janairu, Hukumar Lafiya ta Duniya ta ayyana barkewar cutar a matsayin dokar ta baci ta duniya.
A lokacin da aka fitar da wannan rahoton, cutar ta riga ta bazu ko'ina cikin Sin da kuma wasu ƙasashe 50 a duniya (Figure 2)
Yayin da yanayin ke ci gaba da sauri, har yanzu ana bukatar a ƙayyade iyakar annobar da kuma haɗarinta.
A ranar 11 ga Fabrairu, 2020, wani bincike mai cibiyoyin da aka gudanar akan marasa lafiya 8,866 ciki har da marasa lafiya 4,021 da aka tabbatar da COVID-19 ya ba da ƙarin bayani game da annobar kamar haka (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
SARS-CoV-2 yana shafar mutane na dukan shekaru, amma yana shafar mutanen da ke tsakanin shekaru 30 zuwa 65.
Kusan rabin wadanda suka kamu da cutar (47.7%) sun wuce shekaru 50, kuma kaɗan ne kawai suka kamu da cutar a ƙarƙashin shekaru 20, kuma 14 ne kawai suka kamu da cutar a ƙarƙashin shekaru 10.
SARS-CoV-2 ya fi yawan maza (0.31/100,000) yawan mata (0.27/100,000).
COVID-19 ya bazu tsakanin kungiyoyi a Hobby da kewaye da ita.
COVID-19 yana ɗaukar kimanin kwanaki 5 (2-9) daga lokacin kamuwa da cutar zuwa ganewar asali.
Matsakaicin lokacin da aka yi renon yara ya kai kwanaki 4.8.
Matsakaicin lokacin da aka samu cutar daga farkon zuwa mutuwa ya kai kwanaki 9.5.
Ƙarfin ƙwayoyin halitta na asali ya kai 3.77 (ƙimar amincewa ta 95%: 3.51-4.05) kuma ƙimar ƙwayoyin halitta na asali ya kai 2.23-4.82.
Yawan masu kamuwa da cutar ya ƙaru sosai kafin 23 ga Janairu, 2020, daidai da yawan tafiye-tafiye kafin bikin bazara a China.
Yawan mutuwar da aka tabbatar da shi a cikin marasa lafiya ya kasance 1.44% (sashin amincewa ya kasance 95%: 1.10-1.86%) kuma adadin mutuwar da aka gyara ga marasa lafiya ya kai 3.06% (sashin amincewa ya kasance 95%: 2.02-4.59%).
Babban haɗarin COVID-19 guda uku sune jima'i (maza), shekaru (≥60) da kuma kamuwa da cutar huhu.
Kwayar cutar Corona wani nau'i ne na manyan kwayoyin cuta da ke dauke da kwayoyin halittar RNA guda daya mai kyau.
Ana iya rarraba su zuwa nau'i hudu, wato alpha, beta, gamma, da delta, kuma an san cewa kwayar cutar ta alpha da beta tana kamuwa da mutane.
Fork ɗin da aka rufe (S) na furotin mai sukari yana haɗuwa da masu karɓar kwayoyinsa, wato, anjin mai canza angitocin 2 (ACE2) da kuma bitideal peptidase 4 (DBP4) na SARS-CoV-2 da MERS-CoV-2 a jere, sannan membrane fusion ya faru.
An sake kira da kwayoyin cuta na RNA na kwayar cutar zuwa cytoplasm; bayan an kwafa kwayoyin cuta na RNA, DNA na RNA yana haɗuwa da furotin na sukari da furotin na kwayar cuta na nucleic acid da ke dauke da virions, kuma suna haɗuwa da membrane na plasma don sakin cutar.
An ba da rahoton farkon tsarin halittu na SARS-CoV-2 a ranar 10 ga Janairu, 2020.
An gano cewa SARS-CoV-2 sabon nau'in beta-CoV ne mai ƙarancin ƙimar kwayoyin halitta wanda ya wuce kashi 99.98% a cikin samfurori 10 da aka bincika a cikin jerin da aka tattara daga wurin da cutar ta fara, kasuwar abincin teku ta Wuhan.
SARS-CoV-2 ya fi kama da SARS-CoV fiye da MERS-CoV.
An gano cewa SARS-CoV-2 yana cikin ƙananan sassan iska a cikin mutum.
An gano cewa anjin na mutum mai canzawa zuwa angiotensin 2 shine mai karɓar SARS-CoV-2 da kuma SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana da alaƙa da enzymes na mutum masu canza angiotensin 2 da rauni fiye da SARS-CoV, wanda ya dace da gaskiyar cewa SARS-CoV-2 yana haifar da ƙananan kamuwa da cuta a cikin marasa lafiya fiye da SARS-CoV.
SARS-CoV-2 kuma yana iya samar da wani karamin furotin da aka yi amfani da shi a cikin tsarin orf3b da kuma wani furotin da aka yi amfani da shi a cikin tsarin orf8.
Orf3b a SARS-CoV-2 na iya taka rawa a cikin cutar ta kwayar cuta kuma yana iyakance bayanin IFNβ; duk da haka, orf8 ba shi da wani sikelin ko tsarin da aka sani.
A ranar 18 ga Fabrairu, 2020, Chu da sauransu sun ba da rahoton cikakken tsawon tsarin enzymes na mutum na angiotensin 2 a ƙarƙashin microscope na lantarki mai sanyi mai zurfi 2.9 Å a cikin wani fili tare da mai ɗaukar amino acid B0AT1.
Sun gano cewa mahaɗin, wanda yake da gine-gine na bude da rufe, ya haɗu don ya zama dimer kuma ACE2-B0AT1 na iya ɗaure furotin S, wanda ke ba da shaida don gano cutar corona da kamuwa da cuta.
Maganin sodium na amino acid mai amfani zai iya zama magani don bincika maganin SARS-CoV-2.
Mai watsa shiri na asali da mai watsa shiri na matsakaici
An san cewa SARS-CoV da MERS-CoV sun fito ne daga bats kuma an kawo su ga mutane ta hanyar cats da kuma camels, bi da bi.
Ta hanyar kwatanta juyin halitta na SARS-CoV-2 da na wasu ƙwayoyin cuta na Corona, an dauki bat a matsayin mai karɓar bakuncin SARS-CoV-2, inda sabon cutar ya dace da kashi 96% na kwayar cutar Corona wanda yake kama da SARS daga bat kuma ana kiransa bat-SL-CoVZX45 da bat-SL-CoVZX21.
Duk da haka, ba a san wanda ya taimaka wa cutar ta ƙetare shinge tsakanin jinsuna don ta cutar da mutum ba, kuma har yanzu ba a bayyana hanyar da za a iya kamuwa da ita ba.
Ji da wasu sun ba da shawarar cewa macizai za su iya ɗaukar cutar daga bats zuwa mutane, kuma hakan ya ƙunshi sake fasalin irin wannan a cikin furotin S.
A cewar wani bincike, masu bincike a Guangzhou, China sun nuna cewa ciwon tsutsa - dabbobin da ke cin naman tsutsa da aka fi amfani da su a maganin gargajiya na kasar Sin - suna iya zama masu ba da izini ga SARS-CoV-2 bisa ga kama da kwayoyin halitta na 99% na kwayar cutar Corona da aka gano a cikin ciwon tsutsa da kuma SARS-CoV-2.
Duk da haka, bambancin kashi 1 cikin 100 da ke tsakanin kwayoyin halittar halittu biyu ya kasance bambanci mai girma. Saboda haka, muna jiran sakamako mai kyau tare da hujja mai kyau (Figure 33).
Har yanzu ba a san ainihin halayen SARS-CoV-2 ba.
SARS-CoV da MERS-CoV za su iya rayuwa a cikin dakin gwaje-gwaje na tsawon sa'o'i 48 a cikin yanayin bushe har zuwa kwanaki 5 a zafin jiki a ƙarƙashin digiri na 20 da kuma zafi tsakanin kashi 40 zuwa 50%.
SARS-CoV-2 na iya samun irin wannan fasalin.
An ce SARS-CoV-2 yana da ƙwarewa ga hasken ultraviolet da zafin jiki a 56 ° C na tsawon minti 30; ether, ethanol a cikin kashi 75%, masu tsabtace chlorine, astic peroxyacetic acid, chlorophorus, da sauran mai narkewa mai mai ƙonewa, amma ba chlorophosphate ba, suna iya hana cutar yadda ya kamata.
Dukan 'yan Adam ba su da rigakafi ga SARS-CoV-2, saboda haka suna da mafi haɗari su kamu da sabon kwayar cutar.
A halin yanzu, babu wani bincike mai zurfi game da maganin rigakafi na SARS-CoV-2.
Saboda haka, za mu iya komawa ga wasu bincike na baya game da wasu ƙwayoyin cuta, musamman SARS-CoV, da MERS-CoV (Figure 4)
A kullum, bayan da wani kwayar cutar ta mamaye mai masaukin, tsarin garkuwar jiki na jiki yana gane shi ta hanyar karɓar karɓar tsarin ganewa (PRS) ciki har da karɓa na irin C na irin tacin, karɓa na irin taolin (TLR), karɓa na irin na nucleotide-binding splice range (NLR), da karɓa na irin RIG-I (RLR).
Ta hanyoyi dabam dabam, ƙwayar cuta tana sa abubuwa masu ƙonewa su taso, ƙwayoyin cuta su yi girma, kuma su yi amfani da interferon na nau'i na I (IFN) wanda ke hana yaduwar ƙwayar cuta kuma yana sa ƙwayoyin cuta masu girma su yi sauri.
Duk da haka, furotin N da ke cikin SARS-CoV zai iya taimaka wa ƙwayar cutar ta tsere daga amsawar rigakafi.
Nan da nan, tsarin rigakafi na mutum ya shiga yaƙi da cutar.
Kwayoyin lymphocytes, ciki har da CD4+ da CD8+, suna taka muhimmiyar rawa wajen kāre kansu.
CD4+ yana motsa kwayoyin halitta su samar da kwayoyin cutar da suka dace da cutar, kuma CD8+ tana kashe kwayoyin da suka kamu da cutar kai tsaye.
Kwayoyin T da ke taimakawa wajen kamuwa da cuta suna samar da cytokines masu aiki don taimakawa ƙwayoyin rigakafi.
Koyaya, kwayar cutar korona na iya rage aikin sel na T.I. ta hanyar sa a kashe sel na T.I.
Ƙarfin rigakafi, ciki har da furotin da aka ƙera kamar C3a da C5a da kuma rigakafi, suna da muhimmanci wajen yaki da kamuwa da cutar.
Alal misali, an hana rigakafin rigakafi daga wani mai haƙuri mai lafiya.
A wani ɓangare kuma, yawan ƙwayar rigakafi na jiki yana haifar da ƙwayoyin da ke da yawa a gida wanda zai iya haifar da mummunan lalacewar huhu da sauran gabobin jiki, kuma mafi munin, rashin aiki da gabobin jiki da mutuwa.
Cutar SARS-CoV-2 da aka fara samu a cikin rukuni na tsofaffi da ke fama da cututtuka da yawa da kuma mata masu juna biyu, sun fi yawa.
Mutane da yawa da suka kamu da ƙwayoyin cuta ko kuma waɗanda aka lalata tsarin rigakafi suna da damar kamuwa da cutar fiye da wasu.
Matsakaicin lokacin da SARS-CoV-2 ke kula da shi shi ne kwana 1 zuwa 14, ko kuma tsakanin kwana 3 zuwa 7, bisa ga nazarin mutane 425 na farko a Wuhan.
Ko da yake, wani bincike da aka yi a kan mutane 1,099 ya nuna cewa a matsakaita, lokacin da ake yi wa jariri yana da kwanaki 3 kuma yana tsakanin kwanaki 0 zuwa 24.
Wani sabon bincike, kamar yadda aka nuna a sama, ya nuna cewa lokacin da ake kula da jarirai ya kai kwanaki 4.8 (3.0-7.2) bisa ga yawan mutane 8,866.
Yana da muhimmanci sosai hukumomin kiwon lafiya su daidaita lokacin da za a yi amfani da shi don yin amfani da shi a lokacin da ake kula da shi sosai, don haka mutane da suka kamu da cutar amma ba su da alamun cutar su hana su watsawa wasu.
A matsayin al'ada, ana bukatar mutanen da suka kamu da cutar ko kuma waɗanda suka kamu da ita su yi amfani da dutsen kiwon lafiya na kwanaki 14.
Shin, ya kamata a ƙara tsawon lokacin da za a yi amfani da dutsen zuwa kwana 24?
Sau da yawa zazzabi shi ne babban dalili na COVID-19, kuma ba za a iya samun wata alama ko kuma a haɗa da wasu alamomi ba, kamar tari, rashin numfashi, ciwon tsoka, zazzabi, ciwon kai, kumburi a cikin wuya, kumburi a hanci, ciwon kirji, jin kunyar jiki, da kuma zubar da ciki.
Wasu marasa lafiya suna fama da matsalar numfashi da kuma rashin iskar oxygen a cikin mako guda bayan an fara cutar.
A cikin matsanancin yanayi, yanayin marasa lafiya ya ci gaba da sauri zuwa ciwon cututtukan numfashi mai tsanani, tashin hankali, maye gurbin acid, da kuma rashin lafiyar jini.
Dole ne a bincika marasa lafiya da zazzabi ko alamun numfashi da zazzabi mai tsanani, har ma ba tare da yin hotunan da ke nuna rashin lafiyar huhu ba, don gano cutar a wuri.
Wani bincike na alƙaluma a ƙarshen Disamba 2019 ya nuna cewa yawan alamun cututtuka ya kai kashi 98 cikin dari na rashin lafiya, kashi 76 cikin dari na tari, kashi 55 cikin dari na rashin numfashi, kashi 3 cikin dari na tari; kuma kashi 8 cikin dari na marasa lafiya suna bukatar taimakon numfashi.
An samu irin wannan sakamakon a cikin bincike guda biyu na kwanan nan na wani iyali da kuma wani rukuni da aka kamu da cutar daga wani da ba shi da wata alama.
A kwatanci, wani bincike na alƙaluma a shekara ta 2012 ya nuna cewa marasa lafiya na MERS-CoV sun sha wahala daga zazzabi (98%), tari mai bushe (47%), da rashin numfashi (55%) a matsayin manyan alamomi.
Koyaya, kashi 80 cikin ɗari na su suna bukatar ƙarin taimakon numfashi fiye da waɗanda ke fama da COVID-19 kuma sun yi daidai da mutuwar cutar MERS da ta fi COVID-19 girma.
An kuma lura da tari (kashi 26%) da kumburi (kashi 21%) a cikin marasa lafiya na MERS.
A cikin marasa lafiya na SARS, zazzabi (kashi 99 zuwa 100%) da tari mai bushe (29% zuwa 75%), rashin numfashi (40 zuwa 42%), kumburi (20 zuwa 25%) da kumburi na wuya (13-25%) sune manyan alamun, kuma ana buƙatar samar da taimakon numfashi ga kusan kashi 14% zuwa 20% na marasa lafiya.
A ranar 14 ga Fabrairu, adadin mutuwar COVID-19 ya kai kashi 2 cikin 100 yayin da a duniya an tabbatar da mutum 66,576 da suka kamu da cutar.
A kwatanci, mutuwar SARS ta kai kashi 10 cikin 100 na mutane 8,096 da aka tabbatar da cutar a watan Nuwamba na 2002.
A cewar Mers, kashi 37 cikin ɗari na mutuwar mutane 2,494 ne, bisa ga binciken da aka yi a watan Yuni na 2012.
Wani binciken da aka yi a baya ya nuna cewa, yawan karuwar SARS-CoV-2 ya kai 6.47 a cikin wani yanki na dogara na 95% (CA) daga 5.71 zuwa 7.23, yayin da karuwar SARS-CoV-2 ya kai 2 zuwa 4 kawai.
Idan aka kwatanta SARS-CoV-2 da MS-CoV da SARS-CoV a cikin bayyanar cututtuka, yawan mutuwa, da kuma yawan haihuwa na asali, ana nuna su a cikin jadawalin da ke cikin jadawalin 1.1.
Lambobin da ke sama sun nuna cewa SARS-CoV-2 na da ƙarfin yaduwa fiye da na Mars-CoV da SARS-CoV, amma ba shi da haɗari fiye da na biyun.
Saboda haka, cutar SARS-CoV-2 ta fi wuya a sarrafa ta fiye da cutar MERS-CoV da SARS-CoV.
A cikin ƙungiyoyi, sau da yawa cutar tana faruwa a cikin iyali ɗaya ko a cikin ƙungiya ɗaya ko a cikin jirgi ɗaya, kamar jirgin ruwa.
Sau da yawa marasa lafiya suna da tarihin tafiya zuwa Wuhan ko wasu yankunan da cutar ta shafa ko zama a ciki, ko kuma haɗuwa da mutane ko marasa lafiya a cikin makonni biyu na ƙarshe kafin cutar ta fara.
Koyaya, an ce mutane na iya ɗaukar cutar ba tare da bayyanar cututtuka ba har tsawon makonni biyu, kuma marasa lafiya da suka warke daga asibitoci na iya ɗaukar cutar sake, yana aika da gargadi don ƙara lokacin yin maganin.
A cikin marasa lafiya, yawan fararen hawan jini (musamman na lymphocytes) yana da ƙasa ko kuma yana da ƙasa a farkon lokaci.
Alal misali, an gano rashin ƙwayar lymphoma da yawan ƙwayoyin jini na fari da ke da lita 4×109/litra ciki har da ƙwayoyin jini na 1×109/litra, da kuma yawan masu ɗaukar aspartame da kuma zubar da jini a cikin marasa lafiya 1,099 da ke da cutar COVID-19.
A wasu marasa lafiya, ƙwayoyin cuta na hanta, ƙwayoyin tsoka da na miyagu sun ƙaru a cikin jini, kuma sun ƙara yawan furotin mai aiki da jini C da kuma yawan ƙwayar ƙwayoyin jini na yawancin marasa lafiya.
A cikin marasa lafiya da ke da ciwo mai tsanani, matakin D-demer ya ƙaru, wanda ya haifar da karyewar fibrin a cikin jini, kuma yawan ƙwayoyin lymph ya ragu a hankali.
Yawancin marasa lafiya da ke fama da cutar COVID-19 suna da cututtukan da ke nuna hasken rana da kuma rufin gilashi a cikin huhu.
A wasu lokatai, marasa lafiya suna fama da ciwon huhu da ba a saba gani ba, da kuma ciwon huhu mai tsanani, da kuma cututtukan numfashi mai tsanani (ARDS).
Idan ciwon huhu ya yi tsanani, zazzabin kumburi, tarin ruwa, da kuma ciwon kumburi suna shafar musayar iskar gas.
Rashin aiki na ƙwayoyin huhu na 1 da 2 yana rage yawan ƙwayar cuta da kuma ƙara yawan damuwa, kuma hakan yana rage ƙarfin huhu na faɗaɗa kuma yana ƙara haɗarin fashewar huhu.
Saboda haka, ana kwatanta mafi munin sakamakon hotunan kirji da kuma matsanancin cutar.
A ranar 18 ga Fabrairu, 2020, bincike na farko na COVID-19 ya nuna raguwar ƙwayoyin huhu, kafawar ƙwayar cuta, ƙwayar lymphoma, da ƙwayoyin cuta masu yawa a cikin huhu na wani mai haƙuri da ya mutu saboda cutar, wanda ya dace da ilimin cututtukan cututtukan ƙwayar cuta da cututtukan ƙwayar cuta mai tsanani da kuma abin da ke faruwa ga marasa lafiya da SARS da MS.
An yi amfani da gano RNA na SARS-CoV-2 ta hanyar aikin polymerase mai juyawa na kwayar cutar (BT-PCR) a matsayin babban ma'auni don gano COVID-19.
Duk da haka, saboda yawan sakamako masu banƙyama na karya, wanda zai iya hanzarta annobar, an fara amfani da alamun asibiti don ganewar asali (wanda ba ya dogara da RT-PCR a cikin mutum) a China a ranar 13 ga Fabrairu, 2020.
Wani abu mai kama da haka ya faru a binciken SARS.
Saboda haka, haɗuwa da tarihin cutar, bayyanar cututtuka, gwaje-gwaje na dakin gwaje-gwaje, da kuma binciken hotunan radiation, yana da muhimmanci kuma yana da muhimmanci don yin bincike mai kyau.
A ranar 14 ga Fabrairu, 2020, kungiyar Feng Chang ta bayyana wata yarjejeniya don amfani da fasahar Sherlock da ke kan Crisper don gano SARS-CoV-2, wanda ke gano ɓangarorin RNA da aka kirkira don SARS-CoV-2 a cikin 20 × 10-18 moli / litre zuwa 200 × 10-18 moli / litre (10-100 kofe a kowace microlitre na shigarwa) ta amfani da zurfin aiki a ƙasa da awa ɗaya ba tare da buƙatar kayan aiki na musamman ba.
Muna fatan cewa sabuwar fasahar za ta iya inganta ƙwarewar da kuma dacewa idan aka tabbatar da ita a cikin gwajin asibiti.
Saboda rashin kwarewa game da sabon kwayar cutar korona, likitoci na iya samar da kulawa mai goyan baya ga marasa lafiya na COVID-19, yayin da suke gwada magunguna daban-daban da aka yi amfani da su ko kuma aka ba da shawarar a baya don magance sauran kwayar cutar korona, kamar SARS-CoV, MERS-CoV, da sauran cututtukan kwayar cutar (Table (Table 2).2).
Waɗannan hanyoyin sun haɗa da maganin riga-kafi na yanzu da na gaba, da maganin rigakafi, da magungunan rigakafi, da kuma maganin rigakafi, da kuma maganin plasma na marasa lafiya da suka warke, da maganin kasar Sin, da kuma taimakon tunani.
Har ma da na marasa lafiya da suka warke an ba da izinin yin amfani da su don magani.
Kamfanonin magani suna fafatawa don samar da rigakafi da alluran rigakafi.
SARS-CoV-2 yana kai hari ne ga huhu a farko, kuma yana iya kai hari, a wani mataki, ga wasu gabobin da ke samar da enzyme mai canza angiotensin 2, kamar su tsarin narkewa, hanji, da koda.
Duk da haka, rashin numfashi da rashin aiki yana da haɗari ga marasa lafiya kuma shi ne babban dalilin mutuwa.
Saboda haka, ana bukatar taimakon numfashi don rage alamun cutar da kuma ceton rayuka, kuma ya ƙunshi maganin oxygen na gaba ɗaya, yawan iskar oxygen, tsarin numfashi mara kyau, da kuma na'urorin numfashi na wucin gadi waɗanda suka dace bisa ga yanayin rashin lafiya.
Masu fama da cututtukan numfashi masu tsanani dole ne a tallafa musu da maganin ECMoh, wata fasaha ce ta zuciya da na huhu da ake amfani da ita wajen magance rashin ƙarfi na zuciya ko kuma rashin numfashi mai haɗari.
Bugu da ƙari, kula da daidaiton ruwa, hana cututtuka na biyu da kuma shan wahala, da kuma magance su, da kuma kare ayyukan gabobin jiki, suna da muhimmanci ga marasa lafiya na SARS-CoV-2.
An san cewa hadari na cytokine yana haifar da matsanancin tsarin rigakafi a cikin marasa lafiya na SARS da MS.
Cytocin storm wani nau'i ne na tsarin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Waɗannan kwayoyin suna sa ƙwayoyin rigakafi su saki ƙwayoyin free radicals da yawa kuma suna da babban dalilin cutar ta narkewa da kuma rashin aiki da gabobin jiki.
Kungiyar rigakafi tana da muhimmanci wajen magance hadari na cytokine, musamman ga marasa lafiya masu tsanani.
An yi amfani da kwayoyin halayen da ke aiki, wato, toshilizumab, da kuma maganin antiseptic guda ɗaya na interleukin 6, don magance hadari na cytokine.
Sauran maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin cutar ta hanyar maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin cutar ta cutar ta hanyar maganin maganin maganin maganin maganin maganin maganin cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta cutar ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta ta
Ana amfani da maganin rigakafi da kuma maganin rigakafi a maganin SARS don rage yawan cutar.
Duk da haka, magungunan da aka yi amfani da su a mafi girma ba su taimaka wa marasa lafiya da ke fama da cutar SARS da COVID-19 ba.
Maimakon haka, yana iya haifar da bayyanar cututtuka masu tsanani, musamman ƙarancin ƙashin ƙashin ƙanƙara, wanda ke shafar tsinkayar cutar sosai.
Duk da haka, an ba da shawarar yin amfani da gajeren lokaci na kwayoyin halitta masu aiki a ƙananan zuwa matsakaici a hankali don marasa lafiya masu tsanani na COVID-19.
A lokacin da aka rubuta wannan rahoton, ba a tabbatar da ingancin maganin cutar ba.
Duk da haka, an gano cewa ba da Remdesvir, wani nau'in ƙwayar cuta, yana da tasiri ga wani mai cutar COVID-19 a Amirka.
Remdesivir sabon maganin rigakafi ne wanda Gilead ta haɓaka don magance cututtukan da cutar Ebola da Marburg ke haifarwa.
Daga baya, Reddicevir ya kuma nuna yiwuwar hana wasu ƙwayoyin cuta da ke da ƙwayar cuta mai suna riboside, ciki har da cutar MERS da SARS.
Bisa ga waɗannan ƙwayoyin, Gilead ta ba da samfurin zuwa China don yin wasu gwaje-gwaje a kan mutane da ke da cutar SARS-CoV-2, kuma ana sa ido sosai ga sakamakon.
Bugu da ƙari, ana ba da maganin baricetinub, interferon-alpha, lupinavir/retonavir, da ribavirin a matsayin magani ga marasa lafiya da ke fama da cututtukan numfashi.
Ana iya samun ciwon kumburi, rashin jin daɗi, kumburi, lalacewar hanta, da sauran sakamako masu illa bayan an yi maganin cakuda na Lupinavir/Retonavir.
Dole ne a lura da yadda waɗannan magunguna suke shafar sauran magunguna da ake amfani da su a cikin marasa lafiya.
Plasma daga marasa lafiya da suka warke da kuma samar da antibodies
An daɗe ana tattara jini daga marasa lafiya da suka warke daga cutar da aka shirya don magance wasu marasa lafiya da ke fama da cutar ko kuma don hana mutane lafiya kamuwa da cutar.
A gaskiya ma, marasa lafiya da suka warke suna da ƙwayoyin rigakafi masu yawa a cikin jininsu.
Magungunan rigakafi sune globolin mai hana rigakafi (AG), wanda kwayoyin lymphocytes ke samarwa don yaƙi da abubuwan da ke cutarwa da sauran kwayoyin halitta, kuma suna gane kwayoyin da ke cikin abubuwan da ke cutarwa kuma su kawar da su kai tsaye.
Bisa ga wannan, an tattara plasma daga jinin wasu marasa lafiya da suka warke daga COVID-19 kuma an allura su cikin marasa lafiya 10 da ke da cututtuka masu tsanani.
A cikin sa'o'i 24, bayyanar cututtukan sun inganta, kuma sun rage kamuwa da cuta da kuma ƙaruwa a cikin jini.
Amma, ana bukatar a tabbatar da hakan kafin a yi amfani da wannan hanyar sosai.
Bugu da ƙari, saboda tasirin magani, dole ne a yi la'akari da wasu lahani da ke tattare da plasma.
Alal misali, ƙwayoyin cuta suna iya sa mutum ya yi aiki mai tsanani kuma ya saki cytokines, wanda zai iya zama guba ga rayuwa.
Ana yawan samun ƙananan ƙwayar rigakafi a cikin jini, kuma ana bukatar jini sosai don kula da marasa lafiya da ke da mawuyacin hali.
Yana da wuya a ci gaba da samar da wasu kwayoyin rigakafi da sauri don magance wata annoba ta duniya.
Saboda haka, ware kwayoyin halitta daga marasa lafiya da suka warke da kuma gano sigogin kwayoyin da ke ba da lambar rigakafi mai aiki, ko kuma bincika don gano rigakafin da ke aiki a kan furotin na asali na kwayar cutar, ya fi tabbatacce da kuma aiki.
Ta wannan hanyar, za mu iya ƙara yawan kwayoyin cutar.
An yi amfani da maganin gargajiya na kasar Sin wajen magance cututtuka da dama a kasar Sin tun shekaru dubbai da suka shige.
Duk da haka, tasirinsa ya dogara ne sosai da wasu abubuwa da yawa a cikin wani nau'i daban-daban na maganin da aka gano bisa ga ka'idodin gargajiya na kasar Sin.
Yawancin abubuwa masu amfani ba a san su ba ko kuma ba a san su ba domin yana da wuya a cire su kuma a bincika su daga waɗannan abubuwa ko kuma yadda suka dace.
A yanzu, saboda rashin ingantaccen magani na COVID-19, maganin gargajiya na kasar Sin ya zama muhimmin madadin magani ga marasa lafiya da ke da alamun rashin lafiya ko kuma waɗanda suka warke daga matsanancin yanayi.
Alal misali, an gano cewa maganin Shu Feng Ji-Do da Lian Hua King-Win suna da tasiri wajen magance COVID-19.
An lura da mafi yawan murmurewa a cikin maganin COVID-19 a larduna da dama a China da suka yi amfani da maganin gargajiya na kasar Sin a cikin kashi 87 cikin dari na marasa lafiya, ciki har da Gansu (63.7 cikin dari), Ningxia (50 cikin dari), da Hunan (50 cikin dari), yayin da lardin Hubei, wanda ya yi amfani da maganin gargajiya na kasar Sin ne kawai tare da kusan kashi 30 cikin dari na marasa lafiyar COVID-19, ya kasance da mafi ƙarancin murmurewa (13%).
Amma, wannan kwatanci ne mai kyau, domin akwai wasu dalilai da yawa da za su iya shafar mutum kamar yawan marasa lafiya da kuma yadda yanayin su yake.
A ranar 18 ga Fabrairu, 2020, Polly Chang da abokan aikinsa sun wallafa wani bincike don kwatanta maganin maganin Magungunan Yammacin Turai (WM) da maganin gargajiya na kasar Sin.
Sun gano cewa lokacin da ake bukata don warkewa daga zafin jiki, bayyanar cututtuka, da kuma asibiti ya fi guntu a cikin maganin gargajiya na kasar Sin fiye da na yamma.
Mafi ban sha'awa, yawan rashin bayyanar cututtuka (mai sauƙi zuwa mai tsanani) ya kasance ƙasa da yawa a cikin rukunin maganin gargajiya na gargajiya na kasar Sin a yammacin Turai (7.4% vs. 46.2%) idan aka kwatanta da rukunin maganin gargajiya na yammacin Turai (8.8% vs. 39%) kuma yawan mutuwar ya kasance ƙasa da yawa a cikin rukunin maganin gargajiya na yammacin Turai (8.8% vs. 39%).
Duk da haka, ingancin maganin gargajiya na kasar Sin da kuma amincinsa suna jiran ƙarin gwaji da aka yi nazari sosai a kan manyan sikelin da kuma cibiyoyi.
Zai yi kyau a bayyana yadda ake yin maganin da kuma yadda ake amfani da maganin gargajiya na kasar Sin ko kuma yadda ake hada su.
Masu kamuwa da cutar COVID-19 ko kuma waɗanda aka tabbatar da kamuwa da ita suna jin tsoron kamuwa da cutar mai tsanani da kuma mutuwa, kuma waɗanda suke da rigakafin suna jin haushi, kaɗaici, da fushi.
Bugu da ƙari, alamun kamuwa da cuta kamar zazzabi, rashin iskar oxygen, tari, da kuma mummunan sakamako na magani, kamar rashin barci da ake samu daga kwayoyin halitta, na iya haifar da ƙarin damuwa da rikicewar tunani.
A farkon fasalin SARS, an ruwaito wasu cututtukan tunani da suka hada da baƙin ciki na dindindin, damuwa, tashin hankali, tashin hankali, bayyanar cututtuka na hankali, rashin hankali, har ma da son kashe kansa.
A matsayin wani ɓangare na yadda lafiyar jama'a ke amsawa ga annobar COVID-19, bin diddigin haɗuwa da kuma maganin rigakafi na iya sa mutane su ƙara damuwa da jin laifi game da tasirin kamuwa da cuta, maganin rigakafi, da kuma sa su zama sananne ga iyalansu da abokansu.
Saboda haka, dole ne a kula da lafiyar hankali ga marasa lafiya da ke fama da COVID-19, da waɗanda ake zargi da kamuwa da cutar, da waɗanda suka yi hulɗa da su, da kuma mutanen da suke bukatar ta.
Taimakon tunani ya kamata ya haɗa da kafa ƙungiyoyin lafiya na hankali na fannoni da yawa, wuraren sadarwa masu kyau tare da sabuntawa na yau da kullun da kuma cikakke game da cutar SARS-CoV-2 da kuma shirye-shiryen magance ta, da kuma amfani da na'urori na lantarki da aikace-aikace don kauce wa haɗuwa kai tsaye.
Ana buƙatar alluran rigakafi masu tasiri don yanke jerin watsa kwayar daga adana dabbobi da mutane masu kamuwa da cutar zuwa masu karɓar baƙi masu kamuwa da cutar kuma galibi suna ba da ƙarin maganin rigakafin cutar a cikin yaƙi da cututtukan da ƙwayoyin cuta ke haifarwa.
An yi ƙoƙari wajen samar da alluran rigakafi na S-protein don samar da rigakafi na tsawon lokaci da kuma na tsayayya da SARS-CoV-2 da ke haifar da rigakafi.
An gwada alluran rigakafi na rayuwa a cikin samfurin dabba don maganin SARS.
Duk da haka, ba a tabbatar da yadda waɗannan alluran rigakafin suke da tasiri a jikin tsofaffi da kuma ƙalubalen da suka kai ga mutuwa ba, kuma ba a tabbatar da yadda za su hana su kamuwa da cutar da ke fitowa daga dabba kafin a fara binciken asibiti ba.
Wataƙila saboda SARS ya ɓace shekaru 17 da suka shige kuma ba a samu wani sabon kamuwa da cutar ba tun daga lokacin.
Akasin haka, ana ci gaba da samun mutane da yawa da ke fama da cutar a Gabas ta Tsakiya kuma ana samunsu a wasu yankuna domin ci gaba da samun dabbobi a wuraren da ake fama da cutar.
An kirkiro dabarun rigakafi na cutar MERS ta amfani da kwayar cutar da ba ta aiki ba, da kuma ƙwayoyin cuta na RNA da ba su da iskar oxygen, da masu ɗaukar kwayar cutar, da ƙwayoyin nanoparticles, da ƙwayoyin ƙwayoyin cuta na ƙwayoyin cuta, da kuma ƙananan ƙwayoyin ƙwayoyin ƙwayoyin cuta, wasu kuma an kimanta su a cikin samfurin dabba.
Samar da allurar rigakafi mai lafiya da inganci na SARS-CoV-2 ga mutanen da ba su da rigakafi aiki ne na gaggawa da kuma gaggawa don hana annobar da ke ci gaba a yanzu.
Duk da haka, cin nasara yana da wuyar gaske saboda tsawon lokaci (mafi yawan watanni 18) da ake bukata don ci gaba da allurar rigakafi da kuma canjin canjin coronavirus.
COVID-19 a matsayin sabon cuta, ya fara nuna cikakken yanayin asibiti a cikin dubban marasa lafiya.
A yawancin lokuta, marasa lafiya suna iya warkewa a hankali ba tare da magani ba.
Koyaya, COVID-19, kamar SARS da MERS, yana da alaƙa da yawan kamuwa da cutar da kuma yawan mutuwar marasa lafiya masu tsanani.
Saboda haka, gina tsarin hangen nesa na rashin lafiya yana da muhimmanci ga hukumomin kiwon lafiya su kafa fifiko a kan ayyukan su, musamman a yankunan da ba su da isashen albarkatu.
Bisa ga binciken asibiti da aka ruwaito zuwa yanzu, waɗannan dalilai na iya shafar tsammanin cutar a cikin ko kuma a haɗa da masu cutar COVID-19 (Jadawalin 33):
Shekara: Shekara ita ce muhimmiyar hanyar da za a iya sa ran cutar SARS, kuma hakan ya shafi COVID-19.
Mutane da yawa a tsakanin shekara 30 zuwa 65 sun kamu da COVID-19, kuma kashi 47.7% na waɗannan marasa lafiya sun wuce shekara 50 a cikin binciken da aka yi a kan mutane 8,866 kamar yadda aka nuna a sama.
Marasa lafiya da suke bukatar kulawa ta musamman sun fi fuskantar cututtukan da ke tattare da su da kuma rikitarwa kuma sun tsufa fiye da waɗanda ba su da (a matsakaicin shekaru 66 zuwa 51) wanda ya nuna cewa shekaru suna nuna sakamakon COVID-19 na marasa lafiya.
Jima'i: SARS-CoV-2 ya fi yawan maza fiye da mata (0.31/100,000 da 0.27/100,000), kamar yadda aka nuna a sama.
Cututtuka da kuma rikitarwa: Marasa lafiya da ke bukatar kulawa mai tsanani na COVID-19 sun fi fuskantar cututtukan zuciya da kuma rashin daidaiton bugun zuciya.
Har ila yau, haɗarin zuciya ne ke haifar da mutuwar mutane da ke fama da cutar SARS.
An ce SARS-CoV-2 na iya haɗa ƙwayoyin salula masu kyau da enzyme mai canzawa na angiotensin 2, wanda zai iya haifar da rashin aiki na hanta a cikin marasa lafiya na COVID-19.
Ya kamata a lura cewa tsufa da rashin lafiya suna da alaƙa sosai kuma suna iya haɗuwa.
Sakamakon gwajin bai dace ba: matakin furotin mai aiki da jini na C (CRP) yana nuna yadda za a sami ciwo ko kuma lalacewar ƙwayoyin halitta, kuma an nuna cewa yana nuna alamun rashin lafiya, amsa magani, da kuma murmurewa.
An kuma yi bincike a kan alaƙar da ke tsakanin matakin furotin mai aiki da C da kuma yadda COVID-19 ke da tsanani da kuma yadda ake sa ran zai mutu.
Bugu da ƙari, haɓakar haɓakar haɓakar hydrogen lactate (LDH), aspartate amin transporter (AST), alanin amin transporter (ALT), da creatine kinase (CK) na iya taimakawa wajen hango sakamakon.
Waɗannan enzymes suna bayyana sosai a gabobin jiki da yawa, musamman a zuciya da hanta, kuma ana sakin su yayin lalacewar nama.
Saboda haka, alamun gargajiya ne na rashin aiki na zuciya ko hanta.
Babban alamun asibiti: Ana buƙatar yin amfani da hotunan kirji na kirji da kuma ci gaban alamun asibiti tare da sauran matsaloli don hango sakamakon COVID-19 da kuma abubuwan da ke tattare da shi.
Amfani da maganin hana kamuwa da cuta: Kamar yadda aka nuna a sama, maganin hana kamuwa da cuta na maganin hana kamuwa da cuta ne da ake amfani da su a matsayin magani na taimako don rage yawan cutar.
Tun da aka yi amfani da kwayoyin halitta masu ƙarfi a cikin marasa lafiya na SARS, mutane da yawa da suka tsira sun sha wahala daga rashin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙoshin ƙ.
Saboda haka, dole ne a yi amfani da miyagun ƙwayoyi a ƙananan allurai na ɗan gajeren lokaci a cikin marasa lafiya na COVID-19, idan ya cancanta.
Matsalolin tunani: Kamar yadda aka nuna a sama, a lokacin annobar COVID-19, marasa lafiya da yawa sun sha wahala daga matsanancin damuwa; sau da yawa suna jimre da tsawan lokaci na rashin lafiya, rashin tabbas mai tsanani, kuma sun ga mutuwar dangi da abokan aikin da suke da cutar.
Yana da muhimmanci a ba da shawara ta tunani da kuma goyon baya na dogon lokaci don taimaka wa marasa lafiya su warke daga damuwa kuma su koma rayuwa ta al'ada.
Bisa ga binciken alƙaluma na yanzu, COVID-19 na da halaye na annoba daban-daban daga SARS.
Baya ga haihuwar cikin ƙananan numfashi, SARS-CoV-2 na iya haihuwar cikin sama da kuma haifar da bayyanar cututtuka masu sauƙi ko ba a haifar da alamun cututtuka ba a farkon kamuwa da cuta, kamar sauran ƙwayoyin cuta na Corona waɗanda ke haifar da sanyi.
Saboda haka, marasa lafiya da suka kamu da cutar a farkon lokacin da suke cikin gida ko kuma a lokacin da suke cikin gida suna iya samar da ƙwayoyin cuta da yawa a yayin ayyukan yau da kullum, wanda ke sa ya yi wuya a sarrafa annobar.
Duk da haka, an yi la'akari da cewa SARS-CoV ya faru ne a lokacin da marasa lafiya suke cikin mummunan yanayin rashin lafiya, yayin da yawancin watsawar cutar ba su faru a farkon lokaci ba.
Saboda haka, annobar COVID-19 ta yanzu ta fi tsanani da kuma ta fi ƙarfin sarrafawa fiye da annobar SARS.
A halin yanzu ana yin kokari sosai a kasar Sin, ciki har da rufe Wuhan da biranen da ke kewaye da ita da kuma samar da tsaftacewa ga kusan dukan mazauna kasar da fatan hana cutar SARS-CoV-2.
Ko da yake waɗannan matakan sun yi wa tattalin arziki da sauran sassan ƙasar illa sosai, yawan sababbin marasa lafiya yana raguwa, wanda ke nuna cewa annobar ta ragu.
Mafi kyawun hasashen shine cewa annobar za ta ƙare a watan Maris kuma za a ci gaba da raguwa na watanni 3 zuwa 4.
Amma, wasu masana ba su da irin wannan halin kirki.
Paul Hunter da wasu sun kiyasta cewa COVID-19, wanda ya fi SARS yawa, ba zai ƙare a shekara ta 2020.
Ira Longini da wasu sun kirkiro wani tsari na hango ko wane sakamako za a samu daga annobar kuma sun ce SARS-CoV-2 zai iya shafar kashi biyu bisa uku na yawan duniya.
Wani rukuni na Kanada ya ruwaito cewa an gano SARS-CoV-2 a cikin binciken tsokoki da kuma wuyansa na marasa lafiya da suka warke kuma suka bar asibiti makonni 2 da suka gabata, wanda ke nuna cewa sabon kwayar cutar da aka gano na iya zama wani lokaci-lokaci na kama da mura.
Duk da haka, a kasar Sin, an samu alamun da za su nuna cewa akwai yiwuwar samun sakamako bisa yawan sababbin cututtuka, wanda ya nuna cewa dabarun da ake amfani da su a yanzu suna iya taimaka wa mutane.
An yi hasashen cewa cutar Ebola za ta iya haddasa mutum miliyan guda da kuma mutuwa miliyan rabin.
Amma, a ƙarshe, an kawar da cutar ta hanyar yin amfani da tsauraran matakan rigakafi da kuma warewa.
Kamar SARS-CoV-2, SARS-CoV-2 zai iya zama marar ƙarfi wajen kamuwa da cuta kuma a ƙarshe ya ɓace ko kuma ya zama ƙarancin cutar da ke rayuwa tare da mutane.
Ga kwatancin cutar COVID-19 ta SARS da ta MERS (sanya 55).
SARS-CoV-2 yana wucewa ta hanyar tari ko ƙishirwa, kuma ana iya watsa shi ta hanyar tuntuɓar kai tsaye da abubuwa da ke dauke da cutar.
An kuma gano cutar a cikin fitsari, wanda ya haifar da sabon yiwuwar wucewa daga fitsari zuwa baki.
Wani bincike na kwanan nan da aka yi a kan mutane 138 ya nuna cewa kashi 41 cikin 100 na waɗannan cututtuka na iya faruwa ne daga kamuwa da cuta a asibitoci, ciki har da marasa lafiya 17 da suka kamu da wasu cututtuka da kuma masu kula da lafiya 40.
Saboda haka, ana bukatar a yi taka tsantsan sosai don kare mutane, musamman ma masu ba da kiwon lafiya, masu ilimin zamantakewa, danginsu, abokan aikinsu, har ma da masu wucewa da suka yi hulɗa da marasa lafiya ko kuma waɗanda suka kamu.
Sanya masks na fuska shine farkon tsaro wanda za'a iya amfani dashi don rage haɗarin kamuwa da cuta; amfani da masks na tiyata da N95 masu numfashi (series number 1860s) suna taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Masks na rufe fuska na tiyata suna hana ruwa daga wanda zai iya kamuwa da cutar daga shiga iska ko mannewa da farfajiyar kayan, inda za a iya ba da su ga wasu.
Duk da haka, N95 masks (series number 1860s) ne kawai za su iya kare daga shan ƙananan viruses na 10 zuwa 80 nm, tare da kawai 5% na viruses na iya yin cikakken hawan; SARS-CoV-2 yayi kama da SARS-CoV a girma kuma kowannensu yana da girman kusan 85 nm.
Tun da ƙwayoyin cuta za su iya shiga cikin fuskokin tiyata biyar da aka saka a wuri guda, masu ba da kula da lafiya da ke haɗuwa da su dole ne su sa fuskokin N95 (serial number 1860s) kai tsaye ga marasa lafiya amma ba na tiyata ba.
Baya ga abin rufe fuska, masu kula da lafiya dole ne su sa rigar rigakafi mai dacewa don rage hulɗa da cutar.
Hakanan ƙwayoyin cuta na iya cutar da mutum ta hanyar idanu.
A ranar 22 ga Janairu, 2020, wani likita ya kamu da cutar SARS-CoV-2 duk da cewa ya saka abin rufe fuska na N95; ƙila cutar ta shiga jikinsa ta hanyar idanunsa masu kumburi.
Saboda haka, masu kula da lafiya su sa rigar fuska ko tabarau masu tsabta yayin aiki tare da marasa lafiya.
Ga jama'a a yankunan da aka yi wa cuta ko kuma waɗanda za su iya yi wa cuta, ana ba da shawarar sosai kowa ya yi wanka da sabulu fiye da yadda ya saba, ya yi ƙoƙari ya zauna a gida don ya kasance da tsabta kuma ya rage sadarwa da mutanen da za su iya yin cuta.
An yi nisa da mutum da ya kai ƙafa 3 don ya guje wa mai haƙuri.
Waɗannan matakan hanyoyi ne masu tasiri na rage haɗarin kamuwa da cuta da kuma hana yaduwar cutar.
Ko da yake SARS-CoV-2 ya zo a matsayin sabon kwayar cutar ga ɗan adam, kamanceceniya da SARS-CoV kamar yadda aka ruwaito a ranar 7 ga Janairu, 2020 zai haifar da babban shiri a China bisa zurfin ƙwaƙwalwar ajiyar cutar SARS a 2003.
Duk da haka, darektan Cibiyar Kula da Cututtuka a Wuhan bai tabbatar da 'yan ƙasa ba har zuwa 19 ga Janairu 2020 cewa sabon kwayar yana da ƙarancin kamuwa da cuta da iyakantaccen yaduwar mutum zuwa mutum kuma babu matsala a hana cutar da kuma riƙe ta.
Wannan sakon ya rage yawan mutanen da ke shirye, musamman ma a lokacin da dukan ƙasar ke shirin bikin bazara, kuma lokaci ya yi da zai dace a rage cutar a Wuhan.
Hukumomin yaki da cututtuka a kasar Sin na iya amfana daga wannan darasi mai tsanani kuma su yi wasu ci gaba a nan gaba.
Alal misali, waɗannan hukumomi dole ne su (1) yi hankali sosai wajen samar da bayanan jama'a saboda kowane kalma tana da mahimmanci ga 'yan ƙasa kuma tana iya canza halayensu da shawarwarin su; (2) su kasance masu ƙwarewa da kuma yin hulɗa da bayanan da ba a saba gani ba daga asibitoci maimakon jiran rahotanni na hukuma daga likitoci ko jami'ai; (3) su kasance masu ƙuntatawa don hana yiwuwar annobar a farkon matakanta maimakon ƙoƙarin tabbatar da lafiyar jama'a; (4) su samar da ƙarin horo da kuma ingantaccen horo don haɓaka wayar da kan jama'a game da cututtukan annoba da kuma gwada tsarin amsawar jama'a da kuma inganta shi lokaci-lokaci.
Cutar COVID-19 ta SARS-CoV-2 ta fara a ƙarshen Disamba 2019.
A cikin kasa da watanni biyu, ya bazu ko'ina cikin kasar Sin da kuma wasu kasashe 50 a duniya a lokacin da aka rubuta wannan labarin.
Tun da yake cutar ta yi kama da SARS-CoV kuma alamun sun yi kama da COVID-19 da SARS, cutar ta COVID-19 ta haifar da jin daɗin sake kamuwa da SARS.
Duk da haka, akwai wasu bambance-bambance masu ban mamaki tsakanin COVID-19 da SARS, waɗanda suke da muhimmanci don hana annoba da kuma kula da marasa lafiya.
COVID-19 yana shafar tsofaffi fiye da matasa, maza kuma fiye da mata, kuma yawan kamuwa da cuta da mutuwa ya fi na tsofaffi fiye da na matasa.
SARS na da yawan mutuwar da ta fi na COVID-19 (10.91% da 1.44%).
Masu cutar COVID-19 suna daukar kwayar cutar ko da ba su da wata alama, yayin da marasa lafiya na SARS yawanci suke yin hakan lokacin da suke da ciwo mai tsanani, wanda ke sa ya fi wuya a hana COVID-19 yaduwa daga SARS.
Wannan ya bayyana dalilin da ya sa SARS-CoV-2 ya yi sauri kuma ya fi sarkar SARS-CoV-2 yawa.
Gwajin SARS-CoV-2 na iya zama mummunan a wasu marasa lafiya da ke fama da COVID-19.
A wani bangaren kuma, marasa lafiya da suka warke za su iya sake kamuwa da cutar.
Waɗannan sakamakon sun ƙara haɗarin yaduwar cutar.
Duk da ci gaban da ake samu a bincike kan COVID-19, har yanzu akwai wasu muhimman al'amura da za a magance su, kamar haka:
Daga ina ne Sar-Cov-2 ya fito?
Duk da gano cewa SARS-CoV-2 da kuma cutar Corona suna da kama da SARS a bats, har yanzu ba za mu iya kammala cewa SARS-CoV-2 ya fito ne daga bats ba.
Wane dabba ne ya kasance matsakaici da zai iya canja wurin cutar daga mai masaukinsa, kamar bats, zuwa mutane?
Idan ba mu san amsoshin lambobi 1 da 2 ba, ba za mu iya dakatar da sauyawa yadda ya kamata ba, kuma annobar za ta iya sake faruwa a kowane lokaci.
Ko da yake ƙirar kwayoyin halitta da kuma nazarin halittu sun nuna cewa SARS-CoV-2 yana da alaƙa da enzyme mai canzawa zuwa angiotensin 2, ta yaya ainihin cutar ta shiga cikin ƙwayoyin iska kuma ta haifar da canje-canje masu gamsarwa daga baya?
Shin cutar tana da alaƙa da ƙwayoyin da ke cikin wasu gabobin jiki?
Idan ba mu da amsoshi masu kyau ga waɗannan tambayoyin, ba za mu iya yin bincike da sauri ba kuma ba za mu iya ba da magani mai kyau ba.
Har yaushe za a ci gaba da wannan annoba?
Ta yaya kwayar cutar ta samo asali yayin da take wucewa tsakanin mutane?
Shin zai zama annoba a duniya, ko kuwa zai ɓace kamar SARS, ko kuma zai sake komawa a lokaci-lokaci kamar mura?
Yana da muhimmanci, amma yana iya ɗaukar lokaci kafin a sami amsoshin tambayoyin da ke sama da kuma wasu tambayoyi da yawa.
Duk da haka, ko da mene ne zai kashe mu, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mu dawo da rayuwarmu zuwa yadda ta kasance.
Dabbobi na kwayar cutar korona
Wannan yaduwar da kuma daidaitawa sun haifar da ci gaba tsakanin kwayar cutar Corona da kuma masu karbar bakuncin ta, ciki har da mutane, tun shekaru dubbai da suka gabata.
Kafin shekara ta 2003, an san cewa nau'i biyu na kwayar cutar korona na ɗan lokaci suna haifar da wani abu mai sauƙi, kamar sanyi.
Cutar SARS da kuma cutar MERS sun sa mutane su fuskanci juna don su ga yadda cutar korona za ta iya zama mummunar cuta ga mutane.
Fitowar SARS-CoV-2 a tsakiyar kasar Sin a karshen shekarar 2019 ta sake haskaka cutar korona, kuma mun yi mamakin yadda ta yi sauri amma tana da damar haifar da cutar idan aka kwatanta da ɗan'uwanta SARS-CoV.
Kwayar cutar korona ta mutum cuta ce ta dabbobi, don haka fahimtar asalin dabbobi na kwayar cutar zai taimaka mana sosai.
Yawancin cututtukan corona na mutum sun fito ne daga bats inda ba su haifar da cututtuka ba.
An kuma san su da masu karɓar bakunan wasu ƙwayoyin cuta na korona.
Zaɓin dabbobi masu gida yana da tasiri kai tsaye a kan hana cututtukan mutane.
Binciken dangantakar da ke tsakanin kwayar cutar korona da mai masaukin dabbobin ya ba da muhimmiyar fahimta game da yadda cutar ta korona ta samo asali a cikin mutane.
A cikin wannan bita, za mu ba da cikakken bayani game da cututtukan corona guda bakwai na mutane, muna mai da hankali kan tarihin gano su da kuma asalin dabbobi da kuma yaduwar su tsakanin jinsuna.
Abu mafi muhimmanci shi ne, muna kwatanta da kuma nuna bambancin kwayar cutar korona ta hanyar juyin halitta da kuma sake fasalin kwayoyin halitta.
A cikin wannan mahallin, an tattauna cutar da annobar COVID-19 ta haifar.
Bugu da ƙari, ana kuma ba da haske game da bukatun canja wurin mai masaukin baki da kuma tasirin abubuwan da ke tattare da ci gaban kwayar cutar a cikin tsanani na cutar.
Kwayar cutar Corona ta kasance cikin iyalin korona, wanda ya ƙunshi tarin ƙwayoyin cuta da ke da ƙwayar cuta mai ƙarancin ƙwayar cuta mai ƙarancin ƙwayar cuta mai ƙarancin ƙwayar cuta mai ƙarancin ƙwayar cuta.
Waɗannan ƙwayoyin cuta suna da babban ƙwayar halitta a cikin ƙwayoyin cuta na riboside, suna da tushe daga 26 zuwa 32 kg, kuma ana kiran su "ƙwayoyin cuta na kambi" saboda tsarin su ya yi kama da kambi a ƙarƙashin makami mai kwakwalwa.
A fannin halayyar kwayoyin, kwayar cutar korona tana da kwayoyin halitta da ba a rarraba su ba, kuma suna da tsari iri ɗaya.
Kusan kashi biyu bisa uku na kwayoyin halitta suna da manyan ƙananan ƙididdigar buɗewa (ORF1a da ORF1b), waɗanda ke canzawa zuwa nau'ikan pp1a da pp1ab masu yawa.
Ana kuma sarrafa furotin da yawa don samar da furotin 16 da ba a tsara su ba, wanda ake kira nsp1 zuwa 16.
Ragowar kwayoyin halitta suna da samfurori masu karantawa na gina jiki, kamar su Spike S, E, M, da N.
Hakanan, jinsunan daban-daban na kwayar cutar Corona suna ba da ƙarin furotin daga wasu jinsuna.
Bisa ga bambancin da ke cikin jerin sunadarai, an rarraba kwayar cutar korona zuwa nau'i hudu (kwayar cutar Corona alpha, kwayar cutar Corona beta, kwayar cutar Corona gamma, kwayar cutar Corona Delta), daga cikinsu akwai nau'in kwayar cutar Corona beta wanda ya ƙunshi yawancin kwayar cutar Corona ta mutum kuma an raba shi zuwa nau'i hudu (A, B, J, Wd).
Shaidar juyin halitta ta nuna cewa bats da rodents suna aiki a matsayin asalin asalin yawancin ƙwayoyin cuta na Corona alpha da Corona beta, yayin da tsuntsaye sune babban adana ƙwayoyin cuta na Corona gamma da Corona Delta.
A cikin dubban shekaru, ƙwayoyin cuta na Corona sun ci gaba da ƙetare ƙuntatawa na nau'in kuma sun nuna wasu a matsayin masu haifar da cututtuka masu tsanani a cikin mutane.
An san cewa akwai kwayar cutar korona guda bakwai.
Daga cikin su akwai cutar korona ta mutum-229E da kuma cutar korona ta mutum-NL63, wadanda suka hada da cutar korona alfa.
Sauran ƙwayoyin cuta guda biyar sun hada da cutar korona ta mutum-OC43, cutar korona ta mutum-HKU1, cutar korona da ke da alaƙa da cututtukan huhu mai tsanani (SARS-CoV), cutar korona da ke da alaƙa da cututtukan huhu na Gabas ta Tsakiya (MERS-CoV), da SARS-CoV-2.
Kwayar cutar korona ta mutum-229E, kwayar cutar korona ta OC43, kwayar cutar korona ta HKU1, kwayar cutar korona ta NL63 yawanci suna haifar da bayyanar cututtuka masu sauƙi, kamar sanyi ko kumburi ko duka biyun.
Akasin haka, SARS-CoV, MERS-CoV da kuma sabon kwayar cutar SARS-CoV-2 duk suna haifar da cututtuka sosai, suna haifar da kamuwa da cututtukan ƙananan huhu ga yawancin marasa lafiya tare da yiwuwar kamuwa da cutar ta NCD (Acute NCD) da kuma bayyanar cututtuka marasa huhu.
An cire cutar korona ta mutum-229E, nau'in farko na B814, daga nasal discharge na marasa lafiya masu sanyi a tsakiyar shekarun 1960.
Tun daga lokacin, an tattara bayanai da yawa ta hanyar nazarin da aka yi na kwayar cutar korona ta mutum-229E da kuma kwayar cutar korona ta mutum-OC43, wanda ke warkar da alamun ta atomatik.
A gaskiya ma, an san cewa kamuwa da cutar korona ba ta da lahani har sai an yi SARS.
Cutar SARS ta shekara ta 2003 na cikin annobar da ta fi kashe mutane a tarihinmu, inda ta yi wa mutane 8,000 rauni da kusan kashi 10 cikin 100 na mutuwa.
Shekaru goma bayan haka, ciwon MERS na yau da kullum ya zama annoba a yankin Larabawa da kuma yaduwar da ta yi wa sauran duniya.
Sabon cutar korona ta 2019 (Sabon cutar korona ta 2019), wanda aka sake masa suna SARS-CoV-2, shine abin da ke haifar da cutar ta yanzu cutar coronavirus 2019 (COVID-19), wanda ya kashe mutane sama da 3,120 kuma ya cutar da mutane sama da 91,000 a ranar 3 ga Maris, 2020.
An yi sautin ƙararrawa kuma dole ne duniya ta shirya don cutar SARS-CoV-2 mai zuwa.
Dukkanin cututtukan corona guda bakwai na mutum sun fito ne daga dabbobi kamar bats, beraye, ko dabbobi.
Akwai hujjoji da yawa da suka nuna cewa dukkanin cututtukan corona na mutum sun samo asali ne daga bats, inda ƙwayoyin cuta suka dace sosai kuma ba su haifar da cututtuka ba amma suna nuna bambancin kwayoyin halitta.
Cutar COVID-19 ta kawo gagarumin kalubale na kiwon lafiya, kimiyya, zamantakewa da kuma ɗabi'a ga Sin da kuma duniya.
Bin asalin dabbobi na kwayar cutar korona ta nuna tsarin fahimtar tarihin halitta, da kuma abubuwan da ke motsawa da kuma iyakance motsi tsakanin jinsuna.
Wannan zai iya taimaka wa ko kuma ya sauƙaƙa neman mai riƙe da gidan ajiya, mai ba da sabis, da kuma babban mai ba da sabis na SARS-CoV-2, tare da tasiri mai mahimmanci don hana tasirin gaba.
A wannan bita, za mu yi bayani game da yadda dabbobi suke rayuwa, yadda suke rarraba dabbobi tsakanin jinsuna, da kuma yadda kwayar cutar korona take haddasa cututtuka.
Musamman, za mu tattauna ra'ayin da ake da shi cewa ƙwayoyin cuta na asali na kwayar cutar korona na ɗan adam ba su haifar da cututtuka a cikin mahaifinsu na halitta ba amma suna haifar da cututtuka bayan sun koma tsakanin nau'ikan zuwa sabon mahaifinsu.
Muna kuma nazarin yadda cutar ta Korona ta ɗan adam ta kasance, domin yawanci ƙaruwa a cikin iyawar ta na zuwa yana ƙaruwa a cikin rashin lafiyar.
A wannan mahallin, muna kuma tattauna sakamakon SARS-CoV-2 na yanzu.
An san dabbobi da cutar korona tun daga ƙarshen shekarun 1930.
Kafin a fara ware kwayar cutar korona ta B814 daga cikin nasal discharge na marasa lafiya masu sanyi, an ware nau'ikan kwayar cutar daga dabbobi masu cutar daban-daban, ciki har da turkey, beraye, shanu, alade, cats, da karnuka.
A shekarun da suka gabata, an gano nau'ikan cutar korona guda bakwai.
Wannan taƙaitaccen bayani game da tarihin gano cutar ta Korona a cikin lokaci (Jadawalin 1) zai zama da ilimi da kuma koyarwa.
An cire kwayar cutar korona ta farko daga cikin huhu na marasa lafiya da ke fama da cutar ta sama a shekara ta 1966, kuma daga baya ta daidaita zuwa rayuwa a cikin WI-38 na huhu.
Marasa lafiya da ke da cutar korona-229E suna fama da alamun sanyi na yau da kullum, ciki har da ciwon kai, tari, tari, kumburi, zazzabi, da tari a kusan kashi 10 zuwa 20 cikin dari na lokuta.
Daga baya a shekara ta 1967, an cire kwayar cutar korona ta mutum (OC43) daga gonar 'yan Adam kuma an canja shi zuwa kwakwalwar jarirai.
Halin da ake nunawa na kamuwa da cutar korona-OC43 ya yi kama da wanda ake samu daga cutar korona-229E, wanda ba za a iya gane shi da alamun kamuwa da wasu ƙwayoyin cuta na numfashi kamar su ƙwayoyin cuta na influenza A da ƙwayoyin cuta na hanci ba.
Kwayar cutar korona ta mutum-229E da kuma kwayar cutar korona ta OC43 sun bazu ko'ina cikin duniya, kuma suna da saurin yin ƙaura a lokacin hunturu a yanayi mai laushi.
Yawanci, lokacin da waɗannan ƙwayoyin cuta biyu suke riƙewa bai kai mako ɗaya ba, sai kuma rashin lafiya na kusan makonni biyu.
A cewar wani bincike na aikin sa kai na mutum, mutane masu lafiya da suka kamu da cutar korona-229E sun kamu da sanyi mai tsanani.
Wasu marasa lafiya da ke da cutar HIV sun nuna cewa sun kamu da cutar ta kasa.
SARS, wanda aka fi sani da "rashin ƙwayar cuta ta huhu", ita ce annoba ta farko da aka samu a tarihin 'yan Adam, wadda ta samo asali ne daga SARS-CoV, wanda shi ne cutar ta uku da aka gano.
An fara samun cutar SARS a ƙarshen shekara ta 2002 a lardin Guangdong na kasar Sin.
Cutar SARS ta haifar da mutum 8,096 da suka kamu da cutar kuma ta kashe mutane 774, kuma ta bazu a ƙasashe da nahiyoyi da yawa.
Ko da kuwa wanda ya kamu da cutar ya yi yawa, an kiyasta cewa kamuwa da cutar guda ɗaya zai iya haifar da kusan yanayi biyu na biyu, tare da lokacin kula da kwanaki 4 zuwa 7 kuma ƙarancin ƙwayar cutar ya bayyana a rana ta 10 na rashin lafiya.
Abubuwan SARS-CoV sun fara ne da ciwon tsoka, ciwon kai, zazzabi, rashin jin daɗi, da kuma tsananin tsoro, kuma suna biyo baya a matsayin rashin numfashi, tari da kuma numfashi.
Rashin ƙwayar lymphoma, rashin aikin hanta, da kuma yawan ƙwayar kinase na sarcasm na yau da kullum ne.
A cikin marasa lafiya da ke fama da cutar SARS, ana ganin ciwon da ke saurin yaduwa, ƙwayoyin halitta suna ƙaruwa, kuma ƙwayoyin halitta suna ƙaruwa.
Daga nan sai a yi wa marasa lafiya 20 zuwa 30 cikin 100 kulawa da numfashi.
Baya ga tsarin numfashi na ƙasa, a cikin yanayi mai tsanani, wasu gabobin jiki, kamar na hanji, hanta da koda, suna iya kamuwa da cutar ta cytocin, wadda za ta iya zama mai kisa musamman ga marasa lafiya da ke fama da cutar HIV.
An fara ware cutar daga wani rami na huhu na wani dangi da ya fara kamuwa da cutar daga Guangzhou zuwa Hong Kong.
Tun daga lokacin, an yi ƙoƙari sosai wajen yin bincike game da cutar korona.
An killace cutar korona ta mutum-NL63 daga wani yaro mai wata bakwai a Netherlands a ƙarshen 2004.
Da farko an gano cewa yana da yawa a cikin yara ƙanana, tsofaffi, da marasa lafiya da ke fama da cutar HIV da ke fama da cututtukan numfashi.
Cutar sanyi, kumburi, zazzabi, da kumburi na ƙwayoyin cuta, alamun cututtukan da ke faruwa a duniya ne na cutar da ke tattare da cutar korona-NL63.
Wani bincike na daban ya bayyana cewa an ware cutar daga wani samfurin hanci na wani yaro mai wata takwas da ke fama da cutar huhu a Netherlands.
Ko da yake an gano shi a ƙasar Holland, amma yana da yawa a dukan duniya.
An kiyasta cewa cutar korona ta mutum-NL63 tana da alhakin kusan kashi 4.7% na cututtukan numfashi na yau da kullum, kuma ana samun ta a farkon bazara, bazara da hunturu.
Kwayar cutar korona ta mutum-NL63 tana da alaƙa da ciwon hanci na hanci, wanda aka fi sani da ƙonawa.
A wannan shekarar, an ware wani mutum mai shekara 71 da ake yi masa jinya da cutar korona-HKU1 daga asibiti saboda ciwon huhu da kuma ciwon ƙwayoyin cuta a Hong Kong.
Baya ga kamuwa da cutar huhu da kuma cutar ƙwayoyin cuta, an ruwaito cewa cutar korona ta mutum-HKU1 tana da alaƙa da ciwon asma mai tsanani.
An gano cewa cutar korona ta mutum-HKU1 ta bazu ko'ina cikin duniya, kuma tana haifar da ƙananan cututtukan numfashi, kamar cutar korona ta mutum-NL63, cutar korona ta mutum-229E, da kuma cutar korona ta mutum-OC43.
Dukkanin wadannan kwayar cutar Corona hudu da aka samu daga al'umma sun daidaita da mutane sosai kuma a gaba ɗaya suna da damar yin kamuwa da cututtukan da ke da ƙarancin yaduwar su, amma haɗari ya faru ne saboda dalilai da ba a sani ba kamar yadda yake a cikin yanayin da ba a sani ba na mafi munin nau'in kwayar cutar corona-NL63, wanda aka ruwaito kwanan nan yana haifar da kamuwa da cutar ta kasa a China.
A kullum, idan kwayar cutar korona ta samu ikon yin yaduwa da kuma ci gaba da kasancewa a cikin mutane, za su zama marasa lahani ko kuma marasa lafiya.
An fara kwayar da Mers-Cove a shekara ta 2012 daga huhu na wani mutum mai shekara 60 da ke fama da ciwon huhu da kuma rashin lafiya a Saudiyya.
Ko da yake yawancin lokuta da aka tabbatar da su a cikin dakin gwaje-gwaje sun fito ne daga Gabas ta Tsakiya, an ruwaito a ƙasashen Turai da Tunisiya game da lokuta da aka kawo daga waje da kuma ƙananan ƙananan ƙananan masu haɗuwa da ke da kusanci.
Wani abu na biyu da ya faru a Koriya ta Kudu a 2015 ya haifar da mutum 186 da suka kamu da cutar.
Alamun asibiti na cutar ta MERS suna kama da na SARS, kuma suna nuna ciwon huhu mai tsanani.
Ba kamar SARS ba, mutane da yawa da ke fama da cutar ta MS sun sha wahala daga rashin lafiyar koda, wanda ke sa cutar ta bambanta da sauran cututtukan da cutar ta Korona ta haifar.
Fiye da kashi 30 cikin dari na marasa lafiya suna fama da cututtukan cututtukan hanji, kamar tari da zubar da ciki.
A ranar 14 ga Fabrairu, 2020, an ba da rahoton fiye da 2,500 na lokuta da aka tabbatar da gwaji tare da babban adadin mutuwa na 34.4%, wanda ya sa MERS-CoV ya zama ɗayan ƙwayoyin cuta masu halakarwa da aka sani ga mutane.
Daga tsakiyar watan Disamba zuwa ƙarshen 2019, an gano wasu rukunin marasa lafiya da ke fama da cutar huhu da aka sani daga baya cewa sakamakon kamuwa da cutar SARS-CoV-2 ne a Wuhan, lardin Hubei, a kasar Sin.
Hukumar lafiya ta duniya ta bayyana barkewar cutar ta kasa ta hanyar SARS-CoV-2 a matsayin gaggawa na gaggawa na duniya, kamar yadda ta kira COVID-19.
A ranar 3 ga Maris, 2020, an tabbatar da shari'o'i 90,053 a duk duniya, kuma yawan mutuwar farko ya kai 3.4%.
Ya kamata a lura cewa a lardin Hubei na kasar Sin, adadin mutuwar ya kai kashi 4.2 cikin dari, yayin da a wajen kasar akwai kashi 1.2 cikin dari.
SARS-CoV-2 yana haifar da cututtukan numfashi masu tsanani kamar SARS-CoV da MERS-CoV, kuma suna bayyana a cikin zazzabi, tari da kuma rashin numfashi.
Wasu mutane ma suna fama da ciwo.
Ciwon huhu na cikin manyan cututtuka kuma yana iya zama babban cuta mai tsanani.
Ko da yake SARS-CoV-2 da SARS-CoV-2 sun yi kama da juna saboda yawan daidaituwa a cikin jerin nucleotides na 82%, duk da haka sun kasance daga rassan daban-daban na itacen juyin halitta.
SARS-CoV-2 ya fi muni amma ya fi kamuwa da cuta fiye da SARS-CoV da MERS-CoV.
An ruwaito cewa akwai mutanen da ba su da wata alama ko da sun kamu da cutar Cove-2 kuma suna iya sa ta yadu a duniya.
Kwatanta da bambancin SARS-CoV-2 da sauran cututtukan corona guda shida ya nuna kamanceceniya da bambanci masu muhimmanci.
Na farko, ƙwayar cutar korona ta ɗan adam tana kama da lokacin da ake haifuwa da kuma lokacin da ake kamuwa da cutar.
A wannan yanayin, SARS-CoV-2 yana bin tsarin sauran cututtukan corona guda shida.
Na biyu, rashin lafiyar COVID-19 yana cikin nau'i-nau'i tsakanin SARS-CoV da kuma cututtukan cutar korona guda hudu (wato, cutar korona-229E, cutar korona-OC43, cutar korona-HKU1, da kuma cutar korona-NL63).
A gefe guda, kamuwa da cutar Cove-2 yana nuna alamun da suka fi kowa a cikin kamuwa da kwayar cutar Corona ta hanyar al'umma, ciki har da bayyanar bayyanar cututtuka marasa kyau ko kuma marasa bayyanar cututtuka.
A gefe guda kuma, ana iya ganin ƙananan ƙananan ƙananan cututtukan COVID-19 kamar SARS-CoV, ko da yake adadin ya ƙaru.
Na uku, SARS-CoV-2 ya nuna wasu abubuwa masu ban sha'awa game da kwayar cutar corona da aka samu daga al'umma da SARS-CoV.
A gefe guda, SARS-CoV-2 na iya kamuwa da cutar sosai fiye da yadda za a iya kamuwa da kwayar cutar korona ta 'yan Adam.
A gefe guda kuma, ana ci gaba da bincika ko SARS-CoV-2 zai iya kamuwa da cutar bayan mutum ya kamuwa da cutar kamar yadda yake a SARS-CoV da MERS-CoV.
A ƙarshe, ana iya gano SARS-CoV-2 a cikin samfurori na fitsari kamar yadda ake gano wasu ƙwayoyin cuta na Corona.
Ana bukatar ƙarin bincike a nan gaba don gano ko SARS-CoV-2 ya yi aiki sosai kamar yadda SARS-CoV ke yi a wasu lokuta.
Yana da muhimmanci a san ko SARS-CoV-2 zai iya nuna yaduwar yanayi kamar yadda yake a cikin yanayin kwayar cutar korona ta ɗan adam.
Duk da haka, halaye na SARS-CoV-2, ciki har da yiwuwar kamuwa da cuta, tsarin kamuwa da cuta da kuma ci gaba da yaduwar mutum zai iya shafar makomar annobar COVID-19 ta yanzu.
An yi amfani da kwayoyin cutar Korona guda hudu da ke haifar da bayyanar cututtuka masu sauƙi don daidaitawa da mutane.
Akwai wani ra'ayi kuma, wanda zai iya zama gaskiya, cewa mutane sun daidaita da wadannan cututtukan corona guda hudu.
A wasu kalmomi, wataƙila su biyun sun tsira daga annobar cutar coronavirus ta dā.
An kawar da kwayar cutar korona da ke kamuwa da cututtuka masu tsanani da kuma waɗanda suka kamu da cutar korona.
Don haka, dole ne kwayar cutar ta korona ta yi kwafi a cikin mutane yadda ya kamata don a samu karuwar canji na daidaitawa da masu hanawa ke fuskanta a cikin mai masaukin.
Da wannan ra'ayin, da zarar SARS-CoV-2 ya ci gaba da yaduwa kuma yawan mutane suka kamu, zai iya daidaitawa da mutane.
Idan ya dace sosai, zai yi wuya a hana shi yaduwa tsakanin mutane ta hanyar maganin rigakafi ko wasu matakan hana kamuwa da cuta.
Kwayar cutar korona guda hudu da aka samu daga al'umma sun bazu tsakanin al'ummomin mutane tsawon shekaru, suna haifar da sanyi a cikin mutanen da ke da rigakafi mai kyau.
Waɗannan ƙwayoyin ba sa bukatar wani ajiyar dabbobi.
A akasin haka, SARS-CoV da MERS-CoV da suka haddasa cutar da mutane ba su daidaita da kyau ba, kuma ba za mu iya ci gaba da yin tafiya tsakanin mutane ba.
Suna bukatar su zauna a cikin gidajensu na dabbobi kuma su yi yawa a ciki, sa'an nan kuma su nemi zarafin da ya dace su koma ga maƙasudin mutane mafi tsanani, wataƙila ta hanyar ɗaya ko fiye na matsakaiciyar gidaje masu girma.
SARS-CoV-2 yana da halaye iri ɗaya da SARS-CoV/MERS-CoV da kuma ƙwayoyin cuta huɗu na Corona na ɗan adam da aka samo daga al'umma.
Yana da matukar cutarwa kamar yadda cutar korona ta 'yan Adam ke samu daga al'umma, aƙalla a yanzu.
Amma, yana haddasa cutar fiye da kwayar cutar korona da aka samu daga al'umma kuma kasa da SARS-CoV ko MERS-CoV.
Ba a san ko za ta daidaita da mutane sosai ba kuma za ta yadu ba tare da bukatar wani ajiya ko kuma wani mai kula da dabba ba.
Kafin mu tattauna asalin dabbobi na kwayar cutar korona ta mutum, zai yi kyau mu bincika ma'anar da kuma halaye na masu karɓar bakuncin na halitta, na halitta, na ajiya, na matsakaici, da na kwayar cutar korona ta mutum.
Wani dabba yana da matsayi na ci gaba da karɓar bakuncin kwayar cutar korona idan yana da ƙwayar cuta da ke da alaƙa da shi kuma yana da babban daidaituwa a cikin jerin nucleotides.
A yawancin lokaci, ƙwayar cuta ta asali tana da kyau kuma ba ta haifar da cutar ba.
Hakazalika, mai karɓar bakuncin yana riƙe da kwayar cutar ta mutum a cikin dogon lokaci.
A kowane hali, ana kamuwa da cutar ta halitta kuma ana iya samun ta ne a matsayin mai karɓar kwayar cutar korona ta mutum ko kuma ta mahaifinta.
A akasin haka, idan cutar ta kamu da cutar ta coronavirus ta shiga cikin sabon mai watsa shiri kafin ta kai wa mutane hari ko kuma kusa da ita, ba ta daidaita da sabon mai watsa shiri sosai kuma sau da yawa tana haifar da rashin lafiya.
Wannan mai karɓar baƙon na iya zama tushen dabba na kamuwa da cutar a cikin mutane kuma yana yin aikin mai karɓar baƙon ta hanyar barin kwayar cutar ta ɗan lokaci ta hanyar watsa shi zuwa mutane don faɗaɗa yaduwar kamuwa da cutar tsakanin mutane.
Kwayar cutar korona na iya kaiwa ga hanyar da ta hana mutum shiga idan cutar ta kasa wucewa daga cikin mai masaukin.
A akasin haka, kwayar cutar korona na mutum tana iya daidaitawa da mai masaukin da ke tsakanin su har ta iya zama mai zaman kanta.
A wannan yanayin, mai masaukin baki ya zama mai masaukin ajiya na halitta.
Bayan haka, bayanan annobar sun nuna cewa wanda ya fara kamuwa da cutar SARS yana da tarihin da ya shafi cutar.
Binciken bincike ya nuna cewa masu sayar da dabbobi suna da karin yawan cutar ta IgG ta SARS-CoV fiye da mutane.
An fara gano cewa dabbar dabba mai suna Paguma larvata da kuma raccoon a cikin kasuwanni suna dauke da kwayar cutar SARS-CoV, wadda ta yi daidai da SARS-CoV.
Abin da ya ba da tabbaci a kai tsaye shi ne cewa babu wani sabon labari na wani mai tsaron gida bayan an kashe dukan 'yan kasuwa.
Duk da haka, an bayar da rahoton cewa sakamakon binciken SARS-CoV na cuku mai cin nama da ke rayuwa a cikin daji ko gonaki ba tare da fuskantar kasuwannin dabbobi ba ya kasance da mummunan sakamako, wanda ya nuna cewa cuku mai cin nama na iya zama babban mai masaukin baki ne kawai, amma ba ajiyar halitta ba ne na SARS-CoV.
Wannan ya nuna cewa yayin da kashi 80 cikin 100 na dabbobi a kasuwannin Guanzu ke da maganin SARS-CoV-2, yiwuwar cewa wasu ƙananan dabbobi masu shayarwa suna taka rawa a matsayin matsakaiciyar rundunar SARS-CoV-2 ba a ware ba.
Dukkanin waɗannan baƙi ne da ba su canja wurin SARS-CoV ba.
Binciken da aka yi game da dabba mai masaukin Saras-Cov ya nuna cewa akwai wata alaka da cutar korona ta bats, wadda ake kira HKU3 (High-Horse Horse Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade Blade B B B B Blade B B B B Blade Blade B B B B B B B Blade Blade B B B Blade Blade B B Blade Blade Blade B B Blade Blade B B B Blade B B B B B B Blade B B B Blade Blade B B B B B Blade Blade B B B B B Blade Blade B B B B Blade B B B B B B Blade
An gwada maganin SARS-CoV-3 a cikin waɗannan kwari kuma an gano cewa ƙwayoyin cuta na kwayar cutar ta HKU3 sun kasance masu kyau.
Wannan kwayar cutar da sauran kwayar cutar korona na bats suna da daidaituwa tsakanin kashi 88 zuwa 92% na jerin nucleotides da SARS-CoV.
Waɗannan binciken sun kafa tushen sabon ra'ayi cewa bats suna da alhakin cututtukan da ke tasowa a cikin mutane.
An gano wasu ƙwayoyin cuta masu kama da cutar CRS (CRS) daga bats, amma ba za a iya ware kowanne daga cikinsu a matsayin mai rai ba sai WIV1.
An san wani abu da ake kira SARS-CoV-2 mai karɓa.
An tabbatar da cewa WIV1 wanda aka samo daga samfurin bat na bat yana amfani da enzyme mai canzawa zuwa angiotensin 2 a cikin bats, cats, da mutane a matsayin mai shiga cikin kwayar.
Abin sha'awa, ƙwayar ƙwayar ƙwayar cuta ta waɗanda suka warke daga ciwon huhu mai tsanani ta iya daidaita WIV1.
Har zuwa yanzu, WIV1 shi ne ainihin ƙwayar cuta da ta fi haɗuwa da SARS-CoV a cikin bats, domin suna da kashi 95% na jituwa a cikin jerin nucleotides.
Duk da cewa waɗannan ƙwayoyin sun yi kama da juna, ana ganin cewa WIV1 ba shi ne ainihin mahaifin SARS-CoV ba kuma cewa bats ba su da ainihin gidan ajiyar SARS-CoV ba.
Nazarin ci gaban jinsin Mers-Cov a cikin rukuni na cutar Corona-HKU4 a bats da kuma cutar Corona-HKU5 a bats kanta.
Kwayar cutar Corona-HKU4 a cikin bats da kuma Myrtus-Cov tana amfani da makomar mai masaukin kanta, peptide peptidase4, don shigar da kwayar.
Tsarin polymerization na riboside na tushen riboside na MERS-CoV ya fi kusa da juyin halitta na jinsin zuwa takwarorinsa na kwayar cutar Corona beta a cikin bats da aka ƙayyade a Turai da Afirka.
Ba a gano cewa Merce-Cov yana rayuwa a cikin bats ba tukuna.
Kwayar cutar MERS-CoV da HKU25 a cikin ƙwayoyin cuta da ke kusa da shi sun yi daidai da jerin nucleotides da kashi 87 cikin ɗari.
Saboda haka, ƙwararrun baƙi ba su kasance ajiyar kai tsaye na Mers-Cov.
A wani bangare kuma, binciken da aka yi a Gabas ta Tsakiya ya nuna cewa, mace mai suna Semi-positive ne kawai ga kwayoyin cutar MERS-CoV, kuma mace mai asalin Gabas ta Tsakiya ce a ƙasashen Afirka da yawa.
An cire kwayar cutar da ke cikin mutane daga binciken hanci na mace mai suna Merc-Cove, yana nuna cewa mace tana aiki a matsayin mai masaukin baki na asali na Meres-Cove.
Yana da muhimmanci a lura cewa a cikin wani ɗan gajeren lokaci, an lura da wata alama a cikin Gemal da aka kamu da cutar MERS-CoV, amma an lura da yaduwar cutar.
Kyakkyawan yarinya mai cutar tana yada kwayar cutar ba ta hanyar numfashi kawai ba har ma ta hanyar hanyar da ta wuce ta bakin, wadda ita ce hanyar da ta fi dacewa da yaduwar kwayar cutar daga bats.
Duk da haka, har yanzu akwai tambayoyi domin yawancin mutane da suka kamu da cutar ba su da tarihin da suka yi magana da kyakkyawa kafin bayyanar cututtuka, kuma ana danganta waɗannan yanayin a hankali ga motsi daga mutum zuwa mutum ko hanyoyin wucewa da ba a sani ba da suka haɗa da nau'ikan dabbobi da ba a san su ba ta hanyar kulawa da MERS-CoV.
SARS-CoV-2 RaTG13 cutar korona a cikin fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen fararen
Bambancin jerin tsakanin SARS-CoV-2 da RaTG13 yana da tsayi sosai har ya yi wuya a iya gano mahaifinsu, kamar yadda yake a SARS-CoV da MERS-CoV.
Wannan yana nufin cewa bats ba za su iya zama masu ba da gudummawa kai tsaye ga SARS-CoV-2 ba sai an gano cewa akwai cutar korona a cikin bats a nan gaba.
An yi zaton cewa dabbobi masu karɓar bakuncin SARS-CoV-2 suna cikin nau'ikan da aka sayar da su a kasuwar abincin teku ta Wuhan, inda aka danganta da cututtukan farko na COVID-19, wanda ke nuna yiwuwar watsa daga dabba zuwa mutum.
Yawancin nazarin da aka yi kwanan nan bisa tsarin mitochondrial sun nuna cewa wani rukuni na ƙananan dabbobi masu tasowa da ke cikin haɗari da ake kira predatory ant-eating (Manis javanica) na iya kuma zama tushen kwayar cutar Corona beta da ke da alaƙa da SARS-CoV-2.
Kwayar cutar korona ta sabon hali tana cinye wadannan tsutsa da kuma SARS-CoV-2 a cikin kashi 85 zuwa 92 cikin dari na jerin nucleotides.
Duk da haka, suna da alaƙa da RaTG13 da kusan kashi 90 cikin ɗari na kama da juna a cikin jerin nucleotides.
A cikin jinsuna biyu, ƙwayoyin cuta biyu masu kama da SARS-CoV-2 suna haɗuwa a cikin itacen juyin halitta, ɗayan yana da haɗin kai na gaba (wuri na haɗin kai na gaba) kamar SARS-CoV-2, tare da daidaitaccen amino acid na 97.4%.
A cikin bambanci mai ban mamaki, yankunan haɗin karɓar SARS-CoV-2 sun bambanta da RaTG13, ko da yake tsarin kwayoyin halitta gaba ɗaya ya fi girma.
Wani bincike da aka yi a kan ciwon wasu tsutsotsi masu ci ya nuna cewa akwai kwayoyin cuta daga cikin samfurori na huhu, kuma hakan ya nuna cewa suna da alaƙa da SARS-CoV-2.
Wannan binciken ya yi amfani da hanyoyi daban-daban na tattarawa da kuma sarrafawa ta hannu don samar da jerin kwayoyin halitta na kwayoyin halitta wanda ya ƙunshi jimlar kwayoyin cuta na kusan kashi 86.3 cikin dari.
Ba za mu iya ware yiwuwar cewa tsutsa-tsutsa suna cikin masu karɓar baƙi na SARS-CoV-2.
Duk da haka, a halin yanzu babu wata hujja da ta nuna cewa ciwon kumfa na kai tsaye ne na SARS-CoV-2 saboda bambancin jerin tsakanin SARS-CoV-2 da kwayar cutar Corona-Beta da ke tattare da SARS-CoV-2 a cikin ciwon kumfa.
Bugu da ƙari, bambancin SARS-CoV-2 da RaTG13 ya fi na SARS-CoV-2 da kuma ƙwayar cutar Corona-Beta da ke tattare da SARS-CoV-2 a cikin naman alade.
Har ila yau, ana ci gaba da gano ciwon SARS-CoV-2 a cikin kwari, da kuma wasu dabbobi masu ci.
Yayin da aka sami mafi girma a cikin tsarin kama-da-wane a cikin sassan masu karɓa tsakanin SARS-CoV-2 da kuma tsutsa-tsutsa masu cin nama, kwayar cutar Corona beta da ke da alaƙa da SARS-CoV-2, SARS-CoV-2 da RaTG13 suna da mafi girma a cikin tsarin tsarin kwayoyin halitta.
Ana iya cewa irin wannan kamanceceniya tsakanin sars kov-2 receptor a cikin ƙwayar cuta na coronavirus beta da sars kov-2 yana da muhimmanci wajen ci gaba da zaɓin.
Akwai wani ƙuduri da ya nuna cewa SARS-CoV-2 zai iya sake haɗuwa a cikin ƙwayar cuta na ƙwayar cuta ta Corona Beta da RaTG13 a cikin nau'in dabbobi na uku.
Ana amfani da sake fasalin kwayoyin a cikin kwayar cutar Corona Beta a matsayin abin da ke motsa juyin halitta.
Har yanzu ba a tabbatar da asalin dabba na Sarkof-2 ba.
Baya ga cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Bayanai na juyin halitta sun nuna cewa ko dai kwayar cutar corona ta mutum-NL63 da kwayar cutar corona ta mutum-229E na iya fitowa daga kwayar cutar corona ta bats, yayin da aka gano kwayar cutar mahaifin kwayar cutar corona ta mutum-OC43 da kwayar cutar corona ta mutum-HKU1 a cikin rodents.
An ruwaito cewa cutar korona a cikin bats da ake kira ARCoV.2 (Alash Heights Corona Virus) da aka gano a cikin bats masu launi uku a Arewacin Amirka suna da alaƙa da cutar corona ta mutum-NL63.
A wani bangare kuma, an gano cewa kwayar cutar korona ta mutum-229E tana da nasaba da wani kwayar cutar korona a bats, mai suna Hipposideros/ GhanaKwam/19/2008, wanda aka gano a Ghana, kuma ana zargin cewa mai watsa shiri ne kuma ya dauki bakuncin cutar.
Don ƙarin bayani, an taƙaita bayanin da ke faruwa a yanzu game da asalin dabbobi na kwayar cutar korona ta mutum da aka sani a cikin siffar 1 da kuma jadawalin 2.
Nazarin juyin halitta na jinsuna ya ba da hujja game da yadda mutane suka kamu da cutar coronavirus tsakanin jinsuna a tarihi.
A lokacin da cutar korona ta mutum ta wuce daga nau'in OC43 zuwa na dabbobi a shekara ta 1890, an yi rikodin annobar kamuwa da cutar huhu.
Tarihin watsa kwayar cutar korona-229E tsakanin jinsuna har yanzu ba shi da tabbas.
An gano cewa kwayar cutar Alpha a cikin bats tana da alaƙa da kwayar cutar mutum-229E.
Daga cikinsu akwai cutar korona alfa a Albakia.
Akwai shaidu da yawa da suka nuna cewa cutar tana gudana daga bats zuwa mutane kai tsaye.
Na farko, mutane ba albakas ba ne, amma suna iya yin hulɗa da kwari a cikin gida na muhalli.
Amma mutane suna da dangantaka ta kusa da Albakka.
Na biyu, cutar korona ta mutum-229E da ke cikin kwayar cutar korona alfa a cikin bats tana da yawa kuma ba ta haifar da cututtuka a cikin bats, yayin da cutar korona alfa a cikin Alpeka ke haifar da yaduwar cututtukan numfashi a cikin dabbobi masu cutar.
A ƙarshe, ba a gano cutar korona alfa da ke tattare da albasa a cikin dabbobin daji ba.
Saboda haka, ba za a iya ware yiwuwar cewa Alpeka ta kamu da cutar korona ta mutum-229E ba, wadda ta fito ne daga cutar korona ta Alpha.
A gaskiya, bats sune ainihin tushen ƙwayoyin cuta da ke haifar da cututtuka a cikin mutane ciki har da cutar kare, Ebola, Niba, da Andhra.
Saboda haka ba abin mamaki ba ne cewa bats za su iya watsa cutar korona ta mutum-229E kai tsaye zuwa ga mutane.
Yayin da kwayar cutar korona alpha a cikin bats ke aiki da tattara kwayoyin cutar korona ta mutum-229E, alpacas da kamel mai suna sunna na iya zama masu ba da izini na tsakiya don isar da ƙwayoyin cutar ga mutane, kamar yadda yake a cikin MERS-CoV.
Mers-Cov ya ba da misali mai kyau na canjin jinsuna. Daga bats zuwa unicorn mai kyau, daga unicorn zuwa mutane.
An san asalin halittar bats na Myrrh-Cov tun lokacin da aka fara gano su kuma an ƙarfafa su ta sakamakon da aka samu.
A bayyane yake cewa bats suna samar da tarin ƙwayoyin cuta masu yawa don musayar kwayoyin halitta a cikin jinsin kuma su canja su tsakanin jinsuna.
Batun suna da tsawon rai, suna zama a cikin yankunan da mutane suke da yawa, suna da dangantaka mai kyau da mutane, suna da iyawar tashi sosai, duk waɗannan yanayi ne masu kyau don su zama "masu yada kwayar cutar".
A gefe guda kuma, Myrce-Cov ya koma cikin kyakkyawa mai kyau na shekaru da yawa.
Wannan kyakkyawa zai iya daidaitawa sosai har sai ya zama mai karɓar bakuncin gidan ajiya mai daidaitacce.
Ma'anar cutar Mercer-Cov tana da ƙananan cututtuka kuma tana da ƙananan ƙwayoyin cuta a cikin waɗannan dabbobi.
Saurinsa zuwa ga mutane ya kasance ba zato ba tsammani kuma mutum ba shi da wata hanyar watsawa ga Mars-Cov, inda ba zai iya ci gaba da watsawa ba.
Ba kamar yadda kamel ke yi wajen canja wurin Mers-Cov ba, amma ana ganin cewa ciwon tsatsa-tsatsa na da wani matsayi dabam a canja wurin SARS-Cov.
Musamman, ƙwayar cutar Corona beta da ke tattare da ciwon tsatsa tana sa shi ya kamu da cutar sosai.
Suna iya zama masu karɓar baƙi ba ga SARS-CoV-2 na cutar Corona Beta, kamar cat cat a cikin SARS-CoV.
Nazarin nan gaba zai ƙayyade yiwuwar cewa SARS-CoV-2 zai iya zama na dabba zuwa mutum ta hanyar tabbatar da shi ko kuma kawar da shi.
Na farko, ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar ƙwararrun ƙwar ƙwar ƙwararrun ƙwar ƙwar ƙwararrun ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙ
Mutane da bats suna iya yin amfani da su wajen yin amfani da su wajen yin yanka ko kuma yin hakar kwal.
Na biyu, ciwon tsutsa zai iya zama ɗaya daga cikin manyan masu karɓar bakuncin cutar da aka gano kwanan nan da ke da alaƙa da SARS-CoV-2.
Mutane suna kamuwa da cutar ta wurin cin nama da kuma cin sa.
Da yawa daga cikin dabbobi masu shayarwa, har da dabbobi masu gida, suna iya kamuwa da cutar Cov-2.
Akwai dalilin da ya sa ake yin bincike a kan kwayoyin cutar a dabbobi da kuma cikin daji.
Na uku, kamar yadda aka ambata a sama, ana iya sake yin amfani da kuma daidaitawar SARS-CoV-2 a cikin nau'i na uku wanda ke da alaƙa da kwari da kuma tsutsa.
Ana ci gaba da bincike game da asalin dabba na Sarkof-2.
Baya ga nau'ikan dabbobi masu yawa, akwai manyan abubuwa uku da ke taimakawa wajen ƙetare ƙuntatawa na nau'ikan cutar korona.
Na farko, suna da ƙimar haɓakawa a cikin riboside DNA.
Ana iya ganin cewa ƙididdigar ƙididdigar ƙwayoyin cuta na coronavirus, idan aka kwatanta da sauran ƙwayoyin cuta na RNA guda ɗaya, suna da "matsakaici" ko "babba" tare da matsakaicin canji na ~ 10-4 sauyawa a kowace shekara don wuri na 2, dangane da matakin daidaitawar coronavirus tare da sababbin masu masaukin baki.
Kwayar cutar korona tana da wani abu na waje da ake gyarawa, wanda ke sa a cire shi, wanda ke sa ya zama mai sauyawa sosai ko kuma ba zai iya ci gaba ba.
Abin sha'awa, an san maganin Remdesivir na nucleotide da ikonsa na kwafin kwayar cutar ta coronavirus ta hanyar hana ribonuclease na waje da polymerase na riboside na tushen DNA.
Maganin Redemptive yana da tasiri a kan SARS-CoV-2 kuma ana shirin gwada shi a asibiti.
Amma, yawan yaduwar cutar korona ya ninka na gidajen da ke cikin gida sau miliyan.
Bugu da ƙari, yawanci ana samun ƙaruwa idan ƙwayoyin cuta ba su daidaita da mai masaukin ba.
Sa'ad da aka kwatanta da Sa'ar-Cov da ke da karko mai yawa, sa'ad da aka kwatanta da Sa'ar-Cov, sa'ad da aka kwatanta da Sa'ar-Cov da ke da karko mai yawa, hakan yana nuna cewa mutum ya fi dacewa da shi.
Ya riga ya daidaita da wani mai masaukin da ke kusa da mutum.
Baya ga SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya dace da kyan gani mai kyau.
A ka'idar, ba za a iya ganin cewa rigakafin kwayoyin halitta da magungunan rigakafi na taimakawa wajen hana SARS-CoV-2 da sauri ba.
Na biyu, babban DNA mai girma a cikin kwayar cutar Corona yana ba da ƙarin launi don gyara kwayoyin halitta da kuma sake haɗuwa, yana ƙara yiwuwar juyin halitta tsakanin jinsuna, kuma yana taimakawa wajen samar da sababbin kwayar cutar Corona lokacin da yanayi ya dace.
Wannan yana da nasaba da tsarin karantawa na musamman da kuma ayyukan furotin da aka yi wa lakabi a kusa da ƙarshen 3′ na kwayoyin halitta.
Na uku, kwayar cutar korona tana sauya samfurori a kai a kai ta hanyar kwafin DNA ta hanyar zaɓin kwafin da ya bambanta.
A cikin wani mai karɓar bakuncin da yake kama da kwano, sauyawa na tsari yana faruwa sau da yawa a cikin kwafin kwayar cutar ta corona.
Abubuwan da ke cikin DNA masu girma da kuma na biyu na iya sake tsarawa don samar da sabon kwayar cutar korona.
An gano wata hujja ta juyin halitta don sake tsarawa a cikin kwayar cutar korona ta mutum-HKU1 da kwayar cutar korona ta mutum-OC43, da kuma kwayar cutar korona ta dabba kamar kwayar cutar korona ta cutar ta huhu mai tsanani a cikin bats da kwayar cutar korona-HKU9 a cikin bats.
Hadin gwiwar cutar da mai masaukin da ke da alaƙa da kamuwa da cuta
Baya ga abubuwan da aka ambata a baya, haɗuwa da ƙwayar cuta da mai karɓar baƙo wani babban abu ne mai tasiri a canjin jinsuna.
A wannan batun, za mu ɗauki sake fasalin SARS-CoV-2 a matsayin misali, wanda kuma ya nuna hujja game da zaɓin da ya dace a lokutan da aka yi canji tsakanin jinsuna.
Bisa ga bincike na mutum da kuma cats na crab, an yi zaton cewa SARS-CoV yana daidaitawa cikin sauri a cikin masu karɓar baƙi daban-daban, musamman ta hanyar juyin halitta a cikin haɗin masu karɓar furotin S.
A kullum, ƙwayar ƙwayar ƙwayar cuta ta S na ƙwayar cuta tana hulɗa da ƙwayar ƙwayar cuta kuma tana daɗaɗa ta hanyar amsawar ƙwayar cuta.
A SARS-CoV, ana samun wani fili na ɗaure masu karɓa a cikin amino acid daga 318 zuwa 510 a S1, wanda ke da alaƙa da enzyme mai canzawa na angiotensin 2 da kuma masu karɓa waɗanda ke taimakawa shiga cikin kwayar.
Ƙungiyar masu karɓar SARS-CoV tana iya gano masu karɓar enzymes na angiotensin 2 a cikin dabbobi daban-daban, ciki har da bats, cat cat, mouse, da raccoon, wanda ke ba da damar watsa kwayar cutar tsakanin jinsuna.
A gaskiya ma, an gano amino acid shida kawai da suka bambanta da na mutum da na cats na aljanu a cikin tsarin haɗin kai, kuma hudu daga cikinsu suna cikin tsarin haɗin kai na gaba don hulɗa da na gaba na angiocytensin 2.
Akwai bambance-bambancen K479N da S487T a cikin sarcasm-Cov receptor binding a cikin cat cat cat, wanda zai iya ƙara yiwuwar yin hulɗa da furotin Spike a cikin wani enzyme mai canzawa na angioutensin 2.
A wasu kalmomi, waɗannan amino acid biyu suna iya zama masu maye gurbin da ke hana mutum yin amfani da kwayoyin cutar.
Abin lura shi ne cewa SARS-CoV-2 yana da makami iri ɗaya da na SARS-CoV.
Akwai bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a cikin s1 na S, wanda ke nuna cewa yiwuwar haɗuwa da S a cikin enzymes na mutum na angioutensin 2 ya canza.
A wani bincike da aka yi a kan wani makami mai zurfi na lantarki, an nuna cewa akwai yiwuwar haɗuwa sau 10 zuwa 20 a tsakanin wannan haɗuwa da abin da ke faruwa tsakanin enzymes na mutum na angiotensin 2 da kuma proteins na S.r.s.
Yana da ban sha'awa kuma a ga ko wasu nau'ikan masu karɓar taimako za su iya zama dole don canja wurin SARS-CoV-2.
Abin sha'awa kuma shi ne cewa cutar korona ta mutum-NL63 tana da alaƙa da enzyme mai canzawa zuwa angioutensin 2 amma a wani ɓangare na furotin S.
Akwai wasu masu zuwa na cutar korona ta mutum, kamar mai nazarin furotin N na cutar korona ta mutum-229E, da kuma mai amfani da salicylic acid 9-O na cutar korona ta mutum-OC43.
Suna iya zama masu saurin daidaitawa da kyau na waɗannan ƙwayoyin cuta a cikin mutane bayan sun koma daga dabba zuwa dabba.
Baya ga masu karɓar kwayoyin halitta, sakamakon canjin nau'in kwayar cutar korona na mutum yana ƙarƙashin sauran abubuwan dogaro da ƙuntatawa na mai masaukin.
Idan waɗannan sunadarai na gida sun haɗu da mutane da kuma masu mallakar wuraren ajiyar kwayar cutar korona, kamar su bats, da kuma guda ɗaya mai kyau, da kuma rodents, hakan zai iya zama cikas ga canjin jinsuna.
Ana bukatar kwayar cutar ta 'yan Adam ta sarrafa abubuwan da ke tattare da mai masaukin da kuma rage abubuwan da ke hana su don a samu nasarar canja wurin jinsuna.
A wannan yanayin, ƙayyadaddun kwayoyin a wannan sararin suna da mahimmanci don yin hulɗa da kwayar cutar tare da mai masaukin baki.
Ana iya amfani da bincike mai zurfi na al'ada don bincika abubuwan da ke tattare da kuma iyakancewar sarkar COV-2 ta amfani da fasaha mai ci gaba na Crisper.
An fara sabon kwayar cutar korona: Komawa wurin da aka fara
Bambancin kwayar cutar korona a cikin bats yana ba da dama mai yawa don sake haifar da kwayar cutar korona ta mutum.
Kuma daga wannan ra'ayin, kwayar cutar korona a cikin bats ta kasance tsarin kwayoyin halitta na kwayar cutar korona a cikin mutane.
Bugu da ƙari, hanzari da kuma sake tsara kwayoyin halitta suna motsa ci gaban kwayar cutar korona ta mutum kuma su ne muhimman abubuwa biyu a cikin wannan aikin.
Alal misali, samun ko rasa sabon ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta na ƙwayoyin cuta ya ƙunshi ikon gyara yanayin ƙwayar cuta sosai.
Daga cikin sunadarai masu tsara SARS-CoV, ana ganin cewa ORF8 yana da mahimmanci wajen daidaitawa da mutane, saboda an ware SARS-CoV da ke da alaƙa da ƙwayoyin cuta a cikin bats amma an gano cewa yana ɓoye sunadarai daban-daban na ORF8.
An gano cewa abubuwa 29 na kawar da ƙwayar cuta na SARS-CoV sun kasance a cikin jinsunan da aka ware a farkon annobar.
Wannan cirewa ya haifar da rabuwa na ORF8 zuwa ORF8a da ORF8b, kuma an yi imanin cewa shi ne juyin juya halin da ke ƙarfafa musayar gidaje.
Bugu da ƙari, SARS-CoV yana da tarihin sake haɗuwa da yiwuwar ta hanyar kwayar cutar Corona alpha da gamma, inda aka gano ƙananan yankunan sake haɗuwa a cikin polymerase na RNA mai dogara da RNA.
An kuma gano wuraren sake saiti a nsp9, da yawancin nsp10, da kuma sassan nsp14.
A wani ɓangare kuma, bincike ya nuna cewa cutar ta MERS-CoV ta sami sake haɗuwa tsakanin jinsuna daban-daban, wanda ya faru a cikin kyakkyawa ta Sunni kawai a Saudiyya.
Baya ga SARS-CoV da MERS-CoV, an kuma lura da sake haɗuwa a wasu ƙwayoyin cuta na mutum, inda ƙwayoyin cuta na mutum suka haɗu da wasu ƙwayoyin cuta na dabba a cikin kwayoyin halitta na su.
Ya kamata a lura cewa zabin mutum na iya taimakawa wajen canja al'adun ƙwayoyin cuta ba da gangan ba, wanda yawancinsa ya fito ne daga kawar da ƙwayoyin cuta daga matsin lamba, kamar yadda tsarin rigakafin mai masaukin baki yake yi.
Rashin furotin ORF4 mai tsawon lokaci a cikin tsarin bayyanar cututtukan mutum na coronavirus-229E saboda kawar da nucleotides biyu misali ne na waɗannan tasirin.
Ko da yake ana iya lura da ORF4 mai kyau a cikin ƙwayoyin cuta na kamara da na bats wanda ke da alaƙa da kwayar cutar corona ta mutum-229E, kwayar cutar corona alfa da ke cutar da alpaca tana nuna ƙwayoyin nucleotide guda ɗaya, wanda ke haifar da haɓakar tsarin.
A ƙarshe, ci gaban sabon kwayar cutar korona yana motsa su su zaɓi wuraren da suke ajiye su.
An gano wasu cututtuka da ba su da alamun bayyanar cututtuka ko kuma marasa tsanani a lokacin da bats suka kamu da kwayar cutar korona, wanda ke nuna cewa kwayar cutar ta kamu da juna.
Ta nuna cewa bats sun dace da kwayar cutar ta Corona a fannin tiyata da na ilimin halitta.
Alal misali, an rage rage rashin ƙarfi na maganin rigakafi a cikin bats ta hanyar rage tasirin cututtukan da kwayar cutar Corona ke haifarwa.
Bugu da ƙari, an hana aikin halitta na kwayoyin halitta a cikin bats saboda ƙaruwar ƙwayar cuta mai ƙonewa NKG2/CD94 da kuma rage yawan kwayoyin ƙwayoyin ƙwayoyin cuta na farko.
Bugu da ƙari, yawan adadin oxygen da ke tattare da kwayoyin halitta da ke fitowa daga ƙwayar cuta na bats zai iya haifar da kwayar cutar corona da kuma tasirin gyara ta hanyar ribonuclease na waje, don haka yana ba da matsin lamba don samar da kwayoyin cutar da ke da cutar sosai lokacin da aka kamu da sabon mai masaukin baki.
Ana iya samun wasu kwayoyin cutar daga kwayar cutar ta hanyar sake fasalin, kuma hakan yana haifar da sabon furotin ko kuma sabon fasalin furotin don daidaitawa da mai masaukin.
Saboda haka, ba zato ba tsammani ba ne mutum ya kamu da cututtukan corona guda uku a cikin shekaru 20 da suka gabata.
Kwayar cutar Corona ba ta haifar da cututtuka ko kuma ta haifar da bayyanar cututtuka a cikin gidajen ajiya kamar kwari da kuma raƙuma.
Suna kwafin da ƙarfi ba tare da yin tasiri mai ƙarfi daga mai masaukin ba.
Wannan shi ne ainihin abin da ke sa mutane da ke dauke da cutar su ga rashin bayyanar cututtuka da kuma abin da ke sa mutane su kamu da cutar.
Abubuwan da ke faruwa a cikin jiki suna haifar da yawan ƙwayar cuta da kuma yawan ƙwayar cytokine, kuma idan ƙwayar cuta ta yi ƙarfi, cutar ta ƙaru sosai.
Akasin haka, a cikin masu dauke da cutar da ba su da wata alama, maganin rigakafi ya bambanta da kwafin cutar korona.
Irin wannan dabarar ta hana rigakafin jiki na iya zama da amfani wajen magance SARS-CoV-2.
Halin da ake amfani da interferon yana da ƙarfi sosai a bats.
Saboda haka, ana iya amfana daga shan interferon na nau'i na I aƙalla a farkon matakin kamuwa da cutar Cov-2 a cikin mutum.
Bugu da ƙari, ƙwayar ƙwayar cuta mai suna cryopyrin NLRP3 a cikin bats ba ta da ƙarfi.
Da wannan tunanin, hana ƙwayar cuta mai suna cryopyrin NLRP3 ta amfani da maganin hana cuta na MCC950 yana da amfani wajen magance COVID-19.
An samo SARS-CoV-2 ne bisa ra'ayin da aka samo asali daga SARS-CoV da MERS-CoV.
A lokacin da aka gano cewa SARS-CoV na cutar beta a cikin bats yana da kashi 95% na haɗin nucleotide, akwai kuma wani coronavirus a cikin bats wanda ke da kashi 96% na haɗin nucleotide tare da SARS-CoV-2.
Amma an gano cewa kittens da sauran dabbobi a kasuwa suna da ƙwayoyin cuta irin na SARS-CoV-2 amma ba su gano masu watsa shiri na SARS-CoV-2 ba.
An gano kwayar cutar Corona Beta a cikin naman kaza wanda ke da matukar jituwa da SARS-CoV-2, wanda ke nuna cewa naman kaza na iya zama mai masaukin baki ko kuma kwayar cutar Corona Beta a cikin naman kaza ta ba da gudummawa ga cututtukan kwayoyin halitta wanda ya haifar da samun sigar SARS-CoV-2 ta ƙarshe.
Ko da yake har yanzu ana tambayar tambayoyi, babu wata hujja cewa SARS-CoV-2 na mutum ne da gangan ko kuma ta hanyar haɗari.
An sake mayar da hankali kan cutar korona saboda barkewar cutar SARS-CoV-2.
Nazarin kwayar cutar korona a cikin bats da sauran dabbobi ya canza tunaninmu sosai game da muhimmancin asalin cututtukan dabbobi da kuma wuraren da kwayar cutar korona ta mutum ke gudana a cikin mutum.
Shaidar da ke cikin Damming ta nuna cewa SARS-CoV, MERS-CoV da SARS-CoV-2 duk sun samo asali ne daga bats kuma sun koma ga mutane ta hanyar masu watsa shiri.
Saboda cutar SARS-CoV ta samo asali ne daga tuntuɓar mutane da cats a cikin kasuwanni, an yi zaton rufe kasuwanni don sababbin kayayyaki da kashe cats zai kawo ƙarshen cutar SARS.
A daidai wannan yanayin, ya kamata a kawar da dabbobi masu cin naman kaza daga kasuwannin kayayyaki don hana yaduwar cutar da dabbobi suka haifa, a cikin yanayin gano wasu zuriyar cutar Corona beta a cikin naman kaza, wanda ke da alaƙa da SARS-CoV-2.
Ko da kuwa SARS-CoV-2 ya koma ga mutane ko a'a, ko da wane irin hanyar da ya wuce, ta hanyar dabbobi masu cin ganyayyaki da sauran dabbobi masu shayarwa, har yanzu batun da ake bukatar a bayyana shi a bincike na gaba ne.
A wani bangare kuma, an gano Merce-Cove a cikin kyakkyawa mai kyau na dogon lokaci.
Wannan kyakkyawa hanya ce mai muhimmanci ta sufuri, kuma babbar hanyar samun nama, madara, fata, da kayayyakin ulu ga 'yan ƙasar.
An yi amfani da shi sosai a dukan Gabas ta Tsakiya da Afirka.
Saboda haka, ba za a iya yin hadaya mai kyau ba don sarrafa cutar MERS, kamar yadda jami'an kasuwannin dabbobi na kasar Sin suka yi don hana yaduwar SARS-CoV-2 da SARS-CoV-2 ya yadu.
Don hana cutar ta kamuwa da cutar, ya kamata a yi amfani da tsarin yin allurar rigakafi mai tasiri don cutar ta kamuwa da cutar, da kuma wasu matakan yaki da kamuwa da ita.
Domin mu kasa kawar da waɗannan ƙwayoyin, za a iya samar da sababbin kwayoyin halitta da za su iya haifar da barkewar cutar.
Akwai nau'o'in cututtukan korona da ke tattare da cututtukan dabbobi da ke faruwa a cikin namun daji.
Musamman, kwayar cutar korona tana da bambanci sosai a cikin bats wanda ke da yiwuwar haifar da cututtukan dabba.
Akwai dama mai yawa na kamuwa da cutar korona da ke tattare da cututtukan dabba, wanda ke haifar da sabon coronavirus wanda zai iya kamuwa da cutar da kuma/ko kisa a cikin mutum a nan gaba.
Ya kamata a daina cin dabbobi a wasu wurare a kasar Sin don rage rashin bukatar dabbobi da mutane.
A cikin mawuyacin yanayi da SARS, MERS da COVID-19 suka yi wa 'yan Adam, ya kamata a shirya shirin shiri da kuma amsawa.
Gaskiyar ita ce, yawancin ƙwayoyin cuta sun daɗe suna rayuwa a duniya.
Suna zama a cikin ɗakunan ajiyarsu har sai sun samu damar yin yaduwa.
Ko da yake bats suna da halaye da yawa da ke hana yaduwar ƙwayoyin cuta, za a iya rage haɗarin mutum ya tuntuɓi bats da sauran nau'in dabbobin daji idan mutane suka ɗauki al'adun da ke tilasta musu kaucewa su.
Kula da dabbobi masu shayarwa a kai a kai hanya ce da ake bukata don samun kyakkyawar fahimtar yanayin da ke tattare da kwayar cutar Corona da kuma waɗanda suke karɓar bakinsu, wanda ya tabbatar da amfaninta wajen hana su wucewa daga dabbobi zuwa mutane da kuma hana su bayyana a nan gaba.
A ƙarshe, hanya mafi kyau ta hana cututtukan dabba na ƙwayoyin cuta ita ce ta nisanta mutum daga yanayin da ke tattare da wuraren ajiyar ƙwayoyin cuta na dabba.
A yau, akwai tambayoyi da yawa da za a iya amsawa game da asalin cutar da ke tattare da dabbobi.
Da farko, idan bats sun ba da cutar SARS-CoV-2 ga tsutsa-tsutsa, yana da muhimmanci a san yanayin da ya sa tsutsa-tsutsa da tsutsa-tsutsa suka shiga wannan yanayin.
Na biyu, idan bats suna da tasiri sosai wajen kai cutar ga mutane, to, ya kamata a san yadda mutane za su yi magana da su.
Na uku, idan nau'in dabbobi masu shayarwa na uku ne ainihin matsakaici, to, ya kamata a bayyana yadda suke hulɗa da nau'i-nau'i daban-daban, ciki har da mutum, bats da kuma tsutsa masu cin nama.
A ƙarshe, tun da yake ana iya zargin dabbobi masu shayarwa da yawa da suke da cutar SARS-CoV-2, dole ne a lura da su kuma a yi gwaji.
Ko mai masaukin baƙo ne, ko kuma tsutsa mai cin nama ko wasu dabbobi masu shayarwa, ana sa ran za a gano SARS-CoV-2 ko kuma wanda zai zama mahaifinsa wanda zai zama kusan daidai da mahaifarsa na gaba.
Bincike na ci gaba a wannan fannin zai bayyana ci gaban SARS-CoV-2 a cikin dabbobi, tare da muhimman matakai don hana COVID-19 a cikin mutane da kuma yaƙi da shi.
Ana bukatar a sabunta ka'idodin "mugun da aka yi wa laifi" da kuma "mugun da aka tabbatar" a lokacin da aka gano cewa kana da cutar COVID-19.
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta wallafa wani jagora mai sauri game da ganowa da magance kamuwa da cutar COVID-19 (COVID-19) kuma wannan jagorar ta ba da kwarewarmu da kuma samar da bayanan tunani masu dacewa don magance cutar a duniya.
Ko da yake cutar korona ta 2019 (COVID-19) sabuwar cuta ce, hankali da sani na mu suna ƙaruwa bisa sakamakon bincike da kuma gwajin asibiti; saboda haka ana sabunta hanyoyin bincike da magani a kai a kai.
A cikin wannan jawabin, mun amsa ga wani bayani mai ban mamaki game da jagorarmu kuma mun gabatar da sababbin ka'idodin ganewar asali, "Halin da ake zargi" da "Halin da aka tabbatar", bisa ga sabon jagorar ganewar asali na COVID-19 da magani (sarrafa na 7) na Hukumar Lafiya ta Kasa ta Jamhuriyar Sin.
A watan Disamba na 2019, sabon kwayar cutar Corona 2019 (Covid-19) ta barke, wanda yanzu aka sani da cutar COVID-19 kuma an sanya wa cutar sunan cutar Corona 2 da ke da alaƙa da cututtukan numfashi mai tsanani (SARS-CoV-2).
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya ta bayyana COVID-19 a matsayin annoba.
Don magance cutar SARS-CoV-2, ƙungiyarmu ta tsara jagora mai sauri kuma ta buga ta a kan layi a cikin mujallar Military Medical Research a ranar 6 ga Fabrairu, 2020.
Ya samu karbuwa sosai tun lokacin da aka wallafa shi.
Ka lura cewa ko da yake COVID-19 sabuwar cuta ce, hankali da sani namu suna ƙaruwa bisa sakamakon bincike da kuma gwajin asibiti; saboda haka ana sabunta hanyoyin bincike da magani a kai a kai.
Alal misali, a tsakanin 16 ga Janairu 2020 da 3 ga Maris 2020, an fitar da jagororin bincike da maganin COVID-19 na Hukumar Lafiya ta Kasa ta Jamhuriyar Sin (http://www.nhc.gov.cn), jimlar fitowa bakwai tare da wasu mahallin da aka canza.
Yanzu, shawarwarinmu na jagora sun amsa da wani bayani daga Chu da wasu, waɗanda suka gabatar da wata shawara mai sauƙi don lura da maki bisa ga gwaji na asibiti.
Ƙoƙarce-ƙoƙarcen su sun ƙara sabon jagora ga jagorancinmu kuma sun zama muhimmin abin da ya shafi wannan annoba a dukan duniya.
Muna goyon bayan ƙoƙarinsu kuma muna nuna godiya.
Duk da haka, aikin su na bukatar a sabunta shi bisa ga sabon jagororin bincike da magani na COVID-19 (suna na bakwai) da kuma sabon bincike.
A cewar fitowar ta bakwai (3 ga Maris, 2020), tabbatar da yanayin da ake zargi yana buƙatar haɗuwa da kowane ɗayan abubuwan tarihin cutar ta cutar da abubuwa biyu na bayyanar asibiti don samun cikakken bincike, ko kuma yana buƙatar tabbatar da abubuwa uku na abubuwan asibiti idan babu bayyanar tarihin cutar ta cutar:
Tarihin cutar ta kamuwa da cuta: (1) Tarihin da ya shafi tafiya zuwa birnin Wuhan da kewaye da shi, ko wasu al'ummomin da aka ruwaito sun kamu da cutar COVID-19 ko kuma sun zauna a ciki, a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (2) Tarihin da ya shafi sadarwa tare da mutane da ke kamuwa da cutar SARS-CoV-2 (tare da sakamako mai kyau na gwajin DNA); (3) Tarihin da ya shafi sadarwa tare da marasa lafiya da ke fama da zazzabi ko cututtuka na numfashi daga birnin Wuhan da kewaye da shi ko wasu al'ummomin da aka ruwaito sun kamu da cutar COVID-19 a cikin kwanaki 14 da suka gabata kafin bayyanar cututtuka; (4) Tarihin da ya shafi sadarwa tare da mutane da suka kamu da cutar (wanda ya shafi fiye da 2 daga cikin gidajen aiki da kuma wasu ƙananan hukumomi ko wuraren aiki da aka yi a cikin gidajen aiki da kuma a cikin gidajen aiki da kuma a cikin gidajen aiki da kuma a cikin gidajen aiki da kuma a cikin gidajen aiki da kuma a cikin gidajen aiki da kuma a cikin gidajen aiki.
Bayanan asibiti: (1) zazzabi da/ko alamun tsarin numfashi; (2) tare da halaye da aka tabbatar da gwajin hoto na kamuwa da COVID-19; (3) nuna yawan adadin ƙwayoyin fari na jini a matakin al'ada, ko kaɗan, ko kuma ƙananan adadin lymphocytes a farkon farkon kamuwa da cutar.
Dole ne ganewar asali ya kasance bisa ga yanayin da ake zargi da wanda ya ƙunshi wani daga cikin abubuwan da ke nuna cewa akwai masu cutar ko kuma maganin maganin jini a cikin jini kamar haka: (1) tabbatacce sakamakon gwajin PCR na SARS-CoV-2 na ainihi; (2) daidaitaccen tsarin kwayoyin cuta na cikakken kwayar cuta tare da sanannun halayen kwayar cutar Corona; (3) tabbataccen sakamakon gwajin IgM da IgG na SARS-CoV-2 a cikin jini; ko canzawar IgG na SARS-CoV-2 daga mummunan zuwa tabbatacce, ko kuma cewa matakin da aka samu a lokacin farfadowa ya yi daidai da ko fiye da 4 sau a matakin da ya dace a wannan yanayin.
Mun ga an ƙara gwajin ainihin lokacin polymerase na DNA a cikin hanyoyin numfashi ko kuma a cikin jini zuwa na biyu (18 ga Janairu, 2020) da na uku (22 ga Janairu, 2020).
An ƙara gano abubuwan da ke haifar da cututtuka a cikin samfurin jini zuwa fitowar na huɗu (27 Janairu 2020) da na biyar (8 Fabrairu 2020); sannan an ƙara littafin jagorar maganin jinin jini zuwa fitowar na bakwai.
Waɗannan gyare-gyaren sun dogara ne akan ci gaba da aikin masu bincike don su ƙera cikakken kayan aikin gano DNA don saurin ganewa, da kuma samfurin numfashi ciki har da samfurin jini, wanda ya haifar da haɓaka samfurori daban-daban, da tallafawa canja wurin sakamako mai kyau na antibody zuwa ka'idodin yanayin da aka tabbatar.
Bugu da ƙari, akwai ƙarin tabbaci da ke sa mu yi hankali sa'ad da muke bi da marasa lafiya da ba su da alamun bayyanar cututtuka da kuma yanayin da ba su da alamun bayyanar cututtuka.
Saboda haka, ya kamata mu sabunta abubuwan da ke cikin tsarin bayanan da Shu da sauransu suka yi, inda suka sanya mutumin da ba shi da alamun asibiti a matsayin "ƙarancin haɗari".
Tsarin saka idanu na digiri yana bukatar a tabbatar da lafiyarsa a cikin aikinsa da kuma ƙarin nazarin asibiti.
A ƙarshe, muna fatan samun ƙarin hujjoji kai tsaye kuma muna gayyatar masu karatu su ba mu ra'ayoyinsu.
Don gano "abin da ake zargi da abin da aka tabbatar", muna kira ga a bi sababbin shawarwari daga ƙasashen da mutane suke zama kuma a bi su.
Ƙungiyarmu za ta ba da umurni a lokacin da ya dace don taimaka mana.
Bangladesh ta samu sabbin mutane biyar da suka mutu sakamakon cutar COVID-19, wanda ya fi kowacce rana
Bangladesh ta tabbatar da cewa mutane biyar sun mutu a ranar saboda cutar COVID-19.
Wannan shi ne adadin mutuwar da aka yi a rana daya da cutar.
Cibiyar Kula da Cututtuka da Cututtuka da Bincike (IEDCR) ta Bangladesh ta ruwaito cewa, har zuwa jiya, adadin wadanda suka kamu da cutar sun kai 114 da suka yi aiki kuma 33 sun warke daga gidajen.
An samu mutuwar mutane 17.
Daraktan Cibiyar Kula da Cututtuka da Cututtuka da Bincike, Dr. Mirjadine Sabrina Flora, a wani taron manema labarai na kan layi, ta ruwaito cewa, mutuwar ta shafi maza hudu da mace guda.
Kamar yadda Dr. Mergady ya ambata, akwai mutane biyu da suka wuce shekara 60, da kuma mutane biyu da suka kai shekaru 51 zuwa 60, da kuma mutum daya da ke tsakanin shekaru 41 zuwa 50.
Ta kuma ce mutum biyu daga cikin mutanen da suka mutu sun fito ne daga Dhaka.
Hukumar lafiya ta duniya (WHO) ta bayyana COVID-19 a ranar 11 ga Maris.
Wani jami'in asibitin Anadolu, wata hukumar yada labarai ta kasar, ya ce daya daga cikin wadanda suka mutu shi ne Jalal Seif Rahman, darektan hukumar yaki da cin hanci da rashawa ta Bangladesh, wanda ake kula da shi a asibitin Kuwait Maitrey.
Ministan sufuri da gadaje na Bangladesh, Abd al-Qadar, a cikin wata sanarwa ta yanar gizo a ranar Asabar, ya ce, jigilar jama'a za ta tsaya har zuwa ranar Asabar mai zuwa.
An fara kashe zirga-zirgar jama'a a ranar 26 ga Maris kuma an shirya kashewa a ranar Asabar, 4 ga Afrilu.
Har yanzu ana ba da izinin jigilar kayayyaki masu muhimmanci, wato, kayayyakin kiwon lafiya, man fetur da abinci.
An yi rahoton kamuwa da COVID-19 na farko a Bangladesh a ranar 8 ga Maris, ga mutane biyu da ba Italiya ba, da kuma matar ɗaya daga cikinsu.
Dukansu uku sun warke a ranar 19 ga Maris.
Yawan wadanda suka kamu da cutar SARS-CoV-2 ya zarce miliyan biyu a duniya.
Bayanai daga Jami'ar Johns Hopkins a ranar Alhamis sun nuna cewa jimillar mutane da suka kamu da cutar coronavirus da ke haifar da cutar ta numfashi mai tsanani ta wuce miliyan 1 a duniya.
Cutar COVID-19 da ke tattare da cutar korona ta kashe mutane aƙalla 52,000.
Wannan ci gaba mai tsanani ya faru a ranar da Malawi ta tabbatar da cewa an fara samun kamuwa da cutar korona, kuma an yi rahoton mutuwar farko a Zambia.
Koriya ta Arewa ta ce tun ranar Alhamis ta kasance daya daga cikin kasashe kalilan da har yanzu ba su da cutar korona.
Hukumar lafiya ta duniya ta bayyana mutum 105,1635 da suka kamu da cutar a yau, ciki har da mutum 79,332 a cikin sa'o'i 24 da suka gabata da misalin karfe 10 na safe na tsakiyar Turai (sa'a 0800 na ranar 4 ga Afrilu).
An samu kamuwa da cutar korona fiye da 244,000 a Amurka, kuma an yi sanadiyar mutuwar mutane 5,900.
Labarin CBS News, bisa ga bayanan jami'ar Johns Hopkins, ya ruwaito cewa a ranar Laraba, an samu mutuwar sama da 1,000 a Amurka sakamakon kamuwa da cutar korona.
Kasashe a faɗin duniya sun sanar da tsauraran matakan hana yaduwar cutar.
A ranar Alhamis, magajin birnin Moscow, Sergei Sobyanin, ya sanar da cewa za a rufe birnin har zuwa ranar 1 ga Mayu.
A kasa, Shugaba Vladimir Putin ya sanar da cewa za a ci gaba da biyan albashi ga 'yan Rasha ba tare da su je aiki ba har zuwa ranar 30 ga Afrilu.
Majalisar dokokin Portugal ta amince da tsawaita dokar ta baci ta kasa na kwanaki 15; ta amince da kuri'un 215, ta ƙi kuri'u 10, kuma ta ƙi da kuri'u daya.
Saudiyya ta tsawaita dokar hana zirga-zirga a biranen Makka da Manura zuwa tsawon yini, inda a baya daga karfe 3 na yamma zuwa karfe 6 na safe.
Thailand na shirin yin dokar hana zirga-zirga daga karfe 10 na yamma zuwa karfe 4 na safe.
Gwamnan jihar Ohio, Mr. Mike D. Wayne, ya sanar da cewa jihar ta tsawaita dokar zama a gida har zuwa ranar 1 ga Mayu.
Shagunan Australiya suna rage yawan kuɗin da ake saya don yin magani
Shagon Wal-Worth & Co. na Australiya sun yi ta yin amfani da takardar bayan gida don rage yawan sayensu zuwa shaguna biyu na Wal-Worth da shaguna guda ɗaya na Co.L.S. a kowace ma'amala a duk rassan ƙasar.
A ranar Litinin ne na sa shagon Aldi ya yi wani abu.
An wallafa waɗannan takunkumin a matsayin wasiƙu a wuraren biyan kuɗi a cikin shagunan sayar da kayayyaki da kuma shafukan Facebook.
Rahotanni sun nuna cewa masu sayen sun ajiye su saboda tsoron COVID-19 idan mutane suka bukaci zaman kansu.
A ranar Laraba, shaguna na Wall Worth sun amince da takunkumin da ke hana masu kawo takardar bayan gida zuwa gidaje don yin kwalliya ɗaya don kowane sayayya.
Waɗannan canje-canjen sun zo ne bayan an amince da takunkumin da aka yi a shagon Wall Worth a ranar 4 ga Maris da kuma shagon Coles a ranar 5 ga Maris don ba da izinin sayen nau'i hudu kawai a kowace ma'amala.
Shagunan Coles sun ruwaito a cikin sanarwar da suka fitar a ranar 8 ga Maris cewa duk da cewa an yi amfani da takunkumin nau'i hudu, "shagunan shaguna suna ci gaba da sayar da duk abin da suke da shi a cikin sa'a daya da karɓar shi", kuma sun bayyana buƙatar a matsayin "ba a taɓa gani ba", kamar yadda Aldi Stores ta bayyana a cikin wata sanarwa a Facebook a ranar Talata a matsayin "ba zato ba tsammani".
A makon da ya gabata, tallace-tallace sun ƙaru sosai, in ji wani mai magana da yawun Wal-Worth.
A makon da ya gabata, kantin sayar da kayayyaki na Costco a Canberra ya ce adadin da za a iya saya shi ne faftan.
Don rage ƙarancin, shagunan Coles sun nemi masu samar da kayayyaki su ƙara yawan kayayyaki da kuma saurin kawo kayayyaki, kuma sun nemi ƙarin kayayyaki a Wal-Worth, yayin da shagunan Aldi suka ba da kayayyakinsu don bukukuwa na musamman da aka shirya a ranar Laraba.
Russell Zimmerman, babban darektan kungiyar 'yan kasuwa ta Australiya, ya ce 'yan kasuwa suna ƙoƙarin ƙara yawan kayayyaki, amma ƙuntatawa na hukumar ta gida game da lokacin isar da manyan motoci yana sa hakan ya yi wuya.
Ana sa ran farashin samarwa zai yi girma, domin masu samarwa suna ƙoƙarin biyan bukatar, tare da ƙarancin kayayyaki na musamman.
A ranar Talata, shaguna na Aldi sun sanar da cewa, saboda an samu kayayyakin da wuri, wasu shaguna ba za su iya ba da kyautar ranar Laraba ba.
Wani masanin sayar da kayayyaki a jami'ar Queensland na fasaha, Dokta Gary Mortimer, ya ruwaito a wani rahoto da ya wallafa a News.com.au cewa shaguna suna cika shaguna a kowace dare.
Ya ce takardar bayan gida abu ne mai girma, wanda ke sa yawan kayayyaki ya ragu, kuma idan aka sayar da shi gaba ɗaya, yana barin sarari a kan ɗakunan ajiya, wanda ke ƙara ƙarancin abinci.
Russell Zimmerman, a cewar ABC News, ya ce: "Shops na Coles da Wal-Worth suna da ra'ayi cewa idan akwai kayayyaki da yawa a kan ɗakunan ajiya, kuma idan za a iya [saya] kayayyaki kamar su wando da kuma rigakafi a adadi mai yawa, hakan zai iya rage tsoro".
Kamfanin da ke kera takardar bayan gida da ake sake amfani da ita, wanda ake kira Who Gives a Crap, ya ce a ranar Laraba da ta gabata, kayayyakin da ake ajiyewa sun ƙare.
A cewar wani rahoto daga News.com.au, Kamfanin Cumberly-Clark, wanda ke samar da wando na gidan wanka na Clinix, da Solaris Pepper, wanda ke samar da wando na Surbent, sun tabbatar da cewa suna aiki 24/7 don ci gaba da samar da kayayyakinsu.
Wani shafin yanar gizon gidajen ƙasa mai suna Domain.com ya nuna cewa wasu masu sayar da gidaje suna ba da takardar wanka kyauta ga mai ba da kyauta na farko a cikin gwanjon Melbourne, yayin da aka yi ƙananan gwanjo saboda masu siye sun daina aiki a ƙarshen mako mai tsawo na ranar Al'umma.
A ranar Alhamis, jaridar NTV News, wata jaridar yau da kullum da ke birnin Darwin, ta wallafa wasu shafuka takwas da aka yi da za a iya yanke su kuma a yi amfani da su a matsayin kayan wanka.
Da farko, shagunan sun yi jinkiri game da takunkumin, a cewar wani rahoto da BBC ta fitar a ranar 3 ga Maris; inda shagunan suka ce ba su da shirin takunkumin sayayya.
Russell Zimmerman ya ƙara da cewa akwai bukatar kayayyaki da yawa, har da kayan kwalliya, kayan hanawa, kayan bushewa, wanke hannu, da kuma gari.
A waje da Ostiraliya, a ranar Lahadi da yamma, wani shagon intanet na Burtaniya mai suna Okado ya lura cewa ya tsara sayan takardar bayan gida ta Andres a cikin takardun shafuka 12.
Hukumar lafiya ta duniya ta bayyana cewa COVID-19 na da ciwo
Hukumar lafiya ta duniya WHO ta sanar a ranar Laraba cewa ci gaba da barkewar cutar COVID-19 - cuta da cutar coronavirus da ke tattare da cututtukan numfashi mai tsanani da ake kira SARS-CoV-2 - ta kai matakin annoba.
Ko da yake kalmar "zazzabi" tana nufin yadda cutar ta yadu, ba yadda yanayin da ke faruwa yake da tsanani ba, WHO ta yi gargaɗi cewa ya kamata gwamnatoci su ɗauki matakan da suka dace:
"Dukkanin kasashe za su iya canja yanayin annobar.
Babban darektan Hukumar Lafiya ta Duniya, Tedros Adhanom Gibresos, ya ce: "Idan ƙasashe sun gano, sun yi bincike, sun warkar da mutane, sun ware su, sun biye musu, kuma sun tattara su don fuskantar".
"Dukanmu muna matukar damuwa game da yadda ake yaduwa da kuma yadda ake nuna hadarin da ake yi da kuma yadda ake nuna hadarin".
Kamar yadda Dokta Tom Freuden, tsohon darektan cibiyoyin hana cututtuka a Amirka ya ce, wannan annoba "ba ta taɓa faruwa ba".
A wata sanarwa da CNN ta wallafa a watan Fabrairu, ya ce, "Ba a bi hanyar wani kwayar cutar numfashi ba tun daga farkon bayyanar zuwa ci gaba da yaduwar duniya, banda mura".
Gibresus ya yi irin wannan bayanin: "Ba mu taɓa fuskantar annoba da ta faru da wani kwayar cutar korona ba".
Ya ci gaba da cewa: "Ba mu taɓa ganin wata annoba da za a iya sarrafawa a lokaci guda ba".
An bayyana sabon yanayin a matsayin annoba bayan Hukumar Lafiya ta Duniya a watan Janairu ta bayyana cewa cutar ta haifar da dokar ta baci ta kiwon lafiya ta duniya.
Darakta Anthony Fauci, darektan Cibiyar Kula da Cututtuka da Cututtuka ta Ƙasa a Amirka, ya ce game da annobar: "Abin da ya fi muhimmanci shi ne cewa abubuwa za su ƙara muni".
Hukumar ta Associated Press ta ruwaito cewa, aƙalla mutane 126,000 ne suka kamu da cutar COVID-19 a duniya tun ranar Alhamis, kuma fiye da 4,600 sun mutu.
Cutar cutar Corona 2019-20 cuta ce ta cutar Corona 2019 (Covid-19), wadda ta haifar da cutar Corona 2 da ke da alaƙa da cututtukan numfashi mai tsanani (SARS-CoV-2).
An gano barkewar cutar a Wuhan, China, a watan Disambar 2019, kuma an ayyana ta a matsayin dokar ta baci ta lafiyar jama'a ta kasa da kasa a ranar 30 ga Janairu, 2020, kuma an bayyana ta a matsayin annoba a ranar 11 ga Maris, 2020.
A ranar 10 ga Afrilu, 2020, an samu kimanin mutane miliyan 1.61 da suka kamu da COVID-19 a kasashe da yankuna 210 kuma hakan ya yi sanadiyar mutuwar mutane 97,000.
Mutane 364,000 ne suka warke.
Ana kiyasta cewa a ƙasar Sin, yawan mutuwar mutane ya kai kashi 4 cikin ɗari, a duniya kuma, ya kai kashi 13.04 cikin ɗari a ƙasar Aljeriya da kuma 0.08 cikin ɗari a ƙasar New Zealand.
Alamun da aka fi sani sun haɗa da zazzabi, tari da kuma rashin numfashi.
Abubuwan da ke faruwa a cikin wannan cuta sun haɗa da kumburi da kuma ciwon hanta na numfashi.
Lokaci tsakanin kamuwa da cuta da bayyanar cututtuka yawanci kwanaki biyar ne, amma zai iya kasancewa daga kwana biyu zuwa kwana goma sha huɗu.
Babu maganin rigakafi ko magani na musamman na cutar.
Maganin farko shi ne magani mai taimako da kuma na bayyanar cututtuka. Abubuwan da ake ba da shawara na rigakafi sun haɗa da wanke hannu, rufe baki a lokacin tari, kula da mutane, da kuma kula da waɗanda ake zargi da cutar.
Hukumomi a duk faɗin duniya suna amsa wannan haɗarin ta hanyar hana tafiya, hana yin amfani da dutse, hana tafiya, kula da haɗarin wuraren aiki da rufe wuraren aiki.
Wannan annoba ta haifar da rikice-rikice na zamantakewa da tattalin arziki a duniya, jinkirta ko soke wasanni, addini, siyasa, al'adu, da kuma rashin wadata mai yawa da aka kara daɗa saboda tsananin cin kasuwa.
An rufe makarantu da jami'o'i a ƙasashe 193 ko kuma a gida, wanda ya shafi kusan kashi 99.4 cikin ɗari na yawan ɗaliban duniya.
Bayanai marasa kyau game da cutar sun bazu a Intanet, kuma akwai wasu abubuwan ta'addanci na kasashen waje da nuna bambanci ga Sinawa, da sauran mutanen da suka fito daga Gabas da kudu maso gabashin Asiya, da kuma wasu yankunan da aka samu manyan cututtuka na cutar.
Saboda rage yawan tafiye-tafiye da kuma rufe masana'antu masu nauyi, an rage gurɓataccen iska da kuma fitar da iskar carbon.
Hukumomin lafiya a birnin Wuhan (babban birnin lardin Hubei) na kasar Sin sun sanar da wasu mutane da suka kamu da cutar huhu saboda wani dalili da ba a san dalilin ba a ranar 31 ga Disamba, 2019, kuma an fara binciken a farkon Janairu, 2020.
Ana yawan samun cututtuka a kasuwar sayar da kayan teku ta Wuhan, saboda haka ana ganin cewa kwayar ta fito ne daga dabbobi.
An san cutar da ta haifar da fashewa da SARS-CoV-2, sabon kwayar cutar da aka gano kuma tana da alaƙa da kwayar cutar Corona a cikin bats, da kwayar cutar Corona a cikin abincin tururuwa, da SARS-CoV. Daga baya an gano cewa mutumin da ya fara nuna alamun ya kamu da cutar a ranar 1 ga Disamba, 2019, kuma wannan mutumin bai da wata alaƙa da alamar ruwa da aka gano daga baya.
Daga cikin tarin farkon shari'o'in da aka ruwaito a watan Disamba na 2019, kashi biyu bisa uku sun kasance suna da alaƙa da kasuwa.
A ranar 13 ga Maris, 2020, wani rahoto da ba a tabbatar da shi ba da jaridar South China Morning ya nuna cewa wani hali da aka samu a ranar 17 ga Nuwamba, 2019, mai shekaru 55 daga lardin Hubei, na iya zama farkon hali. A ranar 26 ga Fabrairu, 2020, WHO ta ruwaito cewa duk da cewa sabon yanayin da aka ruwaito a China ya ragu, amma ya karu a Italiya, Iran da Koriya ta Kudu, inda adadin sabbin mutane a waje da China ya wuce adadin sabbin mutane a ciki a karon farko.
Akwai ƙarancin rahoton cututtuka, musamman a cikin waɗanda ke da alamun rashin ƙarfi.
A ranar 26 ga Fabrairu, an ruwaito ƙananan lamuran a tsakanin matasa, inda masu shekaru 19 da ƙasa suka kai kashi 2.4% na lamuran a duk duniya. Babban mai ba da shawara kan kimiyya a Burtaniya, Patrick Vallance, ya kiyasta cewa 60% na Britaniyawa suna bukatar kamuwa da cutar kafin a yi rigakafin garken da ke aiki.
An gano adadin mutanen da aka gwada su da COVID-19 kuma an tabbatar da cewa sun kamu da cutar bisa ga tsarin aiki.
A ranar 23 ga Maris, babu wata ƙasa da ta yi gwajin fiye da kashi 3 cikin 100 na yawanta, kuma ƙasashe da yawa suna da manufofin da suka ce ba za a yi gwajin ga waɗanda kawai suke da alamun rashin lafiya ba, kamar Italiya, Netherlands, Spain, da Switzerland.
Wani bincike da aka wallafa a ranar 16 ga Maris ya gano cewa kimanin kashi 86 cikin 100 na mutanen da suka kamu da COVID-19 ba a gano su a kasar Sin ba, har zuwa 23 ga Janairu, kuma cewa wadannan cututtuka da ba a rubuta su ne suka kai ga kamuwa da kashi 79 cikin 100 na mutanen da aka rubuta.
Bayanai na nazarin kididdiga da aka buga a ranar 30 ga Maris sun nuna cewa yawan wadanda suka kamu da cutar a Italiya sun fi na rikodin.
An kiyasta cewa an yi amfani da R0 don yin yaduwar COVID-19 a tsakanin 1.4 zuwa 2.4.
Wani bincike da Cibiyar Kula da Cututtuka ta Amirka ta wallafa ya nuna cewa zai iya zama 5.7.
Yawancin mutanen da ke da COVID-19 suna warkewa.
Ga waɗanda ba su warke ba, lokaci daga bayyanar cututtuka zuwa mutuwa yana tsakanin kwanaki 6 zuwa 41, kuma mafi yawan kwanaki 14.
A ranar 10 ga Afrilu, 2020, COVID-19 ya yi sanadiyar mutuwar kusan 97,000.
Kimanin kashi 80% na mutuwar a kasar Sin tun daga ranar 5 ga Fabrairu an mayar da hankali ne ga wadanda suka wuce shekaru 60, kuma kashi 75% na su na da cututtukan cututtukan zuciya, jini da ciwon sukari.
Yawan mutuwar COVID-19 na iya zama mafi girma, domin ba za su iya haɗa da mutanen da suka mutu ba tare da an gwada su ba - misali, a gida, ko a gidan kula da tsofaffi, da sauransu.
Bayanai na Italiya sun nuna cewa yawan mutuwar da aka yi a lokacin annobar ta fi adadin mutuwar COVID da aka yi a hukumance da yawa.
Mai magana da yawun Cibiyoyin Kula da Cututtuka da Rigakafin (CDC) a Amurka ya yarda "mun san cewa [ƙididdigar mutuwar da aka sanar] tana nuna ƙimar da ta fi gaskiya", wani abu da rahotanni na rahoto ke tallafawa wanda ke nuna rashin daidaito na ƙididdigar a Amurka. Irin wannan rashin kimantawa yana faruwa a cikin yanayin annoba; kamar cutar H1N1 na 2009 .
A ranar 1 ga watan Fabrairu ne aka fara samun mutuwar mutane a wajen kasar Sin a Philippines, kuma a ranar 14 ga watan Fabrairu ne aka fara samun mutuwar mutane a Faransa a wajen Asiya.
A ranar 28 ga Fabrairu, an yi rajistar mutuwar fiye da goma sha biyu a wajen ƙasar Sin a Iran, Koriya ta Kudu, da Italiya.
A ranar 13 ga Maris, fiye da kasashe da yankuna arba'in sun ba da rahoton mutuwar, a duk nahiyoyi sai dai a Antarctica. Ana amfani da matakan da yawa don ƙayyade mutuwar.
Wadannan adadi sun bambanta bisa ga yanki da lokaci, kuma suna shafar yawan gwaji, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani da lokacin da aka ɗauka tun lokacin da cutar ta fara, halaye na yawan jama'a kamar shekaru, jinsi, da lafiyar jama'a.
Bisa ga kididdigar jami'ar Johns Hopkins, adadin mutuwar da aka samu daga kamuwa da cuta a duniya ya kai kashi 6.0% (97,039/1,617,204) a ranar 10 ga Afrilu, 2020.
Lambar ta bambanta bisa ga yankin.
A China, ƙididdigar mutuwar kamuwa da cuta ta ragu daga kashi 17.3 cikin dari (ga waɗanda suka nuna alamun a tsakanin 1 zuwa 10 ga Janairu 2020) zuwa kashi 0.7 cikin dari (ga waɗanda suka nuna alamun bayan 1 ga Fabrairu 2020). Sauran ma'auni sun nuna yawan mutuwar shari'a (CFR) wanda ke nuna yawan mutanen da suka kamu da cutar da suka mutu, da kuma yawan mutuwar kamuwa da cuta (IFR) wanda ke nuna yawan mutanen da suka kamu (waɗanda suka tabbatar da kamuwa da cutar da waɗanda ba a tabbatar da kamuwa da ita ba) waɗanda suka mutu saboda cutar.
Waɗannan ƙididdigar ba su da wani tsari na lokaci kuma suna bin wani yanki na al'umma daga kamuwa da cutar zuwa ga yanayin.
Wasu masana kimiyya sun yi ƙoƙarin lissafa waɗannan lambobin ga wasu ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwar ƙwararrun ƙwararrun ƙwar ƙwararrun ƙwar ƙwar ƙwararrun ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙwar ƙ
Cibiyar Kula da Asibitoci ta Jami'ar Oxford ta kiyasta cewa yawan mutuwar kamuwa da cutar a duniya ya kai kashi 0.1 zuwa 0.39 cikin ɗari.
Wannan ƙididdigar ta dace da sakamakon gwajin farko na COVID-19 a Jamus, da kuma nazarin ƙididdiga da ke nazarin tasirin gwajin a ƙididdigar mutuwar.
Hukumar lafiya ta duniya ta tabbatar da cewa za a iya sarrafa cutar.
Ba a san lokacin da cutar ta fara da kuma tsawon lokacin da ta yi ba, kuma za su iya bambanta dangane da wurin.
Masig Boney na Jami'ar Pennsylvania ya ce: "Cikintaccen annoba da ta fi ƙarfin mutum yakan kai ga ƙaruwa kuma ya fara raguwa bayan da cutar ta rasa masu watsa shiri.
Amma yanzu ba za mu iya yin hasashen lokacin da hakan zai faru ba".
Babban mai ba da shawara kan harkokin likitancin gwamnatin kasar Sin, Chung Nanchan, ya ce "za a iya kammala shi a watan Yuni" idan za a iya motsa dukkan ƙasashe su bi shawarwarin WHO game da matakan dakatarwa da yaduwar cutar.
A ranar 17 ga Maris, Adam Kocharsky na Makarantar Kula da Lafiya da Magunguna ta London ya ba da rahoton cewa SARS-CoV-2 "zai kasance da yaduwa mai yiwuwa shekara guda ko biyu".
Wani bincike da Jami'ar London ta gudanar a karkashin jagorancin masanin kimiyya Neil Ferguson ya nuna cewa za mu dogara ga nesa da wasu matakan "har sai an samu allurar rigakafi (watakila bayan watanni 18 ko fiye)".
William Shaffner na Jami'ar Vanderbilt ya ce, "Ina ganin ba zai yiwu ba cewa wannan kwayar cutar ta ɓace gaba ɗaya domin tana da sauƙin kamuwa da ita, kuma tana iya zama wata cuta ta yanayi da za ta sake dawowa kowace shekara".
Za a iya ganin cewa za a dawo da shi ne bisa ga tsarin rigakafin da kuma yadda za a canja shi.
Alamu na COVID-19 ba su da iyaka, kuma waɗanda suka kamu da cutar ba su da alamun cutar.
Abubuwa biyu da suka fi kowa a duniya sune zazzabi (88%) da kuma tari (68%).
Alamomin da ba su da yawa sun haɗa da gajiya, numfashi mai numfashi (baƙon numfashi), rashin wari, wahalar numfashi, ciwon tsoka da haɗin gwiwa, kumburi, ciwon kai, haushi, kumburi, zubar da jini, tari, ko kuma tsokoki. Hukumar lafiya ta duniya ta ce kusan mutum 1 cikin 6 yana fama da rashin lafiya mai tsanani kuma yana da wahalar numfashi.
Cibiyar Kula da Cututtuka da Rigakafin (CDC) a Amurka ta ƙuntata alamun gaggawa a cikin wahalar numfashi, ciwo ko matsa lamba a kirji, rikicewar mamaki, wahalar tashi, fuska ko lebe. Ana ba da shawarar samun kulawa ta likita nan da nan idan waɗannan alamun suka bayyana. Haɓaka ci gaban cutar na iya haifar da kamuwa da cutar huhu, cuta mai tsanani, ciwon hanci, bugun jini, da mutuwa.
Wasu marasa lafiya ba su da alamun bayyanar cututtuka, amma sakamakon bincike ya tabbatar da cewa sun kamu, saboda haka masana sun ba da shawara cewa ya kamata a lura da mutanen da suka kamu da cutar kuma a bincika su sosai don a cire cutar.
China ta kiyasta cewa adadin marasa bayyanar cututtuka ya kai kashi 44 cikin ɗari.
Yawanci, lokacin da ake kula da mutum (daga kamuwa da cutar zuwa bayyanar cututtuka) yana tsakanin kwana ɗaya zuwa kwanaki 14; yawanci kwana biyar. Alal misali, a cikin yanayin rikice-rikice, an kiyasta yawan mutanen da ke fama da COVID-19 da suka rasa ƙanshi da farko kashi 30 cikin ɗari, amma kwanan nan ya ragu zuwa 15 cikin ɗari.
Har yanzu ana bincike kan wasu bayanai game da yadda cutar ta yadu.
Ana ganin cewa cutar tana yaduwa ne a lokacin da ake haɗuwa ko ta hanyar watsawa ta hanyar tari ko magana; a lokacin da aka haɗu da mita 1 zuwa 2.
Nazarin ya nuna cewa tari ba tare da rufe bakinka ba zai iya haifar da fesawa da ke da tsayi daga mita 15 zuwa mita 8.2.
Wasu suna ganin cewa kwayar cutar tana iya yin yaduwa ta hanyar iska mai tsawo, wanda zai iya faruwa yayin magana. Hakanan yana iya haifar da iska mai numfashi yayin yin magana, gami da magana, kodayake kwayar cutar ba ta yaduwa ta iska gaba ɗaya.
Za a iya samun iska a bakin ko a hancin mutane ko kuma a numfasa a cikin huhu.
Wasu hanyoyin magani kamar maganin hana jini da kuma na zuciya da huhu (CPR) na iya sa a saki jini a cikin iska kuma a yi yaduwar ta iska.
Zai iya yaduwa idan mutum ya taɓa wani abu mai gurɓataccen jiki, har da fata, ya taɓa idanunsa, hanci ko bakinsa.
Duk da cewa akwai fargaba game da yiwuwar yaduwar fitsari zuwa baki, an yi imanin cewa haɗarin yana da iyaka.
Gwamnatin kasar Sin ta musanta yiwuwar SARS-CoV-2 ya wuce daga fitsari zuwa baki. Kwayar cutar tana da yawa a cikin kwanaki uku na farko na bayyanar cututtuka, kodayake tana iya yaduwa kafin bayyanar kowane bayyanar cututtuka da kuma a cikin matakai na gaba na cutar.
Mutane sun kamu da cutar kwanaki uku kafin bayyanar cututtuka, wanda ke nuna cewa za a iya kamuwa da ita kafin bayyanar cututtuka.
Akwai rahotanni kaɗan game da marasa bayyanar cututtuka da aka tabbatar da su a cikin dakin gwaje-gwaje, amma wasu ƙasashe sun ƙayyade canjin ba tare da bayyanar cututtuka ba a cikin binciken da ke bin diddigin masu cutar.
Cibiyar Turai ta yaki da cututtuka da rigakafinta (ECDC) ta tabbatar da cewa duk da rashin tabbas game da yadda cutar ta iya yaduwa, mutum ɗaya zai iya kamuwa da mutane biyu zuwa uku a gaba ɗaya. Kwayar tana zama a saman daga awanni zuwa kwanaki.
Musamman, an gano cewa ana iya gano cutar har zuwa kwanaki uku a kan filastik (polypropylene) da karfe mai tsananin 304 da kwana ɗaya a kan takarda mai ƙarfi da kuma har zuwa sa'o'i huɗu a kan tagulla.
Koyaya, wannan ya bambanta dangane da zafi da zafin jiki. An tabbatar da cewa dabbobi da sauran dabbobi sun kamu da COVID-19.
Babu wata hujja da ta nuna cewa dabbobi za su iya watsa kwayar cutar ga mutane, duk da haka, hukumomin Burtaniya sun ba da shawarar wanke hannu bayan an haɗa dabbobi, kamar yadda yake a lokacin da mutum ya taɓa wasu farfajiyar da wataƙila wani mai cutar ya taɓa.
Cutar Corona 2 da ke da alaƙa da cutar SARS-CoV-2 ita ce sabuwar cuta, inda aka fara ware mutane uku daga cikin mutanen da ke fama da cutar huhu don wasu cututtukan da ke fama da cutar huhu a Wuhan.
SARS-CoV-2 yana da halaye iri ɗaya da na coronavirus da ke cikin yanayi. A waje da jikin mutum, sabulu na gida yana kashe kwayar, inda yake narkar da membrane na rigakafi. SARS-CoV-2 yana da alaƙa da kwayar cutar SARS-CoV-2 ta asali.
An yi zaton cewa shi na dabba ne.
Binciken kwayoyin ya nuna cewa kwayar cutar Corona tana haɗuwa da kwayar cutar Corona beta, kuma tana cikin ƙaramin nau'in kwayar cutar Sarpi (sarin B) da kuma jinsunan da suka fito daga bats.
Ya yi daidai da kashi 96 cikin 100 na sauran kwayoyin cutar korona a cikin bats (Pat Cove Rat G13).
A watan Fabrairun 2020, masu bincike na kasar Sin sun gano cewa akwai bambanci guda daya kawai a cikin amino acid a wasu sassan tsarin kwayoyin halitta tsakanin ƙwayoyin cuta da ke fitowa daga naman kaza da kuma ƙwayoyin cuta da ke fitowa daga mutum.
Idan aka gwada dukan kwayoyin halitta, za a iya gano cewa akwai kashi 92 cikin 100 na kwayoyin halitta tsakanin cutar korona da SARS-CoV-2 da kuma cutar ta SARS-CoV-2 wanda bai isa ya tabbatar da cewa cutar ta zama na tsakiya ba.
Ana iya gano kamuwa da cutar a wani lokaci bisa ga bayyanar cututtuka, ko da yake a ƙarshe ana tabbatar da shi ta hanyar yin amfani da RNA-PCR (Retr-PCR) don gano cututtuka ko kuma yin CT.
Wani bincike a birnin Wuhan ya kwatanta aikin polymerase mai tsawo da kuma CT na komputa ya nuna cewa CT na da matukar damuwa fiye da aikin polymerase mai tsawo, ko da yake ba shi da cikakken bayani, tare da yawancin halaye na daukar hoto da ke hade da cututtukan huhu da sauran matakai masu cutarwa.
A watan Maris na shekarar 2020, Kwalejin Nazarin Radiography ta Amirka ta ba da shawarar "kada a yi amfani da CT don gano COVID-19 ko a yi la'akari da shi a matsayin gwaji na farko don ganewar cutar".
Hukumar lafiya ta duniya ta wallafa wasu hanyoyin gwajin RNA na SARS-CoV-2 a karon farko a ranar 17 ga Janairu.
Wannan gwajin yana amfani da tsarin polymerase chain reverse reaction (RRT-PCR) a ainihin lokacin.
Ana iya gwada shi a kan jini ko kuma numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin
Ana samun sakamako a cikin 'yan sa'o'i ko kwanaki.
Ana yin wannan gwajin ne ta hanyar shafa hanci, kuma ana iya amfani da shafawa daga wuyan. Yawancin dakunan gwaje-gwaje da kamfanoni suna haɓaka gwajin ƙwayoyin cuta don gano antibodies.
A ranar 6 ga Afrilu, 2020, babu wani daga cikinsu da aka tabbatar da daidaito don amfani da shi a ko'ina.
Gwajin da aka yi na silicon da aka yi na silicon ya samu amincewa don amfani da shi a gaggawa a Amurka a cikin dakunan gwaje-gwaje da aka amince da su kawai.
Abubuwan da ke cikin hotunan radiation da CT na mutanen da ke da alamun rashin daidaituwa na rashin lafiya kamar haushi na gilashin da aka yi da kuma ɓarkewar rufin rufin.
Ƙungiyar Radiation Society ta Italiya ta tattara bayanan bayanai na duniya a kan layi don sakamakon hotunan da aka tabbatar da cutar.
Hoto na radiyo ba tare da yin aikin polymerase mai tsawo ba hanya ce mai iyakanceccen daidaito game da gano COVID-19; saboda haɗuwa da wasu cututtuka kamar kamuwa da cutar ƙwayoyin cuta.
Wani babban bincike a kasar Sin ya kwatanta sakamakon CT na kirji da kuma yadda polymerase mai yawa ke aiki kuma ya nuna cewa, ko da yake daukar hoto bai da kyau wajen tabbatar da kamuwa da cuta, yana da sauri kuma yana da matukar damuwa, yana ba da shawarar a yi amfani da shi a matsayin kayan bincike a yankunan da ke da cutar.
An ci gaba da samar da hanyoyin sadarwa na kwakwalwa na artificial intelligence don gano halaye na daukar hoto na cutar a cikin hotunan radiation da CT.
Dabaru na hana kamuwa da cuta sun haɗa da tsabtace mutum gaba ɗaya, wanke hannu, guje wa taɓa idanu, hanci ko baki da hannayensu marasa wankewa, amfani da takalma lokacin tari ko numfashi sannan a zubar da shi kai tsaye a cikin kwandon shara.
Ana ba da shawarar waɗanda suka riga sun kamu da cutar su sa abin rufe fuska a wuraren jama'a.
Ana kuma ba da shawarar yin zaman lafiya na jiki don hana yaduwar kamuwa da cuta. Gwamnatoci da yawa sun hana ba dole ba tafiya daga ƙasashe da yankuna da cutar ta shafa daga ko kuma sun ba da shawara kada su yi tafiya.
Amma, cutar ta riga ta bazu a cikin dukan al'umma a wurare da dama a duniya.
Wannan yana nufin cewa cutar tana yaduwa a cikin al'ummomi, kuma wasu mutane ba su san inda ko yadda suka kamu da ita ba. Masu ba da kiwon lafiya, waɗanda ke kula da wanda zai iya kamuwa da ita, suna ba da shawarar yin amfani da matakan da aka sani, haɗuwa da kariya ta ido. Bin masu kamuwa da cutar shine hanya mai tasiri don taimakawa hukumomin lafiya gano tushen kamuwa da cutar da hana yaduwar ta.
Gwamnatoci suna amfani da bayanan gano wuri ta wayoyin hannu don bin diddigin sirri, inda Amnesty International da fiye da kungiyoyi 100 suka fitar da wata sanarwa da ke neman a takaita irin wannan sa ido.
An tsara ko kuma an ƙaddamar da aikace-aikacen wayar hannu da yawa don amfani na son rai, kuma tun daga ranar 7 ga Afrilu, 2020, fiye da ƙungiyoyi goma sha biyu na musamman sun yi aiki don nemo mafita na tsare sirri, kamar amfani da Bluetooth don yin rikodin yadda mai amfani yake kusa da sauran wayoyin hannu.
Sa'an nan kuma masu amfani za su karɓi saƙo idan sun zo wurin wani da aka tabbatar da cewa yana da COVID-19. Wannan saƙo yana ɗaukaka ra'ayoyi marasa kyau game da yadda za a hana kamuwa da cuta. Alal misali, wanke hanci da kuma gurgur da wanke baki ba zai iya magance matsalar ba.
Har yanzu babu allurar rigakafin COVID-19, duk da cewa kungiyoyi da yawa suna aiki don samar da allurar.
Ana bada shawara a wanke hannu don hana yaduwar cutar.
Cibiyar Kula da Cututtuka ta ce a yi wa mutane gargaɗi su riƙa wanke hannuwansu da sabulu da ruwa aƙalla na tsawon dakika 20, musamman bayan sun je gidan wanka ko kuma idan hannuwansu sun soma yin kumburi, kafin su ci abinci, bayan sun zubar da hanci ko tari ko ƙishirwa.
Wannan shi ne saboda sabulu na gida yana kashe kwayar cutar a waje da jikin mutum, yana lalata rigarsa.
Cibiyar Kula da Cututtuka ta ba da shawarar yin amfani da maganin hana shan magani da ke dauke da giya aƙalla kashi 60 cikin ɗari a lokacin da babu ruwa da sabulu.
Hukumar lafiya ta duniya ta ce kada ku taɓa idanunku, hanci ko baki da hannuwan da ba a wanke ba.
Ana iya tsabtace farfajiyar ta amfani da masu tsabtace ruwa da yawa (a cikin minti ɗaya na sanya mai tsabtace a kan farfajiyar ƙarfe mai tsayayya), daga cikinsu: ethanol 6271% , isopropanol 50100% , sodium chloride 0.1%, hydrogen peroxide 0.5%, and iodopophodone 0.27.5%.
Akwai wasu masu tsabtace, kamar su chloride benzodiazepine da chlorhexidine gluconate, da ba su da tasiri sosai.
Cibiyar Kula da Cututtuka ta bayar da shawarar cewa idan mutum ya kamu da COVID ko kuma an tabbatar da kamuwa da shi a wani wuri kamar ofis ko cibiyar kulawa, ya kamata a yi wa dukan wurare kamar ofisoshin, dakunan wanka, wuraren zama tare da jama'a, da na'urorin lantarki kamar kwamfutar hannu, allon taɓawa, kwamfutar hannu, na'urorin sarrafawa na nesa da na'urorin musayar kuɗi da mai haƙuri ke amfani da su.
Ƙungiyoyin kiwon lafiya sun ba da shawarar cewa mutane su rufe bakinsu da hanuwansu idan suna tari ko suna numfashi, su lankwasa ƙafansu su sa shi a gaban bakinsu da hanuwansu ko kuma su yi amfani da takarda da kuma cire takarda nan da nan.
Ana ba da shawarar masu fama da cutar su yi amfani da abin rufe fuska na likita, domin ya rage yawan numfashi da kuma nisan da suke yi a lokacin da suke yin magana da tari da tari.
Hukumar lafiya ta duniya ta ba da umarni game da lokacin da za a yi amfani da abin rufe fuska da kuma yadda za a yi amfani da shi.
Stephen Griffin, masanin ilimin cututtuka a Jami'ar Leeds, ya ce, "sawon abin rufe fuska zai iya rage sha'awar [mutane] su taɓa fuskokinsu, kuma wannan shi ne babban tushen kamuwa da cuta idan ba a tsabtace hannayensu yadda ya kamata ba". Ana ba da shawarar cewa masu kula da marasa lafiya su yi amfani da abin rufe fuska.
Hukumar lafiya ta duniya ta ba da shawarar cewa mutane masu lafiya kada su sa abin rufe fuska sai dai idan suna da haɗarin kamuwa da cutar, kamar waɗanda ke kula da wanda ke da COVID-19, ko da yake ta kuma yarda cewa yin abin rufe fuska zai iya taimaka wa mutane su guji taɓa fuskokinsu.
Kasashe da dama sun fara karfafawa talakawa su saka abin rufe fuska.
Cibiyar Kula da Cututtuka da Rigakafinta a Amurka ta ba da shawarar yin amfani da abin rufe fuska na likita da ba na likita ba. China ta ba da shawarar musamman ga masu lafiya su yi amfani da abin rufe fuska na likita, musamman idan mutane sun haɗu (daga mita 1 (3 ƙafa) ko ƙasa da haka) kai tsaye.
Hong Kong ta ba da shawarar saka abin rufe fuska na likita lokacin amfani da sufuri na jama'a ko kasancewa a wurare masu yawa.
Jami'an kiwon lafiya na Thailand sun ƙarfafa mutane su yi abin rufe fuska daga masana'anta a gida kuma su wanke su kullum.
Jamhuriyar Czech da Slovakia sun hana fita a wuraren jama'a ba tare da saka abin rufe fuska ko rufe hanci da baki ba.
A ranar 16 ga Maris, Vietnam ta bukaci kowa ya saka abin rufe fuska lokacin da ya je wuraren jama'a don kare kansa da kuma wasu.
Gwamnatin Austria ta tilasta wa duk wanda ya shiga kantin sayar da kayayyaki ya sa abin rufe fuska.
Isra'ila ta bukaci dukan mazauna su sa abin rufe fuska a wuraren jama'a.
Taiwan, wadda ta samar da masks miliyan 10 a kullum tun tsakiyar watan Maris, ta bukaci fasinjojin jiragen kasa da bas na gari-gidanka su sa masks a ranar 1 ga Afrilu.
Panama ta sa yin amfani da abin rufe fuska a waje ya zama dole, kuma ta kuma ba da shawarar yin abin rufe fuska a gida ga waɗanda ba za su iya saya abin rufe fuska ba.
Ana amfani da abin rufe fuska a Japan, Koriya ta Kudu, Malaysia, da Singapore.
Tsare-tsare na zamantakewa (wanda aka fi sani da nesa da jiki) ya ƙunshi matakan rigakafin kamuwa da cuta waɗanda ke nufin rage yaduwar cutar ta hanyar rage haɗuwa tsakanin mutane.
Hanyoyi sun ƙunshi hanyoyi masu tsabta; ƙuntatawa a kan tafiya; rufe makarantu, wuraren aiki, filayen wasa, wuraren wasan kwaikwayo, ko wuraren cin kasuwa.
Mutane za su iya yin amfani da hanyoyin ware kansu ta wajen kasancewa a gida, rage yawan tafiye-tafiye, guje wa wuraren da mutane suke da yawa, yin gaisuwa ba tare da taɓa su ba, da kuma ware kansu daga mutane.
A halin yanzu gwamnatoci da yawa suna ba da izinin yin zaman lafiya ko kuma suna ba da shawarar yin hakan a wuraren da cutar ta shafa.
Ƙarfin taro da hukumomin gwamnati da na kiwon lafiya na Amirka suka ba da shawarar, an rage shi daga mutane 250 (idan ba a gano cewa COVID-19 ya yadu a yankin ba) zuwa mutane 50 da kuma mutane 10 daga baya.
A ranar 22 ga Maris, 2020, Jamus ta hana taron jama'a na mutane fiye da biyu. Tsofaffi da waɗanda ke fama da cututtuka masu tsanani kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hauhawar jini, rashin ƙarfi na tsarin rigakafi suna da haɗarin kamuwa da cututtuka masu tsanani da kuma rikitarwa. Cibiyar Kula da Cututtuka da Rigakafin Cututtuka ta ba su shawara su zauna a gida kamar yadda zai yiwu a wuraren da cutar ke yaduwa tsakanin al'ummomi. A ƙarshen Maris, 2020, WHO da sauran hukumomin kiwon lafiya sun fara amfani da kalmar "rashin zamantakewa" don bayyana cewa manufar rage haɗin kai na jiki tare da kula da zamantakewa, ko kuma kawar da zamantakewa.
Amfani da kalmar "tsarewar zamantakewa" ya ba da shawarar cewa mutane su shiga cikin cikakken keɓewa ta zamantakewa, maimakon ƙarfafa su su sadarwa tare da wasu ta hanyar madadin. Wasu hukumomi sun ba da umarnin lafiyar jima'i don amfani da su yayin annobar.
Wannan ya haɗa da shawarwari cewa kada ku yi jima'i da wanda ba ku da cutar ko kuma wanda ke da alamun cutar.
Ana ba da shawarar a keɓe mutane a gida ga waɗanda ke da COVID-19 da waɗanda ake zargin sun kamu da cutar.
Hukumomin lafiya sun ba da cikakkun umarni game da ware kai. Gwamnatoci da yawa sun ba da umarnin yin amfani da dutsen kiwon lafiya ga dukan mutanen da ke zaune a yankunan da aka shafa.
An ba da umurni mai ƙarfi game da yin amfani da dutse don waɗanda suka fi fuskantar haɗari.
Waɗanda suka yi hulɗa da wani da ke da cutar COVID-19 kuma suka yi tafiya zuwa wata ƙasa ko yanki da ke da yaduwar kamuwa da cutar, ana ba da shawarar yin amfani da magungunan tsabtace jiki na kwanaki 14 daga lokacin da za su iya kamuwa da cutar.
Dabarun da za a iya amfani da su wajen hana cutar ta yaduwa su ne su hana ta yaduwa.
Ana amfani da hanawa a farkon fasalin cutar kuma ana nufin bin diddigin waɗanda suka kamu da cutar da keɓe su da kuma gabatar da wasu matakan yaki da kamuwa da cuta da alluran rigakafi don hana cutar yaduwa zuwa sauran al'umma.
Idan ba za a iya hana yaduwar cutar ba, sai a sauƙaƙe a rage shi: ana yin wasu ayyuka don rage yaduwar da kuma rage tasirinsa a tsarin kiwon lafiya da kuma al'umma.
Za a iya yin wasu matakan hanawa da kuma ragewa a lokaci guda.
Dakatar da cutar tana bukatar a ɗauki tsauraran matakai don juyawa hanyar annoba ta hanyar rage yawan yaduwar asali zuwa ƙasa da 1. Wani ɓangare na gudanar da annobar cututtukan cututtuka yana ƙoƙarin rage ƙarancin annobar, wanda ake kira daidaita yanayin annobar.
Hakan zai rage yawan matsalolin da ake samu a fannin kiwon lafiya kuma zai ba da lokaci don yin allurar rigakafi da kuma magani.
Hanyoyin da ba na magani ba da za su iya magance cutar sun haɗa da matakan kariya na mutum, kamar tsabtace hannu, saka abin rufe fuska da kuma yin amfani da dutsen tsabta; matakan jama'a da ke nufin ware jiki kamar rufe makarantu da soke manyan taron; hadin kai na al'umma don ƙarfafa karbuwa da shiga cikin irin waɗannan ayyukan; da kuma matakan muhalli kamar tsabtace rufin. An ɗauki matakan da suka fi tsaurara don hana cutar ta cutar a China da zarar an bayyana yadda cutar ta kasance, kamar yin amfani da dutsen lafiya ga dukan birane da kuma sanya takunkumin hana tafiya.
Sauran ƙasashe ma sun ɗauki matakai daban-daban don rage yaduwar cutar.
Koriya ta Kudu ta yi bincike na gida da kuma kula da lafiyar gida, kuma ta ba da gargadi game da motsin mutanen da suka kamu.
Singapore ta ba da tallafi ga wadanda suka ji rauni da suka ware kansu kuma ta caje wadanda suka kasa yin hakan.
Taiwan ta kara samar da masks kuma ta yi wa kayayyakin kiwon lafiya karbuwa. Aikin kwaikwayo na Birtaniya da Amurka ya nuna cewa ragewa (ƙuntata yaduwar annobar ba a dakatar da ita ba) da kuma hanawa (a akasin ci gaban annobar) suna fuskantar manyan kalubale.
Manufofin rage yawan cutar za su iya rage yawan bukatar kiwon lafiya da kashi biyu bisa uku da kuma mutuwar da rabi, amma har yanzu suna haifar da mutuwar dubbai da kuma matsin lamba ga tsarin kiwon lafiya.
Zai fi kyau a hana shi, amma dole ne a ci gaba da yin hakan muddin cutar ta yadu cikin mutane (ko kuma har sai an samu allurar rigakafi, idan hakan ya faru da farko), domin sauyin ya koma baya da sauri idan an rage matakan.
Tsayawa na dogon lokaci na dakile annoba yana jawo farashi na zamantakewa da tattalin arziki.
Babu takamaiman magungunan rigakafin cutar da aka amince da su don COVID-19, amma ana ci gaba da ci gaba, ciki har da gwajin magungunan da ke akwai.
Shan magani na sanyi da ba a rubuta ba, shan ruwa da kuma kwanciyar hankali na iya taimaka wajen rage alamun.
Dangane da tsanani, ana iya bukatar maganin oxygen, ruwa a cikin jijiyoyin jini, da kuma taimakon numfashi.
Yin amfani da miyagun ƙwayoyi zai iya ƙara tsananta sakamakon.
Yawancin kwayoyi da aka riga aka amince da su don magance wasu cututtukan ƙwayar cuta suna ƙarƙashin gwaji don amfani a maganin COVID-19.
Hukumar lafiya ta duniya ta kuma ce wasu "magungunan gargajiya da na gida" za su iya kawo sauƙin bayyanar cututtukan da COVID-19 ke haifarwa.
Ƙara ƙarfin da kuma daidaita cibiyoyin kiwon lafiya don biyan bukatun marasa lafiya na COVID-19 an bayyana su a matsayin manyan matakan amsawa ga barkewar cutar ta WHO.
Cibiyar Kula da Cututtuka ta Turai da Hukumar Kula da Cututtuka ta WHO da Hukumar Kula da Cututtuka ta WHO sun fitar da jagororin asibitoci da sabis na kiwon lafiya na farko don canja wurin albarkatu a matakai da yawa, gami da mayar da hankali ga ayyukan gwaji akan gwajin COVID-19, soke zaɓin zaɓin idan ya yiwu, keɓe COVID-19 da keɓewa, haɓaka ikon kulawa ta ci gaba ta hanyar horar da ma'aikata da haɓaka yawan kayan numfashi na wucin gadi da na iyali.
Akwai ra'ayoyi da yawa game da inda yanayin farko ya taso (wanda ake kira mai haƙuri na 0).
An fara samun sabon kamuwa da cutar korona a ranar 1 ga Disamba, 2019 a birnin Wuhan, a birnin Hobi, a kasar Sin.
A cikin wata guda, adadin masu dauke da cutar korona a Hubei ya ƙaru.
Wannan ya kasance mafi yawa dangane da kasuwar sayar da kayan teku ta Wuhan, wanda kuma ke sayar da dabbobi masu rai, kuma wata ka'ida ta ce cutar ta fito ne daga ɗayan waɗannan nau'ikan dabbobi; ko kuma a wasu kalmomin, ta fito ne daga dabba. An lura da wata ƙungiya da ke fama da cutar huhu don wani dalili da ba a sani ba a ranar 26 ga Disamba kuma an kula da ita ta hanyar Dr. Zhang Jijian a Hubei County Hospital, wanda ya sanar da Cibiyar Kula da Cututtuka a Jianghan Boehhan a ranar 27 ga Disamba.
A ranar 30 ga watan Disamba, wasu likitoci a babban asibitin Wuhan sun yi wa abokan aikinsu gargaɗi game da "Corona virus kamar SARS".
'Yan sanda sun yi gargadi ga likitoci takwas, har da Li Wen Liang, don su yi ta yada jita-jita, kuma sun tsauta wa wata likita, Ai Wen, da shugabannin ta don ta yi gargadi.
Bayan haka, a ranar 31 ga watan Disamba, Hukumar Lafiya ta birnin Wuhan ta ba da sanarwar sanarwa ga Hukumar Lafiya ta Duniya.
An ruwaito isasshen cututtukan cutar huhu da ba a san su ba ga hukumomin lafiya a Wuhan wanda ya sa suka fara bincike a farkon watan Janairu. A farkon farkon barkewar cutar, adadin cututtukan ya ninka kusan kowace kwana bakwai da rabi.
A farkon tsakiyar watan Janairu na 2020, cutar ta shiga wasu lardunan kasar Sin, tare da taimakon motsi a lokacin Sabuwar Shekara ta kasar Sin kuma Wuhan ta zama cibiyar jigilar kayayyaki da kuma hanyar hawan manyan layin dogo.
A ranar 20 ga watan Janairu, kasar Sin ta ba da rahoton kusan sabbin mutane 140 a rana guda, ciki har da mutane biyu a Beijing da kuma daya a Shenzhen.
Bayanai na hukuma da aka sanar daga baya sun nuna cewa mutane 6,174 sun riga sun nuna alamun cutar ta hanyar 20 ga Janairu 2020. Kamar yadda na 26 ga Maris, Amurka ta wuce China da Italiya a duniya, mafi yawan adadin mutane da aka tabbatar da kamuwa da cutar. Kamar yadda na 9 ga Afrilu, 2020, rahotanni sun nuna cewa akwai fiye da miliyan 1.61 a duniya, tare da fiye da mutane 97,000 da suka mutu kuma fiye da mutane 364,000 sun warke.
Kasashe da yankuna 200 sun yi rajistar akalla hali guda ɗaya.
Saboda annobar da ke Turai, ƙasashe da yawa a yankin Shenzhen sun ƙuntata 'yancin motsi kuma sun sanya takunkumin iyaka.
Sakamakon haka ya ƙunshi matakan hanawa, kamar dokar hana fita (wanda aka fi sani da dokar zama a gida, dokar hana fita, ko dokar rufewa) da kuma dokar hana fita. Kamar yadda aka yi a ranar 2 ga Afrilu, kusan mutane miliyan 300, ko kusan kashi 90 cikin ɗari na yawan jama'a, sun sha wani irin rufewa a Amurka, fiye da mutane miliyan 50 sun sha wahala a Philippines, kusan mutane miliyan 59 sun sha wahala a Afirka ta Kudu, mutane biliyan 1.3 sun sha wahala a Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya sun shiga cikin wani nau'in rufewa, wanda ya karu zuwa biliyan 2.6 bayan kwana biyu.
An fara samun mutum na farko da aka tabbatar da cutar COVID-19 a ranar 1 ga Disamba, 2019 a Wuhan; kuma wani rahoto da ba a tabbatar da shi ba ya nuna cewa farkon lamarin ya kasance a ranar 17 ga Nuwamba.
A ranar 26 ga watan Disamba, Dokta Zhang Jiejian ta lura da wasu cututtukan da ba a san dalilinsu ba, kuma ta kai asibitinta ga Cibiyar Kula da Cututtuka ta Jianghan Bohan a ranar 27 ga watan Disamba.
Gwajin farko na jini na marasa lafiya a ranar 27 ga Disamba, 2019 ya nuna cewa akwai kwayar cutar korona kamar SARS.
Hukumar kula da lafiyar birnin Wuhan ta ba da sanarwar a ranar 31 ga watan Disamba.
An sanar da Hukumar Lafiya ta Duniya a wannan ranar.
A lokacin da aka yi wannan sanarwar, 'yan sanda sun gargadi likitoci a Wuhan game da "fitowar jita-jita" game da cutar.
Hukumar lafiya ta kasar Sin ta ce babu wata hujja a kan yadda mutum zai iya yin hakan.
A ƙarshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani babban yunkuri wanda daga baya Sakataren Janar na jam'iyyar kwaminis ta kasar Sin, Xi Jinping, ya bayyana shi a matsayin "yaƙin jama'a" don hana yaduwar cutar.
A matsayin "babban dutse mai kyau a tarihin 'yan adam", an sanar da wani kirtani mai kyau a ranar 23 ga Janairu don dakatar da tafiya daga Wuhan zuwa nan, wanda ya kai ga birane 15 a Hubei, kuma ya shafi mutane miliyan 57.
An haramta amfani da motocin sirri a birnin.
An soke bikin Sabuwar Shekara ta Sin (25 ga Janairu) a wurare da dama.
Hukumomi sun kuma sanar da gina asibiti na wucin gadi, asibitin Hoshinchan, wanda aka kammala a cikin kwanaki 10.
Bayan haka, an gina wani asibiti, wato asibitin Lichenshan, don kula da ƙarin marasa lafiya.
Baya ga asibitocin da aka kafa kwanan nan, kasar Sin ta kuma mayar da wasu wurare 14 a Wuhan, kamar cibiyoyin taro da filayen wasa, zuwa asibitocin wucin gadi. A ranar 26 ga Janairu, gwamnati ta dauki wasu matakan dakile barkewar COVID-19, ciki har da samar da sanarwar lafiya ga matafiya da kuma tsawaita hutun bikin bazara.
An rufe jami'o'i da makarantu a duk faɗin ƙasar.
Ƙasar Hong Kong da Macau sun ɗauki matakai da yawa, musamman ma game da makarantu da jami'o'i.
An yi amfani da matakan yin aiki a nesa a yankuna da yawa na kasar Sin.
An yi wa masu tafiya iyaka a cikin da wajen Hobby.
An gyara hanyoyin sufuri na jama'a, kuma an rufe gidajen tarihi na wucin gadi a duk faɗin ƙasar Sin.
An hana zirga-zirgar jama'a a birane da yawa, kuma an kiyasta cewa kusan mutane miliyan 760 (fiye da rabin yawan jama'a) sun sha wahala daga wasu nau'ikan ƙuntatawa. Bayan barkewar cutar ta zama ta duniya a watan Maris, hukumomin China sun ɗauki tsauraran matakai don hana " kawo" cutar daga wasu ƙasashe.
Alal misali, Beijing ta sanya dokar hana amfani da dutse na kwanaki 14 ga duk waɗanda suka dawo birnin daga wasu ƙasashe. A ranar 23 ga Maris, an yi wani mutum guda a gida a babban yankin China a cikin kwanaki biyar da suka gabata, ta hanyar wani matafiyi da ke komawa Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Shugaban Majalisar Dokokin kasar Sin Li Keqiang ya bayyana cewa an rage yaduwar kamuwa da cutar ta gida da kuma hana barkewar cutar a kasar Sin.
An sassauta takunkumin tafiye-tafiye a Hobi a wannan rana, ban da Wuhan, bayan watanni biyu da aka sanya dokar kulle. Ma'aikatar Harkokin Wajen kasar Sin ta sanar a ranar 26 ga Maris, 2020 da dakatar da masu riƙe da biza ko izinin zama daga ranar 28 ga Maris, ba tare da cikakken bayani game da lokacin da wannan manufar za ta ƙare ba.
Waɗanda suke son shiga ƙasar Sin za su nemi takardar izinin shiga ofishin jakadancin ƙasar Sin.
Gwamnatin kasar Sin ta bukaci kamfanoni da masana'antu da su dawo aiki a ranar 30 ga Maris, kuma ta ba da kyautar kudi ga kamfanoni. Majalisar Dinkin Duniya ta sanar da ranar makoki da za ta fara da minti uku na shiru a ranar 4 ga Afrilu da karfe 10:00 na dare, daidai da bikin Qingming, ko da yake gwamnatin tarayya ta bukaci iyalai su nuna girmamawa ta yanar gizo tare da kiyaye keɓewar jiki don kauce wa sake barkewar COVID-19.
An tabbatar da cewa COVID-19 ya tashi daga China zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020.
Hukumar lafiya ta kasa ta sanar da cewa an samu karuwar yawan wadanda suka kamu da cutar a ranar 20 ga Fabrairu, kuma hakan ya kara da cewa an taru a Daigo don wani sabon addini da ake kira Shincheongji Church of Jesus.
An yi zargin cewa mabiyan Shinchengji da ke ziyartar Daegu daga Wuhan ne suka haddasa cutar.
A ranar 22 ga Fabrairu, mutane 1,261, ko kusan kashi 13% na 9,336 na mabiyan cocin sun ba da rahoton bayyanar cututtuka. Koriya ta Kudu ta sanar da mafi girman matakan shiri a ranar 23 ga Fabrairu, 2020.
A ranar 28 ga Fabrairu, an ruwaito an samu karin mutane 2,000 da suka kamu da cutar a Koriya, inda ya kai 3,150 a ranar 29 ga Fabrairu.
An yi wa dukkan sansanonin Sojojin Koriya ta Kudu allurar rigakafi bayan an tabbatar da cewa sojoji uku sun kamu da cutar.
An kuma shafi lokutan jiragen sama, kuma hakan ya sa aka canja. Koriya ta Kudu ta kafa wani shiri da aka fi sani da shi a duniya don bincika mutane don gano cutar, ta ware duk wani mai kamuwa da ita da kuma bin diddigin waɗanda suka yi kuskure da kuma sanya su cikin rigakafi.
Hanyoyin gwajin sun haɗa da yin wa'azin sirri game da bayyanar cututtuka daga sababbin masu shigowa na duniya ta hanyar wayar hannu, gwada mutane da ke cikin motocin su don sakamakon gwajin ya kasance a rana mai zuwa, da kuma ƙara ƙarfin gwajin zuwa mutane 20,000 a kowace rana.
Shirin Koriya ta Kudu ya nuna nasarar sarrafa cutar duk da cewa ba a yi amfani da dutsen kiwon lafiya ga dukan birane ba. An fara raba jama'ar Koriya ta Kudu game da yadda Shugaba Moon Jae-in ya amsa matsalar.
Yawancin 'yan Koriya sun rattaba hannu kan takardun neman a ware Moon, suna zargin cewa gwamnati ta yi rashin adalci game da annobar, ko kuma suna yaba wa yadda ta amsa.
A ranar 23 ga Maris, an sanar da cewa Koriya ta Kudu ta samu mafi karancin adadin wadanda suka kamu a rana daya a cikin makonni hudu.
A ranar 29 ga Maris, an sanar da cewa daga ranar 1 ga Afrilu, duk sababbin da suka zo daga waje za su yi amfani da dutse na makonni biyu.
A cewar rahotanni na 1 ga Afrilu, Koriya ta Kudu ta karɓi buƙatu daga ƙasashe 121 don taimakawa gwajin cutar.
Iran ta ba da rahoton farkon kamuwa da cutar SARS-CoV-2 a ranar 19 ga Fabrairu a Goma, inda mutane biyu suka mutu a baya a wannan rana, a cewar Ma'aikatar Lafiya da Ilimi na Likita.
Matakan da gwamnati ta sanar sun haɗa da soke kide-kide da sauran al'adu da kuma wasanni, addu'ar Juma'a, rufe jami'o'i, cibiyoyin ilimi da makarantu.
Iran ta ba da tiriliyan biyar na rial don yaki da cutar.
Shugaban kasar Hassan Rouhani ya bayyana a ranar 26 ga Fabrairu 2020 cewa babu wani shiri na dutse a yankunan da cutar ta shafa, za a ware mutane ne kawai.
An sanar da tsare-tsaren rage zirga-zirgar birane a watan Maris, duk da cewa har yanzu akwai zirga-zirga mai yawa tsakanin birane kafin sabuwar shekara ta Farisa.
Har zuwa 16 ga Maris, 2020, wuraren da ake kira Shi'a a Qom sun kasance a buɗe don masu yin hajjin. A watan Fabrairu, Iran ta zama cibiyar yaduwar cutar bayan China.
A cikin zargin da ake yi na rufe Iran a kan annobar, fiye da kasashe goma sun biye da wadanda suka dawo daga Iran tun daga ranar 28 ga Fabrairu, wanda ya nuna cewa annobar na iya wuce adadin mutane 388 da gwamnatin Iran ta ruwaito a wannan ranar.
An rufe majalisar dokokin Iran, inda aka ruwaito cewa an samu mutane 23 da suka kamu da cutar a ranar 3 ga Maris.
A ranar 12 ga watan Maris, Human Rights Watch ta bukaci hukumomin kurkuku na Iran da su saki 'yan kare hakkin dan Adam da aka tsare saboda zanga-zangar lumana, da kuma sakin fursunoni masu cancanta.
Ta ce akwai babban haɗarin yaduwar cutar a wuraren da aka rufe kamar gidajen yari, kuma waɗanda ba su da isasshen kulawar likita.
A ranar 15 ga Maris, gwamnatin Iran ta sanar da mutuwar mutane 100 a rana guda, wanda shi ne mafi yawan mutane da aka samu a kasar tun lokacin da annobar ta fara.
Aƙalla 'yan siyasar Iran da kuma tsoffin jami'an gwamnati 12 za su mutu daga wannan cuta a ranar 17 ga Maris.
A ranar 23 ga watan Maris, Iran ta yi rikodin sababbin mutane 50 da suka kamu da cutar a cikin awa daya, da kuma mutuwar mutum daya a cikin minti 10 sakamakon cutar korona.
Wani jami'in Hukumar Lafiya ta Duniya ya ce, yawan wadanda suka kamu da cutar a Iran zai iya kaiwa sau biyar na wadanda aka bayyana.
An kuma yi imanin cewa takunkumin da Amurka ta dauka kan Iran zai iya shafar karfin tattalin arzikin kasar wajen magance cutar.
Hukumar kare hakkin bil'adama ta Majalisar Dinkin Duniya ta bukaci a sauƙaƙe takunkumin tattalin arziki a kan kasashen da cutar ta fi shafa, ciki har da Iran.
An tabbatar da barkewar cutar a Italiya a ranar 31 ga Janairu, lokacin da gwajin SARS-CoV-2 ya zo ga masu yawon bude ido na kasar Sin a Roma.
Al'amura sun fara ƙaruwa sosai, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen sama daga China zuwa can kuma ta ayyana dokar ta baci.
Daga bisani an gano wani rukuni na marasa alaƙa na COVID-19, farawa da 16 da aka tabbatar a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, majalisar ministocin ta sanar da wata sabuwar doka don dakile barkewar cutar, gami da tsaftacewar fiye da mutane 50,000 daga garuruwa daban-daban 11 a arewacin Italiya.
Firayim Minista Giuseppe Conte ya ce, "Ba za a yarda a shiga ko fita daga wuraren da cutar ta bulla ba.
An riga an ba da umarnin dakatar da ayyukan aiki da wasanni a waɗannan yankuna". A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukan makarantu da jami'o'i a duk faɗin ƙasar inda mutuwar ta kai 100 a Italiya.
An shirya gudanar da dukkan manyan wasannin motsa jiki, gami da wasannin gasar kwallon kafa ta farko, a bayan rufewa har zuwa watan Afrilu, amma a ranar 9 ga Maris, an dakatar da duk ayyukan motsa jiki gaba daya na akalla wata daya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan dukkanin ayyukan kasuwanci, sai dai manyan kantuna da kantunan magani. A ranar 6 ga Maris, Kwalejin Italiyanci ta Narcotics, Rehabilitation and Intensive Care (SIAARTI) ta wallafa shawarwarin ɗabi'ar likita game da yarjejeniyoyin rarrabuwa da za a iya amfani da su.
A ranar 19 ga watan Maris, Italiya ta fi China gaba a matsayin kasar da ta fi yawan mutuwar coronavirus a duniya bayan da ta ba da rahoton mutuwar 3,405 na annoba.
A ranar 22 ga Maris, Rasha ta tura jiragen saman soja tara zuwa Italiya dauke da kayan aikin likita.
A ranar 5 ga Afrilu, an tabbatar da cewa akwai mutane 128,948 da suka kamu da cutar, kuma an samu mutane 15,887 da suka mutu, kuma an samu mutane 21,815 a Italiya, kuma mafi yawan waɗannan sun kasance a yankin Lombardy.
Wani rahoto na CNN ya nuna cewa haɗuwa da yawan tsofaffi da rashin iyawar gwada duk waɗanda suka kamu da cutar a Italiya har zuwa yanzu na iya haifar da hauhawar mutuwar.
Amsar Burtaniya ga cutar ta fara bayyana a matsayin mafi jinkirin tsakanin ƙasashe da suka kamu, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta sanya kowane nau'in keɓewa ta zamantakewa ko matakan kiwon lafiya ga 'yan ƙasa ba.
A sakamakon haka, gwamnati ta sami zargi saboda rashin saurin da take yi da kuma yadda take amsawa ga damuwar da jama'a ke fuskanta. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da wata sanarwa inda ya shawarci kada a yi tafiya ko kuma a yi rikice-rikice na zamantakewa ba dole ba, yana ba da shawarar cewa mutane su yi aiki daga gida kamar yadda zai yiwu kuma su guji wurare da yawa, kamar gidajen cin abinci, gidajen cin abinci, da kuma gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnatin ta sanar da cewa za ta rufe dukkan wuraren nishaɗi kamar gidajen cin abinci da kuma wuraren motsa jiki da wuri-wuri, kuma ta yi alkawarin biyan har zuwa 80% na albashi na ma'aikata a matsakaicin £ 2,500 a wata don rage rashin aikin yi a lokacin rikicin. A ranar 23 ga Maris, Firayim Minista ya sanar da matakan da suka fi tsaurara na nesa, inda aka hana tarurruka fiye da mutane biyu kuma aka hana tafiya da yin aiki a waje na gida sai dai idan ya zama dole.
Ba kamar yadda aka yi a baya ba, 'yan sanda sun yi amfani da takunkumi ta hanyar ba da tarurruka da kuma tarwatsa taron.
An ba da umarnin rufe yawancin kamfanoni, ban da ayyukan kasuwanci "da ake bukata", ciki har da manyan kantuna, kantunan shan magani, bankuna, shagunan kayan aiki, tashoshin mai, da kuma wuraren kiwo.
A ranar 20 ga Janairu, an tabbatar da cewa mutum na farko da aka sani da cutar COVID-19 a jihar Washington a arewa maso yammacin Pacific ya dawo daga Wuhan a ranar 15 ga Janairu.
An kafa tawagar White House don yaki da cutar korona a ranar 29 ga Janairu.
A ranar 31 ga Janairu, gwamnatin Trump ta bayyana dokar ta baci ta kiwon lafiya, ta sanya takunkumi kan shiga matafiya daga China.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka, babbar cibiyar kiwon lafiya ta gwamnati ta Amurka, ta sanar da cewa ta ci gaba da yin gwajin kanta.
Duk da haka, Amurka ta jinkirta fara gwajin, ta hana ainihin yadda annobar ta kasance a lokacin.
Gwajin ya lalata wani rukuni na gwajin da gwamnatin tarayya ta samar a watan Fabrairu, rashin amincewar gwamnatin tarayya ga rukunin gwajin da ba na gwamnati ba (ta hanyar ilimi, kamfanoni da asibitoci) har zuwa ƙarshen Fabrairu, da kuma ƙuntataccen ƙa'idodin mutane don cancanta don gwajin har zuwa farkon Maris (ana buƙatar umarnin likita bayan haka).
A ranar 27 ga Fabrairu, jaridar Washington Post ta ruwaito cewa an yi gwaji kasa da 4,000 a Amurka.
A ranar 13 ga Maris, jaridar Atlantic ta ruwaito cewa an yi gwajin da bai kai 14,000 ba.
A ranar 22 ga Maris, Associated Press ta ruwaito: "Mutane da yawa da ke da alamun cutar kuma suna da umarnin likita suna jiran awanni ko kwanaki don gwaji". Bayan an ruwaito mutuwar farko a Amurka a jihar Washington a ranar 29 ga Fabrairu, Gwamna Jay Insley ya sanar da dokar ta baci, wani mataki da wasu jihohi suka bi.
Makarantun birnin Seattle sun soke karatun a ranar 3 ga Maris, kuma a tsakiyar watan Maris, an rufe makarantun a duk faɗin ƙasar. A ranar 6 ga Maris, 2020, an sanar da Amurka game da tsammanin tasirin cutar coronavirus a ƙasar ta hanyar masana ilimin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cututtukan cututtukan cuttukan cututtukan cuttukan cut
A wannan ranar ne Shugaba Trump ya rattaba hannu kan Dokar Karin Kuɗi don Shirya da Amsawa ga Korona, wanda ya ba da dala biliyan 8.3 na kudade na gaggawa ga hukumomin tarayya don amsawa ga barkewar cutar.
Kamfanoni sun ƙuntata tafiye-tafiyen ma'aikata, sun soke taron, kuma sun ƙarfafa ma'aikata su yi aiki daga gida.
An soke ayyukan wasanni da yanayi. A ranar 11 ga Maris, Trump ya sanar da takunkumin tafiya zuwa yawancin Turai, ban da Burtaniya, na kwanaki 30, daga 13 ga Maris.
Washegari, an tsawaita dokar zuwa Burtaniya da Ireland.
A ranar 13 ga Maris, na sanar da dokar ta baci ta kasa, wadda ta ba da damar amfani da kudaden tarayya don amsa matsalar.
Tun daga ranar 15 ga Maris, kamfanoni da yawa sun rufe ko rage lokutan aiki a duk faɗin Amurka don ƙoƙarin rage yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da annobar a duk jihohi 50 da kuma gundumar Columbia. A ranar 23 ga Maris, an ba da rahoton cewa akwai mutane 10,700 da suka kamu da cutar korona a birnin New York, wanda ya fi yawan adadin mutanen da suka kamu da cutar a Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya ce, ana ganin an samu nasarar kawar da zamantakewar al'umma, inda aka nuna cewa an rage yawan adadin cututtuka daga kwana 2.0 zuwa kwana 4.7.
A ranar 28 ga Maris, akwai mutane 32,308 da suka kamu da cutar a birnin New York, kuma mutane 672 sun mutu saboda cutar. A ranar 26 ga Maris, an ruwaito cewa akwai karin mutane da suka kamu da cutar a Amurka fiye da kowace ƙasa a duniya, ciki har da China da Italiya. A ranar 8 ga Afrilu, an tabbatar da mutane 400,335 a Amurka, kuma mutane 12,841 sun mutu.
A cewar rahotanni na kafofin watsa labarai a ranar 30 ga Maris, Shugaba Trump na Amurka ya yanke shawarar tsawaita umarnin nisantar zamantakewa har zuwa 30 ga Afrilu.
A wannan rana, jirgin ruwa na asibiti mai ɗauke da gado 1,000, USS Comfort, ya tashi a birnin New York.
A ranar 3 ga Afrilu, Amurka ta yi mutuwar mutane 884 sakamakon cutar korona a cikin sa'o'i 24.
A jihar New York, adadin masu cutar ya zarce mutane 100,000 a ranar 3 ga Afrilu. An soki Fadar White House don rage barazanar da kuma sarrafa watsa labarai ta hanyar umarci jami'an lafiya da masana kimiyya su daidaita bayanan jama'a da wallafe-wallafen da suka shafi cutar tare da ofishin mataimakin shugaban kasa Mike Pence.
Gwamnatin Trump ba ta samu karbuwa ba saboda ta jawo karfafawa tsakanin jam'iyyun.
Wasu jami'an Amurka da masu sharhi sun soki yadda Amurka ke shigo da kayayyakin da ake bukata, ciki har da kayayyakin kiwon lafiya na asali, daga kasar Sin.
An yi amfani da nazarin yanayin tafiye-tafiye na iska don tsara taswirar yaduwar da kuma hasashen su kuma an buga su a cikin mujallar asibitin tafiye-tafiye a tsakiyar watan Janairu na 2020.
Bisa ga bayanan da kungiyar jiragen sama ta duniya ta bayar a shekarar 2018, Bangkok, Hong Kong, Tokyo, da Taipei sun fi yawan fasinjoji daga Wuhan.
An kuma ba da rahoton cewa Dubai, Sydney, da Melbourne wurare ne masu kyau ga matafiya daga Wuhan.
An ruwaito cewa ita ce mafi ƙarancin ƙarfin daga cikin wurare 20 da aka fi so a cikin shiri, yayin da biranen Ostiraliya suka kasance mafi ƙarancin ƙarfin. Ostiraliya ta fitar da shirin gaggawa na gaggawa ga sabon cutar coronavirus (COVID-19) a ranar 7 ga Fabrairu.
Ta ce ba a gano abubuwa da yawa game da COVID-19 ba, kuma Ostiraliya za ta yi ƙoƙari sosai wajen kula da kan iyakoki da sadarwa a cikin amsawa ga annobar.
A ranar 21 ga Maris, an sanar da dokar ta baci ta kare lafiyar mutum a Ostiraliya.
Saboda tasirin da hanyoyin sufuri na jama'a ke yi a Wuhan da Hubei, kasashe da dama sun shirya fitar da 'yan ƙasarsu da jami'an diflomasiyya daga yankin, musamman ta hanyar jiragen sama da aka haya daga ƙasashensu, tare da samar da izini daga hukumomin China.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus, da Thailand sun kasance daga cikin kasashe na farko da suka shirya su kwashe 'yan kasarsu.
Pakistan ta ce ba za ta fitar da wani ɗan ƙasarta daga China ba.
A ranar 7 ga Fabrairu, Brazil ta kwashe 'yan Brazil 34 ko kuma 'yan fursuna da suka kai hari, da kuma wasu 'yan Poland hudu, da wani ɗan China, da kuma wani ɗan Indiya.
'Yan ƙasar Poland, China da Indiya sun sauka daga jirgin a Poland, inda jirgin ya tsaya kafin a ci gaba da tafiya zuwa Brazil.
An killace 'yan ƙasar Brazil da suka je Wuhan a wani sansanin soja kusa da Brazil.
A wannan rana, an tura 'yan Kanada 215 (176 daga jirgin farko, 39 daga jirgin na biyu da gwamnatin Amurka ta haya) daga Wuhan zuwa sansanin sojojin Kanada na Trenton don keɓewa na makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama mai dauke da 'yan Kanada 185 daga Wuhan ya sauka a sansanin sojojin Kanada na Trenton.
Hukumomin Ostiraliya sun kori 'yan ƙasa 277 a ranar 3 da 4 ga Fabrairu zuwa Cibiyar Kula da Tsibirin Kirsimeti, wanda aka sake amfani da shi a matsayin gidan kiwon lafiya, inda suka zauna har kwana 14.
Jirgin ceto na New Zealand ya isa Auckland a ranar 5 ga Fabrairu, kuma an ware fasinjojinsa (ciki har da mutanen Ostiraliya da Pacific) a sansanin ruwa na Wangabarawa a arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta saki 'yan Amirka da ke cikin jirgin ruwa mai suna Diamond Princess.
A ranar 21 ga Fabrairu, jirgin sama ya sauka a Trenton, Ontario dauke da fasinjoji 129 na Kanada da aka kwashe daga jirgin Diamond Princess.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar daga Iran. A ranar 14 ga Maris, jirgin saman kamfanin jirgin saman South African Airlines da gwamnatin Afirka ta Kudu ta haya ya dawo da' yan kasar 112 daga Afirka ta Kudu.
An yi musu gwajin likita kafin su tashi, kuma an bar 'yan Afirka ta Kudu huɗu da suka nuna alamun cutar korona don rage haɗarin.
An mayar da 'yan Afirka ta Kudu ne kawai da suka samu sakamako mara kyau.
Sakamakon gwajin ya tabbatar da cewa 'yan Afirka ta Kudu, ciki har da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal, 'yan sanda, da kuma sojojin da ke aikin agaji waɗanda dukansu, a matsayin kariya, suka kasance a ƙarƙashin saka idanu da kuma tsaftacewar gida a wurin shakatawa na Ranch na kwanaki 14, ba su da rauni.
A ranar 20 ga Maris, Amurka ta fara janye dakarunta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen kasar Sin ta ruwaito cewa kasashe 21 (ciki har da Rasha ta White, Pakistan, Trinidad, Tobago, Masar, da Iran) sun aika da taimako zuwa kasar Sin.
Wasu daliban kasar Sin a jami'o'in Amurka sun hada kai don aika taimako zuwa yankunan da ke da cutar a kasar Sin, kuma a cewar wani rukuni na cikin babban yankin Chicago sun sami damar aika da nauyin N95 50,000 zuwa asibitoci a Hubei County a ranar 30 ga Janairu. Hukumar agaji ta Direct Relief, a cikin haɗin gwiwa tare da FedEx, ta aika da nauyin fuska 200,000 da sauran kayan kariya na mutum, ciki har da safar hannu da tufafin ma'aikatan asibiti, ta hanyar jirgin saman gaggawa, zuwa asibitin Wuhan Union ta ranar 30 ga Janairu.
A ranar 5 ga Fabrairu, Bill da Melinda Gates sun sanar da ba da gudummawar dala miliyan 100 ga WHO don tallafawa bincike da kuma maganin rigakafi, tare da kare "masu haɗari a Afirka da Kudancin Asiya".
Kamfanin Interaction ya ruwaito cewa gwamnatin kasar Sin ta ba da kyautar masks 200,000 ga Philippines a ranar 6 ga Fabrairu, bayan da Sanata Richard Gordon ya tura masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Red Cross ta Singapore ta sanar da cewa za ta aika da tallafin dala miliyan 2.26 zuwa kasar Sin.
Japan ta ba da kyautar fuska miliyan ɗaya ga Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta aika da fiye da tan 13 na kayayyakin kiwon lafiya zuwa Wuhan, Malaysia ta sanar da bayar da kyautar safofin hannu miliyan 18 ga China, Jamus ta ba da kayan kiwon lafiya da dama ciki har da riguna masu kariya 10,000, Amurka ta ba da tan 17.8 na kayan kiwon lafiya ga China, kuma ta yi alkawarin samar da ƙarin tallafi na kuɗi na dala miliyan 100 ga ƙasashe da ke fama da cutar. Bayan da yanayin ya daidaita a China, jihar ta aika da agaji ga ƙasashe daban-daban da suka lalace saboda annoba.
A watan Maris, kasar Sin da Cuba da kuma Rasha sun aika da kayan aikin likita da kuma masana don taimakawa Italiya wajen magance annobar korona.
Wani dan kasuwa mai suna Jack Ma ya aika wa Addis Ababa, Habasha, da tarin gwaje-gwaje miliyan 1.1, da masks miliyan shida, da kuma riguna 60,000 da kungiyar tarayyar Afirka ta yi wa rarrabawa.
Daga baya, sai aka tura masa wasu gwaje-gwaje 5,000 da kuma fuska 100,000 da kuma na'urori biyar na numfashi.
Ƙari ga haka, Ma ta ba da kayan aikin likita ga Kanada. Netherlands, Spain, Turkiyya, Georgia, da Jamhuriyar Czech sun nuna damuwarsu game da masks da kuma gwajin gwaji da aka yi a China.
Alal misali, Spain ta janye nau'ikan gwajin cutar korona 58,000 da aka yi a kasar Sin da suka kai kashi 30% kawai, kuma a lokacin, Netherlands ta dawo da masks 600,000 da aka yi a kasar Sin da suka lalace.
Belgium ta mayar da masks 100,000 da aka yi zaton sun fito ne daga kasar Sin amma a gaskiya sun fito ne daga Colombia.
A gefe guda kuma, sassan Latin Amurka da Afirka sun yi maraba da taimakon da kasar Sin ke bayarwa. A ranar 2 ga Afrilu, Bankin Duniya ya kaddamar da ayyukan gaggawa na tallafawa kasashe masu tasowa.
Hukumar lafiya ta duniya ta yaba wa kokarin da gwamnatin kasar Sin ta yi na sarrafa cutar da kuma hana ta yaduwa.
Hukumar lafiya ta duniya ta lura da bambanci tsakanin barkewar cutar SARS tsakanin shekara ta 2002 da 2004, inda hukumomin kasar Sin suka zargi ta da yin duhu wanda ya hana rigakafi da kuma hanawa, da kuma rikicin da ke faruwa a yanzu, inda gwamnatin tsakiya ta ba da "sabuntawa na yau da kullum don kauce wa firgita kafin sabuwar shekara ta wata".
A ranar 23 ga Janairu, a mayar da martani ga shawarar da hukumomin tsakiya suka yanke na aiwatar da haramcin sufuri a Wuhan, wakilin WHO Gudun Gallaya ya lura cewa yayin da wannan "ba shakka ba ne shawarar da WHO ta bayar", amma "mai matukar muhimmanci ne ga nuna cewa an dage da cutar a inda take da matukar damuwa", ya bayyana ta a matsayin "ba a taɓa gani ba a tarihin lafiyar jama'a". A ranar 30 ga Janairu, bayan an tabbatar da cewa an koma daga kasar Sin zuwa waje, da kuma karuwar adadin shari'o'in a wasu ƙasashe, WHO ta bayyana barkewar cutar a matsayin dokar ta baci ta kiwon lafiya ta kasa da kasa (BHIC), lamarin na shida daga cikin dokar ta baci ta kiwon lafiya da kasashe ke neman mafaka ga al'umma tun lokacin da suka yi rashin lafiya a cikin shekarar 2009.
Babban daraktan WHO ya ce, an dauki barkewar cutar a matsayin gaggawa na kiwon lafiya na duniya saboda "hadarin yaduwar duniya, musamman a ƙasashe masu karamin da matsakaicin kudin shiga waɗanda ba su da tsarin kiwon lafiya mai ƙarfi.
A cikin martani ga aiwatar da takunkumin tafiye-tafiye, Tedros ya ce "babu wani dalili da za a yi amfani da shi don yin amfani da shi ba tare da izini ba" da kuma "Kungiyar Lafiya ta Duniya ba ta ba da shawarar rage kasuwanci da sufuri".
A ranar 5 ga Fabrairu, WHO ta yi kira ga al'ummar duniya da su ba da gudummawar dala miliyan 675 a cikin asusun dabarun da aka shirya a ƙasashen da ke da ƙananan kuɗin shiga, suna nuna gaggawa don tallafa wa waɗancan ƙasashen da "ba su da tsarin gano mutanen da ke da cutar, ko da sun bayyana".
Tedros ya kuma yi sharhi cewa "ƙarfinmu yana auna shi ne da ƙarfin mafi rauni a cikinmu" kuma ya bukaci al'ummar duniya su " zuba jari a yau ko kuma su biya babban farashi daga baya". A ranar 11 ga Fabrairu, WHO ta sanar da cutar, a wani taron manema labarai, da sunan COVID-19.
A wannan ranar, Tedros ya ruwaito cewa Sakataren Janar na Majalisar Dinkin Duniya Antonio Guterres ya amince da gabatar da "dukan damar tsarin Majalisar Dinkin Duniya a cikin amsawa".
A sakamakon haka, an kafa tawagar gudanar da rikicin Majalisar Dinkin Duniya, wanda ya ba da damar daidaita cikakken amsa na Majalisar Dinkin Duniya, kuma WHO za ta ba shi damar "daidaita mayar da hankali kan amsawar lafiya yayin da za a iya amfani da ƙwarewar sauran hukumomi don sanin tasirin zamantakewa, tattalin arziki, da ci gaban da ya fi girma na annobar".
A ranar 14 ga Fabrairu, an shirya wata ƙungiya ta haɗin gwiwa da WHO ta jagoranci tare da China don gabatar da masana na duniya da masana na WHO a kan ƙasa a China don taimakawa gudanar da gida da kimanta "ciwo da kuma yiwuwar kamuwa da cutar" ta hanyar shirya bita da taro tare da manyan cibiyoyin ƙasa, da yin ziyara a filin don kimanta " tasirin ayyukan amsawa a larduna da birane, gami da birane da karkara. A ranar 25 ga Fabrairu, WHO ta sanar da cewa "duniya tana buƙatar yin ƙarin shiri don yiwuwar cutar coronavirus", ta ce tun da farko saboda an bayyana ta a matsayin mai yunwa, amma dole ne a nuna cewa "tafiyar cutar tana cikin wani mataki".
A cikin martani ga yaduwar cutar a Iran, WHO ta aika da wata ƙungiya ta hadin gwiwa don tantance halin da ake ciki. A ranar 28 ga Fabrairu, jami'an WHO sun ce kimantawar barazanar cutar coronavirus a duniya za ta tashi daga "babba" zuwa "mafi girma", wanda shine mafi girman matakin gargadi da kimanta haɗari.
Mike Ryan, darektan shirin gaggawa na kiwon lafiya na WHO, ya yi gargadin a cikin wata sanarwa cewa, "Wannan gwaji ne na gaske ga kowace gwamnati a duniya: don haka dole ne mu kasance a shirye.
Wannan cutar na iya zuwa, kuma dole ne ku kasance a shirye don ta, kuma ya bukaci a dauki matakan da za su taimaka wa duniya ta kauce wa "abin da ya fi muni".
Ryan ya kuma ce bayanan da ake samu a yanzu ba sa sa sabawa jami'an lafiya na duniya su bayyana cutar a matsayin annoba ta duniya, yana mai cewa irin wannan sanarwar tana nufin "mu a zahiri mun yarda cewa kowane mutum a duniya zai kamu da cutar".
A ranar 11 ga Maris, Hukumar Lafiya ta Duniya ta bayyana barkewar cutar korona a matsayin annoba.
Darakta janar ya ce WHO "ta damu ƙwarai da mummunan matakan yaduwar, tsanani, da kuma matakan rashin ƙarfi". WHO ta fuskanci mummunan zargi game da abin da aka gani a matsayin rashin isasshen maganin cutar, ciki har da jinkirin bayyana dokar ta baci ta kiwon lafiya ta jama'a, da kuma rarraba cutar a matsayin annoba.
A sakamakon haka, an yi kira ga babban darektan WHO, Tedros Adhanum, ya yi murabus, kuma mutane 733,000 ne suka yi sa hannu a kan wannan takardar tun daga ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, da dama daga cikin masana kare hakkin bil adama na Majalisar Dinkin Duniya sun tabbatar da girmama hakkin kowa a lokacin annobar COVID-19.
Kungiyar ta ce kowa yana da hakkin yin amfani da taimakon da zai ceci rayuka kuma gwamnati ce take da wannan hakkin.
Kungiyar ta jaddada cewa rashin albarkatu ko inshorar lafiya bai kamata ya zama dalilin nuna bambanci ga wani rukuni ba.
Masana sun tabbatar da cewa kowa yana da hakkin samun lafiya, ciki har da nakasassu, 'yan tsiraru, tsofaffi, marasa gida, marasa gida, waɗanda ke rayuwa cikin mummunan yanayi, fursunoni, da 'yan gudun hijira da sauran ɓangarorin da ba a bayyana ba da ke bukatar tallafin gwamnati.
Kungiyoyin gwamnati na duniya suna magance tasirin tattalin arziki da zamantakewar al'umma na rikicin COVID-19.
Kungiyar Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattalin Arzikin Tattarin Tarin Tattalin Arzarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin Tarin T
Daga manufofin ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya don magance tasirin rufewa da ƙuntatawa kan tafiya, Cibiyar Dijital ta ƙunshi kayan aiki na bin diddigin manufofin ƙasa, wanda ke nufin taimaka wa ƙasashe su koya daga juna da sauƙaƙe daidaitaccen amsawar duniya don fuskantar cutar Corona.
Gwamnatin kasar Sin ta fuskanci sukar Amurka, Ministan majalisar ministocin Birtaniya Michael Goff, da Edward Bolsonaro dan shugaban Brazil, Jair Bolsonaro, kan yadda suke magance annobar, wadda ta fara ne a lardin Hubei na kasar Sin.
An kori daraktocin jam'iyyar kwaminisanci ta kasar Sin da dama a bangarori da dama saboda yadda suka bi da kokarin da ake yi na samar da kiwon lafiya a tsakiyar kasar Sin, a wani jawabi da ya nuna rashin jin dadin yadda jami'an siyasa suka amsa barkewar cutar a wadannan yankuna.
Wasu masu sharhi sun yi imanin cewa wannan matakin na nufin kare babban sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping daga rashin jin daɗin jama'a game da barkewar cutar korona.
Wasu jami'an kasar Sin, kamar su Cao Lijian, sun ƙi yarda da cewa cutar ta korona ta fara ne a Wuhan, a kan ka'idodin da Amurka ko Italiya suka yi game da cutar ta COVID-19.
Gwamnatin Donald Trump ta Amurka ta bayyana coronavirus a matsayin "Cinese virus" ko "Wuhan virus", inda ta ce China ta "ba da labari mai zurfi wanda ya haifar da cutar da ta zama annoba ta duniya", wanda wasu masu sukar suka soki shi saboda nuna wariyar launin fata "kuma ya janye [hankali] daga gazawar gudanarwarsa na dakile cutar".
Daily Beast ta samu wata sakon gwamnatin Amurka da ke nuna tsarin sadarwa daga wasu majiyoyi a majalisar tsaro ta kasar, da kuma cewa "dukkanin China ne.
An umurce mu mu yi kokarin yada wadannan sakonni ta kowace hanya da za mu iya, ciki har da taron manema labarai da kuma fitowar talabijin. "Tushen labarai kamar su Politico, Foren Polis, da Bloomberg sun yi ikirarin cewa kokarin da kasar Sin ke yi na aikawa da taimako ga kasashen da cutar ta shafa na daga cikin wani bangare ne na inganta tasirin duniya.
Wani jami'in harkokin wajen Tarayyar Turai, Josep Borrell, ya yi gargadin cewa akwai "wani ɓangare na siyasa da ya ƙunshi gwagwarmayar rinjaye ta hanyar yin juyayi da kuma nuna karimci".
Burrell ya kuma ce "China tana tura sakon cewa, ba kamar Amurka ba, ita ce abokiyar da ta fi dacewa da kuma abin dogara".
China ta kuma bukaci Amurka ta dage takunkunta kan Syria, Venezuela da Iran, yayin da ta ke aikawa da taimakon ga kasashen biyu.
Hukunta ta Amurka ta hana Jack Ma ba da masks 100,000 ga Cuba a ranar 3 ga Afrilu.
An kuma zargi hukumomin Amirka da canja wurin taimakon da aka yi wa wasu ƙasashe zuwa ƙasarsu.
An kuma samu rahotanni game da rikice-rikicen rufe fuska tsakanin wasu ƙasashe, kamar Jamus, Austria, Switzerland, Jamhuriyar Czech, da Italiya.
Bugu da ƙari, Turkiyya ta kama ɗaruruwan na'urorin numfashi na wucin gadi da aka tura zuwa Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin hadin kai na Tarayyar Turai da Italiya da ke fama da cutar korona.
Mauritsso Masari, jakadan Italiya a Tarayyar Turai ya ce, "China ce kawai ta amsa a matakin biyu.
Hakika, wannan ba alama ce mai kyau ga hadin kai na Turai ba".
A ranar 22 ga Maris, bayan wata hira ta waya da Firayim Ministan Italiya Giuseppe Conte, shugaban Rasha Vladimir Putin ya shirya sojojin Rasha don aika da asibitocin soja, keken tsabtace jiki na musamman, da sauran kayan aikin likita zuwa Italiya.
Jaridar La Stampa ta Italiya ta ruwaito wani "babban majiyar siyasa" da ba ta ambata sunanta ba cewa kashi 80 cikin 100 na taimakon da Rasha ta ba ta "ba da amfani ko kuma ba ta da amfani ga Italiya".
Majiyar ta zargi Rasha da kaddamar da harin 'yan siyasa da 'yan diplomasiyya.
Shugaban Lombardy, Attilio Fontana, da Ministan Harkokin Wajen Italiya Luigi Di Maio sun musanta rahoton kuma sun nuna godiyarsu.
Rasha ta kuma tura jirgin saman sufuri da ke dauke da kayan taimako zuwa Amurka.
Kakakin Kremlin Dmitry Peskov ya ce: "Sa'ad da yake taimaka wa abokan aikinsa na Amirka, [Putin] ya ɗauka cewa idan kamfanonin Amurka da ke samar da kayan aiki da kuma kayan aikin likita suka sake aiki, za su iya ba da taimako idan ya cancanta".
Aikin soja na NATO da aka shirya "Guns 2020" za a yi a Jamus, Poland, da kuma kasashen Baltic, shi ne mafi girma a NATO daga karshen Cold War a kan wani m sikelin.
Sakatare Janar na Kamfenin Hana Makamai Na'urorin Nukiliya Kate Hudson ta soki horo na 2020 na makamai, ta ce: "A cikin rikicin lafiyar jama'a na yanzu, horo ba kawai yana barazanar rayuwar sojojin Amurka da na kasashen Turai da yawa ba amma har da mazaunan kasashen da za a yi". Gwamnatin Iran ta yi matukar fama da cutar, inda kusan 'yan majalisa ashirin da wasu tsoffin' yan siyasa goma sha biyar suka kamu da cutar.
Shugaban Iran Hassan Rouhani ya rubuta wata wasika ta gaba ga shugabannin duniya a ranar 14 ga Maris, 2020 inda ya nemi taimako, yana cewa, kasarsa tana gwagwarmaya don yaki da annobar cutar saboda rashin samun damar zuwa kasuwannin duniya sakamakon takunkumin Amurka da aka sanya wa Iran. An yi kira ga Amurka ta aiwatar da manufofin zamantakewa da suka zama sananne a wasu ƙasashe masu arziki, gami da cikakken kiwon lafiya, kula da yara, hutun iyali mai biyan kuɗi, da kuma karin kuɗin kiwon lafiya.
Masu nazarin siyasa sun yi hasashen cewa hakan zai iya shafar damar da Donald Trump zai samu na sake zabar shugaban kasa a shekarar 2020. Dangantakar diplomasiyya tsakanin Japan da Koriya ta Kudu ta lalace saboda annobar.
Koriya ta Kudu ta soki Japan da "matsalolin da ba a sani ba" na aikin kiwon lafiya bayan da Japan ta sanar da cewa duk wanda ya zo daga Koriya ta Kudu za a saka shi a wuraren kiwon lafiya na wasu makonni biyu a wasu wuraren gwamnati.
Da farko dai, al'ummar Koriya ta Kudu sun damu da yadda Shugaba Moon Jae-in ya amsa wannan matsalar.
Yawancin 'yan Koriya sun sanya hannu kan takardun da suka bukaci a ware Moon saboda sun yi zargin cewa gwamnati ta yi rashin kula da annobar ko kuma ta yaba da yadda ta amsa.
Wasu masu sharhi sun nuna cewa suna tsoron hakan zai ba gwamnatoci damar karfafa ikon su.
A Hungary, majalisa ta amince da ba da izinin firaministan kasar Viktor Orban ya yi mulki har abada, da dakatar da majalisar dokoki da kuma zaben, da kuma hukunta wadanda suka yada bayanan karya game da cutar da kuma yadda gwamnati ke magance matsalar.
An zargi barkewar cutar korona da ta haifar da karancin kayayyaki da yawa saboda karuwar amfani da kayan aikin yaki da annobar a duniya, sayen kayayyaki da kuma hana masana'antu da ayyukan samar da kayayyaki aiki.
Hukumar Abinci da Magunguna ta Amirka ta yi gargadi game da rashin magani da kayan aikin likita saboda yawan bukatar masu amfani da kuma dakatar da masu samarwa.
Ƙari ga haka, a yankuna da yawa, ana yin sayayya da tsoro, kuma hakan ya sa kayayyakin da ake bukata kamar abinci, takardar bayan gida, da kwalaben ruwa suka ɓace.
Masana'antun fasaha sun yi gargadin cewa za a yi jinkirin aika kayayyakin lantarki.
A cewar babban darektan WHO, Tedros Adhanum, bukatar kayan kariya ta mutum zai ninka da sau 100.
Wannan bukatar ta sa farashin ya ninka na kusan sau 20 na farashin talakawa kuma ta sa an jinkirta isar da magani na tsawon watanni hudu zuwa shida.
Hakan ya kuma sa a kasa samun kayan kariya a duniya, kuma Hukumar Lafiya ta Duniya ta yi gargadin cewa hakan zai sa ma'aikatan kiwon lafiya cikin hatsari.
A Ostiraliya, annobar ta ba masu sayen kayan gargajiya na Diego sabuwar dama ta sayar da kayayyakin Australiya a kasar Sin.
Aikin ya haifar da karancin madara ga jarirai a wasu manyan kantunan sayar da abinci kuma daga baya gwamnatin Ostiraliya ta hana shi. Duk da yaduwar shari'o'in COVID-19 a arewacin Italiya da yankin Wuhan, da kuma biyo bayan karuwar bukatar kayayyakin abinci, yankunan biyu sun tsira daga matsanancin karancin abinci.
Matakan da kasar Sin da Italiya suka dauka na yaki da adana kayayyakin rayuwa da kuma cinikayya da ba bisa ka'ida ba sun yi nasara wajen kauce wa matsanancin karancin abinci da ake tsammani a Turai da kuma Arewacin Amirka.
Arewacin Italiya ba ta da raguwar yawan aikin gona, amma farashin zai iya tashi bisa ga tsammanin masana'antun.
An yi watsi da ɗakunan abinci na ɗan lokaci, har ma a birnin Wuhan, yayin da jami'an gwamnatin kasar Sin suka saki naman alade don tabbatar da isasshen abinci ga jama'a.
A Italiya, akwai irin wannan dokar da ta bukaci masana'antun abinci su ajiye kayayyaki don irin wannan gaggawa.
Kasar Sin ta ji lalacewar tattalin arzikin duniya: A cewar wani rahoto na kafofin watsa labarai a ranar 16 ga Maris, tattalin arzikin kasar Sin ya yi mummunan rauni a farkon watanni biyu na 2020 saboda matakan da gwamnati ta dauka don rage yaduwar cutar, kuma tallace-tallace na kasuwanci ya ragu da kashi 20.5%.
Tun da babban yankin Sin babban cibiyar tattalin arziki da masana'antu ne, an lura cewa cutar ta haifar da babbar barazana ga kwanciyar hankali na tattalin arzikin duniya.
Agatha Demaris na hukumar kula da tattalin arziki ta ce kasuwanni za su ci gaba da kasancewa masu karko har sai an bayyana sakamakon da zai faru.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa tasirin tattalin arzikin annobar a kan ci gaban duniya zai iya wuce wanda ya faru sakamakon barkewar cutar SARS tsakanin 2002 da 2004.
Wani masanin jami'ar Washington a St. Louis ya ce an yi tasiri a kan kayayyakin da ake samarwa a duniya da suka kai dala biliyan 300 wanda zai iya wuce shekaru biyu.
Rahotanni sun ce kungiyar kasashen da ke fitar da man fetur ta OPEC ta "rubuce" bayan da farashin man fetur ya ragu sosai saboda karancin bukatar kasar Sin.
Kasuwancin jari na duniya sun ragu a ranar 24 ga Fabrairu saboda yawan adadin COVID-19 a wajen babban ƙasar Sin.
A ranar 27 ga Fabrairu, saboda karuwar damuwa game da barkewar cutar coronavirus, yawancin alamun jari na Amurka, ciki har da NASDAQ-100, da S&P 500, da kuma Dow Jones Industrial Average sun yi raguwa mafi girma tun daga 2008, tare da Dow ya ragu da maki 1,191, wanda shine mafi girma a cikin rana daya tun lokacin rikicin kudi a 2007-08.
Ƙididdigar ta ƙare da makonni uku da suka ragu da fiye da kashi 10.
A ranar 28 ga Fabrairu, kamfanin SCOP Ratings ya tabbatar da cewa kamfanin GMPH yana da darajar cinikayya ta kasar Sin, amma ya ci gaba da yin hakan.
Hannun jari ya sake raguwa saboda tsoron cutar korona, kuma mafi girma ya kasance a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai iya ci gaba da raguwa.
Masanin tattalin arziki Mohammed Al-Arian ya yaba da gaggawa da manyan bankuna da kasashen duniya ke dauka a kan lokaci.
Babban bankin ya amsa da sauri fiye da yadda ya yi a lokacin rikicin kudi na 2008.
Yawon shakatawa na ɗaya daga cikin ɓangarorin da aka fi shafa saboda hana tafiya, rufe wuraren jama'a ciki har da wuraren yawon buɗe ido, da kuma gargadi ga gwamnatoci game da tafiya a duk faɗin duniya.
A sakamakon haka, kamfanonin jiragen sama da yawa sun soke jiragen su saboda raguwar buƙata, ciki har da British Airways, China Eastern Airlines, da Kants, yayin da kamfanin jirgin saman yankin na Burtaniya, FlyB ya fadi.
Tasirin da kamfanin jirgin ya yi a kan masana'antar jirgin sama ya kasance ba a taɓa gani ba.
An rufe tashoshin jirgin kasa da tashoshin jiragen ruwa da yawa.
Aikin ya yi daidai da lokacin hutu na bazara da ake kira Chunyun, wanda shine babban lokacin tafiya da ke hade da hutun sabuwar shekara ta kasar Sin.
Gwamnatocin ƙasa da na yanki sun soke wasu abubuwan da suka ƙunshi mutane da yawa, gami da bikin Sabuwar Shekara, tare da kamfanoni masu zaman kansu da ke rufe shagunan su da kansu da wuraren yawon buɗe ido kamar Disneyland Hong Kong da Disneyland Shanghai.
An rufe abubuwan da ake yi a sabuwar shekara da kuma wuraren yawon bude ido don hana manyan taro, ciki har da birnin da aka hana a birnin Beijing da kuma wuraren haikalin gargajiya.
A larduna 24 daga larduna 31, a wasu garuruwa da yankuna a kasar Sin, hukumomi sun tsawaita hutun sabuwar shekara har zuwa 10 ga Fabrairu, kuma sun ba da umarni ga yawancin wuraren aiki da kada su sake buɗewa har zuwa wannan ranar.
Waɗannan yankuna suna wakiltar kashi 80 cikin 100 na GDP na ƙasar da kuma kashi 90 cikin 100 na fitarwa.
Hong Kong ta ɗaga matakin amsawa ga cututtukan cututtuka zuwa mafi girma kuma ta ayyana dokar ta baci, ta rufe makarantu har zuwa Maris kuma ta soke bikin Sabuwar Shekara. An shafi masana'antar sayar da kayayyaki a duniya ta hanyar rage lokacin aiki a shaguna ko rufewar wucin gadi.
Yawan ziyarar dillalai a Turai da Latin Amurka ya ragu da kashi 40 cikin 100.
Kasashen Arewacin Amirka da Gabas ta Tsakiya sun yi kashi 50 zuwa 60 cikin ɗari a cikin kasuwar da ke sayar da kayayyaki.
Wannan kuma ya haifar da raguwar kashi 33 zuwa 43% na zirga-zirgar da ke tafiya zuwa wuraren cin kasuwa a watan Maris idan aka kwatanta da Fabrairu.
Masu amfani da shagunan cinikayya a duniya sun sanya ƙarin matakan, kamar ƙara tsabta, shigar da masu duba hasken wuta don bincika zafin jiki na masu siye, da kuma soke abubuwan da suka faru. Bisa ga kimantawar Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka, koma bayan tattalin arziki na annobar zai iya barin mutane miliyan 14 zuwa 22 cikin matsanancin talauci a Latin Amurka fiye da waɗanda za su sha wahala daga wannan yanayin ba tare da yunwa ba.
A watan Janairu da Fabrairun shekarar 2020, a lokacin da annobar ta yi zafi a birnin Wuhan, mutane miliyan biyar ne suka rasa ayyukansu a kasar Sin.
Yawancin 'yan gudun hijira na kasar Sin da ke ƙauyuka, kimanin miliyan 300, sun makale a gidajensu a cikin lardunan cikin gida, ko kuma a lardin Hubei. A watan Maris na 2020, fiye da Amurkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
Cutar cutar korona na iya kashe mutane miliyan 47 a Amurka, kuma rashin aikin yi na iya kaiwa kashi 32 cikin ɗari, a cewar kiyasta na Federal Reserve Bank of St. Louis. Ruwan Indiya ya bar dubban miliyoyin ma'aikatan Indiyawan da ke ba da izini (wanda ake biya ta hanyar albashi na yau da kullun) marasa aiki. Wani binciken da Cibiyar Angus-Reed ta gudanar ya gano cewa kashi 44% na iyalai na Kanada sun sha wahala daga wani nau'in rashin aikin yi. Kimanin 900,000 na ma'aikatan aikinsu sun rasa a Spain tun lokacin da aka rufe su a tsakiyar Maris 2020.
A cikin rabin watan Maris, ma'aikata miliyan hudu na Faransa sun nemi tallafin rashin aikin yi na wucin gadi da kuma ma'aikata miliyan daya na Birtaniya sun nemi tsarin bashi na cikakken lokaci. Kimanin rabin miliyan na kamfanoni a Jamus sun tura ma'aikatansu cikin shirye-shiryen aiki na gajeren lokaci da gwamnati ke tallafawa da ake kira Courzarbit.
Faransa da Birtaniya sun amince da shirin biyan kuɗin aiki na ɗan gajeren lokaci na Jamus.
An yi tasiri sosai a kan ayyukan ƙungiyoyi da kuma mutane masu aiki da masu zaman kansu a duniya, a kan harkokin wasan kwaikwayo da al'adun gargajiya.
Cibiyoyin fasaha da al'adu sun nemi tallafawa aikinsu (mafi yawanci ana tallafawa ta gwamnati) na samar da damar samun al'adun al'umma, kiyaye lafiyar ma'aikatan su da jama'a, da tallafawa masu fasaha gwargwadon iko.
A watan Maris na shekarar 2020, a ko'ina cikin duniya, an rufe gidajen tarihi, dakunan karatu, wuraren baje kolin, da sauran cibiyoyin al'adu har abada tare da sokewa ko kuma jinkirta baje kolin su da abubuwan da suka faru da kuma abubuwan da suka nuna.
A sakamakon haka, an yi ƙoƙari sosai don samar da ayyuka na madadin ta hanyar dandamali na dijital. Daga cikin sauran abubuwan da ke faruwa na yau da kullun na cutar an soke ayyukan addini, manyan wasanni, da sauran ayyukan zamantakewa, kamar bukukuwa na kiɗa, bukukuwa, tarurruka na fasaha, da kuma nuna kayan ado.
A lokacin da aka yi bikin bikin, an yi bikin bikin bikin bikin ranar Juma'a a Roma, wanda ya faru a makon ƙarshe na lokacin tuba na Kirista a cikin babban azumi.
Yawancin majami'u na Kirista sun ba da shawarar dattawa su zauna a gida maimakon halartar taro a ranar Lahadi; wasu majami'u sun ba da sabis na coci ta hanyar rediyo, watsa shirye-shirye ta yanar gizo ko talabijin yayin da wasu ke ba da ibada ba tare da barin motarsu ba.
Tare da rufe cocin Roman Katolika na Roma da ɗakin ibada, da kuma kwance filin St. Peter daga masu hawan hajji na Kirista, sauran kungiyoyin addini sun kuma soke ayyukan da kuma taron jama'a a majami'u, masallatai, majami'u, majami'u, majami'u, da gurdura.
Ma'aikatar Lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa sannan ta rufe gidajen ibada, yayin da Saudiyya ta hana masu hajjin kasashen waje da mazaunanta shiga wuraren tsarki a Makka da birnin.
Wannan annoba ce ta haifar da babbar matsalar kalandar wasanni a duniya tun lokacin yakin duniya na biyu.
An soke ko kuma an dage yawancin manyan wasannin wasanni, ciki har da gasar zakarun Turai 2019-20, Premier League 2019-20, Europa League 2020, American League Basketball Professional 2019-20, da kuma gasar Hockey ta Kasa 2019-20.
Cutar ta rushe shirin gasar Olympics ta bazara ta 2020, wanda aka shirya zai fara a karshen watan Yuli, kuma Hukumar Olympic ta Duniya ta sanar a ranar 24 ga Maris cewa aikin "za a sake tsara shi zuwa bayan 2020 amma a kalla a lokacin bazara na 2021". An rufe kungiyoyin caca da sauran wuraren wasa a duniya kuma an dage ko an soke gasar caca ta kai tsaye.
Wannan ya sa 'yan caca da yawa suka koma yin caca ta yanar gizo, inda shafukan caca da yawa suka ba da rahoton ƙaruwar yawan sababbin biyan kuɗi. An kuma shafi masana'antar nishaɗi, inda aka dakatar da ƙungiyoyin kiɗa daban-daban ko kuma soke ziyara.
Yawancin manyan gidajen wasan kwaikwayo kamar na Broadway sun dakatar da duk wasan kwaikwayon.
Wasu masu fasaha sun gano hanyoyin ci gaba da samar da aikin da kuma raba shi ta yanar gizo a matsayin madadin aikin kai tsaye na gargajiya, kamar watsa shirye-shiryen kai tsaye ko ƙirƙirar "ƙungiyoyi" na kan layi don masu fasaha su yi aiki, rarraba su, da kuma buga su.
Akwai wasu labaran da ake yi game da cutar korona a Intanet, inda mutane da yawa suka zama abin dariya da ban dariya a lokacin da ba a san abin da zai faru ba.
Tun bayan barkewar cutar COVID-19, an lura da nuna bambanci mai tsanani, ƙiyayya da kuma nuna wariyar launin fata ga mutanen da ke da asalin Sin da na Asiya ta Gabas, da kuma mutanen da ke da matsayi mai zafi a Turai da Amurka da sauran ƙasashe.
An lura da tsoro, shakku da kuma ƙiyayya a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amirka, Asiya da Pacific.
Rahotanni da aka fitar a watan Fabrairu (lokacin da yawancin shari'o'in har yanzu ba su da yawa a China) sun nuna rashin jin daɗin wariyar launin fata da kungiyoyi daban-daban a duniya suka nuna wa Sinawa cewa sun cancanci cutar ko kuma suna karɓar abin da ake zargin suna da adalci.
Ƙa'idodin da ake yi game da Sin sun yi yawa a wasu ƙasashen Afirka.
Mutane da yawa a Wuhan da Hubei sun ba da rahoton nuna bambanci saboda asalin yankin su.
Akwai goyon baya ga 'yan kasar Sin a kan layi da kuma wajen duniya, da kuma ga wadanda ke zaune a yankunan da cutar ta shafa.
Bayan barkewar cutar ta bazu a cikin sabbin wuraren zafi, mutane daga Italiya, ƙasa ta farko a Turai da ta fara samun mummunan barkewar COVID-19, na iya fuskantar shakku da ƙiyayya ga baƙi. 'Yan ƙasa a ƙasashe kamar Malaysia, New Zealand, Singapore, da Koriya ta Kudu sun fara sanya hannu kan buƙatun matsa lamba don hana Sinawa shiga ƙasarsu a cikin ƙoƙarin dakatar da cutar.
A Japan, an wallafa wani hashtag na ChineseDontComeToJapan# a shafin Twitter.
Sinawa da sauran 'yan Asiya a Birtaniya da Amurka sun ruwaito karuwar cin zarafin wariyar launin fata, da kuma hare-haren.
Shugaban Amurka Donald Trump ya fuskanci zargi game da kiran cutar coronavirus "Cinese virus", kalma da masu sukar suka ɗauka mai launin fata da kuma rashin son Sinawa.
Masu zanga-zangar a Ukraine sun kai hari kan motocin bas da ke dauke da 'yan Ukraine da kuma 'yan kasashen waje da ake kwashewa daga Wuhan zuwa Novi Sanzary.
Dalibai daga arewa maso gabashin Indiya, wanda ke kan iyaka da China, da ke karatu a manyan biranen Indiya, sun fuskanci matsala saboda barkewar cutar korona.
Shugaban jam'iyyar Bharatiya Janata a jihar West Bengal, Dillip Gosh, ya ce, 'Sin sun lalata yanayi, kuma shi ya sa Allah ya yi musu rashi.'
A kasar Sin, annoba ta haifar da ƙiyayya da nuna wariyar launin fata ga baƙi da kuma mazaunan da ba 'yan kasar Sin ba, inda aka kwatanta 'yan kasashen waje a matsayin "ƙazamar ƙasashen waje" kuma ana nufin "su kawar da su".
Jaridu da yawa sun cire shafukan biyan kuɗi don wasu ko dukansu na cutar korona.
Masu wallafa kimiyya da yawa sun ba da takardun kimiyya game da annobar don buɗewa.
Wasu masana sun zaɓi su raba binciken su da sauri a kan sabobin da ba a buga su ba kamar bioRxiv.
Sau da yawa cututtuka masu yaduwa suna fitowa daga masu yaduwa, ko kuma hanyar da suke yaduwa.
Duniya da cututtuka  Bayani na duniya da kuma yaduwar cututtuka
Jerin annoba da annoba Jerin mutuwar da aka samu daga cututtuka masu yaduwa
Dabbobin daji da cututtukan dabbobi da suka samo asali haɗarin kiwon lafiya da ke tattare da cinikin dabbobi na daji
Gwajin gwaji na cutar coronavirus ta 2019 (COVID-19) da kuma SARS-CoV-2 da ke da alaƙa ya haɗa da hanyoyin gano cutar inda za a iya gano maganin rigakafi da ke haifar da amsa ga kamuwa da cuta.
RT-PCR na tabbatar da cewa akwai ƙwayoyin cuta a cikin samfurori, inda kwayoyin cuta na RNA na cutar korona suke ganowa.
Wannan gwajin yana da kyau kuma an tsara shi ne don gano DNA na SARS-CoV-2 kawai.
Ana amfani da shi don tabbatar da cewa mutum ya kamu da cutar a kwanan nan ko kuma yana da ciwo.
Ana amfani da maganin rigakafi don ganewa da kuma lura da yawan jama'a.
Gwajin rigakafi ya nuna yawan mutanen da suka kamu da cutar, har da waɗanda ba a bayyana alamun cutar ba ko kuma waɗanda ba su da alamun cutar.
Ana iya sanin ainihin adadin mutuwar da ake yi wa cutar da kuma matakin rigakafin da ake yi wa mutane bisa ga sakamakon gwajin.
Saboda ƙarancin gwaje-gwaje, babu wata ƙasa da a watan Maris na 2020 ta sami tabbataccen bayani game da yaduwar cutar a cikin al'ummarta.
A ranar 23 ga Maris, babu wata ƙasa da ta gwada fiye da kashi 3 cikin 100 na yawan jama'arta, kuma akwai babban sakamako a yawan gwaje-gwajen da aka yi a ƙasashe daban-daban.
Wannan bambancin zai iya shafar yawan mutuwar da aka ruwaito, wanda a wasu ƙasashe ana iya yin hakan sosai.
Ana iya yin bincike ta hanyar amfani da tsarin polymerase na atomatik na kwafin jiki (RRT-PCR) a kan samfurori na numfashi da aka samu ta hanyoyi daban-daban, daga cikinsu akwai numfashi na huhu ko samfurin bulge.
A yawancin lokaci, ana samun sakamako a cikin 'yan sa'o'i zuwa kwanaki biyu.
Ana amfani da CT-PCR ne kawai a makon farko na rashin lafiya.
Daga nan sai cutar ta ɓace daga wuyansa yayin da take ci gaba da yaduwa a cikin huhu.
A mako na biyu, za a iya gwada mutanen da suka kamu da cutar ta hanyar yin maganin shan iska ko kuma yin amfani da maganin tari.
An ƙirƙiri wani gwajin PCR na farko a Sharete a Berlin a watan Janairun 2020 ta amfani da aikin polymerase mai rikitarwa na atomatik (RRT-PCR), kuma ya kafa tushen gwajin gwaji 250,000 da Hukumar Lafiya ta Duniya (WHO) ta rarraba.
Ƙasar Ingila ta kuma ci gaba da gwajin a ranar 23 ga Janairu, 2020. Kamfanin Kogenebiotech na Koriya ta Kudu ya kirkiro kayan aikin gano cutar SARS-CoV-2 (PowerChek Coronavirus) don amfanin asibiti mai aminci kuma ya dogara da PCR a ranar 28 ga Janairu, 2020.
A China, BGI Group na ɗaya daga cikin kamfanonin da suka fara samun izinin gaggawa daga Hukumar Kula da Kayan Aikin Kayan Aiki ta kasar Sin don gano SARS-CoV-2 da ke dogara da PCR. A Amurka, Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka (CDC) sun rarraba takardar ganewar asali na COVID-19 (COVID-19-2019) wanda ya dogara da RT-PCR wanda ke da cibiyoyin bincike na duniya ta hanyar Hukumar samar da Sabbin Abubuwan Ganowa ta Duniya.
Wani gwajin da aka yi a cikin tsofaffin sigogi guda uku na gwajin ya haifar da sakamako mai ban mamaki saboda abubuwan da suka faru, kuma an jinkirta gwajin lokaci ɗaya daga sauran a CDC a Atlanta; hakan ya haifar da gwajin ƙasa da 100 samfurori a kowace rana a matsakaita cikin nasara a cikin watan Fabrairu 2020.
Gwaje-gwaje da ke amfani da abubuwa biyu masu aminci ba su samu ba har zuwa 28 ga Fabrairu, 2020, kuma har zuwa wannan lokacin ba a ba da izinin fara gwajin ga dakunan gwaje-gwaje na gwamnati da na gida ba.
Hukumar Abinci da Magunguna ta amince da gwajin a ƙarƙashin izinin amfani da gaggawa. Labs na kasuwanci a Amurka sun fara yin gwaji a farkon Maris 2020.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da cewa za a samar da gwajin COVID-19 a duk faɗin ƙasar bisa ga RT-PCR.
Hakanan, Quest Diagnostics ta ba da damar gwajin COVID-19 a duk faɗin ƙasar daga 9 ga Maris, 2020.
Babu wani iyakance-yakance da aka bayyana; dole ne a cire samfurori kuma a sarrafa su bisa ga bukatun CDC.
A Rasha, Cibiyar Nazarin Kwayar cuta da Fasaha ta Rayuwa ta Ƙasa ta kirkiro da kuma samar da gwajin COVID-19.
A ranar 11 ga Fabrairu, 2020, Hukumar Kula da Kiwon Lafiya ta Tarayya ta yi rajistar gwajin. A ranar 12 ga Maris, 2020, an ruwaito cewa Mayo Clinic ta haɓaka gwajin gano cutar COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don gwajin da za a iya yi a cikin awanni 3.5 akan manyan adadi, wanda ke ba da damar inji ɗaya ya yi kusan gwaje-gwaje 4,128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, Hukumar Abinci da Magunguna ta ba da izinin amfani da gaggawa (EA) ga dakunan gwaje-gwaje na Abbott don yin gwaji akan tsarin Abbott m2000; Hukumar ta ba da izinin kama da haka ga Hologic, Lab Corp da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Svid ya sami izinin amfani da gaggawa daga Hukumar Abinci da Magunguna don gwajin da ke ɗaukar kimanin minti 45.
Hukumar ta amince da gwajin da ke amfani da fasahar kwayar halitta ta daidaitaccen zafin jiki maimakon PCR.
Tun da ba a bukatar jerin zafin jiki masu zuwa ba, wannan hanyar za ta iya nuna sakamako mai kyau a cikin ƙasa da minti biyar da kuma sakamako mara kyau a cikin minti 13.
A halin yanzu akwai kimanin na'urori 18,000 a Amurka kuma Abbott na tsammanin za a kara samar da su don yin gwaje-gwaje 50,000 a rana. Taiwan kuma tana haɓaka gwaji wanda ke amfani da wani abu mai ƙwayoyin cuta guda ɗaya wanda ke da alaƙa da furotin na kwayar cutar coronavirus, da fatan zai iya samun sakamako a cikin mintina 15 zuwa 20 kamar gwajin mura mai sauri.
Wani bita na nazarin a watan Maris na 2020 ya kammala cewa "ra'ayoyin radiyo na kirji ba su da ƙimar ganewar asali a farkon lokaci, yayin da sakamakon CT [ƙirar CT] na iya zama bayyananne tun kafin bayyanar cututtuka".
Abubuwan da aka saba gani a cikin hotunan hoto na kwamfuta sun haɗa da katako na gilashi mai launin fata da ke da bangarori biyu da yawa tare da rarrabawar da ba ta dace ba da kuma baya.
Ƙarƙashin ƙwayar cuta yana yaduwa kuma yana nuna tabo marasa kyau da kuma ƙaruwa yayin da cutar ta ci gaba.
Wani bincike a birnin Wuhan da ya kwatanta PCR da CT na asali na cutar ta yanzu ya nuna cewa PCR ya fi saurin gani, ko da yake ba shi da cikakken bayani, tare da yawancin halayensa na hoto da ke haɗuwa da cututtukan huhu da sauran matakan rashin lafiya.
A watan Maris na 2020, Kwalejin Nazarin Radiography ta Amurka ta ba da shawarar "ba a yi amfani da CT don gano COVID-19 ko a yi la'akari da shi a matsayin gwaji na farko don gano cutar ba". A watan Maris na 2020, CDC ta ba da shawarar yin amfani da PCR don gwaji na farko.
Wani ɓangare na maganin rigakafi na kamuwa da cuta ya ƙunshi samar da kwayoyin rigakafi, ciki har da IgM da IgG.
Ana iya amfani da su don gano kamuwa da mutane a cikin kwanaki 7 ko bayan bayyanar cututtuka, don tantance rigakafi, kuma a cikin yanayin kula da al'umma. Ana iya yin gwaje-gwaje a cikin manyan dakunan gwaje-gwaje (CLT) ko ta hanyar gwajin asibiti (BCT).
Tsarin da ke aiki sosai a dakunan gwaje-gwaje da yawa za su iya yin wannan bincike, amma yawan da za a iya samarwa zai dogara ne da yawan aikin da ake yi a kowace hanya.
A cikin dakin gwaje-gwaje na musamman, ana amfani da samfurin jini guda ɗaya na jini, ko da yake ana iya yin amfani da samfurin jini don bin diddigin amsawar rigakafi.
A gwajin asibiti, ana cire jini guda ɗaya ta hanyar yin wani rami a cikin fata.
Ba kamar hanyoyin PCR ba, ba a buƙatar yin gwajin gwaji. A ranar 26 ga Maris, 2020, Hukumar Abinci da Magunguna ta gano hukumomi 29 da suka ba da sanarwar ga hukumar bisa ga buƙatun kuma saboda haka waɗannan hukumomi za su iya rarraba abin da suke da shi daga gwajin rigakafi.
A ranar 7 ga Afrilu, 2020, Hukumar Abinci da Magunguna ta amince da gwaji guda ɗaya kawai a ƙarƙashin izinin amfani da gaggawa. A ƙarshen Maris, 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami amincewar Turai don ƙungiyar gwajin su, waɗanda zasu iya gano magungunan IgG da IgA a cikin samfurin jini.
Ana yin gwajin cikin sa'o'i da yawa kuma yana da sauri fiye da na gargajiya na PCR na kwayar cutar riboside.
Ana iya gano rigakafin bayan kwanaki 14 da kamuwa da cuta. A watan Afrilu, Birtaniya ta gano cewa kayan gwajin rigakafin da ta saya ba su da kyau don amfani.
Hong Kong ta samar da shirin da za a iya ba marasa lafiya da ake zargi da cutar su zauna a gidajensu, "sashen gaggawa ya ba marasa lafiya samfurin bututu", su fesa a bututun, kuma su dawo da shi don samun sakamakon gwajin bayan ɗan lokaci. Hukumar Kula da Lafiya ta Birtaniya ta sanar da cewa tana gwada shirin don gwada yanayin da ake zargi da cutar a gida, don haka ya kawar da haɗarin kamuwa da cutar daga marasa lafiya lokacin da suka isa asibiti ko buƙatar hana motar motar motar da ake amfani da ita. Lokacin da aka yi gwajin COVID-19 ga wanda ake zargi da motar ba tare da barin motar ba, mai kula da lafiyar likita yana janye bayanan da suka dace.
Cibiyoyin binciken cikin mota sun ba Koriya ta Kudu damar yin wasu gwaje-gwaje masu sauri da kuma mafi girma a duniya. A Jamus, a ranar 2 ga Maris, Ƙungiyar Likitocin Kula da Lafiya ta Ƙasa ta sanar da cewa ta iya yin gwaje-gwaje kusan 12,000 a kowace rana ga marasa lafiya na waje kuma an gwada mutane 10,700 a makon da ya gabata.
Asusun kiwon lafiya zai biya kuɗin idan likita ya umurce ku da ku yi gwajin.
A cewar shugaban cibiyar Robert Koch, Jamus tana da damar yin gwaji kusan 160,000 a mako.
A ranar 19 ga Maris, an gudanar da gwajin gano cutar a cikin mota a manyan birane da yawa.
A ranar 26 ga Maris, 2020, ba a san yawan gwajin da aka yi a Jamus ba, domin an sanar da sakamakon gwajin ne kawai.
Wani binciken bincike na farko ya nuna cewa tun daga makon 12/2020, an gwada aƙalla samfura 483,295 har zuwa karshen makon 12/2020, kuma samfura 33,491 (6.9%) sun kasance masu kyau ga kamuwa da cutar SARS-CoV-2. A Isra'ila, masu bincike a cikin asibitin Rambam da masu bincike na aikin injiniya sun kirkiro hanyar bincika samfurori daga marasa lafiya 64 a lokaci guda kuma sun yi wannan hanyar, ta hanyar tattara samfurori kuma ba su yi ƙarin gwaje-gwaje ba sai lokacin da samfurin ya tabbatar da cewa samfurin ya kasance mai kyau. A Wuhan, BGI ya buɗe wani gwaji na gaggawa don gano yanayin gaggawa wanda ya ƙunshi fiye da mita 2,000 na "Yanzu-Yanzu-Yanzu" da ake kira "Yanzu-Yanzu-Yanzu" (Fuo: 5), wanda a yau zai iya ƙidaya fiye da 10,000 na "Yanzu-Yanzu-Yanzu" (Yanzu-Yanzu-Yanzu-Yanzu)
Da Wang Jian, wanda ya kafa BGI, ya yi aiki a kan ginin kuma ya ɗauki kwanaki biyar, aikin yin samfurin ya nuna cewa a Hubei, za a samu kashi 47 cikin ɗari na yawan cututtukan da za su iya kashewa kuma za a ninka farashin da ake kashewa don yin wannan gwajin idan ba a yi wannan gwajin ba.
A nan take, Wuhan Lab za ta iya kafa dakin gwaje-gwaje na Huo-Yan a birnin Shenzhen, Tianjin, Beijing, da Shanghai, da kuma a birane 12 a duk faɗin ƙasar Sin.
A ranar 4 ga Maris, 2020, yawan aikin yau da kullun ya kai gwaje-gwaje 50,000 a kowace rana. Origami Assays ta fitar da kayayyaki masu buɗewa da masu watsawa waɗanda zasu iya gwada samfurori 1122 na mai haƙuri don gano COVID-19 ta amfani da gwaji 93 kawai. Ana iya amfani da waɗannan kayayyaki masu daidaitawa a ƙananan dakunan gwaje-gwaje ba tare da buƙatar sarrafa ruwa na atomatik ba.
A watan Maris, rashin isasshen kayan bincike ya kawo matsala a gwajin gwaji da yawa a Tarayyar Turai, Birtaniya da Amurka.
Wannan ya sa wasu masana su binciki hanyoyin samar da samfurori da suka hada da dumama samfurori a 98 ° C (208 ° F) na minti 5 don sakin DNA na ribose don yin karin gwaje-gwaje. A ranar 31 ga Maris, an sanar da cewa UAE ta kasance a saman duniya ta hanyar yawan gwajin cutar coronavirus ga mazaunanta, kuma tana kan hanyar haɓaka matakin gwajin don isa ga yawancin jama'a.
Wannan ya faru ne ta hanyar haɗuwa da kunna ƙarfin gwajin cikin mota, da sayen dakin gwaje-gwaje na yawan aiki mai girma daga Group 42 da BGI (dangane da dakin gwaje-gwajen gano gaggawa na Huo-Yan a China).
Za a gina dakin gwaje-gwaje a cikin kwanaki 14, inda za a iya yin dubban gwaje-gwaje na RT-PCR a kowace rana kuma shi ne dakin gwaje-gwaje na farko a duniya da ke aiki a waje da Sin.
An kirkiro hanyoyin gwaji daban-daban da ke nuna bambancin yanayin kwayoyin cutar korona a China, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar lafiya ta duniya ta amince da shirin Jamus na samar da kayan aiki da ake turawa ƙasashen da ba su da albarkatun samar da kayan aikin kansu.
An sanar da shirin na Jamus a ranar 17 ga Janairu, 2020; yarjejeniyar da Cibiyoyin Kula da Cututtuka da Rigakafin ta Amurka suka kafa ba ta samuwa har zuwa ranar 28 ga Janairu, wanda ya haifar da jinkirin gwajin da ke cikin Amurka. China da Amurka sun fuskanci matsaloli game da amincin gwajin gwajin da wuri na barkewar cutar, kuma waɗannan ƙasashe da Ostiraliya ba su iya samar da isasshen lambobi don biyan buƙata da bin shawarwarin yin gwajin da masana kiwon lafiya suka bayar ba.
A akasin haka, masana sun ce yawan gwajin da ake yi a Koriya ta Kudu ya taimaka wajen rage yaduwar sabon kwayar cutar korona.
Gwamnatin Koriya ta Kudu ta inganta gwajin gwaji sosai a cikin dakunan gwaje-gwaje na kamfanoni na musamman a tsawon shekaru.
A ranar 16 ga Maris, WHO ta yi kira ga karfafa shirye-shiryen gwaji a matsayin mafita mafi kyau don rage ci gaban annobar COVID-19. Ƙaruwar buƙatar gwaji sakamakon yaduwar cutar ta haifar da tara dubban gwaje-gwaje a cikin dakunan bincike na Amurka, kuma an rage wadatar allurar rigakafi da kuma gano sinadarai.
A watan Maris na shekarar 2020, kasar Sin ta ba da rahoton cewa akwai matsaloli a cikin daidaito na gwajinta.
A Amurka, an gano "kurakurai" a cikin kayan gwajin da CDC ta ƙirƙira; sai gwamnatin ta kawar da shinge na hukuma wanda ya hana gwajin musamman. Spain ta sayi kayan gwajin daga kamfanin Shenzhen Bioeasy Biotechnology Limited na China, amma ta gano cewa sakamakon bai dace ba.
Kamfanin ya bayyana cewa sakamakon da bai dace ba zai iya faruwa ne domin ba a tattara samfurori ba ko kuma ba a yi amfani da kayan aikin yadda ya kamata ba.
Ma'aikatar ta Spain ta bayyana cewa za ta janye daga siyan kayan aikin da suka ba da sakamako mara kyau, kuma za ta maye gurbin su da wasu kayan aikin gwaji daga Shenzhen Bioeasy. 80% na kayan aikin gwajin da Czech Republic ta saya daga China sun ba da sakamako mara kyau. Slovakia ta sayi kayan aikin gwaji miliyan 1.2 daga China wanda ya tabbatar da cewa ba daidai ba ne.
Firayim Minista Matović ya ba da shawarar jefa su cikin Kogin Danube. Farfesa Agnet Kara na Ma'aikatar Lafiya ta Turkiyya ya bayyana cewa kayan gwajin da Turkiyya ta saya daga China suna da "hawan kuskuren kuskure" kuma an "hana amfani da su".
Gwaje-gwajen, da kuma gwajin da aka yi wa waɗanda aka tabbatar da cewa suna da cutar, da kuma waɗanda suka haɗu da waɗanda suka kamu da SARS-CoV-2, sun nuna cewa sun yi nasara.
Masu bincike da ke birnin Fow na Italiya, inda aka samu mutuwar COVID-19 ta farko a Italiya, sun yi gwaje-gwaje a kan dukan mazaunan kusan 3,400 sau biyu, kuma hakan ya ɗauki kwanaki goma a kowane lokaci.
Kusan rabin mutanen da aka gwada sun nuna rashin bayyanar cututtuka, kuma an ware duk wadanda aka gano.
Saboda dokar hana zirga-zirga tsakanin garuruwa, an kawar da sababbin kamuwa da cuta.
Cutar coronavirus ta 2020 a Singapore ta sami raguwa sosai a cikin yaduwar idan aka kwatanta da sauran ƙasashe masu tasowa, amma ba tare da takunkumi masu ƙarfi kamar tilasta rufe gidajen abinci da wuraren siyarwa ba; ta hanyar bin diddigin dabaru da sanya takunkumi kan tafiya cikin gida, gwaji da kuma kiwon lafiya.
An soke taron da yawa, kuma Singapore ta riga ta fara ƙarfafa mazauna su zauna a gidajensu a ranar 28 ga Maris, amma an sake buɗe makarantu a ranar 23 ga Maris a kan lokaci bayan hutu.
Wasu ƙasashe da yawa sun kuma sarrafa cutar ta hanyar bin diddigin da aka yi da kuma sanya takunkumin tafiye-tafiye na cikin gida, gwaji, da kuma tsaftacewar lafiya, amma tare da yanke shawara mai ƙarancin tsauri, kamar Iceland da Koriya ta Kudu.
Wani bincike ya nuna cewa kasashen da suka yi gwaji da yawa fiye da yadda suka yi mutuwa, sun fi yawan wadanda suka mutu, wataƙila domin sun fi iya gano waɗanda ba su da alamun cutar.
Hukumar lafiya ta duniya ta shawarci kasashen da ba su da ikon yin gwaje-gwaje ko kuma suna da dakunan gwaje-gwaje na gida da ƙarancin gogewa game da COVID-19 su aika da samfurori biyar na farko na COVID-19 da kuma samfurori goma na farko na COVID-19 zuwa ɗaya daga cikin dakunan gwaje-gwaje 16 da WHO ta amince da su don tabbatar da gwajin.
Daga cikin dakunan gwaje-gwaje 16 da aka amince da su, akwai bakwai a Asiya, biyar a Turai, biyu a Afirka, ɗaya a Arewacin Amirka, ɗaya kuma a Ostiraliya.
A cikin jadawalin da ke gaba, shafi na "% na gwajin da aka yi na tabbatacce" ya shafi manufofin da jihar ke bi wajen yin gwajin.
Kasar da ke yin gwajin ga mutanen da aka kai asibiti kawai za ta sami kashi 100 na gwajin da ya fi na duk mazaunanta, ko suna da alamun cutar ko a'a, idan aka yi la'akari da wasu dalilai.
Wanke hannu (ko wanke hannu), wanda aka fi sani da tsabtace hannu, tsari ne na tsabtace hannu don cire datti, kitse, ƙwayoyin cuta ko wasu abubuwa marasa kyau.
Yin wanka da sabulu a kai a kai a "lokaci na musamman" na rana yana hana kamuwa da cututtuka da yawa, kamar tari da kuma cutar kolera, da ke gudana ta hanyar hanta.
Mutane za su iya kamuwa da cututtukan numfashi kamar mura ko sanyi, misali, idan ba su wanke hannuwansu kafin su taɓa idanunsu ko hancinsu ko bakinsu ba (watau ƙwayar mucosa).
Abubuwa biyar da suka fi muhimmanci a rana su ne wanke hannu da sabulu: kafin ka yi maniyyi da kuma bayan ka yi maniyyi, bayan ka tsabtace bayan yaron ko ka canja gashin gashin, kafin ka ciyar da yaron, kafin ka ci, kafin ka shirya abinci ko kuma ka yi amfani da nama ko kifi ko kaji da aka yi maniyyi da kuma bayan ka yi hakan.
Idan babu ruwa da sabulu, za a iya wanke hannu da toka.
Kafin abinci ya shirya, a lokacinsa, da kuma bayan.
Kafin ka kula da wani mai ciwo, ka kuma bi bayan ka kula da shi.
Bayan an canja wa yaro suturar hannu ko kuma an tsabtace shi bayan an yi amfani da shi a gidan wanka.
Bayan an wanke hancinka, ko kuma ka yi tari, ko kuma ka yi gumi.
Bayan ka taɓa dabbobi, ko abinci, ko kuma sharar gida.
Tsabtace hannu na nufin tsabtace jiki da ke tattare da aikin likita.
Yin wanka kafin a ba da magani ko kuma a kula da lafiya zai iya hana ko kuma ya hana kamuwa da cutar.
Babban manufar wanke hannu a likita shi ne tsabtace hannu daga abubuwan da ke haddasa cututtuka (kwayoyin cuta, ƙwayoyin cuta, ko wasu ƙwayoyin cuta da za su iya haifar da cutar) da kuma sunadarai da za su iya haifar da lahani ko cuta.
Wannan yana da muhimmanci musamman ga mutanen da ke kula da abinci ko kuma waɗanda ke aiki a fannin likita, amma kuma yana da muhimmanci ga mutane.
Yin wanka hannu yana da fa'idodi masu yawa ga lafiyar jiki, ciki har da rage yaduwar mura, coronavirus, da sauran cututtuka masu yaduwa, hana cututtuka masu yaduwa da ke haifar da tari, da rage kamuwa da cututtukan numfashi,
Kuma rage yawan mutuwar jarirai a lokacin haihuwa a gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa wanke hannu da kyau zai iya inganta tsayin yara a ƙasa da shekara biyar.
A ƙasashe masu tasowa, ana iya rage yawan mutuwar yara daga cututtukan numfashi da kumburi ta hanyar yin canje-canje a cikin hali, kamar wanke hannu da sabulu.
Wannan hanya mai sauƙi za ta iya rage yawan mutuwar da ake samu daga waɗannan cututtukan da kusan kashi 50.
Yin amfani da kayan wanke hannu zai iya rage yawan cututtukan na fama da tari da kashi uku, kuma hakan zai iya kawo ruwa mai tsabta a yankunan da ba su da isashen kuɗi.
Ana iya danganta kashi 48 cikin ɗari na rage yawan cututtukan na zubar da jini da wanke hannu da sabulu. Wanke hannu da sabulu shine hanya mafi inganci da rahusa don hana zubar da jini da cututtukan huhu mai tsanani (ARE) lokacin da ake amfani da halayyar atomatik a gidaje, makarantu da al'ummomi a duniya.
Ciwon huhu, wanda shi ne babban ciwon huhu mai tsanani, shi ne sanadin mutuwar yara a ƙarƙashin shekara biyar, inda ake kashe yara miliyan 1.8 a kowace shekara.
A kowace shekara, ana kashe yara miliyan 3.5 da ciwon kumburi da kumburi.
A cewar UNICEF, yin wanka da sabulu kafin cin abinci da bayan amfani da gidan wanka ya zama al'ada mai sauƙi, zai iya ceton rayuka fiye da kowane rigakafi ko magani, yana rage mutuwar da ke tattare da tari da kusan rabin, da mutuwar da ke tattare da cututtukan huhu da yawa da kwata.
Ana haɗa wanke hannu da wasu matakan tsabtace jiki a matsayin ɓangare na shirye-shiryen ruwa, tsabtace ruwa da tsabtace jiki (ruwa, tsabtace ruwa da tsabtace jiki).
Yin wanka hannu kuma yana kare mutum daga cutar kwaya da ke faruwa ta hanyar yin magana da kai tsaye.
Yin wanka hannu yana da wata illa mai sauƙi. Sau da yawa wanke hannu zai iya haifar da lalacewar fata.
Wani bincike a ƙasar Denmark a shekara ta 2012 ya nuna cewa yin wanka sosai a hannu zai iya haifar da cututtukan fata na dandano da kuma ciwon da ake kira eczema ko kuma cututtukan hannu, wanda ya zama sananne musamman ga ma'aikatan kiwon lafiya.
Ana kuma ganin cewa wanke hannu sosai a matsayin wata alama ce ta rashin lafiyar jiki.
Akwai lokatai biyar a rana da ake bukatar yin wanka da sabulu don rage yaduwar cututtuka ta hanyar bakin: bayan yin wanka (tafiya, yin wanka), bayan wanke bayan yaron (canza gashin gashi), kafin ciyar da yaron, kafin cin abinci, da/bayan shirya abinci ko kuma bi da nama, kifi ko kaji da aka yi.
A wasu lokatai, ya kamata a yi wanka da kyau kafin a yi maganin cututtuka ko raunuka ko kuma bayan an yi maganin, bayan an yi numfashi ko a yi tari ko a tsabtace hancinka, bayan an taɓa ko an yi amfani da takardar dabba, ko kuma bayan an taɓa shara.
A ƙasashe da yawa, yawan wanke hannu da sabulu ya ragu.
Wani bincike kan wanke hannu a kasashe 54 a shekarar 2015 ya gano cewa a matsakaita, kashi 38.7% na iyalai suna wanke hannu da sabulu. Wani bincike da aka gudanar a shekarar 2014 ya nuna cewa Saudiyya ta Saudiyya tana da mafi yawan kashi 97 bisa dari, Amurka ta kusan kusan kashi 77 bisa dari, kuma kasar Sin ta kasa da kashi 23 bisa dari. Yanzu akwai hanyoyin sauya hali da yawa don kara amfani da wanke hannu da sabulu a lokutan da ake bukata. Ana yin wanke hannu a taron yara a wasu lokutan rana daga cikin zaɓuɓɓukan da ke akwai a ƙasashen da ke tasowa don karfafa wanke hannu a cikin halayen yara.
Shirin kula da lafiya na asali da ma'aikatar ilimi ta ƙasar Filifin ta gudanar misali ne na yin aiki sosai don inganta lafiyar yara da kuma iliminsu.
Yin maganin kwari sau biyu a shekara, da kuma wanke hannu da sabulu kullum da kuma wanke hakora kullum da ruwan 'ya'yan itace ainihin shirin na kasa.
An yi nasara a Indonesia.
Ƙara sabulu ko kayan wankewa a ruwa yana taimaka wa mutum ya kawar da ƙwayoyin cuta daga fata.
Babban tasiri na sabulu da kayan tsabtace jiki shi ne rage abubuwan da ke hana su narkewa, da kuma ƙara narkewa.
Ruwa shi kaɗai ba shi da tsabtace fata domin kitse da furotin, wato, abubuwan da ke cikin ƙasa, ba sa narkewa cikin ruwa.
Duk da haka, samun ruwa mai yawa yana taimakawa wajen tsabtace ...
Sabulu mai ƙarfi, saboda yanayin sake amfani da shi, zai iya ɗauke da ƙwayoyin cuta da aka samu daga amfani da su a dā.
Wasu bincike da suka lura da yadda kwayoyin suke canja wuri daga sabulu mai ƙonewa zuwa sabulu mai ƙonewa sun nuna cewa ba zai yiwu ba domin ana wanke su da kumfa.
Cibiyoyin Kula da Cututtuka da Rigakafin Cututtuka sun ce "ya fi kyau a yi amfani da sabulu mai ruwa fiye da na'urori da ba su taɓa su ba don yin amfani da sabulu".
Ana amfani da sabulu na antibacterial sosai ga masu amfani da ke da sha'awar kiwon lafiya.
Har yanzu babu wata hujja da ta nuna cewa an zaɓi yin amfani da maganin hana rigakafi ko kuma maganin hana hana rigakafi don kawar da kwayoyin da ke hana rigakafin kwayoyin halitta.
Duk da haka, sabulu na antibacterial yana dauke da wasu abubuwa masu cutar da kwayoyin cuta kamar triclosan, wanda ba ya shafar yawancin kwayoyin halitta.
Saboda haka, idan sabulu na antibacterial bai shafi jinsunan da ba su da maganin rigakafi, ba zai yi tasiri kamar yadda ake tallatawa ba.
Baya ga rage tashin hankali da kuma kare fata, ci-gaba da haɗuwa na iya ƙunsar acid (acetic acid, ascorbic acid, lactic acid) a matsayin mai tsara acid da kuma benzoic acid mai aiki na antibacterial da sauran kayan haɗi na fata (sabar, bitamin, menthol, kayan tsami). Wani cikakken bincike da Kwalejin Kiwon Lafiya ta Jami'ar Oregon ta yi ya nuna cewa sabulu na yau da kullum yana da tasiri kamar sabulu na antibacterial na masu amfani da ke dauke da triclosan a cikin hana cututtuka da kuma kawar da kwayoyin daga hannayen.
Ruwan da ya dace da wanke hannu ba shi da zafi sosai don kashe ƙwayoyin cuta.
Kwayoyin suna girma da sauri sosai a zafin jiki (da digiri 37).
Amma, ruwa mai dumi da sabulu sun fi ruwan sanyi da sabulu kyau wajen cire man fetur na halitta da ke riƙe da ƙura da ƙwayoyin cuta.
Akasin abin da mutane suke tunani, binciken kimiyya ya nuna cewa yin amfani da ruwa mai dumi ba ya rage yawan kwayoyin a hannu.
Mai tsabtace hannu ko kuma mai tsabtace hannu abu ne da ba ruwa ba don wanke hannu.
A ƙarshen shekarun 1990 da farkon ƙarni na 21, kayan wanke hannu na giya da ba na ruwa ba da kuma ƙarancin ƙarancin ruwa (wanda aka fi sani da wanke hannu da kayan ado kamar giya, wanke hannu mai tsabta ko ƙarancin hannu) sun fara samun shahara.
Mafi yawa daga cikinsu suna dogara ne akan isopropyl ko ethanol da aka haɗa da wani abu mai narkewa kamar carpomer (acrylic acid polymer) a cikin gel, mai danshi kamar glycerin a cikin ruwa, ko kumfa don sauƙin amfani da rage tasirin bushewar da barasa ya haifar.
Ƙara yawan sinadarin hydrogen peroxide yana ƙara ƙwayoyin cuta. Sanya kayan hana shan giya a hannu wanda ya ƙunshi giya aƙalla kashi 60 zuwa 95% yana da tasiri wajen hana ƙwayoyin cuta.
Ana kashe kwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta masu ƙwayoyin cuta (MHV, herpes, respiratory mucosa, nasal viruses, albasa, influenza, hepatitis), da kuma fungi.
Kwayar hana shan giya da ke dauke da kashi 70% na barasa ta hanyar hanci ta kashe kashi 99.97% (rage na logarithmic na 3.5, kamar yadda aka rage na decibel na 35) na kwayoyin dake hannayen bayan dakika 30 da kafa kuma kashi 99.99% zuwa 99.999% (rage na logarithmic na tsakanin 4 zuwa 5) na kwayoyin dake hannayen bayan minti 1 da kafa. Kwayar hana shan magani ta fi tasiri ga kwayoyin kuma ta fi tasiri ga wasu ƙwayoyin cuta.
Kayan hana shan giya na hannu kusan ba su da tasiri sosai a kan ƙwayoyin cuta na neurovirus (ko neurwalk), wanda shine mafi yawan abin da ke haifar da ciwon ciki da hanji wanda ke haifar da kamuwa da cuta. Dole ne a yi amfani da isasshen maganin hana shan giya ko rubin giya don wanke ko rufe hannuwan biyu gaba ɗaya.
Ka shafa gaba da baya na hannunka, da tsakanin yatsunsu da kuma gefuna na kusan dakika 30 har sai ruwa, kumfa, ko ruwan 'ya'yan itace ya bushe.
Cibiyar Kula da Cututtuka ta Amirka ta ba da shawarar cewa a yi wanka a hannu, musamman idan hannuwan sun yi ƙazanta sosai.
Ana amfani da waɗannan kayan wanke hannu sosai saboda sauƙin amfani da su da kuma hanzarta kawar da ƙwayoyin cuta; duk da haka, kada su zama madadin wanke hannu mai kyau sai dai idan ruwa da sabulu ba su da.
Yin amfani da kayan hana shan giya sau da yawa zai iya sa fata ta bushe idan ba a ƙara ruwan sama ko kayan da ke sa hannu a cikin fata ba ko duka biyun.
Za a iya rage ko kawar da shan giya ta wajen ƙara wasu kayan da ake amfani da su a cikin fata ko kuma duka biyun.
Gwaje-gwaje na asibiti sun nuna cewa maganin hana shan giya da ke dauke da ruwan sama yana sa fata ta yi sanyi da bushewa fiye da sabulu ko kuma kayan tsabtace jiki.
Ba a yawan samun cututtukan fata na fata na fata na fata ko kuma na fata na fata na fata na fata ko kuma na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na fata na shan shan giya.
Rashin yiwuwar kamuwa da cututtukan fata na jiki ya zama abin jawo hankali idan aka kwatanta da wanke hannu da ruwa da sabulu.
Ko da yake kayan wanke hannu da ba na ruwa ba suna da tasiri, ba sa wanke hannu daga abubuwa masu ƙwayoyin halitta, amma suna hana su yin amfani da su.
Saboda haka, maganin hana shan magani na hannu ba ya da tasiri kamar sabulu da ruwa wajen hana yaduwar cututtuka da yawa, domin cututtuka suna kasancewa a hannayenmu.
Aikin hana shan giya ya dogara da kayan da aka yi amfani da shi, kuma a tarihi, yana da tasiri sosai fiye da wanda ya ƙunshi giya wanda ya dogara da rubbing giya.
A kwanan nan, an tabbatar da cewa sinadarai da ke amfani da chloride benzalkonium suna da tasiri mai yawa da ke ci gaba a matsayin maganin ƙwayoyin cuta bayan amfani, sabanin giya da aka tabbatar da ƙarancin tasiri bayan amfani da shi sau da yawa, wataƙila saboda rashin amfani da fata.
Mutane da yawa a cikin al'ummomin da ba su da kuɗi sosai ba za su iya sayen sabulu kuma su yi amfani da toka ko ƙasa a maimakon haka.
Ash ko ƙura suna iya yin aiki fiye da ruwa kaɗai, amma suna iya yin aiki ƙasa da sabulu.
Wani abin da ake damuwa shi ne, idan ƙura ko toka sun kamu da ƙwayoyin cuta, za su iya ƙara yaduwar cutar maimakon rage ta.
Ƙura kuma, kamar sabulu, tana da tsabta domin tana yin narkewa a lokacin da ta taɓa ruwa.
Hukumar lafiya ta duniya ta ba da shawarar yin amfani da toka ko yashi a matsayin madadin sabulu idan babu shi.
Hanyar wanke hannu da aka ba da shawarar ta cibiyoyin hana cututtuka na Amirka don hana kamuwa da cutar ta ƙunshi waɗannan matakai:
Ka wanke hannunka da ruwan sanyi ko mai dumi.
Ana ba da shawarar yin amfani da ruwa mai gudana domin tafkuna da ke wurin suna iya zama masu gurɓataccen ruwa, kuma a lokaci guda, zafin ruwan ba ya nuna bambanci.
Ka yi kumfa a hannunka da sabulu mai yawa, ka haɗa da baya da yatsunsu da ƙusa.
Sabulu yana kawar da ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa mutane suna yawan wanke hannu sosai idan sun yi amfani da sabulu maimakon ruwa.
Ka yi wanka na akalla dakika 20.
Fursunoni suna haifar da taɓawa, wanda ke taimaka wajan cire ƙwayoyin cuta daga fata, kuma yana kawar da taɓawa na tsawon lokaci.
Ka yi wanka sosai a ƙarƙashin ruwa mai gudana.
Ruwa hannu a cikin tafkin zai iya sake gurɓata su.
Ka bushe shi da tawul mai tsabta ko kuma ka bar shi ya bushe a cikin iska.
Hannun da suka yi ruwa da kuma rigar suna da sauƙi su sake gurɓata. Mafi yawan ɓangarorin da aka fi watsi da su sune yatsunsu, wuyan hannu, yankunan da ke tsakanin yatsunsu, da kuma ƙarƙashin kusoshi.
Naƙoƙi na wucin gadi da kuma zanen ƙusa na iya ƙunsar abubuwa masu ƙarancin gaske.
Ana yawan ba da shawarar yin amfani da maganin shafawa don hana bushewar hannu, saboda haka bushewar fata na iya lalata jiki wanda zai iya ƙara haɗarin kamuwa da cuta.
Za a iya samar da zaɓuɓɓuka daban-daban masu ƙarancin kuɗi don sauƙaƙe wanke hannu a ƙasashe masu tasowa, inda babu ruwa na bututu, sabulu ko duka biyun, kamar zuba ruwa daga kwanon rufi da aka rataye ko yin ramuka da ya dace da shi da / ko amfani da toka idan ya cancanta. A wuraren da aka iyakance samar da ruwa (kamar makarantu ko yankunan karkara a ƙasashen da ke tasowa), akwai hanyoyin da za a iya daidaita yawan amfani da ruwa, kamar "Tibet na ruwa" da sauran zaɓuɓɓuka masu ƙarancin kuɗi.
Hanyar da ake amfani da ita ita ce yin amfani da wata farantin ruwa da aka rataye a igiya da kuma wata makami mai sarrafawa da ke aiki da ƙafa don zuba ruwa a hannayen da kuma sabulu.
Yin bushewa da kyau na hannu wani muhimmin ɓangare ne na tsabtace hannu, amma akwai wasu muhawara game da yadda za a yi bushewa a cikin ruwa na kowa.
Ƙari ga haka, bincike ya nuna cewa tawul ɗin takarda sun fi na lantarki da ke cikin ruwa da yawa lafiya.
A shekara ta 2008, Jami'ar Westminster a London ta gudanar da wani bincike, tare da taimakon taron bitar masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antu na Turai, don kwatanta matakan tsabta da masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antun masana'antu suka samar, da masu bushe hannu da iska mai zafi, da kuma masu bushe hannu da iska mai tsabta.
Bayan an wanke hannayenmu kuma an bushe su da na'urar busar da iska mai dumi, an gano cewa adadin kwayoyin ya ƙaru da kashi 194 cikin ɗari a cikin yatsunsu da kuma kashi 254 cikin ɗari a cikin hannayenmu.
Yin amfani da na'urar busassun iska ta ƙara yawan kwayoyin a cikin yatsunsu da kashi 42 cikin ɗari kuma a hannayensu da kashi 15 cikin ɗari.
Bayan an wanke hannuwan kuma an bushe su da tawul, adadin kwayoyin a cikin yatsunsu ya ragu da kashi 76 cikin ɗari kuma a cikin kwanciyar hannayensu ya ragu da kashi 77 cikin ɗari, kuma masana kimiyya sun gudanar da gwaje-gwaje don sanin ko akwai yiwuwar kamuwa da cutar ga sauran masu amfani da ruwa da kuma yanayin ruwa sakamakon kowane irin bushewa.
Mai bushewar iska mai iska, wanda ke fitar da iska daga na'urar a cikin saurin da zai iya kaiwa 180 m/s (650 km/h; 400 mph), yana iya busa abubuwa masu ƙaranci daga hannu da na'ura, kuma yana iya watsa kamuwa da cuta ga sauran masu amfani da ruwa da kuma yanayin da ke cikin ruwa a nesa har zuwa mita 2.
Yin amfani da mai bushewa mai iska mai dumi yana sa ƙwayoyin cuta su yi nesa da mai bushewa da mita 0.25.
A shekara ta 2005, wani bincike da kamfanin TÜV Produkt und Umwelt ya yi ya nuna yadda ake bushe hannu.
Bayan an bushe hannu, an lura da canje-canje a yawan kwayoyin:
Akwai masana'antun bushe-kayan hannu da yawa, kuma suna amfani da tawul ɗin takarda don bushe-tufa.
Yin wanka hannu da wando na hana kamuwa da cuta yana da kyau a lokacin tafiya saboda babu sabulu da ruwa.
Dole ne a ƙunsar da maganin hana shan giya aƙalla kashi 60 cikin ɗari na giya.
Yin wanka hannu a likita ya zama wajibi tun bayan da likitan Hungary Agnetus Semmelweis ya gano (a shekara ta 1846) cewa yana da tasiri wajen hana cututtuka a asibiti.
Akwai na'urorin lantarki da ke rubuta bayanan da ke tunatar da ma'aikatan asibiti su wanke hannayensu idan sun manta.
Wani bincike ya gano cewa yin amfani da su ya rage yawan kamuwa da cuta.
Ka wanke hannuwanka na tsawon dakika 15, ka yi amfani da sabulu da ruwa da kuma ruwan 'ya'yan itace don yin kumfa da kuma shafa kowane ɓangaren hannu.
Ka haɗa hannayenka da yatsunka.
Idan akwai wasu ƙura a ƙarƙashin yatsunsu, za a iya cire su ta amfani da goga mai gashi mai ƙura.
Tun da yake ƙwayoyin cuta suna iya kasancewa a cikin ruwan da ke hannayenmu, yana da muhimmanci mu tsabtace su da kyau kuma mu bushe su da tawul mai tsabta.
Bayan an bushe, sai a rufe ruwan da tawul ɗin takarda (kuma a buɗe kofa ta fita idan ya cancanta).
Wannan zai hana hannuwan su sake gurɓata daga saman.
Manufar wanke hannu a wurin kula da lafiya shi ne kawar da kwayoyin cuta ("kwayar cuta") da kuma guje wa canja wurin su.
Jaridar New England Journal of Medicine ta ruwaito cewa rashin wanke hannu har yanzu ba a yarda da shi a yawancin yanayin likita ba, da kuma yawancin likitoci suna manta da wanke hannu kafin su taɓa marasa lafiya, suna isar da ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kuma wasu ayyuka masu sauƙi za su iya rage yawan kamuwa da cututtukan jini da ke tattare da cataract da kashi 66 cikin ɗari. Ƙungiyar Lafiya ta Duniya ta wallafa wata jarida da ta bayyana yadda ake wanke hannu da kuma yadda ake wanke su a fannonin kiwon lafiya.
Za a iya samun takardar umarnin tsabtace hannu da aka gabatar daga ƙungiyar a shafinta kuma za a iya yin amfani da ita don yin bayani a kai.
Whitby da wasu sun yi nazari mai kyau.
Kasuwanci za su iya auna tsabtace hannu kuma su tabbatar da hakan, idan ya zama dole a tabbatar da cewa an bi ka'idodin.
Hukumar lafiya ta duniya tana da "Lokaci Biyar" don wanke hannu:
Bayan an zubar da jini da kuma ruwa.
Kafin aikin hana haihuwa, kuma
Bayan kula da marasa lafiya. Ƙara sinadarai masu tsabta zuwa sabulu ("na likita" ko "antibacterial") yana ƙara wani abu mai kashewa ga mai wanke hannu.
Wannan kayan kashewa na iya zama da kyau kafin tiyata ko a wuraren da kwayoyin rigakafin maganin rigakafi ke yaduwa. Lokacin da aka "sage" hannun wani don tiyata, ana buƙatar samar da bututun da za a iya kunnawa da kuma kashewa ba tare da taɓa hannu ba, wasu na chlorhexide ko iodine, towels masu hanawa don bushewa bayan wanka, goga mai hanawa don yin amfani da hanci, da sauran kayan aikin hanawa don tsabtace ƙusa.
Dole ne a cire dukan kayan ado.
Wannan aikin yana bukatar wanke hannuwanka da na hannuwanka har zuwa kafadarka, yawanci na tsawon minti biyu zuwa shida.
Ba lallai ba ne a yi dogon shakatawa na minti 10.
Idan kana wanke hannu, kada ka bar ruwa ya koma hannunka.
Bayan an gama wanke hannu, sai a bushe hannu da wani kayan wankewa kuma a saka rigar tiyata.
Don hana kamuwa da ƙwayoyin cuta, ya fi kyau a wanke hannu kafin a kula da wani mai ciwo da kuma bayan an yi amfani da wanka.
Don hana kamuwa da cuta a asibitoci, an gano cewa amfanin mafi girma na wanke hannu ya fito ne daga kashi 20 na farko na wanke, kuma ya sami karamin amfani idan an ƙara yawan wanke hannu zuwa sama da kashi 35 na yawan.
Yin wanka da sabulu na yau da kullum yana haifar da fiye da sau uku na kamuwa da cututtukan cuta na cuta da ke wucewa zuwa abinci fiye da yin wanka da sabulu na cuta. Idan aka kwatanta wanke hannu da maganin shan giya da wanke hannu da sabulu na cuta na cuta na tsawon dakika 30, an gano cewa wanke giya yana rage kamuwa da cuta ta cuta da kashi 26% fiye da sabulu na cuta.
Amma ruwa da sabulu sun fi wanke hannu ta hanyar shan giya tasiri wajen rage cutar H1N1 da kuma cutar da ke damun hannayen hannu. Ayyukan inganta tsabtace hannu a wuraren kiwon lafiya na iya haɗa da ilimantar da ma'aikata game da wanke hannu, ƙara wadatar wanke hannu ta hanyar shan giya, da kuma rubuce-rubuce da kuma tunatarwa ga ma'aikata.
Ana bukatar ƙarin bincike don sanin ko wane ne ya fi tasiri a wuraren kula da lafiya daban-daban.
A ƙasashe masu tasowa, ana samun labari cewa wanke hannu da sabulu yana da muhimmanci sosai don samun koshin lafiya, da kuma abinci mai gina jiki.
Amma rashin wadataccen ruwa, sabulu, ko kuma kayan wanke hannu a gidaje, makarantu, da wuraren aiki yana sa ya yi wuya a samu halaye na wanke hannu.
Alal misali, a yawancin yankunan karkara na Afirka, ba a samun famfo na wanke hannu a kusa da kowane gidan wanka na musamman ko na jama'a ba, ko da yake akwai zaɓuɓɓukan da ba su da tsada don gina tashoshin wanke hannu.
Amma, rashin wanke hannu zai iya kasancewa sakamakon halin da ake ciki maimakon rashin sabulu ko ruwa.
Ƙarfafa wanke hannu da sabulu da kuma kiran su a cikin yanke shawara na siyasa na iya sa a ƙara sanin amfanin wanke hannu, kuma ya haifar da canjin halin jama'a a cikin dogon lokaci.
Don yin hakan, ana bukatar a riƙa saka idanu a kan abin da ya faru.
Wani nazari na tsarin bincike na 70 ya gano cewa tsarin zamantakewa yana da tasiri wajen kara wanke hannu a ƙasashe masu matsakaitan kudade, yayin da kamfen ɗin talla na zamantakewa bai da tasiri. Misali daya na inganta wanke hannu a makarantu shine "hanyar tauraro uku" da UNICEF ta tsara don karfafa makarantu su dauki matakai masu sauki da tsada don tabbatar da cewa dalibai suna wanke hannu da sabulu, a tsakanin sauran bukatun kiwon lafiya.
Idan aka cika ƙa'idodin, makarantu za su iya yin ƙaura daga taurari ɗaya zuwa taurari uku a ƙarshe.
Gina wuraren wanke hannu na iya zama wani ɓangare na kamfen na tallata wanke hannu don rage cututtuka da mutuwar yara.
Ranar wanke hannu ta duniya misali ne na wasu kamfen na wayar da kan jama'a da ke ƙoƙarin kawo canjin hali. Saboda annobar cutar korona 2019-20, UNICEF ta karfafa karɓar lambar sanarwa don wanke hannu.
Kadan ne kawai suka yi bincike kan yadda ake amfani da yawan kudin wanke hannu a ƙasashe masu tasowa da kuma yadda ake amfani da shi wajen daidaita shekarun rayuwa bisa ga nakasassu.
Amma, wani bincike ya nuna cewa yin amfani da sabulu wajen wanke hannu yana da amfani sosai fiye da yin amfani da ruwa da kuma tsabtace ruwa.
An fara fahimtar muhimmancin wanke hannu ga lafiyar mutane - musamman ga mutanen da ke fuskantar mawuyacin yanayi kamar iyaye masu haihuwa ko kuma sojoji da aka ji rauni a asibitoci - a tsakiyar karni na 19 ta hanyar manyan masu tsabtace hannu biyu: likitan Hungary Agnates Simmelweis wanda ya yi aiki a Vienna, Austria, da kuma Turanci Florence Nightingale "wanda ya kafa aikin jinya na zamani".
A lokacin, mutane da yawa sun yi imanin cewa cutar ta kasance ne saboda munanan ƙanshin da ake kira miasma.
A shekarun 1980, cututtukan da ke tattare da abinci da cututtukan da ke tattare da kiwon lafiya sun sa Cibiyoyin Kula da Cututtuka na Amurka su inganta tsabtace hannu yadda ya kamata a matsayin babbar hanya don hana yaduwar kamuwa da cuta.
Cutar da aka yi wa alade a shekara ta 2009 da kuma annobar COVID-19 a shekara ta 2020 sun sa mutane da yawa suka san muhimmancin wanke hannu da sabulu don kare kansu daga cututtukan da ke kamuwa da cutar.
Alal misali, an rataye wasu alamun da ke ɗauke da "Hanyoyin da suka dace na wanke hannu" a kusa da wanke-wanke a cikin gidajen wanka na jama'a da kuma a cikin wuraren wanke-wanke na ofisoshin da kuma filayen jirgin sama a Jamus.
"Tashi hannu" yana nufin cewa mutum ba ya son ya ɗauki alhakin wani abu ko kuma ya yi tarayya da shi.
An samo asali ne daga wani aya a cikin Littafi Mai Tsarki a cikin Matta inda Bilatus na Pantius ya wanke hannayensa daga hukuncin gicciye Yesu Kristi, amma an yi amfani da kalmar ta fiye da haka a wasu al'ummomin Ingilishi.
A wasan kwaikwayo na Shakespeare, Mrs. Macbeth ta fara wanke hannayenta sosai don ta yi ƙoƙari ta tsabtace wani abu na tunanin da ya nuna cewa tana da laifi saboda laifuffukan da ta aikata da kuma laifuffukan da mijinta ya sa ta yi.
An kuma gano cewa bayan mutane sun nuna ko kuma sun yi tunani game da ayyuka marasa kyau, suna yawan wanke hannu fiye da wasu, kuma suna da ra'ayin yin amfani da kayan wanke hannu.
Bugu da ƙari, waɗanda aka ba da izinin wanke hannu bayan wannan binciken ba su da wataƙila su yi wasu ayyukan "tsabtace" kamar aikin sa kai.
Addinai suna kwatanta wanke hannu don dalilai na kiwon lafiya da na alama. Yin wanke hannu na alama, ta amfani da ruwa ba tare da wanke hannu ba, wani ɓangare ne na al'adun wanke hannu waɗanda suka bayyana a cikin addinai da yawa, gami da Baha'u'u'llah, Hindu, Teflana, wanke hannu a Yahudanci, wanke hannu a cikin Kiristanci, da haske a cikin Musulunci. Addinai kuma suna tilasta wanke hannu mai tsabta, musamman bayan wasu ayyuka.
Hindu, Yahudawa da Musulmi suna bukatar a wanke hannuwanmu bayan yin amfani da gidan wanka.
Addinin Hindu, Buddha, Sikh, Yahudawa da Musulmi suna bukatar a wanke hannu kafin da bayan kowane abinci.
Kula da haɗarin COVID-19 a wurin aiki
A wurin aiki, ana amfani da matakan kula da haɗari na COVID-19 wajen aiwatar da tsarin lafiya da kiwon lafiya na aikin yi don hana cutar COVID-19.
Ana yin amfani da matakan da suka dace na sarrafa haɗari a wurin aiki don daidaita wurin aiki da aikin aiki, bisa ga kimanta haɗarin tushen haɗari, haɗarin cutar a cikin al'umma, da kuma abubuwan haɗari da ke barazanar mutane masu aiki waɗanda za su iya kamuwa da COVID-19.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aikin Amurka (OSHA), ayyukan da ke da ƙananan haɗarin haɗari sun ƙunshi sadarwa tare da jama'a da sauran abokan aiki, yanayin da ake ba da shawarar yin amfani da matakan rigakafin kamuwa da cuta, gami da wanke hannu, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, kula da halayen tari da tari, da kiyaye al'adun tsabtace da tsabtace yanayin aiki.
Ayyuka masu haɗarin haɗari sun haɗa da waɗanda ke buƙatar haɗuwa da mutane da yawa ko kusa da waɗanda ba a san su ko waɗanda ake zargi da COVID-19, amma waɗanda za su iya kamuwa da cutar ta hanyar watsawa ta hanyar jama'a ko tafiya ta duniya.
Wannan ya haɗa da ma'aikata da ke tuntuɓar jama'a kamar yadda suke a makarantu, da wuraren aiki da yawa, da kuma wasu manyan wuraren sayar da kayayyaki.
Ƙuntatawa na haɗari na wannan rukuni, da kuma matakan kariya na asali na kamuwa da cuta, iska ta amfani da matattarar iska mai inganci, shinge na kariya daga ƙanshi, da kuma amfani da kayan kariya na mutum da ke samuwa idan ya yi aiki da wani wanda ke da COVID-19.
Hukumar lafiya da lafiya ta ce ma'aikatan kiwon lafiya da kuma adana gawawwakin da suka kamu da wanda aka sani ko ake zargi da cutar COVID-19 suna fuskantar haɗarin haɗari mai yawa, wanda ke ƙara haɗarin haɗari idan ma'aikata suka ɗauki nauyin aiwatar da ayyukan samar da iska, ko tattara samfurori daga wanda aka sani ko ake zargi da cutar COVID-19.
Kulawa da ke da kyau ga kula da haɗarin waɗannan ma'aikatan ya ƙunshi kulawar injiniya kamar dakunan iska masu matsi, da kuma kayan kariya na mutum da suka dace da aikin.
Cutar COVID-19 na iya haifar da sakamako mai yawa a wurin aiki.
Ma'aikata suna iya barin aiki saboda rashin lafiya, ko kuma bukatar kula da wasu, ko kuma tsoron yin aiki.
Hanyoyin kasuwanci na iya bambanta dangane da irin kayayyakin da ake so da kuma yadda ake samun su (kamar sayayya a lokacin da ba a cikin lokutan da ake yin biki ba, ko ta hanyar sabis na jigilar kaya ko sayayya ba tare da barin mota ba).
A ƙarshe, ana iya dakatar da jigilar kaya daga yankunan da COVID-19 ya shafa sosai. Ana iya amfani da shirin shiri da amsawa don cututtukan da ke haifar da kamuwa da cuta don tsara matakan kariya.
Shirye-shiryen suna magance matakan haɗari da ke tattare da wuraren aiki da ayyuka daban-daban, gami da tushen haɗari, abubuwan haɗari daga gida da wuraren jama'a, da abubuwan haɗari ga ma'aikatan mutum kamar tsufa ko yanayin likita na yau da kullun.
Ƙari ga haka, ya ƙayyade abin da za a yi don a magance waɗannan haɗarin, da kuma shirin gaggawa na yanayin da za a iya tasowa sakamakon barkewar cutar.
Shirye-shiryen shiri da kuma amsawa ga cututtuka masu yaduwa na iya kasancewa ƙarƙashin shawarwarin ƙasa da ƙasa.
Manufofin amsawa ga annobar sun haɗa da rage yaduwar kamuwa da cuta tsakanin ma'aikata, kare mutanen da suka fi fuskantar haɗarin cututtukan kiwon lafiya masu illa, kula da ayyukan kasuwanci, da rage tasirin mummunan tasiri ga sauran kamfanoni a cikin hanyoyin samar da su.
Matsayin da ake ciki a cikin al'umma inda ake kasuwanci yana shafar yadda ake amsawa.
Tsarin tsarin kula da haɗari na haɗari tsarin aiki ne da aka yi amfani da shi sosai a cikin lafiya da lafiya na aiki don rarraba matakan kula da haɗari bisa ga inganci.
Tun da ba za a iya kawar da haɗarin COVID-19 ba, mafi ingancin sarrafawa shine sarrafa injiniya, sannan sarrafawa, kuma a ƙarshe kayan kariya na mutum.
Gudanar da aikin injiniya ya ƙunshi ware ma'aikata daga haɗarin aiki ba tare da dogaro da halayen ma'aikata ba, kuma zai iya zama mafi inganci ga farashin aiwatarwa.
Gudanar da gudanarwa shine canje-canje a cikin manufofin aiki ko kuma ayyukan da ke buƙatar aiki daga ma'aikaci ko mai aiki.
Kayan kariya ta mutum (PBE) ba su da tasiri sosai fiye da na injiniya da na gudanarwa, amma suna iya taimakawa wajen hana wasu wuraren da za a iya samun haɗari.
Ya kamata a zaɓi duk nau'ikan kayan kariya ta mutum bisa ga haɗarin da ma'aikaci yake fuskanta, dacewa da dacewa kamar yadda ake buƙata (kamar na'urorin numfashi), a koyaushe a sawa daidai, a bincika, a kula da su, a maye gurbin su a kai a kai, idan ya cancanta, a cire su, a tsabtace su, a adana su, ko a kawar da su yadda ya kamata don kauce wa gurɓatawa.
A cewar Hukumar Kula da Lafiya da Lafiya ta Aikin Amurka (OSHA), ayyukan da ba su da haɗari sosai suna ƙunshe da kasancewa a cikin hulɗa da jama'a da sauran abokan aiki.
Abubuwan da ake bukata don hana kamuwa da cuta a duk wuraren aiki sun haɗa da wanke hannuwanmu akai-akai da kuma gaba ɗaya, ƙarfafa ma'aikata su zauna a gida idan suna rashin lafiya, kula da ɗabi'ar tari da tari da rufe bakinsu da hanci lokacin tari da tari, samar da tabarau da kwantena, shirye-shiryen aiki daga nesa ko daidaita aikin lokaci idan ya cancanta, hana ma'aikata amfani da kayan aiki da na'urorin wasu, kula da tsabtace da tsabtace aikin yau da kullun.
Gano mutane da ke da damar kamuwa da cutar da kuma ware su nan take mataki ne mai muhimmanci wajen kare ma'aikata, abokan ciniki, baƙi, da sauransu a wurin aiki.
Cibiyoyin Kula da Cututtuka na Amirka (CDC) sun ba da shawarar cewa ma'aikatan da ke da alamun cututtukan cututtukan numfashi na tsanani su zauna a gida har sai zazzabi, alamun zazzabi da wasu alamun sun tafi aƙalla sa'o'i 24 ba tare da yin amfani da maganin zazzabi ko wasu magungunan da ke inganta alamun ba, kuma manufofin izinin rashin lafiya su kasance masu sassauƙa, kuma ma'aikatan su kasance a gida don kula da wani dangin da ke ciwo, kuma ma'aikatan su kasance sanannun waɗannan manufofin.
A cewar Hukumar Lafiya da Lafiya ta Aikin, ayyukan da ke da haɗarin haɗari na matsakaici sun haɗa da waɗanda ke buƙatar sadarwa ta kusa ko ta kusa a cikin ƙafa shida (1.8 m) na mutanen da ba a san su da cutar COVID-19 ba ko kuma waɗanda ake zargin sun kamu da ita, amma suna iya kamuwa da SARS-CoV-2 saboda ci gaba da kamuwa da cutar a cikin al'umma da ke kusa da wurin aiki, ko kuma saboda mutumin da ya yi tafiya na duniya zuwa wurin da COVID-19 ke yaduwa.
Wannan ya hada da ma'aikata da ke shiga cikin jama'a kamar yadda ake yi a makarantu, da wuraren aiki masu yawa, da wasu wuraren sayar da kayayyaki masu yawa. Waɗannan sun haɗa da sarrafawa na injiniya da kuma rukunin masu haɗari da yawa. Sun haɗa da shigar da matatun iska masu inganci, ƙara yawan iska, shigar da shinge na zahiri kamar su iska mai tsabta, da shigar da windows don sabis na abokan ciniki da ke sayayya ba tare da barin mota ba. Waɗannan sun haɗa da sarrafawa da manyan rukunin kasuwanci waɗanda ke ƙarfafa ma'aikatan marasa lafiya su shiga cikin gida, maye gurbin tarurruka da kuma samar da hanyoyin sadarwa, samar da tsarin aiki da ba a ƙayyade ba, ƙayyadewa da ƙididdigar aiki, ƙayyadewa da ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙidid
Ma'aikatan da ke cikin wannan rukunin haɗari ba sa bukatar yin amfani da na'urorin numfashi.
Idan mutum ya yi rashin lafiya a cikin jirgin sama, matakan kariya da suka dace don kare ma'aikata da sauran fasinjoji sun haɗa da nisantar mai haƙuri da wasu da ƙafa 6, ba da sabis ga memba na jirgin sama, ba da abin rufe fuska ga mai haƙuri ko kuma buƙatar mai haƙuri ya rufe bakinsa da hancinsa da takarda na takarda lokacin tari ko ƙishirwa.
Ma'aikatan jirgin dole ne su sa safarar likita da za a iya kawar da su lokacin da suke hulɗa da wani mai haƙuri, ko kuma sun taɓa ruwan jiki ko rufin da ke da gurɓataccen jiki, kuma wataƙila su yi amfani da ƙarin kayan kariya idan mai haƙuri yana fama da zazzabi, tari ko wahalar numfashi.
Dole ne a kawar da safar hannu da sauran abubuwa da za a iya kawar da su a cikin jakar rigakafin haɗari na rayuwa, kuma dole ne a tsabtace ruɓaɓɓun farfajiyar kuma a lalata su. Ga jigilar kaya, gami da jiragen ruwa masu yawon shakatawa da sauran jiragen ruwa, kula da haɗari ya haɗa da jinkirta tafiya lokacin rashin lafiya, keɓancewa da sanar da cibiyar likitancin jirgin nan da nan idan wani ya kamu da zazzabi ko wasu alamomi yayin da yake cikin jirgin.
A cikin yanayi mai kyau, dole ne a yi kula da likita a cikin ɗakin da ke keɓewa. Ga makarantu da wuraren kula da yara, Cibiyar Kula da Cututtuka ta bada shawarar rufewa na ɗan gajeren lokaci don tsaftacewa ko tsaftacewa idan mai kamuwa da cuta yana cikin ginin makarantar ba tare da la'akari da yadda ya bazu a cikin al'umma ba.
Idan akwai iyaka ga yaduwar kamuwa da cuta a cikin al'umma tsakanin iyaka da matsakaici, ana iya aiwatar da dabarun nesa da zamantakewa kamar soke tafiye-tafiye, tarurruka, da sauran manyan tarurruka kamar darussan motsa jiki ko darussan ƙungiyar kiɗa ko cin abinci a cikin gidan wuta, ƙara nesa tsakanin ofisoshin, tsara lokaci na halarta da fita, rage baƙi marasa mahimmanci, da amfani da ofishin kiwon lafiya na musamman ga yara masu alamun cutar mura.
Idan akwai yaduwar kamuwa da cuta a cikin al'umma, da kuma dabarun nesa da zamantakewa, ana iya la'akari da tsawon lokacin da za a bar makaranta. Ga ma'aikatan tilasta yin doka waɗanda ke yin ayyukan yau da kullun, cibiyar kula da cututtuka ta ɗauki haɗarin lafiyar kai tsaye a matsayin ƙasa.
Jami'an tsaro na doka sun ba da shawarar cewa waɗanda suka tuntubi waɗanda aka tabbatar ko kuma ake zargin suna da COVID-19 su bi umarnin da ke cikin dokar ta-baci ta likita, ciki har da kayan kariya na sirri.
Idan akwai tuntuɓe kai tsaye a lokacin da aka tsare, ma'aikata su tsabtace belun kunne da kayan aiki kafin su sake amfani da su ta amfani da sprayer ko mai tsabtace gida, su bi matakan aiki guda ɗaya don magance gurɓataccen yanayi da kawar da kayan kariya na mutum da aka yi amfani da su da kuma tattara tufafi da wanke su.
Hukumar lafiya da lafiya ta ce wasu ma'aikatan kiwon lafiya da kuma masu ajiye gawawwakin mutane suna cikin waɗanda ke da haɗari mai yawa ko kuma masu haɗari sosai.
Ayyuka masu haɗari sun haɗa da ma'aikatan kula da lafiya, tallafi, magani, da sufuri waɗanda ke fama da cutar COVID-19 ko kuma waɗanda ake zargi da kamuwa da ita.
Wannan zai zama babban haɗari idan ma'aikata suka yi aikin samar da iska, kuma sun tattara samfurori daga marasa lafiya da aka tabbatar ko ake zargi da kamuwa da COVID-19.
Ayyukan samar da iska sun haɗa da aikin allura, aikin motsa tari, gwajin ƙura, wasu ayyuka da gwaje-gwaje da suka shafi hakora, ko kuma tattara samfurori na ƙura.
Ayyukan babban fayil na gawawwakin masu haɗarin haɗari sun haɗa da ma'aikata da ke shiga cikin shirya gawawwakin mutanen da aka tabbatar ko ake zargi da kamuwa da COVID-19 a lokacin mutuwarsu; waɗanda ke da matakin haɗari sosai idan suka yi autopsy. Ƙarin kulawar injiniya ga waɗannan rukunin masu haɗari sun haɗa da dakunan keɓewa na marasa lafiya da aka sani ko ake zargi da kamuwa da COVID-19, gami da lokacin aiwatar da ayyukan samar da iska.
Ana iya yin iska mai ƙarancin ƙarfi a wasu wuraren kiwon lafiya da kuma ajiye gawawwakin.
Dole ne a bi da samfurori bisa ga matakan tsaro na 3.
WHO ta ba da shawarar ware marasa lafiya da ke zuwa wuraren jiran aiki daban-daban dangane da ko ana zargin su da COVID-19. Bugu da ƙari, wasu kayan aikin kariya na mutum, DSS na ba da shawarar yin amfani da na'urorin numfashi ga waɗanda ke aiki a nesa da ƙafa 6 daga marasa lafiya da aka sani ko ake zargi da cutar SARS-CoV-2, da waɗanda ke yin aikin samar da iska.
A Amirka, ana bukatar a yi amfani da na'urorin numfashi da ke rufe fuska da N95 mai tacewa, wanda aka amince da shi daga Cibiyar Kula da Lafiya da Lafiya ta Ƙasa, ko kuma na'urori masu kyau, a cikin tsarin shirin kariya na na numfashi, wanda ya ƙunshi gwaji da kuma dacewa, horo, da kuma jarrabawar likita.
Sauran nau'ikan na'urorin numfashi na iya ba da kariya mai yawa da kuma inganta kwanciyar hankali ga ma'aikata. Hukumar lafiya ta duniya ba ta ba da shawarar yin amfani da na'urori masu numfashi ba, saboda COVID-19 cuta ce ta numfashi maimakon ta hanyar ruwan jiki.
Hukumar lafiya ta duniya ta ba da shawarar yin amfani da abin rufe fuska na tiyata kawai ga ma'aikatan binciken a wurin shiga.
Ga waɗanda suke tattara samfurori na numfashi daga marasa lafiya na COVID-19, ko kula da su, ko kuma motsa su ba tare da wani aikin samar da iska ba, WHO ta ba da shawarar yin amfani da abin rufe fuska na tiyata, tabarau masu kariya, rigar fuska, da kuma sirinji da kuma takalma.
Idan an yi aikin samar da iska, an maye gurbin abin rufe fuska da abin rufe fuska na N95 ko FFP2.
Tun da yake samar da kayan kariya na mutum a duniya bai isa ba, WHO ta ba da shawarar rage bukatar kayan kariya ta mutum ta hanyar yin magani ta nesa, da shinge na zahiri kamar windows masu haske, wanda kawai ya ba waɗanda ke cikin kulawa ta kai tsaye damar shiga ɗakin da mai haƙuri da COVID-19 ke ciki, ta amfani da kayan kariya na mutum kawai da ake buƙata don takamaiman aikin, da ci gaba da amfani da abin rufe fuska na numfashi ba tare da cire shi ba yayin kula da marasa lafiya da yawa da ke da ganewar asali iri ɗaya da kuma kula da jerin samar da kayan kariya na mutum da kuma daidaita shi, ba tare da amfani da abin rufe fuska ga mutanen da ba su nuna alamun bayyanar cututtuka ba.
Daga: Catherine Maher, Shugaba na Wikimedia
Ga: Dukan ma'aikatan Wikimedia
[COVID-19] Rage nauyi da kuma shirya don nan gaba
Ranar watsa shirye-shirye: 14 ga Maris, 2020, 00:24 UTC
Lasisi: CC0: Babu haƙƙoƙin da aka tanada
Mun sami kanmu a cikin yanayi na musamman a wannan watan.
Cutar COVID-19 ta zama abin da ya nuna yadda mutane suke da alaka da juna a duniya da kuma yadda muke da hakkin kula da mutane.
Tarihinmu bai taɓa fuskantar irin wannan ƙalubale ba, amma mun san cewa amsar da ta fi dacewa ta dogara ne akan irin tausayi na duniya, haɗin kai da kuma gina al'umma, abubuwan da ke cikin zuciyar wannan kungiya.
Abokantaka da kuma kulawar da muke da ita tsakanin abokan aikinmu ta hanyar imel, kira da tattaunawa tabbaci ne mai ban mamaki na tunanin ɗan adam da ke kewaye da mu, sa'ar al'amarin shine, hanyarmu ta kasuwanci.
Ina godiya sosai kuma ina alfahari da cewa ku abokan aiki ne na gaske.
A makon da ya gabata, wani ya aika min da sakon nuna godiya ga aikinmu.
Sun tuna min da muhimmancin yadda duniya take iya yin amfani da Wikipedia a yanzu, da kuma yadda wannan muhimmin kayan aiki yake da ƙarfi don kasancewa a kan layi da kuma a fili ga kowa.
Ƙoƙarcenku ne ya sa hakan ya yiwu, ko ta wajen ci gaba da yin amfani da shafukan yanar gizo, ko kuma ta wajen biyan abokan aikinmu albashin da muke yi, ko kuma ta wajen tabbatar da lafiyar al'ummominmu.
Duniya tana bukatar bayanai a kan Wikipedia fiye da dā.
Lokaci ne da za mu iya yin tasiri ga duniya ba kawai a kan ƙoƙarinmu ba, amma kuma a yadda muke yin hakan.
Saboda muhimmancin wannan aiki da kuma rawar da kuke takawa, za mu yi canje-canje masu yawa a yadda muke aiki tare daga mako mai zuwa.
Gyara tsarin aiki da jadawalin aiki
Kamar yadda Robin ya ambata, ƙungiyar ta haɗu a jiya don tattauna yadda za mu yi da kuma jadawalinmu na kwanaki da watanni masu zuwa.
A wannan tattaunawar, mun ga abin da muka gani zai iya zama amsa mai kyau ga abin da muke fuskanta, kuma hanya mafi kyau don ci gaba da ci gaba da kasuwancinmu a wannan lokacin.
Muna son mu kawar da damuwa da kuma damuwa, mu tallafa wa aikinmu a cikin dogon lokaci.
Idan kana so ka rage nauyi da kuma ayyuka, to, ba laifi.
Ga dukan ma'aikata, 'yan kwangila da ma'aikatan kwangila:
Ana sa ran yin aiki na sa'o'i 4 a rana ko kuma 20 a mako har sai an ba da sanarwa.
Ba za mu sanar da hutu ba, don haka idan za ka iya yin aiki na tsawon lokaci fiye da yadda kake yi, za ka iya ƙara ƙoƙarinka.
Duk da haka, a yanzu haka, yanayin duniya ba shi da tabbas, kuma ko kana so ka kula da ƙaunatattunka, ko ka sayi kayayyaki, ko ka je wurin likita, amincinka ne abu mafi muhimmanci.
Ba mu bi sa'o'inku ba.
Idan kana rashin lafiya, kada ka yi aiki.
Ya kamata a fahimci cewa ba a bayyana shi ba, amma muna tuna da shi a fili.
Ba a buƙatar hutu na rashin lafiya ko na albashi, kawai ka sanar da manajanka da ƙungiyarka su duba kalandarka da jadawalin lokaci don tabbatar da cewa ka rufe manyan wuraren aiki.
(Idan likita ya gano cewa kana da cutar COVID-19, ka gaya wa Brian a sashen horarwa da takardun shaida don sashen horarwa da takardun shaida ya taimaka wajen tallafa maka da kuma tabbatar da cewa kana samun kulawar da ta dace daga sashen.)
Ma'aikatan da suke aiki a kowane lokaci suna samun cikakken albashin su.
Mun riga mun ambata hakan, kuma muna sabunta wannan alkawarin da muka yi wa abokan aikinmu da kuma abokan aikinmu.
Kowane ma'aikaci zai sami albashinsa bisa ga sa'o'in aiki na yau da kullum.
Wannan ya haɗa da ko ma'aikaci yana rashin lafiya ko ba zai iya aiki ba.
Idan kana son aiki, muna goyon bayanka.
Mutane da yawa suna amfani da aikin su shawo kan matsin lamba da ke tattare da mu.
Abin da za mu iya yi zai zama mai amfani sosai, musamman a lokacin wahala kamar wannan.
A wani lokaci, yana da game da kula da kansa.
Muna rokonka ka tuntubi manajanka kawai don ya san abin da za ka iya tsammani kuma ya daidaita hanyoyin da za ka bi.
Wasu ayyuka suna da muhimmanci.
Akwai wasu abubuwa da ya kamata mu ci gaba da yi.
Ƙungiyoyin injiniya na wurin aiki, HR, amincewa, gaskiya, tara kuɗi (da sauransu) suna yin aiki mai muhimmanci, kuma yana bukatar ƙarin tallafi.
Za mu fara aiki tare da dukkan sassan gwamnati don tantance manufofin da muke da su a yanzu kuma mu mayar da hankali ga tallafawa abubuwan da suka dace don cimma burinmu.
Akwai aiki mai yawa da dukanmu za mu yi, kuma za mu mai da hankali ga ayyukan da suka fi muhimmanci.
Idan muka yi hakan a yanzu, ba za mu ci gaba da yin hakan ba.
Ba ma shirin "biyan lokaci don sarrafa abin da ya gabata" bayan annobar ta ƙare.
Ba a sa ran za mu yi karin sa'o'i don cika takaddun da ba su dace ba.
Mun yarda cewa yanayin ya canja, kuma za mu yi aiki don kafa sababbin manufofi da jadawalin lokacin da ya dace.
Menene ke faruwa a cikin shirin shekara-shekara (APP)?
Don daidaitawa da sabon gaskiya da kuma tsammanin lokutan aiki na yau da kullum, muna shirin gyara jadawalin isarwa na shirinmu na shekara-shekara na 2020-2021.
Muna da niyyar ba da shawarar tsawaita shirinmu na 2019-2020 don ba da ƙarin lokaci don tsara kasafin kuɗi don bawa ma'aikata damar fifita mahimman ayyuka, kula da kansu da kula da ƙaunatattunsu tare da daidaita yanayin waɗanda suke buƙatar aiki a cikin jadawalin rage yawan aiki ko kuma suna so, a cikin 'yan makonnin nan.
Wannan tsawaita jadawalin yana rage nauyin da ake yi a yanzu da kuma matsa lamba a dukan cibiyar.
Za mu gabatar da shawarwarinmu ga Hukumar a mako mai zuwa kuma za mu sanar da wakilai da kuma ƙungiyoyi game da matakan da za su biyo baya da zarar an tabbatar da hakan.
Muna godiya ga ƙungiyar shirin shekara-shekara don rawar da ta taka a wannan batun.
Yanayin ofishin, nunawa da tsaftacewa
A makon da ya gabata, mun san cewa wani abokin aikinmu a San Francisco na iya kamuwa da cutar COVID-19.
Duk da haka, da yake muna da hankali sosai kuma muna da tsari sosai, mun tura wani rukuni na tsabtace ƙwayoyin cuta don tsabtace rufin a ofishinmu na San Francisco.
Ƙungiyar ta yi amfani da maganin rigakafin cutar da ake amfani da shi a asibitoci don tsabtace rufin, da kuma ɗakunan da ke kai mu hawa.
Ginin ya yi amfani da tsarin kula da gidansa ta amfani da kayayyakin da ke tallafa wa lafiyar mazauna gidan.
Muna jin daɗin cewa ofishin ya shirya sosai har sai mun soma aiki.
Ofishinmu a Washington, D.C. yana cikin wani ginin da ke ƙarƙashin kamfanin Weaver, wanda muka haɗa kai da tsarin COVID-19 da kuma dukan ma'aikatanmu a hedkwatarmu a Washington, D.C.
Tun makon da ya gabata, ofishinmu a Washington, D.C., ya koma wani wuri dabam bisa ga umurnin da muke da shi a San Francisco.
Kamar yadda wasu abokan aikinmu a hedkwatarmu a birnin New York suka sani, mun tattauna game da hayar wani wuri a Brooklyn.
Har ila yau, ana tattaunawa game da wannan, amma zai iya jinkirta.
Wasu abokan aikinmu suna aiki ne a nesa a karon farko.
Abokan aikinmu da suka daɗe suna aiki a nesa sun san cewa zai iya zama gyara, kuma sun so su ba ku wasu shawarwari:
Ya kamata a ba da lokaci na taro na sa'a ɗaya ko kuma a ƙara sa'o'i biyu.
Idan ana bukatar a yi taro na tsawon lokaci, ya kamata a yi tunani a kan yadda za a raba shi cikin kwanaki da yawa.
Ya kamata a tsara taron a fili, a shirya jadawalin ayyukan, kuma a aika da abubuwan da za a karanta a gaba.
Ya kamata mu yi amfani da bidiyo a matsayin mafita ta yau da kullum, kuma mu yi amfani da kayan aiki kamar Google Docs da Zoom don sauƙaƙa haɗin kai da sadarwa kai tsaye.
Ya kamata a gudanar da taron a kai a kai, kuma a yi wa wani mai lura da tattaunawar aiki don ya san tambayoyin da kuma bin jerin masu magana, kuma wani ya taimaka wajen rubuta bayanin kula (ko kuma yin aikin rubuta bayanin kula na hadin kai).
Za a aika imel zuwa ga masu goyon bayan sana'a idan ana bukatar belun kunne masu kyau.
Za a iya amfani da shirin biyan kuɗin kiwon lafiya da kuma lafiyar jiki don samun kuɗin cin abinci mai sauƙi.
Za ka iya shiga tashar #remoties ta Slack don ka yi magana da abokanka game da aikin da aka rarraba
Ƙungiyar HR tana neman jagora don abubuwan da ke da amfani da masu amfani da ke kan layi don tallafawa ƙaruwar kasuwancin da aka rarraba ta hanyar ƙungiyarmu.
A makon da ya gabata, mun nemi duk masu karbar tallafin jama'a su soke duk wani taron da Wikimedia ta tallafawa, kamar taron editan yanar gizo Editathon har sai WHO ta sanar da ƙarshen annobar.
Mun gaya musu cewa mun fahimci cewa neman mu soke da kuma wasu ƙuntatawa zai sa ba za a iya kammala ayyukan ba da tallafi da aka amince da su ba, kuma ba za a yi wa kowa fansa ba domin bukatar jinkirta ko gyara waɗannan manufofin.
A mako mai zuwa za mu fitar da ƙarin jagora don biye da su game da Wikimedia da sauran taron yanki da na al'umma.
Ƙa'idodin da ke rinjayar al'umma a duniya sun bambanta tsakanin baƙin ciki da rashin jin daɗi da kuma farin ciki da kuma kasancewa da gaskiya da kuma iya mayar da hankali ga al'ummomin su da kuma Wikimedia da sauransu.
A cikin wannan ci gaba, ƙungiyar masu ba da amsa ga rikice-rikice suna aiki don tsara shafi a cikin Metawiki don samar da sarari ga al'umma don lura da tasiri da kuma bin duk hanyoyin sadarwa.
Kasancewa da sanarwa game da COVID-19
Za mu aika gayyata zuwa kalandarku a ranar Alhamis mai zuwa, da ƙarfe 14:00 na lokaci na duniya, da ƙarfe 7:00 na lokaci na yankin Pacific don taron ƙungiyar ma'aikata.
Za mu yi amfani da wannan lokacin don mu ba da ƙarin bayani, mu amsa tambayoyi, kuma mu yi amfani da lokaci don mu riƙa tattaunawa da juna.
Muna yin wannan aikin tare kuma muna shirye mu taimaka sosai.
A lokacin, za mu iya ci gaba da samun bayanai daga wannan imel ɗin, da kuma duk sauran bayanan da suka dace game da COVID-19 da ke cikin ofishin Wiki.
Ƙungiyarmu za ta ci gaba da sabunta waɗannan shafuka kuma ta sa dukan bayanan su kasance a wuri guda.
Muna kuma ci gaba da sadarwa da ma'aikata da ke zama a ƙasashen da aka yi wa mummunan rauni.
Idan kana da wasu tambayoyi game da tafiya, abubuwan da suka faru, manyan fannonin aiki, ƙalubalen ɗaukar hoto, ko kuma wani abu da kake buƙatar taimako game da shi, ka sanar da mu kuma ka yi aiki tare da ƙungiyar amsa rikice-rikice.
Muna shirye mu ba da tallafi da kuma sadarwa a duk lokacin da ake bukata.
Idan kana da wata matsala mai muhimmanci ko kuma mai ban sha'awa, ka aika wa Brian Goodin, manajan ayyukan HR na duniya imel.
Babu wani canji da za a iya ɗauka a matsayin wanda ya fi aiki da muke yi ko kuma abin da muke da shi.
Maimakon haka, a yanzu, mun fahimci cewa aikinmu da kuma ayyukanmu suna bukatar mu daidaita da yanayin yadda ba mu taɓa yi ba.
Muna ganin cewa waɗannan matakan suna da muhimmanci don tallafa wa juna, don mu ci gaba da aiki, mu ba ma'aikatanmu goyon bayan da suke bukata, kuma mu ba duniya sabis ɗin da suke dogara da shi.
Ayyukan da muka shirya za su jira mu sa'ad da lokaci ya yi.
Yanzu lokaci ne da kowa zai taimaka wa wani kuma ya samar da sarari don muhimmin aiki da zai faru a makonni da watanni masu zuwa.
Muna bukatar ku duka ku cim ma wannan, don haka muna bukatar ku kula da kanku da iyalanku don ku kasance cikin mafi kyawun yanayi lokacin da ƙoƙarinku ya ƙare.
Don Allah ku wanke hannuwanku yanzu kuma kada ku taɓa fuskarku!
Catherine, manajan ƙungiyar amsa rikice-rikice (Amanda K, Amy V, Brian J, Doreen D, Gregory V, Jimmy V, Joel L, Lenny L, Ryan M, da Tony S), da sauran mambobin ƙungiyar jagoranci (Grant I, Heather W, Jimmy V, Janine U, Lisa S, Robin A, Ryan M, da Toby N).
Anjima mai canzawa zuwa angiotensin 2 (ACE2) yana da alaƙa da ƙwayoyin da ke cikin huhu, jijiyoyi, zuciya, koda koda hanji.
Anjeotensin-2 yana hana aikin anjeotensin-transforming enzyme (ACE) ta hanyar rage adadin angioutensin-2 da kuma ƙara angioutensin (1-7); yana mai da shi magani mai alƙawarin magani a cikin maganin cututtukan zuciya da jijiyoyin jini.
Ana kiran kwayar halitta ta ɗan adam hACE2.
An san wani enzyme mai jujjuyawar angiotensin 2 da yake dauke da sinadarin zinc da ke jikin jikin jikin jikin mutum da sauran kwayoyin halitta.
Protein din da ke canza ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantattun ingantantantattun ingantattun ingantantantantantattun ingantattun ingantantantant.
Angiotensin-2 mai canzawa shine furotin mai wucewa guda ɗaya na nau'i 1, wanda ke da ƙwayoyin cuta masu aiki a saman ƙwayoyin huhu da sauran ƙwayoyin.
A cikin jini, wani furotin mai narkewa yana fitowa daga cikin jini kuma daga nan sai ya fita ta cikin fitsari.
Ana samun enzymes na angiotensin 2 a yawancin gabobin jiki: yana da alaƙa da ƙwayoyin ƙwayoyin cuta na jini na nau'i 2 a cikin huhu, a cikin ƙwayoyin hanji na ƙananan hanji, ƙwayoyin jijiyoyin jini da jijiyoyin jini, da kuma a cikin ƙwayoyin jijiyoyin jini na garkuwar jijiyoyin jiki a yawancin gabobin.
Ana samun DNA mai aiki da shi na angiotensin-2 a cikin ƙwaƙwalwar kwakwalwa, da tsarin, da kuma yankin da ke ƙarƙashin hanci, da kuma ƙashin kwakwalwa.
Babban aikin amincin angiotensin 2 shine aiki a matsayin daidaitaccen amincin angiotensin.
Wannan enzyme mai juyawa na angiotensin yana sa hormone angiotensin 1 ya zama angiotensin 2 mai riƙe jini.
A madadin haka, wani enzyme mai canza ingyotensin 2 ya raba karboxyl antifungal amino acid phenylenine daga ingyotensin 2 (aspartite-arginine-valine-thyrocin-isoliosin-hestidine-proline-phenylenine) kuma ya canza shi zuwa ingyotensin (1-7), (hestidine-aspartite-arginine-valine-thyrocin-isoliosin-hestidine-proline-phenylenine).
An enzymes da ke canza angiotensin 2 sun rabu zuwa wasu wasu ƙwayoyin cuta daga cikinsu [des-arginine9] - bradricinine, aplenine, neurotensin, denorphine A, da gerlin.
Hakanan anjin na angiotensin-2 yana daidaita hanyar wucewa ta membrane don ɗaukar amino acid SLC6A19 wanda ba shi da tsaka-tsaki, kuma yana da rawa a cikin cutar Hartnep.
Anzyme mai canzawa na angioutensin 2, a matsayin furotin na membrane, shine babban hanyar shiga cikin kwayoyin wasu cututtukan corona, wanda ya haɗa da kwayar cutar NL63, SARS-CoV (kwayar cutar SARS) da SARS-CoV-2 (kwayar cutar COVID-19).
Musamman, furotin Spike S1 na SARS-CoV-2 da kuma SARS-CoV-2 suna haɗuwa da ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta na ƙwayoyin cuta da ƙwayoyin cuta da ƙwayoyin cuta suna shiga cikin ƙwayoyin cuta.
Wannan aikin na bukatar a yi amfani da protease na protease na membrane, sirin2 na mai masaukin baki, wanda har yanzu ana gwada shi a matsayin magani mai yiwuwa. Wannan ya sa wasu suka yi zaton cewa rage matakan enzymes na angiotensin 2 a cikin kwayoyin zai iya taimakawa wajen tsayayya da kamuwa da cuta.
Ko ta yaya, kungiyoyi da yawa da kuma kungiyoyi masu zaman kansu sun ba da shawarar ci gaba da amfani da masu hana ingancin inginesin da ake amfani da su, da kuma masu hana inginesin a matsayin magani.
Wani bincike da kuma bincike na Teloy da aka buga a ranar 11 ga Yuli, 2012 ya nuna cewa "ta amfani da masu hana amfani da enzymes masu canzawa zuwa angioutensin suna da raguwar haɗarin kamuwa da cutar huhu da kashi 34% idan aka kwatanta da ƙungiyar da aka kwatanta".
Bugu da ƙari, "hadarin kamuwa da cutar huhu ya ragu a tsakanin waɗanda aka yi musu magani da maganin hana ƙwayoyin cuta na angiotensin, waɗanda suka fi fuskantar haɗarin kamuwa da cutar huhu, musamman waɗanda ke fama da bugun jini ko rashin zuciya.
Yin amfani da masu hana amfani da enzymes masu canzawa zuwa angioutensin ya rage yawan mutuwar da ke faruwa daga kamuwa da cutar huhu, ko da yake sakamakon ya kasance ƙasa da haɗarin kamuwa da cutar huhu".
Ana ganin cewa ƙwayar cuta ta mutum mai canzawa zuwa angitocin 2 (rhACE2) za ta zama sabon magani don cututtukan huhu masu tsanani. An gano cewa tana inganta aikin jini na huhu, da kuma satar oxygen a cikin aladu da ke fama da cutar shan numfashi mai tsanani da sukari mai yawa ke haifar.
Anjin da ke canzawa zuwa angiotensin 2 yana da rabin rayuwarsa na kusan sa'o'i 10, yayin da yake aiki bayan minti 30, kuma yana ci gaba da aiki (lokacin lokaci) har zuwa awanni 24.
Akwai alamun da yawa da ke nuna cewa anjin mai maye gurbin angiotensin 2 na iya zama magani mai alkawura ga waɗanda ke fama da rashin haƙuri da na gargajiya na RAS (RAS) masu hanawa, da kuma cututtuka da ke tattare da hawan jini na angiotensin 2. Akwai gwaji na asibiti da ke cikin kimantawa, game da tasirin da anjin mai maye gurbin angiotensin 2 ke yi a maganin cututtukan cututtukan numfashi mai tsanani.
Aikace-aikacen COVID-19 aikace-aikace ne na software don na'urorin hannu waɗanda aka tsara musamman don taimakawa bin diddigin mutanen da suka kamu da cutar a cikin amsa ga annobar COVID-19 2019, wanda ke nufin aiwatar da gano mutanen ("da ke kamuwa da cutar") waɗanda zasu iya haɗuwa da mai kamuwa da cutar.
An tsara ko kuma an ba da shawarar aikace-aikace da yawa tare da tallafin gwamnati a wasu yankuna da yankunan shari'a.
An tsara tsarin aiki da yawa don tsara aikace-aikacen bin diddigin ɓoye.
Mutane da yawa sun nuna damuwa game da tsare sirri, musamman game da tsarin da ke dogara da bin diddigin masu amfani da aikace-aikace.
Sauran hanyoyin da ba su da tsattsauran ra'ayi sun haɗa da yin amfani da siginar Bluetooth don yin rikodin kusa da mai amfani daga wasu wayoyin salula.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa sun haɗa aikin da ke tallafawa waɗannan aikace-aikacen da ke amfani da Bluetooth, kai tsaye a cikin tsarin aiki na Android da iOS.
A kasar Sin, gwamnatin kasar ta haɗa kai da kamfanin Alipay ta wallafa wani aikace-aikace da ke ba 'yan kasar damar duba ko sun haɗu da mutanen da ke dauke da cutar COVID-19.
Yana da wani app da mutane ke amfani da shi a birane fiye da 200 na kasar Sin. A Singapore, mutane suna amfani da wani app da ake kira TraceTogether.
Kungiyar fasaha ta IT ta gida ta dauki nauyin zane na aikace-aikacen, ta saki shi a matsayin aikace-aikacen budewa kuma ana shirin mika shi ga gwamnati. Macedonia ta Arewa ta ƙaddamar da aikace-aikacen!StopKorona, aikace-aikacen da ke dogara da amfani da Bluetooth don bin diddigin haɗuwa da mutanen da ke da yiwuwar kamuwa da cuta da kuma ba da amsa mai sauri ga hukumomin kiwon lafiya.
Ma'aikatar Sadarwa da Fasaha ta yi aiki tare da Ma'aikatar Lafiya don tsara aikace-aikacen.
A ranar 14 ga Afrilu, 2020, app ɗin yana jiran tallafin Google Play Store da App Store daga Apple.
A ranar 12 ga Afrilu, gwamnati ta sanar da cewa aikace-aikacen bin diddigin ɓoye yana cikin ci gaba, kuma zai iya zama samuwa don rarrabawa a cikin makonni. Ireland da Faransa suna shirin ƙaddamar da irin wannan aikace-aikacen, wanda shine ("StopCovid").
Ostiraliya da New Zealand suna tunanin tsara aikace-aikace bisa TraceTogether da Singapore ta ƙaddamar, da kuma yarjejeniyar BlueTris.Toteniya Rasha ta gabatar da aikace-aikacen da ke amfani da yanayin yanayin yanayin yanayin yanayin yanayin marasa lafiya waɗanda likitoci suka gano COVID-19 daga mazaunan Moscow, wanda aka tsara don tabbatar da cewa ba su bar gida ba.
Ross Anderson, farfesa a jami'ar Cambridge, ya ambata wasu matsaloli masu yuwuwa da ke kewaye da tsarin da ke kan aikace-aikace, ciki har da rashin amfani da aikace-aikacen idan an yi amfani da su ne kawai ga ƙaramin ɓangare na yawan jama'a.
Don magance fargaba game da yaduwar ɓatarwa ko cutarwa ta coronavirus, Apple ya sanya takunkumi kan nau'ikan ƙungiyoyi waɗanda zasu iya ƙara aikace-aikacen da suka danganci coronavirus zuwa shagon aikace-aikacen ta; inda ya iyakance wannan ga ƙungiyoyi "masu izini" ko wasu masu suna.
Google da Amazon sun yi amfani da irin wannan takunkumi.
Masu goyon bayan tsare sirri sun nuna damuwa game da sakamakon saka idanu na rukuni da amfani da aikace-aikacen coronavirus ke haifar da, musamman game da ko tsarin saka idanu da aka tsara don magance cutar coronavirus zai ɓace da zarar barazanar ta ƙare.
Amnesty International da fiye da kungiyoyi 100 sun fitar da wata sanarwa inda suka bukaci a takaita irin wannan sa ido.
Ƙungiyoyin sun kuma bayyana sharuɗɗa guda takwas ga ayyukan gwamnati:
Dole ne a yi "doka, wajibi da kuma dacewa" da ke kula da su.
Ƙarfafawar saka idanu da kuma saka idanu ya kamata ya ƙunshi sassan da suka shafi lokacin da za a dakatar da su;
Ya kamata a yi amfani da bayanai ne kawai don dalilai na COVID-19.
Dole ne a kare tsaro da sirrin masu mallakar bayanai kuma a tabbatar da cewa an kare su bisa hujja;
Dole ne a guji ƙara nuna bambanci da kuma warewa.
Ya kamata a ƙayyade ko wane raba bayanai da wasu a cikin doka;
Ya kamata a samar da abubuwan karewa daga cin zarafi da kare hakkin 'yan kasa don magance cin zarafi;
Ana buƙatar "shirye-shiryen" daga duk "masu sha'awar da ke da alaƙa", ciki har da masana kiwon lafiya na jama'a da kungiyoyin da aka yi watsi da su. Jamusanci Chaos Computer Club (CCC) da Reporter ohne Grenzen (RSF) sun kuma fitar da jerin bita.
Manufar da aka gabatar ta Google/Apple na magance matsalar saka idanu ta ci gaba ta hanyar cire na'urar bin diddigin daga tsarin aiki na na'urori da zarar an gama buƙatar su.
Wasu ƙasashe sun yi amfani da bin diddigin yanar gizo maimakon yin amfani da aikace-aikace, wanda ya kawar da bukatar sauke aikace-aikacen kuma ya ba da damar kaucewa bin diddigin.
A Isra'ila, jami'ai sun yi amfani da hanyar sadarwa.
Amma hanyoyin sadarwa da ke da damar samun bayanai na asali na yanar gizo suna da manyan matsalolin sirri.
Duk da haka, ba duk tsarin da ke da cibiyar sadarwa ba ne ke bukatar samun damar bayanan sirri na wurin; an kafa wasu tsarin tsare sirri da ke amfani da cibiyar sadarwa don sadarwa ta tsakanin mutane kawai (duba sashe na gaba a ƙasa).
A Koriya ta Kudu, jami'ai sun yi amfani da tsarin da ba ya dogara da aikace-aikace don bin diddigin ɓatanci.
Maimakon amfani da wani aikace-aikace na musamman, tsarin yana tattara bayanan bin diddigin daga tushe daban-daban, ciki har da bayanan bin diddigin wayar hannu da bayanan ma'amala na katin, kuma yana haɗa waɗannan bayanan don aika saƙonnin rubutu zuwa ga mutanen da ke da yiwuwar kamuwa da cutar.
Baya ga yin amfani da wannan bayanin don faɗakar da masu iya yin kuskure, gwamnati ta kuma ba da bayanan wuraren a fili, wanda hakan ya faru ne saboda canje-canje masu yawa a dokokin tsare sirrin bayanai bayan barkewar cutar coronavirus da ke haifar da ciwon huhu na Gabas ta Tsakiya a wannan ƙasar.
Ana samun wannan bayanin a cikin aikace-aikace da kuma shafukan intanet. Kasashe, ciki har da Jamus, sun yi la'akari da amfani da tsarin da ke da tsakiya da kuma tsare sirri.
A ranar 6 ga Afrilu, 2020, ba a bayyana cikakken bayani game da wannan ba tukuna.
Abubuwan da ke tattare da tsare sirri na sirri suna bin wata ma'ana mai kyau da kuma ingantacciyar ma'ana da kuma goyon bayan bincike mai ƙarfi wanda ya fara daga akalla 2013. A ranar 7 ga Afrilu, 2020, fiye da goma sha biyu na masana sun yi aiki don samun mafita mai dacewa da tsare sirri, kamar low-power Bluetooth (PLE) don yin rajista kusa da mai amfani daga sauran wayoyin salula.
Duk da haka, BEPB-PT wani shiri ne na daidaitawa wanda ya ƙunshi tsarin cibiyar da na cibiyar, ba yarjejeniya ta mutum ba. Tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin tsarin
A cikin waɗannan ƙa'idodin, ba a barin bayanan sirri daga na'urar ba, kuma duk aikin daidaitawa yana faruwa a kan na'urar.
Ƙungiyar masu zaman kansu a MIT Media Lab suna aiki a kan SafePaths, dandamali don amfani da fasahar tsare sirri don tattara bayanai na wurare ko kuma haɗuwa da hanyoyi da kuma amfani da su don bin diddigin yaduwar COVID-19.
An yi amfani da bincike daga rahoton "The Applications Face: Maintaining Personal Privacy in the Shadow of the Pandemic" da aka fitar a watan Maris na 2020. SafeTrace dandamali na Enigma MPC, wani kamfanin bunkasa fasahar sirri wanda kuma ya samo asali ne a MIT Media Lab, wani irin wannan yunƙuri ne.
SafeTrace yana amfani da fasahar tsaro na'urori don ba masu amfani damar raba bayanan wuri da kuma lafiyar lafiya tare da masu amfani da sauran jami'ai ba tare da yin tasiri ga sirrin bayanai ba.
A ranar 5 ga Afrilu, 2020, ƙungiyoyin da ke da sha'awar abin da ya kasance a matsayin daidaitaccen tsarin da kuma yarjejeniyoyi masu yawa sun kafa ƙungiyar bin diddigin lambobin sadarwa na duniya, tare da manufar rage rarrabuwa da kuma ba da damar musayar duniya tsakanin aikace-aikacen bin diddigin da faɗakarwa, babban fasalin samun amfani da yaduwa.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta sanya yarjejeniyar Blue Tris, wanda aikace-aikacen gwamnati na yau da kullun ke amfani da shi, a bude.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke sarrafa tsarin aiki na Android da iOS, sun sanar da wani shiri na bin diddigin ɓoye; inda suka yi ikirarin cewa za su ci gaba da tsare sirri ta hanyar haɗa fasahar Bluetooth mai ƙarancin ƙarfi da ɓoye ɓoye.
Sun kuma wallafa takamaiman fasahohin da ake amfani da su a cikin tsarin.
A cewar Apple da Google, manufar ita ce a gabatar da tsarin a matakai uku, wato:
Bayar da kayan aiki don ba gwamnatoci damar ƙirƙirar aikace-aikacen sirri na hukuma don bin diddigin cutar coronavirus
Wannan aikin ya haɗa kai tsaye cikin Android da iOS kamar yadda Google da Apple ke shirin warware matsalolin amfani da ci gaba da saka idanu ta hanyar rarraba tsarin farko ta hanyar sabunta tsarin aiki sannan ta hanyar cire su ta hanyar da ta dace da lokacin da barazanar ta ƙare.
Sake amfani da magani (wanda aka fi sani da sake amfani da shi, sake amfani da shi, sauyawa, sauya manufa ko sauya maganin magani) shine sake amfani da magani wanda aka amince da shi don magance wata cuta ko yanayin likita daban da wanda aka tsara don maganin asali.
Wannan shi ne tsarin bincike na kimiyya da masu bincike ke bi don samar da lafiya da kuma ingantaccen maganin COVID-19.
Sauran hanyoyin bincike sun haɗa da haɓaka allurar COVID-19 da kuma watsa plasma na masu shayarwa. Kwayar SARS-CoV-2 tana da kusan sunadarai 66 masu magani, kowannensu yana da wurare masu yawa na haɗin gwiwa.
Binciken waɗannan rukunin yanar gizon yana ba da kyakkyawan shiri game da ci gaban maganin rigakafin cutar da ke lalata furotin COVID-19.
Daga cikin furotin da ke da muhimmanci ga SARS-CoV-2 akwai protease mai kama da papine, polymerase mai kama da riboside, helix, protein S, da adenosine biphosphate riboside.
Hussain A.A., da sauransu sun yi nazarin wasu kwayoyin da aka yi amfani da su, kuma daga baya aka inganta su kuma aka bincika su don su yi kama da magunguna masu kama da juna, kuma hakan ya sa aka yi gaggawa wajen samar da wani magani mai ƙarfi na riga-kafi na SARS-CoV-2 a cikin binciken da ya yi kafin a yi asibiti don a ba da shawarar a cikin binciken asibiti.
Chlorokine magani ne na maganin zazzabin cizon sauro wanda likitoci ke amfani da shi wajen magance wasu cututtukan rigakafi.
A ranar 18 ga Maris, Hukumar Lafiya ta Duniya ta sanar da cewa chlorine da hydroxychloroquine da ke da alaƙa za su iya kasancewa cikin magunguna huɗu da ake nazari a matsayin wani ɓangare na gwajin haɗin kai na asibiti.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin jihar New York akan chlorine da hydroxychloroquine zai fara a ranar 24 ga Maris. A ranar 28 ga Maris, Hukumar Abinci da Magunguna ta ba da izinin amfani da sulfur hydroxychloroquine da chlorine phosphates a ƙarƙashin lasisin gaggawa (AUA).
Hukumar Kula da Abinci da Magunguna ba ta amince da maganin ba kuma an ba shi izini a ƙarƙashin lasisin gaggawa kawai a matsayin gwaji na gaggawa don kula da marasa lafiya da aka shigar asibiti amma ba za su iya samun magani a gwajin asibiti ba.
Hukumar ta ce ba a riga an ƙayyade "amfani da hydroxychloroquine don hana kamuwa da cutar SARS-CoV-2 ko magani ko allurai ko lokacinsa ba".
Likitoci sun ce suna amfani da maganin ne a lokacin da "babu wani zaɓi".
Wani bincike na Turkiyya a Istanbul yana gudanar da wani karamin bincike a kan amfani da chlorine da zinc, bitamin A, bitamin C da bitamin D.
Akwai manyan karatu a Jami'ar Duke da kuma Jami'ar Oxford.
Kwalejin Likita ta New York ta Langon tana gudanar da gwaji kan amincin amfani da hydroxychloroquine da kuma ingancinsa.
Gwaje-gwajen asibiti na kasar Sin a Wuhan da Shenzhen sun yi ikirarin cewa Favivir yana da "ainihin tasiri".
Daga cikin marasa lafiya 35 da ke birnin Shenzhen, an gwada su da mummunan sakamako na kwanaki 4, yayin da a cikin marasa lafiya 45 da ba su samu ba, sun yi kwanaki 11.
A wani bincike da aka yi a Wuhan, an yi wa marasa lafiya 240 da ke fama da ciwon huhu, an ba rabin su favivir, kuma an ba da sauran rabin su omefinofer.
Hukumar Kula da Magunguna ta Italiya ta gaya wa mutane cewa akwai ƙarancin tabbaci na farko game da miyagun ƙwayoyi.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi kayan daga Japan don a saka su a cikin ajiyarta, kuma za ta yi amfani da sojojin don isar da kayan zuwa asibitocin jami'a, inda za a yi amfani da su wajen kula da marasa lafiya da COVID-19.
Kamar yadda jaridar South China Morning ta ruwaito, Shinzo Abe ya yi tattaunawa ta farko da gwamnatin Trump game da sayen maganin. Maganin na iya zama ƙasa da tasiri wajen magance yanayin da suka fi tsanani inda cutar ta riga ta ninka.
Yana iya zama ba shi da haɗari ga mata masu ciki ko waɗanda suke son yin ciki.
Wani bincike da ya yi amfani da lupinavir/retonavir (Calitra), wani sinadarin da ke haɗa maganin cutar Lupinavir da Rettonavir, ya ce sakamakon "ba ya da amfani".
An tsara miyagun ƙwayoyi don hana cutar ta HIV ta zama mai ƙonewa da protease.
Wata ƙungiyar masu bincike a Jami'ar Colorado na ƙoƙarin gyara magunguna don samun wani abu da ke da alaƙa da SARS-CoV-2 Protein, kuma ƙungiyar kimiyya ta fuskanci halin sukar tura albarkatu don sake gano manufar magunguna da aka tsara musamman don magance HIV / AIDS.
Hukumar lafiya ta duniya ta ƙara Lupinavir/Retonavir a cikin gwajin hadin kai na duniya.
Gilead Sciences ta ci gaba da yin maganin cutar Remdesivir a matsayin magani ga cutar Ebola da cutar Marburg. Gilead Sciences ta gano cewa Remdesivir yana da aikin anti-virus a cikin dakin gwaje-gwaje game da ƙwayoyin cuta da yawa, ƙwayoyin cuta da kuma coronavirus.
Ɗaya daga cikin matsalolin maganin rigakafi na ƙwayoyin cuta shi ne ci gaba da ƙin rigakafi ta hanyar juyawa wanda zai iya haifar da cututtuka masu tsanani da kuma yaduwa.
Wasu bincike na farko na farko sun nuna cewa Remdesivir na iya nuna wani babban ginshiƙi na kwayoyin halitta ga juriya. Akwai gwaje-gwaje na asibiti da yawa a yanzu, ciki har da gwaje-gwaje biyu da asibitocin Jami'ar Cleveland ke yi. Ɗaya daga cikinsu game da marasa lafiya ne, ɗayan kuma na musamman ga marasa lafiya masu tsanani.
Akwai gwaje-gwaje uku na asibiti game da maganin anti-virus na bitamin C a kan marasa lafiya da aka kwantar da su asibiti kuma suna fama da mummunan cuta saboda COVID-19, da kuma gwaje-gwaje biyu na sarrafawa na amfani da maganin karya (China, Kanada) da gwajin da ba a sarrafawa ba a Italiya.
Jihar New York ta fara gwaji game da maganin maganin azithromycin a ranar 24 ga Maris, 2020.
Cibiyar Kula da Lafiya da Magunguna ta Japan (NCGM) na shirin gudanar da gwaji na asibiti game da amfani da alvesco (siliconide) na Teijin, wani corticosteroid da aka tsotse don maganin asma, don kula da marasa lafiya da ke da sabon coronavirus kafin bayyanar cututtuka.
A halin yanzu ana gudanar da gwaji na mataki na biyu ta amfani da wani nau'i na enzyme mai canzawa zuwa angiotensin 2 a kan marasa lafiya 200 da ake bukata su shiga gwajin daga cikin cututtukan da suka shiga asibiti a Denmark, Jamus, da Austria don sanin tasirin magani.
Masu bincike daga Cibiyar Zuciya ta Montreal a Kanada suna nazarin matsayin Colchicine wajen rage kamuwa da cuta da kuma cututtukan huhu a cikin marasa lafiya da ke da alamun bayyanar cututtukan COVID-19.
Wannan binciken, wanda ake kira Colcorona, ya shafi manya 6,000 da suka kai shekara 40 da sama da suka kamu da COVID-19 kuma suka sha wahala daga bayyanar cututtuka marasa tsanani ba tare da bukatar zuwa asibiti ba.
Mata masu ciki ko waɗanda suke shayar da nono na halitta ko kuma waɗanda ba su da wata hanya mai kyau na hana haihuwa ba za su iya yin hakan ba.
Ana gwada maganin rigakafi da yawa a Italiya.
Ana amfani da ƙananan nauyin kwayoyin halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar halittar hali
An sanar da gudanar da bincike mai ci gaba a Italiya a kan marasa lafiya 300 don nazarin amfani da sodium inoxabarin a allurai na rigakafin cututtuka da allurai na magani a ranar 14 ga Afrilu.
Saboda SARS-CoV-2 ne, kimiyya ta mai da hankali sosai ga sake amfani da magungunan rigakafin cutar da aka ƙera don magance cututtukan da suka gabata kamar cutar Mars, SARS, da West Nile.
Masu bincike sun bada shawarar yin amfani da ribavirin don magance COVID-19 bisa ga tsarin 7 na dokokin kasar Sin.
Omfinofer: Masana sun bada shawarar yin amfani da Omfinofer don maganin COVID-19 bisa ga sigar 7 na jagorar kasar Sin
Wasu maganin rigakafi da masana suka gano cewa za a iya sake amfani da su a matsayin maganin COVID-19 sun haɗa da:
Tosilizumab (Anti-Interloquin receptor 6): An amince da shi daga ƙasar Sin.
An kuma gwada su a Italiya da China. Ka duba Tosilizumab #COVID-19.
Allurar rigakafin COVID-19 allurar rigakafin cutar korona 2019 ce.
Ko da yake ba a kammala gwajin rigakafi ba, ana ƙoƙari sosai a ci gaba da yin wannan rigakafin.
A ƙarshen Fabrairu 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin za a sami allurar rigakafin SARS-CoV-2, cutar da ke haifar da cutar, a cikin ƙasa da watanni 18.
An samu rigakafin rigakafi guda biyar a cikin binciken farko na lafiya a watan Afrilu.
An gano COVID-19 a watan Disamba na shekarar 2019.
A shekarar 2020, wata babbar cuta ta bazu a duniya, wanda ya haifar da saka hannun jari mai yawa da kuma bincike don samar da rigakafi.
Ƙungiyoyi da yawa suna amfani da kwayoyin halitta da aka wallafa don samar da alluran rigakafin SARS-CoV-2.
Abubuwan da ake bukata na shirin haɗin gwiwar da ke kan abubuwan kirkire-kirkire na shirye-shiryen annobar rigakafi, wanda aka sanar a watan Afrilu, su ne saurin, samarwa, yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yaduwar yadu.
A watan Afrilu, masana kimiyyar Coalition da ke da alhakin kirkire-kirkire na shirye-shiryen annobar sun ba da rahoton cewa dandamali daban-daban 10 na fasaha suna cikin bincike da ci gaba a farkon 2020 don ƙirƙirar allurar rigakafin COVID-19.
Babban burin dandamali da aka gabatar zuwa matakin farko na nazarin tsaro sun hada da:
DNA (Riboside DNA mai ƙarancin oxygen da RNA mai ƙarancin jini) (mai haɓaka mataki na farko da kuma allurar da aka zaɓa: Moderna, da mRNA-1273)
Mai ɗaukar hoto (mai haɓaka mataki na farko da kuma allurar da aka zaɓa: Moderna, mai ɗaukar hoto na ƙwayoyin cuta na nau'in 5)
A cewar masana kimiyya na Coalition da ke da alhakin kirkire-kirkire na shirye-shiryen annobar a watan Afrilu, akwai allurai 115 na alluran rigakafi a farkon matakan ci gaba, tare da ayyukan aiki 78 da aka tabbatar (79, a cewar Cibiyar Milken), kuma an sanar da wasu ayyukan 37, amma tare da karancin bayanan jama'a (wanda ake zaton suna cikin shiri ko tsarawa).
Ana gwada gwajin farko da na biyu na farko na aminci da rigakafi, yawanci bazuwar, kuma ana sarrafa su da hankali, a wurare da yawa, tare da ƙayyade ƙarin ƙayyadaddun allurai.
Gwaje-gwaje na mataki na uku yawanci sun haɗa da ƙarin mahalarta, ciki har da rukunin bincike, da kuma gwada ingancin allurar rigakafin cutar, tare da lura da tasirin sakamako mara kyau na mafi kyawun sashi.
Daga cikin alluran rigakafi 79 da aka ƙaddara da ke ci gaba da aiki (an tabbatar da su a farkon Afrilu 2020), 74 ba su kasance a cikin kimantawar ɗan adam ba tukuna (har yanzu ana bincike "kafin asibiti").
A ranar 24 ga Janairu, 2020, a Ostiraliya, Jami'ar Queensland ta sanar da cewa tana binciken yiwuwar yin aiki na allurar rigakafin kwayoyin cuta wanda zai gyara kwayoyin cutar ta hanyar kwayoyin halitta don motsawa.
A ranar 24 ga Janairu, 2020 a Kanada, Cibiyar Hoto ta Duniya (VIDO-InterVac) a Jami'ar Saskatchewan ta sanar da fara aikin allurar rigakafi, inda ake shirin fara gwaji a cikin mutane a 2021.
An sanar da ayyukan ci gaban alluran rigakafi a Cibiyar Sadarwa da Rigakafin Cututtuka ta China a ranar 26 ga Janairu, 2020, kuma a Jami'ar Hong Kong a ranar 28 ga Janairu.
A ranar 29 ga Janairu, 2020, Kamfanin Janssen Pharmaceuticals, wanda Hanneke Schweitmaker ke jagoranta, ya sanar da cewa sun fara aiki a kan samar da allurar rigakafi.
Janssen tana aiki tare da abokin aikinta na fasaha, Vaxart wajen samar da allurar baki.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwar masana'antu tare da Vaxart don haɓaka allurar.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya wallafa wani bincike game da ƙirar allurar rigakafi tare da fasaha irin ta waɗanda ake amfani da su wajen magance ciwon daji tare da sabon allurar antibody.
A ranar 25 ga Maris, shugaban cibiyar bincike ya sanar da cewa sun gama yin allurar kuma sun fara gwajin.
A ranar 27 ga Fabrairu, 2020, NuGenerex Immuno-Oncology, wani kamfani na Generex, ya sanar da cewa ya fara aikin allurar rigakafi don ƙirƙirar maganin peptide na Ii-Key na COVID-19.
Sun so su samar da allurar rigakafi da za a iya gwadawa a cikin mutane "a cikin kwanaki 90".
A ranar 5 ga Maris, 2020, Jami'ar Washington ta St. Louis ta sanar da ayyukanta na samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Rundunar Sojojin Amurka ta Kula da Bincike da Kayan Aiki a Fort Derek da Walter Reed Military Research Institute a Silver Spring, a yammacin Maryland, sun sanar da cewa suna aiki a kan allurar rigakafi.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta haɗu da Novavax Inc.
A cikin ci gaba da yin rigakafi.
Abokan hulɗa sun kuma sanar da shirye-shiryen gwajin farko da gwajin gwaji na farko na farko zuwa Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa tana aiki da shari'o'i 11 na keɓewa, kuma har ma da hanzarta aiki zai ɗauki aƙalla shekara ɗaya da rabi zuwa kusan shekaru biyu don haɓaka allurar rigakafi.
A ranar 12 ga Maris, 2020, Medicago, wani kamfanin kere kere na Quebec City, Quebec, ya ba da rahoton cewa an ci gaba da wani abu mai kama da cutar Corona, wanda aka tallafawa shi ne daga Cibiyoyin Nazarin Lafiya na Kanada.
Allurar rigakafin da aka zaɓa za ta kasance a cikin dakin gwaje-gwaje, kuma ana shirin gwada ta a cikin mutane a watan Yuli ko Agusta 2020.
A farkon makon nan, jaridar The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba CureVac "babban kuɗi" don samun damar yin amfani da allurar COVID-19, abin da gwamnatin Jamus ta bukaci.
A ranar 17 ga Maris, 2020, kamfanin magunguna na Amurka Pfizer ya sanar da haɗin gwiwa tare da kamfanin BioNTech na Jamus don shiga cikin haɓaka allurar rigakafin da aka ƙaddamar da RNA.
A halin yanzu ana gwada allurar rigakafi ta hanyar BNT162 mai ba da izini, kuma ana sa ran gwajin gwaji zai fara a watan Afrilu na 2020.
A Italiya a ranar 17 ga Maris, 2020, Takis Biotech, wani kamfani na fasaha mai mahimmanci na Italiya, ya sanar da cewa zai sami sakamakon gwajin gwaji na farko a watan Afrilu na 2020 kuma zai iya fara gwajin rigakafin na ƙarshe a cikin mutane a cikin kaka.
A Faransa a ranar 19 ga Maris, 2020, kungiyar ta CEBA ta sanar da zuba jari na dala miliyan 4.9 a wata kungiya ta bincike kan allurar COVID-19 da ta hada da Cibiyar Bastor, Themis Bioscience (Vienna, Austria), da Jami'ar Pittsburgh, wanda ya sa jimlar zuba jari na kungiyar ta bunkasa allurar COVID-19 ta kai dala miliyan 29.
Abokan haɗin gwiwar da ke da alhakin ƙirƙirar shirye-shiryen annobar COVID-19 don haɓaka allurar rigakafin COVID-19 sune Moderna, Curevac, Novavax, Jami'ar Hong Kong, Jami'ar Oxford, da Jami'ar Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana kimiyya sun fara gwajin dabbobi na alluran rigakafi guda shida daban-daban.
A ranar 20 ga Maris, 2020, masu binciken Kwalejin Imperial a London sun sanar da cewa suna ci gaba da samar da rigakafin riboside na COVID-19 wanda ya kara girman kansa.
An samar da allurar rigakafi a cikin kwanaki 14 bayan an karɓi jerin daga China.
A ƙarshen Maris, gwamnatin Kanada ta sanar da ba da tallafin dala miliyan 275 na Kanada ga ayyukan bincike 96 game da matakan likita na COVID-19, gami da alluran rigakafi da yawa da aka ƙaddara a kamfanoni da jami'o'i na Kanada, kamar su Medicago da Jami'ar Saskatchewan.
A daidai wannan lokacin, gwamnatin Kanada ta sanar da cewa za ta ba da dala miliyan 192 na Kanada don samar da allurar COVID-19, tare da shirye-shiryen kafa bankin allurar rigakafi na kasa na sababbin alluran rigakafi da za a iya amfani da su idan wani sabon annobar cutar ta coronavirus ta faru.
A ranar 2 ga Afrilu, 2020, masu bincike a Kwalejin Likita ta Jami'ar Pittsburgh sun ba da rahoton gwaje-gwaje na PittCoVacc, yiwuwar allurar COVID-19 a cikin beraye, inda suka ce "sars-CoV-2 S1 subunit alluran da aka ba da allura mai ƙarancin ƙarfi sun haifar da amsa mai ƙarfi ga takamaiman antibody antibodies [a cikin beraye] sun kasance bayyane tun daga makonni 2 bayan allurar".
A Kanada a ranar 16 ga Afrilu, 2020, Kwalejin Magunguna ta Jami'ar Waterloo ta sanar da ƙirar allurar rigakafi mai amfani da ƙwayoyin cuta na RNA mai ƙarancin oxygen a matsayin mai yuwuwar maganin hanci.
Ta amfani da maganin rigakafi, ƙwayar cuta mai ƙarancin oxygen za ta tsara oxygen don ta haihu a cikin ƙwayoyin cuta na mutum don samar da ƙwayoyin cuta marasa lahani kamar ƙwayar cuta, wanda zai iya motsa tsarin garkuwar jiki ya samar da kwayoyin cutar SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun haɗa kan albarkatun don samun damar zuwa manyan kwamfutocin IBM, tare da albarkatun girgije na Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu alluran rigakafi suna da sakamako na musamman, kuma ana kiransu sakamako na rashin tabbas.
Wannan yana nufin cewa za su iya samun amfanin da ya wuce na cutar da kake yaki.
Wani gwaji a Ostiraliya ya yi da'awar yin rajistar ma'aikatan kiwon lafiya 4,170.
Ana iya ganin cewa alluran da ake ci gaba da yi ba su da lafiya ko tasiri.
Bincike na farko na kimanta tasirin allurar rigakafi ta amfani da samfurin dabba na musamman na COVID-19, kamar beraye da aka gyara ta hanyar maganin maye gurbin angiotensin 2, da sauran dabbobi na dakin gwaje-gwaje, da shugabannin da ba mutane ba, ya nuna bukatar matakan kiyaye lafiyar halittu na matakin 3 don magance ƙwayoyin cuta masu rai, da kuma daidaitawar duniya don tabbatar da daidaitattun matakan tsaro.
An gwada alluran rigakafin SARS da kuma ciwon numfashi na Gabas ta Tsakiya a kan wasu dabbobi da ba mutane ba.
A shekara ta 2020, babu magani ko rigakafin SARS da aka tabbatar da cewa yana da lafiya da tasiri ga mutane.
A cewar takardun bincike da aka buga a 2005 da 2006, ganowa da kuma ci gaba da sababbin alluran rigakafi da magunguna don magance SARS ya kasance fifiko ga gwamnatoci da hukumomin kiwon lafiya na duniya. Babu kuma wani allurar rigakafi da aka amince da ita don cutar ta hanyar numfashi ta Middle East.
Lokacin da Mars ya fara, an yi imanin cewa binciken da ake yi game da SARS zai iya samar da samfurin da zai taimaka wajen samar da alluran rigakafi da magunguna don kamuwa da cutar Mars-Cov.
A watan Maris na shekarar 2020, akwai allurar rigakafi guda ɗaya na cututtukan numfashi na Middle East (wanda ya dogara da DNA mai ƙarancin oxygen) da ya kammala gwajin farko na asibiti a cikin mutane, kuma akwai wasu alluran rigakafi guda uku da ake ci gaba da su, dukansu alluran rigakafi ne na cutar, alluran rigakafi na cutar sankara (ChAdOx1-MERS, BVRS-GamVac), da allurar rigakafi guda ɗaya na MVA-MERS-S.
Shafukan sada zumunta sun kawo ka'idar da ta ce an san cewa cutar COVID-19 tana da tasiri kuma riga an samu allurar rigakafi.
Abubuwan da aka yi amfani da su a kafofin watsa labarun sun nuna cewa akwai wasu kwayoyin halitta da aka yi amfani da su wajen tsara kwayoyin halitta da kuma alluran rigakafi don wasu kwayoyin corona kamar SARS.
Cutar korona ta 2019 (Covid-19) ta kasance sakamakon cutar korona ta 2 da ke tattare da cutar ta SARS-CoV-2.
Alamomin da aka fi sani sun haɗa da zazzabi, tari, da kuma rashin numfashi.
Sauran alamun sun haɗa da gajiya, ciwon tsoka, tari, kumburi, rashin wari, ciwon ciki.
Lokaci tsakanin kamuwa da cuta da bayyanar cututtuka yawanci kwanaki biyar ne, amma zai iya kasancewa daga kwana biyu zuwa kwana goma sha huɗu.
Ko da yake yawancin cututtuka suna da alamun bayyanar cututtuka, wasu suna haifar da ciwon huhu da kuma rashin aiki da gabobin jiki.
A ranar 17 ga Afrilu, 2020, an ba da rahoton kamuwa da mutane sama da miliyan 2.24 a cikin ƙasashe da yankuna 210, wanda ya haifar da mutuwar sama da 153,000.
Fiye da mutane 568,000 sun warke. An yi amfani da kwayar cutar ne wajen yaɗa mutane a lokacin da suke yin taro, kuma sau da yawa ta hanyar fesawa a lokacin tari, numfashi, ko magana.
Sa'ad da aka watsa man fetur a lokacin da ake yin man shafawa, yakan sauko ƙasa ko sama maimakon ya yi ta yaduwa ta nesa.
Mutane kuma suna iya kamuwa da cutar idan sun taɓa ruɓaɓɓen ƙasa kuma suka taɓa idanunsu, hancinsu ko bakinsu.
A saman rufin, cutar za ta iya tsira har tsawon sa'o'i 72.
Ana iya samun kamuwa da cutar a cikin kwanaki uku na farko na bayyanar cututtuka, ko da yake yana iya yaduwa kafin bayyanar cututtuka da kuma a cikin lokutan da suka gabata na cutar. Hanyar ganewar asali ita ce ta hanyar yin amfani da RNA-PCR ta hanyar narrowing.
Ana ba da shawarar yin amfani da abin rufe fuska ga waɗanda ake zargi da kamuwa da cutar da kuma waɗanda suke kula da su.
Shawarwarin da mutane suke yi game da yin amfani da abin rufe fuska sun bambanta. Wasu hukumomi sun ce kada a yi amfani da shi, wasu kuma sun ce ba zai yiwu ba, wasu kuma sun ce wajibi ne a yi amfani da shi.
A halin yanzu, babu maganin rigakafi ko maganin rigakafin COVID-19.
An samu rahoton kamuwa da cutar a gida a mafi yawan ƙasashe a dukan yankuna shida na WHO.
Mai yiwuwa waɗanda suke da cutar ba su da wata alama ko kuma suna da alamun mura kamar zazzabi, tari, gajiya, da kuma rashin numfashi.
Ana ba da shawarar samun taimako na gaggawa idan akwai alamun gaggawa kamar wahalar numfashi, ciwo ko matsa lamba a yankin kirji, rashin jin daɗi, wahalar farkawa, fuska ko lebe suna da launin shuɗi.
A wasu lokatai, ana iya samun cututtukan da ke saurin numfashi kamar su gumi ko kumburi ko kumburi.
An lura da alamun tsarin narkewa kamar naƙuda, kumburi da kumburi a hanyoyi dabam dabam.
Da farko, wasu mutane a kasar Sin sun sha wahala daga ciwon kirji da kuma taurin kai.
A wasu, cutar tana iya zama kumburi, rashin aiki da gabobin jiki da kuma mutuwa.
Wannan shi ne lokacin da ake kira "karanta".
Yawanci, lokacin da COVID-19 ke cikin gida yana daga kwana biyar zuwa shida, amma zai iya kasancewa daga kwana biyu zuwa kwana 14.
Kashi 97.5 cikin 100 na mutanen da suka kamu da cutar za su nuna alamun cutar a cikin kwanaki 11.5 na kamuwa da cutar. Rahotanni sun nuna cewa ba dukan mutanen da suka kamu da cutar za su iya nuna alamun cutar ba.
Har yanzu ba a san cikakken matsayin masu dauke da cutar ba tare da bayyanar cututtuka ba a cikin yaduwar kamuwa da cuta; duk da haka, shaidar farko ta nuna cewa suna iya taimakawa wajen yada cutar.
Ba a san yawan mutanen da ke da cutar ba tare da bayyanar cututtuka ba a yanzu, kuma cibiyoyin hana cututtuka da rigakafin cutar KCDC na Koriya sun ruwaito cewa kashi 20 cikin dari na yawan mutanen da aka tabbatar da cutar ba su da bayyanar cututtuka a lokacin da suke asibiti.
Hukumar lafiya ta kasar Sin ta fara lissafin marasa bayyanar cututtuka a cikin adadin yau da kullum a ranar 1 ga Afrilu. Daga cikin mutane 166 da suka kamu a wannan rana, akwai 130 (78%) daga cikin wadanda ba su da bayyanar cututtuka a lokacin gwajin.
Ana iya samun ƙwayoyin cuta da yawa a cikin wasanni.
Yana daɗa ƙaruwa daga yin magana da ƙarfi fiye da yadda yake a cikin magana.
Wani bincike a Singapore ya nuna cewa tari ba tare da rufe bakinka ba zai iya haifar da fesawa da ke kaiwa mita 4.5 (15 feet).
Ko da yake ba a yawan watsa kwayar ta iska ba, amma National Academy of Sciences ta nuna cewa za ta iya watsa ta hanyar iska mai rai, kuma duba samfurori daga tarin iska a cikin ɗakin waje na ɗakunan mutane ya haifar da sakamako mai kyau na RNA.
Wasu hanyoyin magani kamar maganin hana cutar da kuma farfado da zuciya (CPR) na iya sa a saki ƙwayar numfashi a cikin spray, kuma a sa'an nan kuma cutar ta yada ta iska.
Ko da yake akwai fargaba cewa zai iya yaduwa ta hanyar fitsari, an yi imanin cewa haɗarin yana da iyaka. Kwayar cutar tana da haɗari sosai idan mutane suna da alamun; kuma yayin da zai iya yaduwa kafin bayyanar bayyanar cututtuka, haɗarin ya fi ƙasa.
Cibiyar Turai ta hana cututtuka da kuma yaki da su (ECDC) ta ce duk da rashin tabbas game da yadda cutar ta iya yaduwa, mutum ɗaya zai iya kamuwa da mutane biyu zuwa uku a gaba ɗaya. Kwayar ta kasance a kan rufin daga awanni zuwa kwanaki.
A musamman, an gano cewa cutar tana rayuwa har kwana ɗaya a takarda mai ƙarfi har zuwa kwana uku a kan filastik (polypropylene) da bakin karfe (AISI 304), har zuwa sa'o'i huɗu a kan 99% jan ƙarfe.
Amma, yanayin zafi da kuma yanayin zafi sun bambanta.
Sabuna da kuma maganin hana cutar suna da tasiri idan aka yi amfani da su yadda ya kamata. Sabuna suna narkar da ƙwayar cuta da ke hana cutar kuma suna hana ta aiki, da kuma kawar da fata da sauran farfajiyar.
Akwai wasu hanyoyin da za su iya taimaka wa mutane, kamar su chloride benzalkonium da chlorhexidine gluconate, da kuma wasu abubuwa da ba su da tasiri sosai. A wani bincike a Hong Kong, an yi amfani da samfurori na saliva bayan kwana biyu a asibiti.
A cikin mutum biyar cikin shida, samfurin farko ya nuna cewa yana da mafi yawan ƙwayoyin cuta, kuma a rana ta biyu na gwajin, mutum na shida ya nuna cewa yana da mafi yawan ƙwayoyin cuta.
Cutar Corona 2 da ke da alaƙa da cututtukan huhu mai tsanani (SARS COF-2) sabon kwayar cutar Corona ne da ke da alaƙa da cututtukan huhu mai tsanani, inda aka fara ware mutane uku da ke fama da cutar huhu a cikin rukunin cututtukan huhu mai tsanani a Wuhan.
Sabon SARS-CoV-2 yana da halaye iri ɗaya da na related coronaviruses da ke cikin yanayi.
A waje da jiki, sabulu na gida yana kashe kwayar, inda yake lalata ƙwayar cutar. SARS-CoV-2 yana da alaƙa da asalin SARS-CoV.
Fushi biyu sune ɓangarorin da COVID-19 ya fi shafa saboda cutar ta shiga cikin ƙwayoyin da ke karɓar baƙon ta hanyar enzyme mai canzawa na angiotensin 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin cuta na nau'i na biyu da ke cikin huhu.
Wannan ƙwayar tana amfani da wani furotin mai suna spike don ya haɗa da EC2 kuma ya shiga cikin ƙwayoyin da ke ba da baƙi.
Kashi 12 cikin 100 na mutanen da aka kwantar a asibiti a birnin Wuhan a kasar Sin sun sha wahala daga mummunan bugun zuciya, kuma hakan ya fi faruwa a cikin mawuyacin hali.
Ana nuna alamun cututtukan zuciya da jijiyoyin jini da yawa, saboda amsawar kumburi da kuma rashin lafiyar garkuwar jiki a ci gaban cutar, amma cututtukan zuciya na iya haɗuwa da masu karɓar ACE2 a zuciya.
Abubuwan da ke karɓar ACE2 suna da muhimmanci sosai a zuciyarmu kuma suna taimaka mana mu yi aiki.
An samu karuwar yawan hawan jini (31%) da jini na jini (25%) a cikin marasa lafiya a cikin ICU da ke fama da COVID-19 wanda zai iya kasancewa da alaƙa da rashin hasashen abin da yanayin zai haifar. An gano a cikin autopsy ga gawawwakin mutanen da suka mutu saboda COVID-19 yaduwar cutar Senephrine (DAD), da kuma ciwon kumburi na inflammatory wanda ke dauke da ƙwayoyin cuta a cikin huhu.
Ko da yake SARS-CoV-2 yana zuwa ga ƙwayoyin baya na ACE2 a cikin numfashi, marasa lafiya masu tsanani na COVID-19 suna fama da alamun hyperinflammatory.
Musamman, an gano cewa ƙwayoyin T da ke fitar da GMCSF masu haifar da cututtuka suna da alaƙa da kawo ƙwayoyin guda ɗaya da ke fitar da Interlocin 6, wanda ke haifar da kamuwa da cuta da cututtukan huhu masu tasowa a cikin marasa lafiya na COVID-19.
An kuma ba da rahoton cewa akwai wani abu mai ban tsoro a lokacin da aka yi wa gawa.
Hukumar lafiya ta duniya ta wallafa wasu takardun shaida na gwajin cutar.
Hadin kai na polymerase mai tsawo na ART-PCR shine hanyar gwaji ta yau da kullum.
Ana yin gwajin ne ta amfani da samfurori na numfashi da aka samu daga wani goge hanci; amma ana iya amfani da goge hanci ko kuma samfurin goge hanci.
A yawancin lokaci, ana samun sakamako a cikin 'yan sa'o'i ko kwanaki biyu.
Ana iya yin gwajin jini, amma yana bukatar a ɗauki jini na mako biyu kuma sakamakon yana da sauƙi.
Masana kimiyya na kasar Sin sun iya ware wani kwayar cutar Corona kuma sun yada tsarin kwayoyin halitta don haka dakunan gwaje-gwaje a duniya za su iya samar da gwajin polymerase chain reaction (PCR) da kansu don gano kamuwa da cutar.
A ranar 4 ga Afrilu, 2020, ana ci gaba da gwajin rigakafin (wanda zai iya gano kamuwa da cuta mai aiki da ko mutum ya kamu da cutar a baya ko a'a) amma har yanzu ba a yi amfani da shi sosai ba.
Gwajin da aka yi a kasar Sin ya nuna cewa an yi daidaici tsakanin kashi 60 zuwa 70 cikin 100.
Hukumar Abinci da Magunguna ta Amurka ta amince da gwajin farko na asibiti na kulawa a ranar 21 ga Maris, 2020 don amfani a ƙarshen wannan watan. Jagorancin bincike daga asibitin Chungnan na Jami'ar Wuhan ya ba da shawarar hanyoyin gano kamuwa da cuta bisa ga asibiti da haɗarin annoba.
Gilashin gilashi mai launin fata yana da ɓoye-ɓoye da yawa da ke kewaye da shi, ba daidai ba, kuma yana da halaye na baya da aka saba da su a farkon kamuwa da cutar.
Ƙarƙashin ƙarancin ƙwayar cuta zai iya zama ƙarancin ƙwayar cuta da kuma haɗuwa da ciwon.
Akwai bayanai kadan game da cututtukan kwayoyin cuta da kuma ilimin halayyar cutar COVID-19.
Babban binciken da aka samu daga binciken gawawwakin:
Binciken microscopy: ciwon kumburi, kumburi, kumburi da kumburi na huhu
Ana iya lura da nau'i hudu na kamuwa da cutar huhu:
Ƙarƙashin huhu: ciwon huhu, ƙwayoyin huhu masu yawa, ƙwayoyin cuta masu yawa, ƙwayoyin cuta masu yawa, ƙwayoyin cuta masu yawa, ƙwayoyin cuta tare da ƙwayoyin cuta da kuma samar da ƙwayoyin cuta masu yawa.
Cutar huhu mai tsanani: lalacewar cutar Sinha da ke yaduwa (DAD) tare da yaduwar cutar Sinha.
Rashin ƙwayar cuta na jini yana haifar da cututtukan cututtukan numfashi mai tsanani (ARDS) da kuma rashin iskar oxygen a cikin jini.
Maganin ciwon huhu: tsara ɓarkewar jini a cikin rami na huhu da kuma ƙwayar huhu
Jini: jini yana taɓarɓarewa a cikin jijiyoyin jini (DIC); Halitta na jini suna aiki.
Ka'idoji na rigakafi don rage yiwuwar kamuwa da cuta sun haɗa da kasancewa a gida, guje wa wurare masu ɗumbun jama'a, wanke hannuwanka da sabulu da ruwa sosai na aƙalla dakika 20, yin tsabtace numfashi mai kyau, da guje wa taɓa idanu, hanci ko baki da hannaye marasa wankewa.
CDC ta ba da shawarar rufe bakinka da hanunka da takalma don tari ko numfashi, kuma ta ba da shawarar yin amfani da ciki na takalma idan babu takalma.
Ana ba da shawarar a tsabtace hannuwanku sosai bayan kun tari ko kun tari.
CDC ta ba da shawarar yin amfani da suturar fuska a wuraren jama'a, wani ɓangare don rage yaduwar kamuwa da cuta ga waɗanda ba su da alamun bayyanar cututtuka. Dabarun nesa da zamantakewa suna nufin rage haɗuwa da masu cutar da manyan ƙungiyoyi ta hanyar rufe makarantu da wuraren aiki, ƙuntata tafiya da soke manyan tarurruka na jama'a.
Dokokin nesa kuma sun ce mutane su yi nesa da juna aƙalla mita 6.
Babu wani magani da aka sani da zai iya hana COVID-19. Kuma tun da ba a yi tsammanin ƙirƙirar allurar rigakafi ba har zuwa 2021 a gaba, babban ɓangaren sarrafa COVID-19 shine ƙoƙarin rage ƙarancin annobar, wanda ake kira "ƙirar kwance".
CDC ta kuma ba da shawarar cewa mutane su riƙa wanke hannuwansu da sabulu da ruwa aƙalla na tsawon dakika 20, musamman bayan sun je gidan wanka ko kuma idan hannuwansu sun yi gurɓataccen ruwa, kafin su ci abinci, bayan sun wanke hanci ko tari ko ƙishirwa.
Ana kuma ba da shawarar yin amfani da maganin hana shan taba hannu wanda ya ƙunshi aƙalla kashi 60% na barasa, idan sabulu da ruwa kawai ba su samuwa ba. Ga yankunan da ba a samun kayan tsabtace hannu na kasuwanci da sauƙi, WHO tana ba da kayan haɗin gida biyu.
Waɗannan abubuwa biyu suna da ƙwayar cuta da ke hana ƙwayoyin cuta.
Ana amfani da hydrogen peroxide don taimakawa wajen kawar da ƙwayoyin cuta a cikin giya; "ba abu ne mai tsabtace hannu ba".
Ana ƙara glycerol a matsayin mai narkewa.
Ana kula da mutane da taimako, wanda zai iya haɗa da maganin ruwa, taimakon oxygen, da kuma taimakon sauran gabobin da suka shafi rayuwa.
Hukumar ta ce masu da ake zaton suna da cutar su saka abin rufe fuska mai sauƙi.
Ana amfani da Oxygen Oxygen (ECMO) don magance matsalar numfashi, amma ana ci gaba da nazarin amfaninta.
Ana ba da shawarar tsabtace jiki da kuma rayuwa mai kyau da kuma abinci mai kyau don inganta rigakafi.
Magungunan da ke tallafawa za su iya taimaka wa waɗanda ke fama da bayyanar cututtuka a farkon lokacin kamuwa da cuta. Hukumar lafiya ta duniya da kuma Hukumar Lafiya ta kasar Sin sun wallafa shawarwari don kula da waɗanda aka kwantar da su asibiti saboda COVID-19.
Masu kula da gaggawa da masu kula da cututtukan huhu a Amirka sun tattara shawarwarin magani daga wasu hukumomi a cikin wani littafi na kyauta, littafin kula da cututtuka masu tsanani da ke cikin layi.
A watan Afrilu na shekarar 2020, babu wani magani na musamman na COVID-19.
Domin bayyanar cututtuka, wasu likitoci na musamman suna ba da shawarar yin amfani da acetaminophen a matsayin magani na farko maimakon ibuprofen.
Ya kamata a yi la'akari da yadda za a rage haɗarin kamuwa da cutar, musamman a wuraren kiwon lafiya lokacin da ake yin ayyukan da za su iya haifar da spraying, kamar allura ko numfashi na hannu.
Ga ma'aikatan kiwon lafiya da ke kula da mutanen da ke da COVID-19, CDC ta ba da shawarar sanya mutum a cikin dakin keɓewa na kamuwa da cutar ta iska (AIR) da kuma amfani da daidaitattun tsare-tsare, tsare-tsare na haɗuwa da kuma tsare-tsaren kamuwa da cutar ta iska. CDC ta ba da umarnin amfani da kayan kariya ta mutum (PBE) a lokacin annoba.
Kayan aiki da aka ba da shawarar: maɓallin kayan kariya na mutum, na'urar numfashi ko abin rufe fuska, na'urar rufe idanu, na'urar tufafi na likita. Ana amfani da na'urorin numfashi (maimakon na'urar rufe fuska) idan akwai.
An yi amfani da na'urorin numfashi na N95 don masana'antu, amma Hukumar Abinci da Magunguna ta ba da izinin yin amfani da abin rufe fuska a ƙarƙashin lasisin gaggawa (EA).
An tsara su don su kāre su daga kwayoyin da ke cikin iska kamar ƙura, amma ba a tabbatar da ingancin su a kan wani abu ba idan aka yi amfani da su don wasu dalilai da ba a bayyana ba.
Idan ba a samun abin rufe fuska ba, CDC ta ba da shawarar yin amfani da rigakafin fuska ko abin rufe fuska na gida a matsayin mafita na ƙarshe.
Yawancin cututtukan COVID-19 ba su da tsanani sosai har suka bukaci numfashi ko kuma wasu hanyoyin maye gurbin, amma wasu suna bukatar hakan.
Irin taimakon numfashi da ake bayarwa ga waɗanda ke fama da rashin numfashi da ke da alaƙa da COVID-19 ga waɗanda ke asibitoci suna ƙarƙashin nazarin aiki, tare da wasu shaidu na yiwuwar kauce wa tsokoki ta amfani da babban jijiyar huhu ko kuma matsin lamba mai kyau na iska.
Ba a san ko waɗannan zaɓuɓɓukan biyu suna da amfani ga waɗanda suke da yanayin rashin lafiya mai tsanani ba.
Wasu likitoci sun fi son ci gaba da amfani da numfashi na roba a duk lokacin da ya dace saboda wannan fasaha ta rage yaduwar ƙwayoyin cuta fiye da na ƙwayar ƙwayar cuta mai yawa.
Kasashe da yawa da suka ci gaba ba su da isasshen asibitoci don yawan jama'a, wanda ke iyakance ikon tsarin kiwon lafiya na jimre da ƙaruwar yawan cututtukan COVID-19 da ke bukatar shiga asibiti.
Wani bincike a kasar Sin ya gano cewa kashi 5 cikin 100 na mutane sun shiga cikin cibiyar kula da marasa lafiya, kashi 2.3 cikin 100 na mutane sun bukaci taimakon numfashi, kuma kashi 1.4 cikin 100 sun mutu.
A kasar Sin, kusan kashi 30 cikin 100 na mutanen da aka kwantar da su asibitoci saboda COVID-19 sun shiga cikin cibiyar kula da marasa lafiya.
Hatsarin numfashi na zamani ya zama da wuya yayin da cututtukan cututtukan numfashi na musamman (ARDS) suka taso a cikin mutanen da ke da COVID-19 kuma yana da wuya a samu iskar oxygen.
Ana bukatar tsarin numfashi da yanayin da ke sarrafa matsa lamba da kuma karfin jini na jini don a iya samun iskar oxygen sosai yayin da ake rage haɗarin kamuwa da huhu da ke tattare da numfashi da kuma numfashi.
Ƙarfin ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwa
An fara bincike a watan Janairun 2020 don yiwuwar warkarwa, kuma ana gwada magungunan riga-kafi da yawa a asibiti.
Kamar dai Redemption ne ya fi kowa yin bishara.
Ko da yake sababbin magunguna za su iya ɗaukar har zuwa shekara ta 2021 don ci gaba, yawancin magunguna da ake gwadawa sun riga sun sami amincewa don wasu amfani ko kuma suna cikin ci gaba da gwaji.
Ana iya gwada magungunan rigakafin cutar a kan waɗanda suke da mawuyacin hali.
Hukumar lafiya ta duniya ta ba da shawarar cewa masu aikin sa kai su shiga cikin gwaje-gwaje na tasirin da lafiyar yiwuwar magunguna. Hukumar Abinci da Magunguna ta ba da izini na wucin gadi don amfani da plasma mai tsabta a matsayin magani na gwaji a lokuta inda rayuwar mutum ke cikin haɗari ko kai tsaye.
Ba a yi masa gwaji na asibiti ba don ya tabbatar da cewa yana da lafiya da kuma tasiri a kan cutar.
A watan Fabrairun shekarar 2020, kasar Sin ta kaddamar da wani app na wayar hannu don magance annobar.
Ana bukatar masu amfani su saka suna da lambar shaidar.
Aikace-aikacen yana iya gano 'rashin daidaituwa' ta amfani da bayanan kulawa kuma saboda haka yana iya haifar da haɗarin kamuwa da cuta.
Kowane mai amfani zai iya bincika yanayin wasu masu amfani uku.
Idan aka gano wata haɗari, ba wai kawai ana ba da shawarar yin amfani da dutsen ba, amma kuma ana faɗakar da jami'an kiwon lafiya na gida. Ana amfani da manyan bayanan bayanai na bayanan wayar hannu, fasahar gano fuska, bin diddigin wayar hannu, da kuma fasaha ta wucin gadi don bin diddigin waɗanda suka kamu da cutar da waɗanda suka haɗu da su a Koriya ta Kudu, Taiwan da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba jami'an tsaro damar bin diddigin wayar salula na mutanen da ake zaton sun kamu da cutar korona.
Ana yin hakan ne don a yi amfani da dutsen kiwon lafiya da kuma kare waɗanda za su iya yin tuntuɓe ga mutanen da suka kamu.
A watan Maris na shekarar 2020, kamfanin dillancin labarai na Deutsche Telekom ya raba bayanan wuraren da aka tattara da kamfanin gwamnatin tarayya na Jamus, Cibiyar Robert Koch, don bincike da hana yaduwar cutar.
Rasha ta yi amfani da fasahar fuska don gano rashin lafiyar dutse.
Kwamishinan lafiya na Italiya, Mr. Giulio Galleria, ya ce kamfanonin wayar hannu sun gaya masa cewa "kashi 40 cikin 100 na mutane suna tafiya ko'ina".
Gwamnatin Jamus ta gudanar da taron na tsawon sa'o'i 48 a karshen mako inda mutane fiye da 42,000 suka halarci.
Shugabar Estonia, Kirsty Kalilaide, ta kuma yi kira ga dukan duniya su gabatar da sababbin hanyoyin hana yaduwar cutar.
Mutane za su iya jin ƙyama saboda rashin lafiya, ƙuntatawa a tafiya, sakamako na magani ko tsoron cutar kanta.
BBC ta wallafa wani bayani ga Rory O'Connor cewa "Ƙara yawan zaman kaɗaici, kadaici, damuwa game da lafiya, damuwa da kuma koma bayan tattalin arziki babban hadari ne da ke damun lafiyar mutum da kuma jin dadinsa".
Cutar tana iya zama da sauƙi, ko kuma ba ta da alamun bayyanar cututtuka, kamar sauran cututtukan da ke faruwa a cikin na'urar numfashi kamar sanyi.
A cikin mako biyu, ana warkar da marasa lafiya kaɗan, amma a cikin mako uku zuwa shida, ana warkar da marasa lafiya da suka fi tsanani ko kuma masu tsanani.
Mata masu juna biyu na iya kamuwa da cutar COVID-19 sosai bisa ga bayanan wasu irin ƙwayoyin cuta, kamar SARS da MERS, amma har yanzu akwai ƙarancin bayanai game da COVID-19. COVID-19 na iya shafar huhu a wasu mutane ta hanyar haifar da kumburi.
A cikin mutanen da suka fi fama da cutar, COVID-19 zai iya zama cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Abubuwan da ke tattare da COVID-19 sun haɗa da ciwon hanta, hawan jini, da kuma cutar zuciya, koda da hanta.
An gano cewa kashi 6 cikin 100 na mutanen da ke da cutar COVID-19 da aka kai asibiti suna da cututtukan jini, musamman ƙara yawan lokaci na prothrombin, yayin da kashi 4 cikin 100 suka sami rashin aikin koda.
Kimanin kashi 20 zuwa 30 cikin 100 na mutanen da ke fama da cutar ta COVID-19 sun sami ci gaban ƙwayoyin cuta na hanta (aminotransmitters).
A cewar wannan rahoton, matsakaicin lokacin da aka samu a tsakanin bayyanar cututtuka da mutuwa kwanaki 10 ne, daga cikinsu kwana biyar a asibiti.
Amma, matsakaicin lokacin da aka kai ga ICU tsakanin shiga asibiti da mutuwa ya kai kwanaki bakwai.
A wani bincike na farko, matsakaicin lokacin bayyanar cututtuka na farko zuwa mutuwa ya kai kwanaki 14, kuma a jimlar yanayin ya kai kwanaki shida zuwa kwanaki 41.
A wani bincike da hukumar lafiya ta kasar Sin ta gudanar, mace-mace a maza sun kai kashi 2.8 cikin dari, mata kuma kashi 1.7 cikin dari.
Binciken da aka yi wa samfurori na huhu bayan mutuwa ya nuna cewa an sami ciwon hanta a cikin huhu biyu, kuma a cikin huhu biyu akwai ɓarkewar fibromycin.
An lura da canje-canje a cikin ƙwayar cuta a cikin ƙwayoyin cuta.
Hoton da aka yi a cikin huhu yana nuna ciwon hanta na numfashi (ARDS).
A kasar Sin, cutar zuciya da aka samu ta hanyar karuwa a matakin thrombin ko kuma bugun zuciya, ya kai kashi 11.8 cikin 100 na mutuwar da Hukumar Lafiya ta Kasa ta sanar.
A cewar bayanan da aka fitar daga Amurka a watan Maris, kashi 89 cikin 100 na mutanen da aka kai asibiti sun riga sun kamu da rashin lafiya. Samun wadatar magani da kuma yanayin tattalin arzikin yankin na iya shafar mutuwar.
Yawan mutuwar da ake samu a cikin yanayin ya bambanta saboda bambancin da ke tsakanin yankuna, amma kuma saboda rashin daidaito.
Ƙuntataccen ƙuntatawa na ƙananan lokuta na iya sa ƙididdigar mutuwar ta fi gaskiya.
Amma, gaskiyar cewa an yi kisa a dā na iya nuna cewa yawan mutuwar da ake yi yanzu ba haka ba ne.
Masu shan sigari suna da haɗari da yawa na shan wahala daga bayyanar cututtuka na COVID-19 da sau 1.4 da suke buƙatar kulawa mai tsanani da kuma mutuwa sau 2.4 fiye da waɗanda ba masu shan sigari ba. An yi ta daɗaitar da damuwa game da matsalolin cutar a cikin dogon lokaci.
Asibitin Hong Kong ya nuna cewa wasu da suka warke daga cutar sun samu raguwar kashi 20 zuwa 30 cikin 100 na ƙarfin huhu, kuma gwajin huhu ya nuna cewa an yi musu rauni.
Hakan kuma zai iya haifar da ciwon ciwon hanta bayan an warke.
A watan Maris na shekarar 2020, ba a san ko waɗanda suka warke daga kamuwa da cutar da suka gabata za su samu rigakafi mai inganci da na dogon lokaci ba.
Ana ganin cewa ana iya samun rigakafi, bisa halayyar wasu ƙwayoyin cuta, amma an bayyana cewa akwai wasu da suka warke daga COVID-19 kuma daga baya suka sake kamuwa da shi.
Ya yi imanin cewa waɗannan yanayin za su yi muni idan kamuwa da cuta ta ci gaba da faruwa fiye da yadda ta faru.
Ya yi imanin cewa cutar ta kasance na halitta ne kuma ta samo asali ne daga dabbobi, saboda yaduwar kamuwa da cuta.
Ba a san ainihin asalinsa ba, amma a watan Disamba na 2019, yaduwar cutar ta kasance sakamakon yawancinsu na wucewa daga mutum zuwa mutum.
Wani bincike da aka yi a kan mutane 41 da aka fara tabbatar da cutar COVID-19, wanda aka buga a cikin jaridar The Lancet a watan Janairun 2020, ya nuna cewa ranar 1 ga Disamba, 2019 ce ranar farko da alamun cutar suka fara bayyana.
Rahotanni na WHO sun bayyana cewa ranar 8 ga Disamba, 2019 ne ranar farko da bayyanar cututtuka ta fara.
Ana yin ayyuka da yawa don sanin yawan mutuwar.
Wadannan adadi sun bambanta bisa ga yanki da lokaci kuma suna shafar yawan jarrabawa, ingancin tsarin kiwon lafiya, zaɓuɓɓukan magani, tsawon lokacin da cutar ta fara, da kuma halaye na yawan jama'a kamar shekaru, jinsi da lafiyar jama'a.
A ƙarshen 2019, WHO a cikin bita na 10 na Ƙungiyar Cutar Duniya ta rarraba lambar gaggawa U 07.1 ga mutuwar SARS-CoV-2 da aka tabbatar da cutar ta hanyar gwaji da lambar U 07.2 ga mutuwar COVID-19 da aka gano ta hanyar cutar COVID-2 a asibiti ko annobar ba tare da tabbatar da cutar ta hanyar gwaji ba.
Bisa ga kididdigar Jami'ar Johns Hopkins, adadin mutuwar kamuwa da cuta a duniya ya kai kashi 6.9% (153,822/2,240,191) a ranar 17 ga Afrilu, 2020.
Yawan ya bambanta bisa ga yanki. Sauran ma'auni sun haɗa da yawan mutuwar (CFR), wanda ke nuna yawan mutanen da aka gano sun kamu da cutar kuma suka mutu saboda cutar, da kuma yawan mutuwar kamuwa da cutar (IFR), wanda ke nuna yawan mutanen da suka kamu (wanda aka gano da waɗanda ba a gano su ba) da waɗanda suka mutu saboda cutar.
Waɗannan ƙididdigar ba su da wani tsari na lokaci, kuma suna bin wani yanki na al'umma daga kamuwa da cutar har zuwa ƙaddarar yanayin.
Ko da yake ba dukan waɗanda suka kamu da cutar ba ne ke samar da maganin rigakafi, kasancewa da su zai iya ba da bayani game da yawan waɗanda suka kamu da cutar.
A wani wuri da ake fama da cutar a ƙasar Italiya, ƙauyen Castilloni di Ada, da ke da mazauna 4,600, ya riga ya kashe mutane 80 (kashi 1.7 bisa ɗari).
A Junglet, cutar ta bazu saboda bukukuwan Carnival, kuma ta ratsa matasa, yana haifar da ƙarancin mutuwar, kuma wataƙila ba a rarraba duk mutuwar COVID-19 a matsayin sakamakon hakan ba.
Bugu da ƙari, ba a kawar da tsarin kiwon lafiya na Jamus ba.
A Netherlands, na iya samun kashi 3 cikin 100 na kwayoyin cutar, bisa ga kimantawa na biyan masu ba da jini.
An tabbatar da mutuwar 69 (0.004% na yawan jama'a) saboda COVID-19.
Sakamakon cutar da kuma yawan mutuwar da ta haifar sun bambanta tsakanin maza da mata.
A cikin binciken da aka yi a kasar Sin da Italiya, yawan mutuwar maza ya fi hakan.
Mafi hatsari ga maza a shekara ta 50 ne, kuma bambanci tsakanin maza da mata ya ragu ne kawai a shekara ta 90.
A kasar Sin, yawan mutuwar maza ya kai kashi 2.8 cikin 100, mata kuma kashi 1.7 cikin 100.
Ba a san ainihin dalilan da ke sa a sami bambancin jima'i ba, amma akwai yiwuwar cewa akwai abubuwan da ke cikin jini da kuma halayyar mutum.
Wataƙila bambancin rigakafin jiki bisa jinsi, rashin yaduwar shan taba tsakanin mata da kuma kamuwa da cututtuka na lokaci guda a cikin maza kamar hawan jini a ƙarami fiye da mata sun sa mace-mace ta fi girma a cikin maza.
A Turai, maza ne suka kai kashi 57 cikin 100 na wadanda suka kamu da cutar, kuma maza ne suka kai kashi 72 cikin 100 na wadanda suka mutu sakamakon COVID-19.
Tun daga watan Afrilu na shekarar 2020, gwamnatin Amirka ba ta bin diddigin cututtukan COVID-19 da aka rarraba bisa jinsi ba.
Bincike ya nuna cewa cututtukan cuta kamar Ebola, HIV, mura, da SARS suna shafar maza da mata dabam-dabam.
Yawan ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, mata ne, kuma suna da haɗarin kamuwa da cutar.
Hukumar lafiya ta duniya ta sanar a ranar 11 ga Fabrairu, 2020 cewa sunan cutar COVID-19 ne.
Babban daraktan Hukumar Lafiya ta Duniya, Tedros Aadhanum Jibrisos, ya bayyana cewa, Kotu gajeriyar kalma ce ga Coronavirus, kuma gajeriyar kalma ce ga Virus ود gajeriyar kalma ce ga cutar da kuma 19 tana nufin shekarar da aka fara gano annobar: 31 ga Disamba, 2019.
Zaɓi sunan don kauce wa nuna wani wuri na musamman (kamar China), nau'in dabba ko rukuni na mutane, daidai da shawarwarin lakabi na duniya da ke nufin hana tabo. An kira kwayar cutar da ke haifar da COVID-19 kwayar cutar Corona 2 da ke da alaƙa da cutar ta numfashi mai tsanani (SARS-CoV-2).
Ƙari ga haka, WHO tana amfani da furcin "COVID-19" da kuma "COVID-19" a cikin bayanan jama'a.
Ana kiran cutar da kuma kwayar cutar "Corona virus".
A lokacin annobar farko a birnin Wuhan, a kasar Sin, an kira wannan cutar da kuma cutar "Corona Virus" da kuma "Wuhan Coronavirus".
A watan Janairun 2020, WHO ta ba da shawarar yin amfani da sunayen coronavirus 2019 da cututtukan numfashi masu tsanani da ke da alaƙa da coronavirus 2019 a matsayin sunayen ɗan lokaci na cutar da cutar bisa ga jagororin 2015 waɗanda suka hana amfani da shafuka a cikin sunayen cututtuka da ƙwayoyin cuta.
An fitar da sunayen COVID-19 da SARS-CoV-2 a ranar 11 ga Fabrairu, 2020.
Saboda ƙarancin ƙarfin da ke cikin jerin kayayyaki, kamfanonin dijital suna fitar da kayayyakin kiwon lafiya kamar su hanci da sassan na'urorin numfashi.
Alal misali, a lokacin da asibiti na Italiya ya bukaci wani bawul na numfashi da gaggawa, kuma mai ba da kayayyaki bai iya kawo su a kan lokaci ba, wani kamfani na gida ya yi aikin da ya dace kuma ya samar da bawul 100 da ake bukata a dare ɗaya.
Bayan barkewar cutar ta farko ta COVID-19, ka'idodin makirci da kuma rashin fahimta game da asalin cutar, yadda ta ke yaduwa, yadda za a hana ta, yadda za a bi da ita da sauran fannoni sun bazu cikin sauri a Intanet.
Da alama mutane suna iya watsa kwayar cutar zuwa wasu dabbobi.
Binciken bai samu tabbacin yaduwar cutar a alade, da dabino, da kaji ba.
Babu magani ko allurar rigakafi da aka amince da su don magance cutar.
Hukumomi, kungiyoyin ilimi da masana'antu suna gudanar da bincike na kasa da kasa game da alluran rigakafi da magunguna don COVID-19.
A watan Maris, Hukumar Lafiya ta Duniya ta kaddamar da gwajin "Solidarity Test" don tantance tasirin maganin maganin riga-kafi guda huɗu da ke da tasiri sosai.
Babu allurar rigakafi, amma hukumomi daban-daban suna aiki sosai wajen samar da alluran rigakafi.
An yi amfani da binciken da aka yi a dā game da SARS-CoV-2 domin yana kama da SARS-CoV-2 wajen amfani da masu karɓar ACE2 wajen shiga cikin ƙwayoyin mutum.
Ana nazarin dabarun rigakafi guda uku.
Na farko, masu bincike suna son samar da cikakken rigakafin cutar.
Ana amfani da irin wannan kwayar cutar, ko ita ce mara aiki ko matattu, don ta haifar da amsawar rigakafi ta gaggawa a jikin mutum game da sabon kamuwa da COVID-19.
Hanyar ta biyu, rigakafin kwayoyin halitta, ita ce ta samar da rigakafin da zai sa tsarin garkuwar mutum ya zama mai saurin kamuwa da kwayoyin halitta.
A cikin SARS-CoV-2, wannan bincike ya mai da hankali ne ga furotin Spike S wanda ke taimaka wa cutar ta shiga cikin masu karɓar enzyme ACE2.
Hanyar ta uku ita ce rigakafin DNA (RBA ko rigakafin RNA, sabuwar fasaha ce ta samar da rigakafi).
Dole ne a gwada alluran rigakafin da aka samu daga kowane irin dabarun don tabbatar da amincin su da ingancin su. A ranar 16 ga Maris, 2020, an fara gwajin farko na allurar a kan masu aikin sa kai huɗu a Seattle.
An nuna cewa ƙwayar cutar ta ci gaba da amfani da maganin rigakafi a matsayin ƙalubale mai yiwuwa ga sababbin maganin SARS-CoV-2, amma wannan ba daidai ba ne.
An yi gwaje-gwaje na asibiti sama da 300 a yanzu tun daga watan Afrilu 2020.
An yi gwaji bakwai da aka riga an amince da su a kan maganin zazzabin cizon sauro, ciki har da nazari hudu game da hydroxychloroquine ko chlorine.
Magungunan rigakafin cutar da ake shirin sake amfani da su wajen magance sabon cuta sun kasance mafi yawan binciken kasar Sin, ta hanyar gwaji tara na mataki na uku akan Remdesivir a cikin kasashe da dama da za a bayar da rahoton sakamakon a ƙarshen Afrilu.
An gudanar da nazarin ci gaban asibiti na alluran rigakafi da kuma abubuwan da ke tattare da COVID-19 tun daga watan Afrilu 2020. Ana yin nazarin magungunan antiviral da yawa da ke akwai don maganin COVID-19, ciki har da Remediciver, Chlorokine, Hydroxychloroquine, Lupinavir/Retonavir, Lupinavir/Tonavir da aka haɗa tare da Interferon Beta.
Akwai hujjoji na farko na yadda Remdesivir ke aiki, tun daga Maris 2020.
An lura da ci gaba a cikin asibiti a cikin marasa lafiya da aka yi musu magani da Remdesivir don amfani da alherin.
Ana gudanar da gwaji na asibiti na uku a Amurka, China da Italiya. An yi nazarin chloroquine, wanda a baya aka yi amfani da shi don maganin zazzabin cizon sauro a kasar Sin a watan Fabrairun 2020, kuma yana da sakamako na farko.
Duk da haka, ana kiran mutane su yi bitar binciken.
Hukumomin kiwon lafiya na kasar Sin da na Koriya sun ba da shawarar yin amfani da chloroquine.
Amma, Cibiyar Nazarin Kwayoyin Kwayar cuta ta Wuhan ta ce, ko da yake an bada shawarar kashi ɗaya na gram, rashin amfani da wannan kashi yana da haɗari sosai kuma yana iya haifar da mutuwa.
A ranar 28 ga Maris, 2020, Hukumar Abinci da Magunguna ta ba da izinin gaggawa don amfani da hydroxychloroquine da chlorokin a cewar likitoci masu kula da waɗanda ke fama da COVID-19. Shafin 7 na jagororin kasar Sin ya hada da interferon, ribavirin ko omefenovir don amfani da maganin COVID-19.
Bayanai na farko sun nuna cewa ana bukatar karin rigakafin ribavirin don hana SARS-CoV-2 a cikin dakin gwaje-gwaje.
An ba da shawarar yin ƙarin bincike game da tasirin nitasoxaneid a cikin kwayoyin halitta bayan an tabbatar da hana shi don ƙananan ƙwayar SARS-CoV-2. Nazarin ya nuna cewa farkon tsari na furotin Spike ta hanyar membrane-transfer serine protease 2 (TMPRS2) yana da mahimmanci don shigar da SARS-CoV-2 ta hanyar hulɗa da mai karɓar ACE2.
Nazarin chloroquine da hydroxychloroquine tare da azithromycin ko kuma ba tare da shi ba sun ƙunshi manyan rashi da suka hana al'ummar likitanci karɓar waɗannan hanyoyin magani ba tare da ƙarin bincike ba. Oseltamivir ba ya hana SARS-CoV-2 a cikin dakin gwaje-gwaje kuma ba shi da sanannen aiki a cikin maganin COVID-19.
Wata hadari mai suna cytokine na iya zama wani abu mai rikitarwa a cikin ƙarshen COVID-19.
Akwai hujja cewa hydroxychloroquine na iya samun maganin sitokin. Hukumar Lafiya ta kasar Sin ta kara da Tosilizomab zuwa ga jagororin magani bayan kammala karamin bincike.
Ana gwada shi a matakin ƙasa a Italiya bayan ya nuna sakamako mai kyau ga waɗanda ke da yanayin rashin lafiya mai tsanani.
Baya ga yin amfani da ferritin a cikin jini don gano hadari na cytokine, ana nufin ya magance irin wannan ci gaban, wanda ake zaton shi ne dalilin mutuwar wasu marasa lafiya.
Hukumar Abinci da Magunguna ta amince da maganin maganin intraloquine-6, maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin maganin alchemic, bisa ga nazarin yanayin farfadowa don magance cututtukan fitowar cytokine na masu karɓar ba tare da amsa steroid ba tare da dalili daban-daban a cikin 2017.
Har yanzu, babu wata hujja mai kyau da ta nuna cewa tosilezumab magani ne mai kyau ga cututtukan fitowar cytokine.
Hanyar da aka yi amfani da ita wajen canja wurin maganin rigakafi da aka yi amfani da shi ta hanyar rigakafin da aka yi wa waɗanda suka warke daga COVID-19 za a yi nazarin su a matsayin hanyar da ba ta da allurar rigakafi don yin kamuwa da cutar.
An gwada wannan dabarar a kan SARS kuma sakamakon bai kasance mai kyau ba.
Yin amfani da kwayar cutar a matsayin hanyar da za a yi amfani da ita wajen magance cutar ta SARS-CoV-2 ya zama hanyar kare kansa.
Amma, wataƙila za a iya amfani da wasu hanyoyin, kamar su maganin ƙwayoyin cuta na ƙwayoyin cuta, ƙwayoyin cuta, ko duka biyun.
Ana ci gaba da yin amfani da wasu hanyoyin maganin rigakafi, kamar amfani da maganin rigakafi na musamman.
Za a iya ƙara samar da maganin saurin jini, wanda ya ƙunshi ruwa daga jinin marasa lafiya da suka warke kuma yana ɗauke da ƙwayoyin riga-kafi na musamman don ƙwayar cutar, don a yi amfani da shi da sauri.
Cutar Corona, wata cuta ce da ke da nasaba da juna.
Li Wen Liang, likita a babban asibitin Wuhan, ya kamu da cutar kuma ya mutu saboda COVID-19 bayan ya jawo hankali game da yaduwar cutar.
